1	Blood	NN	O	blood	nn	2	SENT_1	[p1l741t81r808b103],
2	Cells	NNS	O	cell	_	0	SENT_1	[p1l818t81r879b106],
3	,	,	O	,	_	0	SENT_1	[p1l818t81r879b106],
4	Molecules	NNS	O	molecule	conj_and	2	SENT_1	[p1l889t81r1009b103],
5	and	CC	O	and	_	0	SENT_1	[p1l1019t81r1063b103],
6	Diseases	NNS	O	disease	conj_and	2	SENT_1	[p1l1073t81r1173b103],
7	50	CD	NUMBER	50	number	8	SENT_1	[p1l1184t82r1212b103],
8	(	CD	NUMBER	(	dep	2	SENT_1	[p1l1224t81r1303b108],
9	2013	CD	DATE	2013	dep	8	SENT_1	[p1l1224t81r1303b108],
10	)	CD	NUMBER	)	num	11	SENT_1	[p1l1224t81r1303b108],
11	166-170	CD	NUMBER	166-170	dep	2	SENT_1	[p1l1316t82r1419b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l713t191r847b215],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l861t191r918b215],
3	available	JJ	O	available	amod	2	SENT_2	[p1l931t191r1058b215],
4	at	IN	O	at	_	0	SENT_2	[p1l1071t194r1098b215],
5	SciVerse	NNP	O	SciVerse	nn	6	SENT_2	[p1l1111t191r1240b215],
6	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1253t191r1458b215],

1	Blood	NN	O	blood	nn	2	SENT_3	[p1l616t287r761b334],
2	Cells	NNS	O	cell	_	0	SENT_3	[p1l783t287r915b341],
3	,	,	O	,	_	0	SENT_3	[p1l783t287r915b341],
4	Molecules	NNS	O	molecule	appos	2	SENT_3	[p1l937t287r1198b334],
5	and	CC	O	and	_	0	SENT_3	[p1l1220t287r1314b334],
6	Diseases	NNS	O	disease	conj_and	4	SENT_3	[p1l1336t288r1554b334],

1	J	NN	O	j	_	0	SENT_4	[p1l14t420r250b454],
2	+	CC	O	+	_	0	SENT_4	[p1l14t420r250b454],
3	journal	NN	O	journal	nn	4	SENT_4	[p1l611t422r735b451],
4	homepage	NN	O	homepage	conj_+	1	SENT_4	[p1l753t422r948b451],
5	:	:	O	:	_	0	SENT_4	[p1l753t422r948b451],
6	www	NN	O	www	dep	1	SENT_4	[p1l966t422r1556b447],
7	.	.	O	.	_	0	SENT_4	[p1l966t422r1556b447],

1	e	LS	O	e	dep	2	SENT_5	[p1l966t422r1556b447],
2	|	SYM	O	|	_	0	SENT_5	[p1l966t422r1556b447],
3	sevier.com/locate/bcmd	SYM	O	sevier.com/locate/bcmd	dep	2	SENT_5	[p1l966t422r1556b447],

1	The	DT	O	the	det	2	SENT_6	[p1l6t569r98b614],
2	impact	NN	O	impact	_	0	SENT_6	[p1l119t570r293b625],
3	of	IN	O	of	_	0	SENT_6	[p1l312t569r364b614],
4	the	DT	O	the	det	8	SENT_6	[p1l378t569r458b614],
5	CYP2C9	NN	O	cyp2c9	nn	8	SENT_6	[p1l479t571r671b614],
6	and	CC	O	and	_	0	SENT_6	[p1l692t569r784b614],
7	VKORC1	NN	O	vkorc1	nn	8	SENT_6	[p1l802t571r1007b614],
8	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_6	[p1l1034t569r1430b625],
9	on	IN	O	on	dep	2	SENT_6	[p1l1452t582r1514b614],
10	acenocoumarol	NN	O	acenocoumarol	nn	12	SENT_6	[p1l1534t569r1921b614],
11	dose	NN	O	dose	nn	12	SENT_6	[p1l1942t569r2056b614],
12	requirements	NNS	O	requirement	pobj	9	SENT_6	[p1l9t641r349b697],
13	in	IN	O	in	dep	2	SENT_6	[p1l371t641r417b685],
14	a	DT	O	a	det	16	SENT_6	[p1l437t653r463b686],
15	Romanian	JJ	MISC	romanian	amod	16	SENT_6	[p1l483t641r738b686],
16	population	NN	O	population	pobj	13	SENT_6	[p1l758t640r1033b697],

1	Anca	NNP	PERSON	Anca	nn	4	SENT_7	[p1l6t745r104b779],
2	Dana	NNP	PERSON	Dana	nn	4	SENT_7	[p1l120t746r220b779],
3	Buzoianu	NNP	PERSON	Buzoianu	nn	4	SENT_7	[p1l236t744r419b779],
4	“‘	NN	O	“‘	_	0	SENT_7	[p1l434t742r458b784],
5	,	,	O	,	_	0	SENT_7	[p1l434t742r458b784],
6	Florentina	NNP	PERSON	Florentina	nn	8	SENT_7	[p1l475t743r677b779],
7	Claudia	NNP	PERSON	Claudia	nn	8	SENT_7	[p1l693t743r839b779],
8	Militaru	NNP	PERSON	Militaru	appos	4	SENT_7	[p1l855t743r1014b779],
9	3	CD	NUMBER	3	dep	8	SENT_7	[p1l1029t742r1052b784],
10	,	,	O	,	_	0	SENT_7	[p1l1029t742r1052b784],
11	Stefan	NNP	PERSON	Stefan	nn	13	SENT_7	[p1l1069t743r1192b789],
12	Cristian	NNP	PERSON	Cristian	nn	13	SENT_7	[p1l1208t744r1359b779],
13	Vesa	NNP	PERSON	Vesa	appos	4	SENT_7	[p1l1373t746r1466b779],
14	"	``	O	"	punct	13	SENT_7	[p1l1480t737r1537b784],
15	"	``	O	"	punct	16	SENT_7	[p1l1480t737r1537b784],
16	*	NN	O	*	dep	13	SENT_7	[p1l1480t737r1537b784],
17	,	,	O	,	_	0	SENT_7	[p1l1480t737r1537b784],
18	Adrian	NNP	PERSON	Adrian	nn	20	SENT_7	[p1l6t797r140b833],
19	Pavel	NNP	PERSON	Pavel	nn	20	SENT_7	[p1l156t797r259b833],
20	Trifa	NNP	PERSON	Trifa	appos	4	SENT_7	[p1l274t797r365b833],
21	b	NN	O	b	dep	20	SENT_7	[p1l379t789r405b838],
22	,	,	O	,	_	0	SENT_7	[p1l379t789r405b838],
23	Sorin	NNP	PERSON	Sorin	nn	27	SENT_7	[p1l422t798r524b833],
24	Crisan	NNP	PERSON	Crisan	nn	27	SENT_7	[p1l540t798r662b843],
25	C	NNP	O	C	nn	27	SENT_7	[p1l677t796r691b813],
26	3	NNP	NUMBER	3	nn	27	SENT_7	[p1l6t872r15b882],
27	Department	NNP	O	Department	appos	4	SENT_7	[p1l26t874r166b900],
28	of	IN	O	of	_	0	SENT_7	[p1l174t873r199b899],
29	Clinical	JJ	O	clinical	amod	30	SENT_7	[p1l204t873r289b894],
30	Pharmacology	NN	O	pharmacology	prep_of	27	SENT_7	[p1l297t873r466b899],
31	,	,	O	,	_	0	SENT_7	[p1l297t873r466b899],
32	“	CD	NUMBER	“	appos	30	SENT_7	[p1l478t873r539b894],
33	Iuliu	NNP	O	Iuliu	nn	36	SENT_7	[p1l478t873r539b894],
34	Hatieganu	NNP	O	Hatieganu	nn	36	SENT_7	[p1l548t873r680b900],
35	”	NNP	O	”	nn	36	SENT_7	[p1l548t873r680b900],
36	University	NNP	ORGANIZATION	University	dep	4	SENT_7	[p1l689t873r805b899],
37	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l815t873r840b900],
38	Medicine	NNP	ORGANIZATION	Medicine	prep_of	36	SENT_7	[p1l844t873r949b894],
39	and	CC	O	and	_	0	SENT_7	[p1l958t873r1001b894],
40	Pharmacy	NNP	O	Pharmacy	conj_and	38	SENT_7	[p1l1009t873r1129b899],
41	,	,	O	,	_	0	SENT_7	[p1l1009t873r1129b899],
42	6th	JJ	ORDINAL	6th	amod	44	SENT_7	[p1l1141t873r1177b894],
43	Pasteur	NNP	LOCATION	Pasteur	nn	44	SENT_7	[p1l1186t874r1274b894],
44	Street	NNP	LOCATION	Street	appos	4	SENT_7	[p1l1281t874r1352b897],
45	,	,	O	,	_	0	SENT_7	[p1l1281t874r1352b897],
46	400349	CD	NUMBER	400349	appos	44	SENT_7	[p1l1362t874r1454b897],
47	,	,	O	,	_	0	SENT_7	[p1l1362t874r1454b897],
48	Cluj-Napoca	NNP	LOCATION	Cluj-Napoca	appos	44	SENT_7	[p1l1465t873r1611b900],
49	,	,	O	,	_	0	SENT_7	[p1l1465t873r1611b900],
50	Cluj	NNP	LOCATION	Cluj	appos	44	SENT_7	[p1l1622t873r1670b899],
51	,	,	O	,	_	0	SENT_7	[p1l1622t873r1670b899],
52	Romania	NNP	LOCATION	Romania	poss	55	SENT_7	[p1l1680t873r1782b894],
53	'	POS	O	'	_	0	SENT_7	[p1l6t903r16b917],
54	’	NNP	O	’	nn	55	SENT_7	[p1l6t903r16b917],
55	Department	NNP	ORGANIZATION	Department	appos	44	SENT_7	[p1l27t909r167b935],
56	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l176t908r201b935],
57	Medical	NNP	ORGANIZATION	Medical	nn	58	SENT_7	[p1l204t908r296b929],
58	Genetics	NNP	ORGANIZATION	Genetics	prep_of	55	SENT_7	[p1l305t908r406b933],
59	,	,	O	,	_	0	SENT_7	[p1l305t908r406b933],
60	“	CD	NUMBER	“	appos	44	SENT_7	[p1l418t908r478b929],
61	Iuliu	NNP	O	Iuliu	nn	64	SENT_7	[p1l418t908r478b929],
62	Hatieganu	NNP	O	Hatieganu	nn	64	SENT_7	[p1l487t908r619b935],
63	”	NNP	O	”	nn	64	SENT_7	[p1l487t908r619b935],
64	University	NNP	ORGANIZATION	University	dep	4	SENT_7	[p1l628t908r744b935],
65	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l754t908r779b935],
66	Medicine	NNP	ORGANIZATION	Medicine	prep_of	64	SENT_7	[p1l783t908r888b929],
67	and	CC	O	and	_	0	SENT_7	[p1l897t908r940b929],
68	Pharmacy	NNP	O	Pharmacy	prep_of	64	SENT_7	[p1l949t908r1069b935],
69	,	,	O	,	_	0	SENT_7	[p1l949t908r1069b935],
70	6th	JJ	ORDINAL	6th	amod	72	SENT_7	[p1l1080t908r1116b929],
71	Pasteur	NNP	LOCATION	Pasteur	nn	72	SENT_7	[p1l1125t909r1213b929],
72	Street	NNP	LOCATION	Street	appos	4	SENT_7	[p1l1220t909r1291b933],
73	,	,	O	,	_	0	SENT_7	[p1l1220t909r1291b933],
74	400349	CD	NUMBER	400349	appos	4	SENT_7	[p1l1301t909r1393b933],
75	,	,	O	,	_	0	SENT_7	[p1l1301t909r1393b933],
76	Cluj	NNP	LOCATION	Cluj	appos	4	SENT_7	[p1l1404t908r1550b935],
77	.	.	O	.	_	0	SENT_7	[p1l1404t908r1550b935],

1	—	NN	O	—	_	0	SENT_8	[p1l1404t908r1550b935],
2	.	.	O	.	_	0	SENT_8	[p1l1404t908r1550b935],

1	Napoca	NNP	PERSON	Napoca	nn	7	SENT_9	[p1l1404t908r1550b935],
2	,	,	O	,	_	0	SENT_9	[p1l1404t908r1550b935],
3	Cluj	NNP	LOCATION	Cluj	appos	7	SENT_9	[p1l1561t908r1609b935],
4	,	,	O	,	_	0	SENT_9	[p1l1561t908r1609b935],
5	Romania	NNP	LOCATION	Romania	appos	7	SENT_9	[p1l1619t908r1721b929],
6	C	NNP	O	C	nn	7	SENT_9	[p1l6t942r15b952],
7	Department	NNP	ORGANIZATION	Department	_	0	SENT_9	[p1l25t944r165b969],
8	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l173t942r198b969],
9	Internal	NNP	ORGANIZATION	Internal	nn	14	SENT_9	[p1l202t943r294b964],
10	Medicine	NNP	ORGANIZATION	Medicine	nn	14	SENT_9	[p1l302t943r412b967],
11	,	,	O	,	_	0	SENT_9	[p1l302t943r412b967],
12	5th	JJ	ORGANIZATION	5th	amod	14	SENT_9	[p1l422t943r459b964],
13	Medical	JJ	ORGANIZATION	medical	amod	14	SENT_9	[p1l469t942r560b964],
14	Clinic	NNP	ORGANIZATION	Clinic	prep_of	7	SENT_9	[p1l569t943r637b967],
15	,	,	O	,	_	0	SENT_9	[p1l569t943r637b967],
16	Municipal	NNP	ORGANIZATION	Municipal	nn	17	SENT_9	[p1l646t943r763b969],
17	Hospital	NNP	ORGANIZATION	Hospital	appos	14	SENT_9	[p1l772t943r872b969],
18	,	,	O	,	_	0	SENT_9	[p1l772t943r872b969],
19	"	``	O	"	punct	23	SENT_9	[p1l884t942r944b964],
20	Iuliu	NNP	O	Iuliu	nn	23	SENT_9	[p1l884t942r944b964],
21	Hatieganu	NNP	O	Hatieganu	nn	23	SENT_9	[p1l953t943r1085b970],
22	”	NNP	O	”	nn	23	SENT_9	[p1l953t943r1085b970],
23	University	NNP	ORGANIZATION	University	dep	7	SENT_9	[p1l1094t943r1211b969],
24	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l1220t942r1245b969],
25	Medicine	NNP	ORGANIZATION	Medicine	prep_of	23	SENT_9	[p1l1249t943r1354b964],
26	and	CC	O	and	_	0	SENT_9	[p1l1363t942r1406b964],
27	Pharmacy	NNP	O	Pharmacy	prep_of	23	SENT_9	[p1l1415t943r1535b969],
28	,	,	O	,	_	0	SENT_9	[p1l1415t943r1535b969],
29	11th	JJ	ORDINAL	11th	advmod	31	SENT_9	[p1l1548t942r1597b964],
30	Tdbdcarilor	NNP	O	Tdbdcarilor	nn	31	SENT_9	[p1l1607t943r1739b964],
31	Street	NNP	O	Street	rcmod	23	SENT_9	[p1l1746t944r1818b967],
32	,	,	O	,	_	0	SENT_9	[p1l1746t944r1818b967],
33	400139	CD	NUMBER	400139	appos	31	SENT_9	[p1l1827t944r1919b967],
34	,	,	O	,	_	0	SENT_9	[p1l1827t944r1919b967],
35	Cluj-Napoca	NNP	LOCATION	Cluj-Napoca	appos	31	SENT_9	[p1l1930t943r2076b969],
36	,	,	O	,	_	0	SENT_9	[p1l1930t943r2076b969],
37	Cluj	NNP	LOCATION	Cluj	appos	31	SENT_9	[p1l7t977r55b1004],
38	,	,	O	,	_	0	SENT_9	[p1l7t977r55b1004],
39	Romania	NNP	LOCATION	Romania	appos	31	SENT_9	[p1l64t978r167b999],

1	ARTICLE	NN	O	article	_	0	SENT_10	[p1l6t1113r230b1135],
2	INFO	NN	O	info	nn	3	SENT_10	[p1l278t1113r401b1135],
3	ABSTRACT	NN	O	abstract	dep	1	SENT_10	[p1l691t1113r960b1135],

1	Article	NNP	O	Article	nsubj	16	SENT_11	[p1l6t1190r82b1212],
2	history	NN	O	history	nsubj	7	SENT_11	[p1l91t1190r178b1217],
3	:	:	O	:	_	0	SENT_11	[p1l91t1190r178b1217],
4	Aim	NNP	O	Aim	dep	2	SENT_11	[p1l6t1230r67b1254],
5	:	:	O	:	_	0	SENT_11	[p1l6t1230r67b1254],
6	To	TO	O	to	aux	7	SENT_11	[p1l78t1231r110b1254],
7	investigate	VB	O	investigate	infmod	1	SENT_11	[p1l121t1230r268b1260],
8	the	DT	O	the	det	12	SENT_11	[p1l279t1229r322b1254],
9	genotype	NN	O	genotype	nn	12	SENT_11	[p1l332t1229r621b1260],
10	—	NN	O	—	nn	12	SENT_11	[p1l332t1229r621b1260],
11	phenotype	NN	O	phenotype	nn	12	SENT_11	[p1l332t1229r621b1260],
12	correlation	NN	O	correlation	dobj	7	SENT_11	[p1l632t1229r780b1254],
13	in	IN	O	in	_	0	SENT_11	[p1l791t1230r815b1254],
14	Romanian	JJ	MISC	romanian	amod	15	SENT_11	[p1l826t1230r962b1254],
15	patients	NNS	O	patient	prep_in	12	SENT_11	[p1l973t1230r1081b1260],
16	treated	VBN	O	treat	_	0	SENT_11	[p1l1092t1229r1188b1254],
17	with	IN	O	with	_	0	SENT_11	[p1l1198t1229r1260b1254],
18	acenocoumarol	NN	O	acenocoumarol	prep_with	16	SENT_11	[p1l1271t1229r1484b1254],
19	.	.	O	.	_	0	SENT_11	[p1l1271t1229r1484b1254],

1	Submitted	VBN	O	submit	_	0	SENT_12	[p1l6t1271r130b1293],
2	9	CD	DATE	9	num	5	SENT_12	[p1l154t1272r167b1293],
3	October	NNP	DATE	October	nn	5	SENT_12	[p1l191t1271r286b1293],
4	2012	CD	DATE	2012	num	5	SENT_12	[p1l309t1272r367b1293],
5	Material	NNP	O	Material	dep	1	SENT_12	[p1l746t1273r857b1297],
6	and	CC	O	and	_	0	SENT_12	[p1l886t1273r934b1297],
7	methods	NNS	O	method	conj_and	5	SENT_12	[p1l964t1273r1082b1297],
8	:	:	O	:	_	0	SENT_12	[p1l964t1273r1082b1297],
9	We	PRP	O	we	dobj	1	SENT_12	[p1l1111t1274r1157b1297],
10	studied	VBD	O	study	dep	1	SENT_12	[p1l1185t1273r1283b1297],
11	301	CD	NUMBER	301	num	13	SENT_12	[p1l1311t1274r1356b1297],
12	consecutive	JJ	O	consecutive	amod	13	SENT_12	[p1l1388t1273r1544b1297],
13	patients	NNS	O	patient	dobj	10	SENT_12	[p1l1572t1273r1678b1303],
14	who	WP	O	who	nsubj	15	SENT_12	[p1l1705t1273r1764b1297],
15	required	VBD	O	require	rcmod	13	SENT_12	[p1l1793t1273r1905b1303],
16	treatment	NN	O	treatment	dep	27	SENT_12	[p1l1933t1276r2067b1297],
17	with	IN	O	with	_	0	SENT_12	[p1l2093t1273r2154b1297],
18	acenocoumarol	NN	O	acenocoumarol	nn	22	SENT_12	[p1l6t1317r215b1345],
19	,	,	O	,	_	0	SENT_12	[p1l6t1317r215b1345],
20	AV3	NN	O	av3	dep	22	SENT_12	[p1l230t1312r341b1334],
21	“	CD	NUMBER	“	num	22	SENT_12	[p1l230t1312r341b1334],
22	3b1	NN	O	3b1	prep_with	16	SENT_12	[p1l230t1312r341b1334],
23	'	''	O	'	_	0	SENT_12	[p1l230t1312r341b1334],
24	3	CD	NUMBER	3	num	25	SENT_12	[p1l230t1312r341b1334],
25	Online	NN	O	online	dep	27	SENT_12	[p1l352t1312r426b1334],
26	15	CD	NUMBER	15	num	27	SENT_12	[p1l438t1313r466b1334],
27	N	NN	O	n	dep	31	SENT_12	[p1l477t1312r602b1334],
28	°	CD	NUMBER	°	num	29	SENT_12	[p1l477t1312r602b1334],
29	V	NN	O	v	dep	27	SENT_12	[p1l477t1312r602b1334],
30	€	CD	NUMBER	€	num	31	SENT_12	[p1l477t1312r602b1334],
31	mb	NN	O	mb	dep	15	SENT_12	[p1l477t1312r602b1334],
32	'	''	O	'	_	0	SENT_12	[p1l477t1312r602b1334],
33	3F	NN	O	3f	dobj	35	SENT_12	[p1l477t1312r602b1334],
34	2012	CD	DATE	2012	num	33	SENT_12	[p1l613t1313r671b1334],
35	admitted	VBN	O	admit	partmod	31	SENT_12	[p1l922t1317r1042b1342],
36	within	IN	O	within	_	0	SENT_12	[p1l1057t1318r1144b1342],
37	the	DT	O	the	det	39	SENT_12	[p1l1160t1317r1202b1342],
38	Municipal	JJ	O	municipal	amod	39	SENT_12	[p1l1218t1318r1350b1348],
39	Hospital	NN	O	hospital	prep_within	35	SENT_12	[p1l1366t1317r1475b1348],
40	of	IN	O	of	_	0	SENT_12	[p1l1490t1317r1518b1342],
41	Cluj-Napoca	NNP	LOCATION	Cluj-Napoca	prep_of	39	SENT_12	[p1l1530t1317r1692b1348],
42	and	CC	O	and	_	0	SENT_12	[p1l1707t1318r1755b1342],
43	the	DT	O	the	det	48	SENT_12	[p1l1771t1318r1814b1342],
44	Heart	NNP	ORGANIZATION	Heart	nn	48	SENT_12	[p1l1829t1319r1903b1342],
45	Institute	NNP	ORGANIZATION	Institute	nn	48	SENT_12	[p1l1918t1318r2028b1342],
46	“	NNP	O	“	nn	48	SENT_12	[p1l2044t1318r2154b1342],
47	Niculae	NNP	MISC	Niculae	nn	48	SENT_12	[p1l2044t1318r2154b1342],
48	Stanciou	NNP	MISC	Stanciou	prep_of	39	SENT_12	[p1l6t1357r130b1381],
49	"	``	O	"	punct	31	SENT_12	[p1l6t1357r130b1381],
50	in	IN	O	in	_	0	SENT_12	[p1l146t1357r171b1381],
51	Cluj	NNP	LOCATION	Cluj	nn	52	SENT_12	[p1l185t1357r247b1387, p1l8t1397r201b1424],
52	(	NNP	O	(	prep_in	31	SENT_12	[p1l185t1357r247b1387, p1l8t1397r201b1424],
53	Communicated	VBN	O	communicate	partmod	52	SENT_12	[p1l185t1357r247b1387, p1l8t1397r201b1424],
54	by	IN	O	by	_	0	SENT_12	[p1l210t1397r239b1424],
55	J.	NNP	PERSON	J.	nn	56	SENT_12	[p1l245t1398r260b1424],
56	Adamson	NNP	PERSON	Adamson	agent	53	SENT_12	[p1l270t1397r388b1422],
57	,	,	O	,	_	0	SENT_12	[p1l270t1397r388b1422],
58	M.D.	NNP	O	M.D.	appos	56	SENT_12	[p1l399t1398r458b1422],
59	,	,	O	,	_	0	SENT_12	[p1l399t1398r458b1422],
60	30	CD	DATE	30	appos	58	SENT_12	[p1l6t1434r35b1455],
61	October	NNP	DATE	October	tmod	53	SENT_12	[p1l45t1433r140b1455],
62	2012	CD	DATE	2012	num	61	SENT_12	[p1l149t1433r218b1460],
63	)	CD	NUMBER	)	nsubj	1	SENT_12	[p1l149t1433r218b1460],

1	Napoca	NN	PERSON	napoca	_	0	SENT_13	[p1l6t1551r104b1580],
2	over	IN	O	over	_	0	SENT_13	[p1l114t1557r173b1574],
3	a	DT	O	a	det	5	SENT_13	[p1l182t1557r196b1574],
4	3-year	JJ	DURATION	3-year	amod	5	SENT_13	[p1l206t1551r292b1580],
5	period	NN	O	period	prep_over	1	SENT_13	[p1l302t1550r393b1580],
6	.	.	O	.	_	0	SENT_13	[p1l302t1550r393b1580],

1	For	IN	O	for	_	0	SENT_14	[p1l404t1551r446b1574],
2	each	DT	O	each	det	3	SENT_14	[p1l456t1550r516b1574],
3	patient	NN	O	patient	prep_for	5	SENT_14	[p1l527t1550r621b1580],
4	we	PRP	O	we	nsubj	5	SENT_14	[p1l629t1557r669b1574],
5	recorded	VBD	O	record	dep	18	SENT_14	[p1l680t1550r797b1574],
6	clinical	JJ	O	clinical	amod	7	SENT_14	[p1l808t1550r900b1574],
7	parameters	NNS	O	parameter	dobj	5	SENT_14	[p1l910t1553r1060b1580],
8	which	WDT	O	which	nsubj	10	SENT_14	[p1l1070t1550r1152b1574],
9	could	MD	O	could	aux	10	SENT_14	[p1l1162t1550r1234b1574],
10	interfere	VB	O	interfere	rcmod	7	SENT_14	[p1l1245t1550r1358b1574],
11	with	IN	O	with	_	0	SENT_14	[p1l1368t1550r1429b1574],
12	the	DT	O	the	det	13	SENT_14	[p1l1439t1550r1482b1574],
13	achievement	NN	O	achievement	prep_with	10	SENT_14	[p1l6t1590r177b1614],
14	of	IN	O	of	_	0	SENT_14	[p1l187t1589r215b1614],
15	stable	JJ	O	stable	prep_of	13	SENT_14	[p1l222t1590r299b1614],
16	therapeutic	JJ	O	therapeutic	amod	15	SENT_14	[p1l309t1590r461b1620],
17	international	JJ	O	international	amod	15	SENT_14	[p1l471t1590r642b1614],
18	normalized	VBD	O	normalize	_	0	SENT_14	[p1l653t1589r803b1614],
19	ratio	NN	O	ratio	dobj	18	SENT_14	[p1l814t1590r874b1614],
20	(	CD	NUMBER	(	num	22	SENT_14	[p1l887t1590r963b1619],
21	INR	NN	O	inr	nn	22	SENT_14	[p1l887t1590r963b1619],
22	)	NN	O	)	nsubj	18	SENT_14	[p1l887t1590r963b1619],
23	.	.	O	.	_	0	SENT_14	[p1l887t1590r963b1619],

1	We	PRP	O	we	nsubj	2	SENT_15	[p1l973t1591r1019b1614],
2	performed	VBD	O	perform	_	0	SENT_15	[p1l1030t1589r1170b1620],
3	genetic	JJ	O	genetic	amod	4	SENT_15	[p1l1180t1590r1276b1620],
4	analysis	NN	O	analysis	dobj	2	SENT_15	[p1l1286t1590r1390b1620],
5	which	WDT	O	which	dobj	8	SENT_15	[p1l1400t1590r1482b1614],
6	Keywords	NNPS	O	Keywords	nsubj	8	SENT_15	[p1l1599t1606r1720b1633],
7	:	:	O	:	_	0	SENT_15	[p1l1599t1606r1720b1633],
8	consisted	VBD	O	consist	rcmod	4	SENT_15	[p1l6t1629r129b1654],
9	of	IN	O	of	_	0	SENT_15	[p1l137t1629r165b1654],
10	genotyping	VBG	O	genotype	prepc_of	8	SENT_15	[p1l169t1630r319b1660],
11	the	DT	O	the	det	13	SENT_15	[p1l326t1629r368b1654],
12	CYP2C9	NN	O	cyp2c9	nn	13	SENT_15	[p1l376t1631r477b1654],
13	gene	NN	O	gene	dobj	10	SENT_15	[p1l484t1636r547b1660],
14	and	CC	O	and	_	0	SENT_15	[p1l555t1629r603b1654],
15	the	DT	O	the	det	17	SENT_15	[p1l611t1630r653b1654],
16	VKORC1	NN	O	vkorc1	nn	17	SENT_15	[p1l659t1631r767b1654],
17	gene	NN	O	gene	conj_and	13	SENT_15	[p1l778t1636r847b1660],
18	.	.	O	.	_	0	SENT_15	[p1l778t1636r847b1660],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_16	[p1l855t1630r960b1654],
2	were	VBD	O	be	auxpass	3	SENT_16	[p1l967t1636r1033b1654],
3	divided	VBN	O	divide	_	0	SENT_16	[p1l1041t1629r1139b1654],
4	in	IN	O	in	_	0	SENT_16	[p1l1147t1630r1172b1653],
5	three	CD	NUMBER	three	num	6	SENT_16	[p1l1179t1629r1248b1654],
6	groups	NNS	O	group	prep_in	3	SENT_16	[p1l1255t1636r1346b1660],
7	according	VBG	O	accord	_	0	SENT_16	[p1l1354t1629r1482b1660],
8	Acenocoumarol	NNP	O	Acenocoumarol	prep_according	6	SENT_16	[p1l1598t1642r1787b1663],
9	to	TO	O	to	_	0	SENT_16	[p1l6t1675r32b1696],
10	the	DT	O	the	det	12	SENT_16	[p1l41t1672r83b1696],
11	acenocoumarol	NN	O	acenocoumarol	nn	12	SENT_16	[p1l92t1672r294b1696],
12	dose	NN	O	dose	prep_to	8	SENT_16	[p1l304t1672r364b1696],
13	needed	VBN	O	need	partmod	12	SENT_16	[p1l374t1672r470b1696],
14	to	TO	O	to	aux	15	SENT_16	[p1l479t1675r505b1696],
15	reach	VB	O	reach	xcomp	13	SENT_16	[p1l514t1672r585b1696],
16	a	DT	O	a	det	18	SENT_16	[p1l594t1679r608b1696],
17	stable	JJ	O	stable	amod	18	SENT_16	[p1l617t1672r694b1696],
18	INR	NN	O	inr	dobj	15	SENT_16	[p1l704t1673r758b1696],
19	:	:	O	:	_	0	SENT_16	[p1l704t1673r758b1696],
20	the	DT	O	the	det	27	SENT_16	[p1l769t1672r811b1696],
21	low	JJ	O	low	amod	27	SENT_16	[p1l820t1672r869b1696],
22	dose	NN	O	dose	nn	27	SENT_16	[p1l878t1672r938b1696],
23	group	NN	O	group	nn	27	SENT_16	[p1l946t1679r1024b1702],
24	(	CD	NUMBER	(	num	27	SENT_16	[p1l1035t1672r1087b1702],
25	37	CD	NUMBER	37	num	27	SENT_16	[p1l1035t1672r1087b1702],
26	mg/week	JJ	O	mg/week	amod	27	SENT_16	[p1l1100t1672r1242b1702],
27	)	NN	O	)	dep	18	SENT_16	[p1l1100t1672r1242b1702],
28	,	,	O	,	_	0	SENT_16	[p1l1100t1672r1242b1702],
29	the	DT	O	the	det	32	SENT_16	[p1l1251t1672r1294b1696],
30	medium	NN	O	medium	nn	32	SENT_16	[p1l1303t1672r1414b1696],
31	dose	NN	O	dose	nn	32	SENT_16	[p1l1422t1672r1483b1696],
32	group	NN	O	group	appos	27	SENT_16	[p1l6t1719r84b1742],
33	(	CD	NUMBER	(	num	34	SENT_16	[p1l95t1712r147b1742],
34	>	JJR	O	>	dep	41	SENT_16	[p1l95t1712r147b1742],
35	7	CD	NUMBER	7	num	36	SENT_16	[p1l95t1712r147b1742],
36	mg	NN	O	mg	dep	34	SENT_16	[p1l160t1719r202b1742],
37	and	CC	O	and	_	0	SENT_16	[p1l210t1712r259b1736],
38	<	JJR	O	<	conj_and	36	SENT_16	[p1l268t1713r320b1736],
39	28	CD	NUMBER	28	num	40	SENT_16	[p1l268t1713r320b1736],
40	mg/week	NN	O	mg/week	dep	41	SENT_16	[p1l332t1712r467b1742],
41	)	NN	O	)	dep	49	SENT_16	[p1l332t1712r467b1742],
42	and	CC	O	and	_	0	SENT_16	[p1l478t1712r526b1736],
43	the	DT	O	the	det	47	SENT_16	[p1l535t1712r578b1736],
44	high	JJ	O	high	amod	47	SENT_16	[p1l587t1712r646b1742],
45	acenocoumarol	NN	O	acenocoumarol	nn	47	SENT_16	[p1l655t1712r857b1736],
46	dose	NN	O	dose	nn	47	SENT_16	[p1l867t1712r927b1736],
47	group	NN	O	group	dep	49	SENT_16	[p1l936t1719r1014b1742],
48	(	CD	NUMBER	(	num	49	SENT_16	[p1l1025t1712r1094b1742],
49	>	JJR	O	>	dep	18	SENT_16	[p1l1025t1712r1094b1742],
50	28	CD	NUMBER	28	num	52	SENT_16	[p1l1025t1712r1094b1742],
51	mg/week	NN	O	mg/week	nn	52	SENT_16	[p1l1107t1712r1249b1742],
52	)	NN	O	)	dep	49	SENT_16	[p1l1107t1712r1249b1742],
53	.	.	O	.	_	0	SENT_16	[p1l1107t1712r1249b1742],

1	Romanian	JJ	MISC	romanian	amod	3	SENT_17	[p1l6t1757r127b1779],
2	population	NN	O	population	nn	3	SENT_17	[p1l147t1757r277b1784],
3	Results	NNS	O	result	_	0	SENT_17	[p1l711t1748r808b1773],
4	:	:	O	:	_	0	SENT_17	[p1l711t1748r808b1773],
5	We	PRP	O	we	nsubj	6	SENT_17	[p1l832t1749r878b1773],
6	found	VBD	O	find	dep	3	SENT_17	[p1l903t1748r979b1773],
7	that	IN	O	that	complm	13	SENT_17	[p1l1005t1748r1058b1773],
8	patients	NNS	O	patient	nn	10	SENT_17	[p1l1083t1748r1195b1779],
9	’	JJ	O	’	amod	10	SENT_17	[p1l1083t1748r1195b1779],
10	age	NN	O	age	nsubj	13	SENT_17	[p1l1221t1755r1265b1779],
11	was	VBD	O	be	cop	13	SENT_17	[p1l1289t1755r1341b1773],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_17	[p1l1367t1748r1528b1779],
13	different	JJ	O	different	ccomp	6	SENT_17	[p1l1553t1748r1667b1773],
14	between	IN	O	between	_	0	SENT_17	[p1l1691t1748r1806b1773],
15	groups	NNS	O	group	prep_between	13	SENT_17	[p1l1831t1755r1921b1779],
16	(	CD	NUMBER	(	num	17	SENT_17	[p1l1949t1748r2092b1779],
17	p	NN	O	p	npadvmod	18	SENT_17	[p1l1949t1748r2092b1779],
18	<	JJR	O	<	amod	15	SENT_17	[p1l1949t1748r2092b1779],
19	0.001	CD	NUMBER	0.001	num	20	SENT_17	[p1l1949t1748r2092b1779],
20	)	NN	O	)	dep	15	SENT_17	[p1l1949t1748r2092b1779],
21	.	.	O	.	_	0	SENT_17	[p1l1949t1748r2092b1779],

1	No	DT	O	no	det	2	SENT_18	[p1l2118t1749r2154b1773],
2	differences	NNS	O	difference	nsubj	5	SENT_18	[p1l6t1788r150b1813],
3	Genetic	JJ	O	genetic	amod	4	SENT_18	[p1l164t1793r255b1815],
4	variability	NN	O	variability	dep	2	SENT_18	[p1l264t1793r386b1820],
5	existed	VBD	O	exist	_	0	SENT_18	[p1l850t1788r944b1813],
6	between	IN	O	between	_	0	SENT_18	[p1l954t1788r1068b1813],
7	groups	NNS	O	group	prep_between	5	SENT_18	[p1l1079t1795r1169b1819],
8	regarding	VBG	O	regard	_	0	SENT_18	[p1l1180t1789r1308b1819],
9	the	DT	O	the	det	10	SENT_18	[p1l1317t1789r1360b1813],
10	pathologies	NNS	O	pathology	prep_regarding	7	SENT_18	[p1l1370t1788r1522b1819],
11	which	WDT	O	which	nsubj	12	SENT_18	[p1l1532t1788r1614b1813],
12	required	VBD	O	require	rcmod	10	SENT_18	[p1l1625t1789r1737b1819],
13	anticoagulation	NN	O	anticoagulation	nn	14	SENT_18	[p1l1747t1788r1952b1819],
14	therapy	NN	O	therapy	dobj	12	SENT_18	[p1l1962t1788r2065b1819],
15	or	CC	O	or	_	0	SENT_18	[p1l2075t1796r2103b1813],
16	the	DT	O	the	det	19	SENT_18	[p1l2112t1788r2154b1813],
17	concomitant	JJ	O	concomitant	amod	19	SENT_18	[p1l6t1828r172b1852],
18	CYP2C9	NN	O	cyp2c9	nn	19	SENT_18	[p1l205t1829r297b1849],
19	treatment	NN	O	treatment	conj_or	14	SENT_18	[p1l910t1831r1048b1852],
20	.	.	O	.	_	0	SENT_18	[p1l910t1831r1048b1852],

1	The	DT	O	the	dep	108	SENT_19	[p1l1075t1828r1124b1852],
2	following	VBG	O	follow	dep	108	SENT_19	[p1l1152t1828r1277b1858],
3	parameters	NNS	O	parameter	dep	108	SENT_19	[p1l1304t1831r1454b1858],
4	increased	VBD	O	increase	dep	108	SENT_19	[p1l1482t1828r1607b1852],
5	the	DT	O	the	dep	108	SENT_19	[p1l1635t1828r1677b1852],
6	odds	NNS	O	odds	dep	108	SENT_19	[p1l1705t1828r1767b1852],
7	of	IN	O	of	dep	108	SENT_19	[p1l1795t1828r1823b1852],
8	receiving	VBG	O	receive	dep	108	SENT_19	[p1l1828t1828r1949b1858],
9	a	DT	O	a	dep	108	SENT_19	[p1l1976t1835r1990b1852],
10	low	JJ	O	low	dep	108	SENT_19	[p1l2018t1828r2067b1852],
11	dose	NN	O	dose	dep	108	SENT_19	[p1l2094t1828r2154b1852],
12	of	IN	O	of	dep	108	SENT_19	[p1l6t1873r34b1898],
13	acenocoumarol	NN	O	acenocoumarol	dep	108	SENT_19	[p1l38t1873r249b1898],
14	:	:	O	:	_	0	SENT_19	[p1l38t1873r249b1898],
15	patient	NN	O	patient	dep	108	SENT_19	[p1l262t1874r375b1904],
16	's	POS	O	's	dep	108	SENT_19	[p1l262t1874r375b1904],
17	age	NN	O	age	dep	108	SENT_19	[p1l386t1880r430b1904],
18	VKORCI	NN	O	vkorcus	dep	108	SENT_19	[p1l450t1870r547b1891],
19	over	IN	O	over	dep	108	SENT_19	[p1l1139t1880r1198b1898],
20	65	CD	DURATION	65	dep	108	SENT_19	[p1l1212t1874r1244b1898],
21	years	NNS	NUMBER	year	dep	108	SENT_19	[p1l1258t1880r1327b1904],
22	(	CD	NUMBER	(	dep	108	SENT_19	[p1l1344t1873r1399b1904],
23	OR	NN	O	or	dep	108	SENT_19	[p1l1344t1873r1399b1904],
24	,	,	O	,	_	0	SENT_19	[p1l1344t1873r1399b1904],
25	3.2	CD	NUMBER	3.2	dep	108	SENT_19	[p1l1414t1874r1461b1901],
26	;	:	O	;	_	0	SENT_19	[p1l1414t1874r1461b1901],
27	p	NN	O	p	dep	108	SENT_19	[p1l1479t1880r1494b1904],
28	=	JJ	O	=	dep	108	SENT_19	[p1l1504t1883r1528b1893],
29	0.01	CD	NUMBER	0.01	dep	108	SENT_19	[p1l1538t1874r1601b1901],
30	;	:	O	;	_	0	SENT_19	[p1l1538t1874r1601b1901],
31	95	CD	PERCENT	95	dep	108	SENT_19	[p1l1619t1874r1702b1898],
32	%	NN	PERCENT	%	dep	108	SENT_19	[p1l1619t1874r1702b1898],
33	Cl	NN	O	cl	dep	108	SENT_19	[p1l1619t1874r1702b1898],
34	:	:	O	:	_	0	SENT_19	[p1l1619t1874r1702b1898],
35	1.24-8	CD	NUMBER	1.24-8	dep	108	SENT_19	[p1l1721t1873r1868b1903],
36	.25	CD	NUMBER	.25	dep	108	SENT_19	[p1l1721t1873r1868b1903],
37	)	NN	O	)	dep	108	SENT_19	[p1l1721t1873r1868b1903],
38	,	,	O	,	_	0	SENT_19	[p1l1721t1873r1868b1903],
39	the	DT	O	the	dep	108	SENT_19	[p1l1883t1873r1925b1898],
40	presence	NN	O	presence	dep	108	SENT_19	[p1l1940t1880r2057b1904],
41	of	IN	O	of	dep	108	SENT_19	[p1l2072t1873r2100b1898],
42	the	DT	O	the	dep	108	SENT_19	[p1l2112t1873r2154b1898],
43	CYP2C9	NN	O	cyp2c9	dep	108	SENT_19	[p1l6t1919r135b1943],
44	*	NN	O	*	dep	108	SENT_19	[p1l6t1919r135b1943],
45	3	CD	NUMBER	3	dep	108	SENT_19	[p1l6t1919r135b1943],
46	allele	NN	O	allele	dep	108	SENT_19	[p1l148t1919r217b1943],
47	(	CD	NUMBER	(	dep	108	SENT_19	[p1l231t1919r286b1949],
48	OR	NN	O	or	dep	108	SENT_19	[p1l231t1919r286b1949],
49	,	,	O	,	_	0	SENT_19	[p1l231t1919r286b1949],
50	3.4	CD	NUMBER	3.4	dep	108	SENT_19	[p1l298t1920r345b1947],
51	;	:	O	;	_	0	SENT_19	[p1l298t1920r345b1947],
52	p	NN	O	p	dep	108	SENT_19	[p1l359t1920r493b1949],
53	=	JJ	O	=	dep	108	SENT_19	[p1l359t1920r493b1949],
54	0.005	CD	NUMBER	0.005	dep	108	SENT_19	[p1l359t1920r493b1949],
55	;	:	O	;	_	0	SENT_19	[p1l359t1920r493b1949],
56	95	CD	PERCENT	95	dep	108	SENT_19	[p1l6t1960r90b1983],
57	%	NN	PERCENT	%	dep	108	SENT_19	[p1l6t1960r90b1983],
58	CI	NN	O	ci	dep	108	SENT_19	[p1l6t1960r90b1983],
59	:	:	O	:	_	0	SENT_19	[p1l6t1960r90b1983],
60	1.41-8	CD	NUMBER	1.41-8	dep	108	SENT_19	[p1l108t1959r255b1989],
61	.34	CD	NUMBER	.34	dep	108	SENT_19	[p1l108t1959r255b1989],
62	)	NN	O	)	dep	108	SENT_19	[p1l108t1959r255b1989],
63	,	,	O	,	_	0	SENT_19	[p1l108t1959r255b1989],
64	and	CC	O	and	dep	108	SENT_19	[p1l270t1959r318b1983],
65	the	DT	O	the	dep	108	SENT_19	[p1l333t1959r376b1983],
66	GA	NN	O	ga	dep	108	SENT_19	[p1l390t1960r429b1983],
67	or	CC	O	or	dep	108	SENT_19	[p1l443t1966r471b1983],
68	AA	NN	O	aa	dep	108	SENT_19	[p1l484t1960r523b1983],
69	genotype	NN	O	genotype	dep	108	SENT_19	[p1l536t1963r660b1989],
70	of	IN	O	of	dep	108	SENT_19	[p1l675t1959r703b1983],
71	c.-1639G	NN	O	c.-1639g	dep	108	SENT_19	[p1l714t1960r875b1983],
72	>	JJR	O	>	dep	108	SENT_19	[p1l714t1960r875b1983],
73	A	DT	O	a	dep	108	SENT_19	[p1l714t1960r875b1983],
74	polymorphism	NN	O	polymorphism	dep	108	SENT_19	[p1l889t1959r1084b1989],
75	of	IN	O	of	dep	108	SENT_19	[p1l1099t1959r1127b1983],
76	VKORC1	NN	O	vkorc1	dep	108	SENT_19	[p1l1138t1960r1245b1983],
77	(	CD	NUMBER	(	dep	108	SENT_19	[p1l1265t1959r1320b1989],
78	OR	NN	O	or	dep	108	SENT_19	[p1l1265t1959r1320b1989],
79	,	,	O	,	_	0	SENT_19	[p1l1265t1959r1320b1989],
80	6.5	CD	NUMBER	6.5	dep	108	SENT_19	[p1l1335t1960r1382b1987],
81	;	:	O	;	_	0	SENT_19	[p1l1335t1960r1382b1987],
82	p	NN	O	p	dep	108	SENT_19	[p1l1398t1966r1414b1989],
83	=	JJ	O	=	dep	108	SENT_19	[p1l1423t1969r1447b1978],
84	0.01	CD	NUMBER	0.01	dep	108	SENT_19	[p1l1456t1960r1522b1987],
85	;	:	O	;	_	0	SENT_19	[p1l1456t1960r1522b1987],
86	95	CD	PERCENT	95	dep	108	SENT_19	[p1l1537t1960r1621b1983],
87	%	NN	PERCENT	%	dep	108	SENT_19	[p1l1537t1960r1621b1983],
88	Cl	NN	O	cl	dep	108	SENT_19	[p1l1537t1960r1621b1983],
89	:	:	O	:	_	0	SENT_19	[p1l1537t1960r1621b1983],
90	138-305	CD	NUMBER	138-305	dep	108	SENT_19	[p1l1639t1960r1775b1987],
91	;	:	O	;	_	0	SENT_19	[p1l1639t1960r1775b1987],
92	respectively	RB	O	respectively	dep	108	SENT_19	[p1l1791t1959r1951b1989],
93	OR	NN	O	or	dep	108	SENT_19	[p1l1965t1960r2008b1987],
94	,	,	O	,	_	0	SENT_19	[p1l1965t1960r2008b1987],
95	11.6	CD	NUMBER	11.6	dep	108	SENT_19	[p1l2024t1960r2088b1987],
96	;	:	O	;	_	0	SENT_19	[p1l2024t1960r2088b1987],
97	p	NN	O	p	dep	108	SENT_19	[p1l2105t1966r2121b1989],
98	=	JJ	O	=	dep	108	SENT_19	[p1l2130t1969r2154b1978],
99	0.003	CD	NUMBER	0.003	dep	108	SENT_19	[p1l6t2000r86b2027],
100	;	:	O	;	_	0	SENT_19	[p1l6t2000r86b2027],
101	95	CD	PERCENT	95	dep	108	SENT_19	[p1l101t2000r185b2023],
102	%	NN	PERCENT	%	dep	108	SENT_19	[p1l101t2000r185b2023],
103	Cl	NN	O	cl	dep	108	SENT_19	[p1l101t2000r185b2023],
104	:	:	O	:	_	0	SENT_19	[p1l101t2000r185b2023],
105	2.26	CD	NUMBER	2.26	dep	108	SENT_19	[p1l200t1998r364b2029],
106	—	CD	NUMBER	—	dep	108	SENT_19	[p1l200t1998r364b2029],
107	59.58	CD	NUMBER	59.58	dep	108	SENT_19	[p1l200t1998r364b2029],
108	)	NN	O	)	_	0	SENT_19	[p1l200t1998r364b2029],
109	.	.	O	.	_	0	SENT_19	[p1l200t1998r364b2029],

1	A	DT	O	a	det	4	SENT_20	[p1l376t1999r396b2023],
2	high	JJ	O	high	amod	4	SENT_20	[p1l409t1998r467b2029],
3	acenocoumarol	NN	O	acenocoumarol	nn	4	SENT_20	[p1l480t1998r682b2023],
4	dose	NN	O	dose	nsubj	7	SENT_20	[p1l695t1998r755b2023],
5	was	VBD	O	be	cop	7	SENT_20	[p1l768t2005r820b2023],
6	less	RBR	O	less	advmod	7	SENT_20	[p1l834t1998r881b2023],
7	likely	JJ	O	likely	_	0	SENT_20	[p1l893t1998r964b2029],
8	to	TO	O	to	aux	10	SENT_20	[p1l975t2002r1001b2023],
9	be	VB	O	be	auxpass	10	SENT_20	[p1l1013t1998r1044b2023],
10	administered	VBN	O	administer	xcomp	7	SENT_20	[p1l1056t1998r1231b2023],
11	to	TO	O	to	_	0	SENT_20	[p1l1243t2002r1269b2023],
12	an	DT	O	a	det	14	SENT_20	[p1l1281t2005r1312b2023],
13	elderly	JJ	O	elderly	amod	14	SENT_20	[p1l1324t1998r1415b2029],
14	patient	NN	O	patient	prep_to	10	SENT_20	[p1l1427t1998r1521b2029],
15	(	CD	NUMBER	(	num	16	SENT_20	[p1l1534t1998r1589b2028],
16	OR	NN	O	or	dep	14	SENT_20	[p1l1534t1998r1589b2028],
17	,	,	O	,	_	0	SENT_20	[p1l1534t1998r1589b2028],
18	0.24	CD	NUMBER	0.24	appos	16	SENT_20	[p1l1601t1999r1664b2026],
19	;	:	O	;	_	0	SENT_20	[p1l1601t1999r1664b2026],
20	p	NN	O	p	dep	16	SENT_20	[p1l1679t2005r1694b2029],
21	=	JJ	O	=	amod	20	SENT_20	[p1l1702t2008r1725b2018],
22	0.001	CD	NUMBER	0.001	tmod	21	SENT_20	[p1l1734t1999r1814b2026],
23	;	:	O	;	_	0	SENT_20	[p1l1734t1999r1814b2026],
24	95960	CD	NUMBER	95960	dep	16	SENT_20	[p1l1828t1999r1913b2023],
25	:	:	O	:	_	0	SENT_20	[p1l1828t1999r1913b2023],
26	0.1	CD	NUMBER	0.1	dep	24	SENT_20	[p1l1927t1998r2050b2029],
27	.	.	O	.	_	0	SENT_20	[p1l1927t1998r2050b2029],

1	—	NN	O	—	_	0	SENT_21	[p1l1927t1998r2050b2029],
2	.	.	O	.	_	0	SENT_21	[p1l1927t1998r2050b2029],

1	O.	NNP	O	O.	_	0	SENT_22	[p1l1927t1998r2050b2029],
2	56	CD	NUMBER	56	number	3	SENT_22	[p1l1927t1998r2050b2029],
3	)	CD	NUMBER	)	amod	15	SENT_22	[p1l1927t1998r2050b2029],
4	or	CC	O	or	dep	5	SENT_22	[p1l2064t2005r2091b2023],
5	to	TO	O	to	dep	3	SENT_22	[p1l2102t2002r2128b2023],
6	a	DT	O	a	det	7	SENT_22	[p1l2140t2005r2154b2023],
7	patient	NN	O	patient	pobj	5	SENT_22	[p1l6t2038r100b2069],
8	with	IN	O	with	_	0	SENT_22	[p1l115t2038r176b2063],
9	the	DT	O	the	det	10	SENT_22	[p1l193t2038r235b2063],
10	CA	NNP	O	CA	prep_with	7	SENT_22	[p1l253t2040r292b2063],
11	or	CC	O	or	_	0	SENT_22	[p1l307t2046r335b2063],
12	AA	NNP	O	AA	nn	13	SENT_22	[p1l349t2039r388b2063],
13	genotype	NN	O	genotype	conj_or	10	SENT_22	[p1l403t2042r526b2069],
14	(	CD	NUMBER	(	num	13	SENT_22	[p1l544t2039r599b2069],
15	OR	NN	O	or	dep	1	SENT_22	[p1l544t2039r599b2069],
16	,	,	O	,	_	0	SENT_22	[p1l544t2039r599b2069],
17	0.2	CD	NUMBER	0.2	appos	15	SENT_22	[p1l615t2040r662b2067],
18	;	:	O	;	_	0	SENT_22	[p1l615t2040r662b2067],
19	p	NN	O	p	dep	20	SENT_22	[p1l680t2040r789b2069],
20	<	JJR	O	<	dep	15	SENT_22	[p1l680t2040r789b2069],
21	0.001	CD	NUMBER	0.001	dep	20	SENT_22	[p1l680t2040r789b2069],
22	;	:	O	;	_	0	SENT_22	[p1l803t2046r807b2067],
23	95Cl	CD	PERCENT	95cl	num	24	SENT_22	[p1l825t2040r909b2063],
24	%	NN	PERCENT	%	dep	15	SENT_22	[p1l825t2040r909b2063],
25	:	:	O	:	_	0	SENT_22	[p1l825t2040r909b2063],
26	0.09-0	CD	NUMBER	0.09-0	number	27	SENT_22	[p1l927t2040r1064b2067],
27	.45	CD	NUMBER	.45	dep	24	SENT_22	[p1l927t2040r1064b2067],
28	;	:	O	;	_	0	SENT_22	[p1l927t2040r1064b2067],
29	respectively	RB	O	respectively	advmod	30	SENT_22	[p1l1082t2038r1241b2069],
30	OR	NN	O	or	dep	15	SENT_22	[p1l1257t2040r1300b2067],
31	,	,	O	,	_	0	SENT_22	[p1l1257t2040r1300b2067],
32	0.05	CD	NUMBER	0.05	appos	30	SENT_22	[p1l1317t2040r1380b2067],
33	;	:	O	;	_	0	SENT_22	[p1l1317t2040r1380b2067],
34	p	NN	O	p	dep	15	SENT_22	[p1l1399t2046r1414b2069],
35	=	JJ	O	=	amod	34	SENT_22	[p1l1427t2049r1451b2058],
36	0.006	CD	NUMBER	0.006	tmod	35	SENT_22	[p1l1463t2040r1544b2067],
37	;	:	O	;	_	0	SENT_22	[p1l1463t2040r1544b2067],
38	95	CD	PERCENT	95	num	39	SENT_22	[p1l1562t2040r1646b2063],
39	%	NN	PERCENT	%	dep	15	SENT_22	[p1l1562t2040r1646b2063],
40	CI	NN	O	ci	dep	39	SENT_22	[p1l1562t2040r1646b2063],
41	:	:	O	:	_	0	SENT_22	[p1l1562t2040r1646b2063],
42	0.007	CD	NUMBER	0.007	number	43	SENT_22	[p1l1664t2039r1829b2069],
43	—	CD	NUMBER	—	dep	15	SENT_22	[p1l1664t2039r1829b2069],
44	0.43	CD	NUMBER	0.43	num	45	SENT_22	[p1l1664t2039r1829b2069],
45	)	NN	O	)	dep	43	SENT_22	[p1l1664t2039r1829b2069],
46	.	.	O	.	_	0	SENT_22	[p1l1664t2039r1829b2069],

1	Conclusion	NN	O	conclusion	_	0	SENT_23	[p1l1846t2038r1991b2063],
2	:	:	O	:	_	0	SENT_23	[p1l1846t2038r1991b2063],
3	The	DT	O	the	det	6	SENT_23	[p1l2009t2038r2058b2063],
4	stable	JJ	O	stable	amod	6	SENT_23	[p1l2077t2038r2154b2063],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_23	[p1l987t2078r1139b2108],
6	dose	NN	O	dose	nsubj	10	SENT_23	[p1l1151t2078r1212b2102],
7	of	IN	O	of	_	0	SENT_23	[p1l1224t2078r1252b2102],
8	acenocoumarol	NN	O	acenocoumarol	prep_of	6	SENT_23	[p1l1261t2078r1463b2102],
9	is	VBZ	O	be	cop	10	SENT_23	[p1l1477t2078r1496b2102],
10	dependent	JJ	O	dependent	dep	1	SENT_23	[p1l1509t2078r1652b2108],
11	of	IN	O	of	_	0	SENT_23	[p1l1664t2078r1692b2102],
12	patient	NN	O	patient	poss	14	SENT_23	[p1l1701t2078r1813b2108],
13	's	POS	O	's	_	0	SENT_23	[p1l1701t2078r1813b2108],
14	age	NN	O	age	prep_of	10	SENT_23	[p1l1826t2085r1877b2108],
15	,	,	O	,	_	0	SENT_23	[p1l1826t2085r1877b2108],
16	the	DT	O	the	det	17	SENT_23	[p1l1890t2078r1932b2102],
17	presence	NN	O	presence	attr	10	SENT_23	[p1l1945t2085r2062b2108],
18	of	IN	O	of	_	0	SENT_23	[p1l2075t2078r2102b2102],
19	the	DT	O	the	prep_of	17	SENT_23	[p1l2112t2078r2154b2102],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_24	[p1l651t2117r780b2141],
2	*	CD	NUMBER	*	number	3	SENT_24	[p1l651t2117r780b2141],
3	3	CD	NUMBER	3	num	4	SENT_24	[p1l651t2117r780b2141],
4	allele	NN	O	allele	dep	1	SENT_24	[p1l791t2117r860b2141],
5	and	CC	O	and	_	0	SENT_24	[p1l871t2117r919b2141],
6	the	DT	O	the	det	7	SENT_24	[p1l929t2117r971b2141],
7	c.-1639G	NN	O	c.-1639g	conj_and	4	SENT_24	[p1l982t2118r1143b2141],
8	>	JJR	O	>	amod	10	SENT_24	[p1l982t2118r1143b2141],
9	A	DT	O	a	det	10	SENT_24	[p1l982t2118r1143b2141],
10	polymorphism	NN	O	polymorphism	dep	1	SENT_24	[p1l1153t2117r1349b2147],
11	of	IN	O	of	_	0	SENT_24	[p1l1359t2117r1387b2141],
12	VKORC1	NN	O	vkorc1	prep_of	10	SENT_24	[p1l1392t2118r1509b2141],
13	.	.	O	.	_	0	SENT_24	[p1l1392t2118r1509b2141],

1	Introduction	NN	O	introduction	_	0	SENT_25	[p1l9t2444r405b2497],

1	Acenocoumarol	NNP	O	Acenocoumarol	nsubj	8	SENT_26	[p1l104t2615r564b2667],
2	is	VBZ	O	be	cop	8	SENT_26	[p1l605t2616r646b2667],
3	the	DT	O	the	det	8	SENT_26	[p1l686t2615r778b2667],
4	most	RBS	O	most	advmod	6	SENT_26	[p1l818t2623r963b2667],
5	widely	RB	O	widely	advmod	6	SENT_26	[p1l999t2615r1199b2680],
6	used	VBN	O	use	amod	8	SENT_26	[p1l1236t2615r1371b2667],
7	oral	JJ	O	oral	amod	8	SENT_26	[p1l1410t2615r1521b2667],
8	anticoagulant	NN	O	anticoagulant	ccomp	16	SENT_26	[p1l1560t2615r1961b2680],
9	in	IN	O	in	_	0	SENT_26	[p1l1999t2616r2052b2667],
10	Romania	NNP	LOCATION	Romania	prep_in	8	SENT_26	[p1l10t2700r266b2752],
11	and	CC	O	and	_	0	SENT_26	[p1l293t2699r400b2752],
12	other	JJ	O	other	amod	14	SENT_26	[p1l428t2699r586b2752],
13	European	JJ	MISC	european	amod	14	SENT_26	[p1l612t2703r891b2765],
14	countries	NNS	O	country	conj_and	10	SENT_26	[p1l919t2700r1204b2760],
15	,	,	O	,	_	0	SENT_26	[p1l919t2700r1204b2760],
16	indicated	VBD	O	indicate	_	0	SENT_26	[p1l1233t2699r1503b2752],
17	for	IN	O	for	prep	16	SENT_26	[p1l1532t2699r1613b2752],
18	the	DT	O	the	det	19	SENT_26	[p1l1639t2699r1732b2752],
19	treatment	NN	O	treatment	nsubj	16	SENT_26	[p1l1759t2707r2054b2752],
20	and	CC	O	and	_	0	SENT_26	[p1l9t2784r116b2837],
21	prophylaxis	NN	O	prophylaxis	conj_and	19	SENT_26	[p1l154t2784r498b2850],
22	of	IN	O	of	_	0	SENT_26	[p1l535t2784r596b2837],
23	thromboembolic	JJ	O	thromboembolic	amod	24	SENT_26	[p1l625t2784r1117b2837],
24	diseases	NNS	O	disease	prep_of	19	SENT_26	[p1l1153t2784r1406b2837],
25	.	.	O	.	_	0	SENT_26	[p1l1153t2784r1406b2837],

1	Anticoagulant	JJ	O	anticoagulant	amod	2	SENT_27	[p1l1441t2784r1854b2850],
2	treatment	NN	O	treatment	nsubj	6	SENT_27	[p1l1889t2792r2052b2837, p1l10t2878r163b2922],
3	is	VBZ	O	be	cop	6	SENT_27	[p1l193t2870r234b2922],
4	always	RB	O	always	advmod	6	SENT_27	[p1l265t2870r465b2935],
5	a	DT	O	a	det	6	SENT_27	[p1l496t2885r526b2922],
6	challenge	NN	O	challenge	_	0	SENT_27	[p1l556t2870r834b2935],
7	for	IN	O	for	_	0	SENT_27	[p1l865t2869r947b2922],
8	clinicians	NNS	O	clinician	prep_for	6	SENT_27	[p1l975t2870r1246b2922],
9	because	IN	O	because	_	0	SENT_27	[p1l1277t2869r1508b2922],
10	of	IN	O	of	_	0	SENT_27	[p1l1539t2869r1600b2922],
11	the	DT	O	the	det	12	SENT_27	[p1l1622t2870r1715b2922],
12	difﬁculties	NNS	O	difﬁculties	prep_because_of	6	SENT_27	[p1l1746t2869r2052b2922],
13	to	TO	O	to	aux	14	SENT_27	[p1l9t2962r65b3007],
14	match	VB	O	match	infmod	12	SENT_27	[p1l85t2954r264b3007],
15	an	DT	O	a	det	17	SENT_27	[p1l284t2970r352b3007],
16	appropriate	JJ	O	appropriate	amod	17	SENT_27	[p1l372t2955r707b3020],
17	dose	NN	O	dose	dobj	14	SENT_27	[p1l727t2954r872b3007],
18	.	.	O	.	_	0	SENT_27	[p1l727t2954r872b3007],

1	An	DT	O	a	det	3	SENT_28	[p1l890t2957r970b3006],
2	insufﬁcient	JJ	O	insufﬁcient	amod	3	SENT_28	[p1l990t2954r1312b3007],
3	dose	NN	O	dose	nsubj	5	SENT_28	[p1l1330t2954r1461b3007],
4	will	MD	O	will	aux	5	SENT_28	[p1l1480t2954r1587b3006],
5	lead	VB	O	lead	_	0	SENT_28	[p1l1608t2954r1725b3007],
6	to	TO	O	to	_	0	SENT_28	[p1l1745t2962r1800b3007],
7	a	DT	O	a	det	8	SENT_28	[p1l1821t2970r1851b3007],
8	failure	NN	O	failure	prep_to	5	SENT_28	[p1l1871t2954r2052b3007],
9	to	TO	O	to	aux	10	SENT_28	[p1l9t3048r65b3092],
10	prevent	VB	O	prevent	infmod	8	SENT_28	[p1l83t3048r306b3105],
11	thrombosis	NN	O	thrombosis	dobj	10	SENT_28	[p1l322t3040r659b3100],
12	,	,	O	,	_	0	SENT_28	[p1l322t3040r659b3100],
13	while	IN	O	while	mark	18	SENT_28	[p1l677t3040r838b3092],
14	an	DT	O	a	det	15	SENT_28	[p1l855t3055r924b3092],
15	overdose	NN	O	overdose	nsubj	18	SENT_28	[p1l941t3040r1201b3092],
16	will	MD	O	will	aux	18	SENT_28	[p1l1217t3040r1324b3092],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	18	SENT_28	[p1l1343t3040r1693b3105],
18	increase	VB	O	increase	advcl	5	SENT_28	[p1l1709t3041r1943b3092],
19	the	DT	O	the	det	21	SENT_28	[p1l1961t3040r2053b3092],
20	hemorrhagic	JJ	O	hemorrhagic	amod	21	SENT_28	[p1l10t3125r377b3190],
21	risk	NN	O	risk	dobj	18	SENT_28	[p1l403t3125r518b3185],
22	,	,	O	,	_	0	SENT_28	[p1l403t3125r518b3185],
23	acenocoumarol	NN	O	acenocoumarol	appos	21	SENT_28	[p1l546t3125r985b3177],
24	being	VBG	O	be	cop	30	SENT_28	[p1l1011t3125r1170b3190],
25	a	DT	O	a	det	30	SENT_28	[p1l1194t3140r1224b3177],
26	low	JJ	O	low	amod	30	SENT_28	[p1l1250t3125r1356b3177],
27	therapeutic	JJ	O	therapeutic	amod	30	SENT_28	[p1l1380t3125r1710b3190],
28	index	NN	O	index	nn	30	SENT_28	[p1l1736t3125r1896b3177],
29	drug	NN	O	drug	nn	30	SENT_28	[p1l1920t3125r2054b3190],
30	[	NN	O	[	xcomp	18	SENT_28	[p1l13t3211r100b3277],
31	1	CD	NUMBER	1	num	32	SENT_28	[p1l13t3211r100b3277],
32	]	NN	O	]	dep	30	SENT_28	[p1l13t3211r100b3277],
33	.	.	O	.	_	0	SENT_28	[p1l13t3211r100b3277],

1	The	DT	O	the	det	4	SENT_29	[p1l105t3298r211b3350],
2	most	RBS	O	most	advmod	4	SENT_29	[p1l234t3306r379b3350],
3	frequent	JJ	O	frequent	amod	4	SENT_29	[p1l400t3297r652b3363],
4	complications	NNS	O	complication	nsubj	10	SENT_29	[p1l672t3298r1080b3363],
5	of	IN	O	of	_	0	SENT_29	[p1l1103t3297r1164b3350],
6	acenocoumarol	NN	O	acenocoumarol	nn	7	SENT_29	[p1l1178t3298r1626b3350],
7	treatment	NN	O	treatment	prep_of	4	SENT_29	[p1l1648t3306r1943b3350],
8	are	VBP	O	be	cop	10	SENT_29	[p1l1963t3313r2052b3350],
9	hemorrhagic	JJ	O	hemorrhagic	amod	10	SENT_29	[p1l10t3382r384b3448],
10	accidents	NNS	O	accident	_	0	SENT_29	[p1l405t3382r691b3443],
11	,	,	O	,	_	0	SENT_29	[p1l405t3382r691b3443],
12	including	VBG	O	include	_	0	SENT_29	[p1l714t3382r989b3448],
13	cerebral	JJ	O	cerebral	amod	16	SENT_29	[p1l1010t3382r1245b3435],
14	and	CC	O	and	_	0	SENT_29	[p1l1267t3382r1373b3435],
15	digestive	JJ	O	digestive	conj_and	13	SENT_29	[p1l1395t3382r1657b3448],
16	hemorrhage	NN	O	hemorrhage	prep_including	10	SENT_29	[p1l1680t3382r2051b3448],
17	,	,	O	,	_	0	SENT_29	[p1l1680t3382r2051b3448],
18	which	WDT	O	which	nsubj	22	SENT_29	[p1l8t3467r189b3519],
19	are	VBP	O	be	cop	22	SENT_29	[p1l212t3482r301b3519],
20	the	DT	O	the	det	22	SENT_29	[p1l324t3467r417b3519],
21	most	RBS	O	most	advmod	22	SENT_29	[p1l441t3475r586b3519],
22	severe	JJ	O	severe	rcmod	16	SENT_29	[p1l609t3482r809b3520],
23	.	.	O	.	_	0	SENT_29	[p1l609t3482r809b3520],

1	*	NN	O	*	_	0	SENT_30	[p2l44t19r65b44],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_30	[p2l103t19r449b71],
3	author	NN	O	author	dobj	2	SENT_30	[p2l467t19r633b61],
4	.	.	O	.	_	0	SENT_30	[p2l467t19r633b61],

1	E-mail	NN	O	e-mail	_	0	SENT_31	[p2l105t88r254b130],
2	addresses	NNS	O	address	dep	1	SENT_31	[p2l271t88r502b130],
3	:	:	O	:	_	0	SENT_31	[p2l271t88r502b130],
4	abuzoianu@umfcluj.ro	NN	O	abuzoianu@umfcluj.ro	dep	2	SENT_31	[p2l523t88r1048b141],
5	(	CD	NUMBER	(	num	8	SENT_31	[p2l1072t88r1182b140],
6	A.D.	NNP	O	A.D.	nn	8	SENT_31	[p2l1072t88r1182b140],
7	Buzoianu	NNP	O	Buzoianu	nn	8	SENT_31	[p2l1203t88r1453b140],
8	)	NN	O	)	dep	4	SENT_31	[p2l1203t88r1453b140],
9	,	,	O	,	_	0	SENT_31	[p2l1203t88r1453b140],

1	claudiamilitaru@yahoo.com	NNP	O	claudiamilitaru@yahoo.com	tmod	8	SENT_32	[p2l9t157r664b209],
2	(	CD	NUMBER	(	num	1	SENT_32	[p2l686t157r783b209],
3	F.C.	NNP	PERSON	F.C.	nn	5	SENT_32	[p2l686t157r783b209],
4	Militaru	NNP	PERSON	Militaru	nn	5	SENT_32	[p2l803t157r1025b209],
5	)	NNP	O	)	dep	1	SENT_32	[p2l803t157r1025b209],
6	,	,	O	,	_	0	SENT_32	[p2l803t157r1025b209],
7	stefanvesa@gmail.com	NNP	O	stefanvesa@gmail.com	nsubj	8	SENT_32	[p2l1045t157r1576b209],
8	(	VBD	O	(	_	0	SENT_32	[p2l1598t157r1696b210],
9	$	$	MONEY	$	advmod	8	SENT_32	[p2l1598t157r1696b210],
10	.	.	MONEY	.	_	0	SENT_32	[p2l1598t157r1696b210],

1	C.	NNP	O	C.	nn	3	SENT_33	[p2l1598t157r1696b210],
2	Vesa	NNP	O	Vesa	nn	3	SENT_33	[p2l1713t157r1857b209],
3	)	NNP	O	)	_	0	SENT_33	[p2l1713t157r1857b209],
4	,	,	O	,	_	0	SENT_33	[p2l1713t157r1857b209],
5	adi_trifa@yahoo.co.ul	NN	O	adi_trifa@yahoo.co.ul	dep	6	SENT_33	[p2l9t226r526b278],
6	<	JJR	O	<	appos	3	SENT_33	[p2l9t226r526b278],
7	(	CD	NUMBER	(	num	10	SENT_33	[p2l547t226r651b278],
8	A.P.	NNP	ORGANIZATION	A.P.	nn	10	SENT_33	[p2l547t226r651b278],
9	Trifa	NNP	ORGANIZATION	Trifa	nn	10	SENT_33	[p2l668t226r809b278],
10	)	NN	O	)	dep	6	SENT_33	[p2l668t226r809b278],
11	,	,	O	,	_	0	SENT_33	[p2l668t226r809b278],
12	crisan.sorin@gmail.com	NNP	O	crisan.sorin@gmail.com	nn	16	SENT_33	[p2l829t226r1385b278],
13	(	NNP	O	(	nn	16	SENT_33	[p2l1408t226r1463b278],
14	S.	NNP	PERSON	S.	nn	16	SENT_33	[p2l1408t226r1463b278],
15	Crisan	NNP	PERSON	Crisan	nn	16	SENT_33	[p2l1482t226r1661b280],
16	)	NN	O	)	appos	3	SENT_33	[p2l1482t226r1661b280],
17	.	.	O	.	_	0	SENT_33	[p2l1482t226r1661b280],

1	1079-9796	CD	DURATION	1079-9796	_	0	SENT_34	[p2l12t364r310b414],
2	/	:	O	/	punct	1	SENT_34	[p2l12t364r310b414],
3	$	$	MONEY	$	nsubj	5	SENT_34	[p2l12t364r310b414],
4	—	CD	MONEY	—	num	3	SENT_34	[p2l331t390r356b394],
5	see	VBP	O	see	dep	1	SENT_34	[p2l376t377r449b407],
6	front	JJ	O	front	amod	7	SENT_34	[p2l469t365r584b407],
7	matter	NN	O	matter	dobj	5	SENT_34	[p2l602t371r760b407],
8	©	CD	NUMBER	©	num	11	SENT_34	[p2l777t368r815b407],
9	2012	CD	DATE	2012	num	11	SENT_34	[p2l835t367r949b407],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_34	[p2l970t365r1154b407],
11	Inc.	NNP	ORGANIZATION	Inc.	dep	7	SENT_34	[p2l1172t368r1251b407],
12	.	.	O	.	_	0	SENT_34	[p2l1172t368r1251b407],

1	All	DT	O	all	det	2	SENT_35	[p2l1268t365r1331b406],
2	rights	NNS	O	rights	nsubj	3	SENT_35	[p2l1351t365r1484b417],
3	reserved	VBN	O	reserve	_	0	SENT_35	[p2l1504t365r1717b407],
4	.	.	O	.	_	0	SENT_35	[p2l1504t365r1717b407],

1	http://dx.doi.org/10.1016/j.bcmd.2012.10.010	NN	O	http://dx.doi.org/10.1016/j.bcmd.2012.10.010	_	0	SENT_36	[p2l9t434r1091b487],

1	©	RB	O	©	advmod	2	SENT_37	[p2l1062t519r1106b564],
2	2012	CD	DATE	2012	_	0	SENT_37	[p2l1130t519r1262b564],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	4	SENT_37	[p2l1285t516r1498b564],
4	Inc.	NNP	ORGANIZATION	Inc.	dep	2	SENT_37	[p2l1519t519r1610b565],
5	.	.	O	.	_	0	SENT_37	[p2l1519t519r1610b565],

1	All	DT	O	all	det	2	SENT_38	[p2l1630t516r1703b564],
2	rights	NNS	O	rights	nsubj	3	SENT_38	[p2l1726t516r1880b576],
3	reserved	VBN	O	reserve	_	0	SENT_38	[p2l1903t516r2148b565],
4	.	.	O	.	_	0	SENT_38	[p2l1903t516r2148b565],

1	Apart	RB	O	apart	_	0	SENT_39	[p2l149t820r314b884],
2	from	IN	O	from	_	0	SENT_39	[p2l333t817r474b871],
3	its	PRP$	O	its	poss	4	SENT_39	[p2l494t818r560b871],
4	toxicity	NN	O	toxicity	prep_apart_from	9	SENT_39	[p2l581t818r803b884],
5	oral	JJ	O	oral	amod	7	SENT_39	[p2l821t817r932b871],
6	anticoagulant	JJ	O	anticoagulant	amod	7	SENT_39	[p2l953t817r1355b884],
7	treatment	NN	O	treatment	nsubjpass	9	SENT_39	[p2l1374t825r1671b871],
8	is	VBZ	O	be	auxpass	9	SENT_39	[p2l1689t818r1731b871],
9	characterized	VBN	O	characterize	_	0	SENT_39	[p2l1753t817r2149b871],
10	by	IN	O	by	_	0	SENT_39	[p2l50t904r123b970],
11	a	DT	O	a	det	14	SENT_39	[p2l145t919r175b957],
12	great	JJ	O	great	amod	14	SENT_39	[p2l199t912r351b970],
13	inter	NN	O	inter	nn	14	SENT_39	[p2l374t904r837b957],
14	—	NN	O	—	agent	9	SENT_39	[p2l374t904r837b957],
15	individual	JJ	O	individual	amod	16	SENT_39	[p2l374t904r837b957],
16	variability	NN	O	variability	dobj	9	SENT_39	[p2l859t904r1159b970],
17	regarding	VBG	O	regard	_	0	SENT_39	[p2l1183t904r1468b970],
18	its	PRP$	O	its	poss	19	SENT_39	[p2l1491t905r1558b957],
19	efﬁcacy	NN	O	efﬁcacy	prep_regarding	16	SENT_39	[p2l1583t904r1817b970],
20	.	.	O	.	_	0	SENT_39	[p2l1583t904r1817b970],

1	Treatment	NN	O	treatment	nn	2	SENT_40	[p2l1840t907r2152b957],
2	monitoring	NN	O	monitoring	nsubjpass	5	SENT_40	[p2l51t991r384b1056],
3	is	VBZ	O	be	auxpass	5	SENT_40	[p2l418t991r461b1043],
4	usually	RB	O	usually	advmod	5	SENT_40	[p2l497t990r708b1056],
5	done	VBN	O	do	_	0	SENT_40	[p2l742t990r886b1043],
6	by	IN	O	by	_	0	SENT_40	[p2l922t990r994b1056],
7	INR	NN	O	inr	nn	8	SENT_40	[p2l1028t993r1135b1043],
8	determination	NN	O	determination	agent	5	SENT_40	[p2l1167t990r1604b1051],
9	,	,	O	,	_	0	SENT_40	[p2l1167t990r1604b1051],
10	which	WDT	O	which	nsubj	11	SENT_40	[p2l1638t990r1821b1043],
11	has	VBZ	O	have	rcmod	8	SENT_40	[p2l1856t990r1953b1043],
12	to	TO	O	to	aux	14	SENT_40	[p2l1989t998r2045b1043],
13	be	VB	O	be	auxpass	14	SENT_40	[p2l2081t990r2150b1043],
14	kept	VBN	O	keep	xcomp	11	SENT_40	[p2l51t1075r182b1142],
15	between	IN	O	between	_	0	SENT_40	[p2l208t1075r464b1128],
16	speciﬁc	JJ	O	speciﬁc	amod	17	SENT_40	[p2l492t1075r710b1142],
17	limits	NNS	O	limit	prep_between	14	SENT_40	[p2l738t1075r916b1137],
18	,	,	O	,	_	0	SENT_40	[p2l738t1075r916b1137],
19	according	VBG	O	accord	_	0	SENT_40	[p2l945t1075r1233b1142],
20	to	TO	O	to	prepc_according_to	11	SENT_40	[p2l1258t1083r1316b1128],
21	the	DT	O	the	det	22	SENT_40	[p2l1344t1075r1438b1128],
22	pathology	NN	O	pathology	pobj	11	SENT_40	[p2l1466t1075r1762b1142],
23	approached	VBD	O	approach	partmod	22	SENT_40	[p2l1788t1075r2149b1142],
24	.	.	O	.	_	0	SENT_40	[p2l1788t1075r2149b1142],

1	Variability	NN	O	variability	nsubjpass	6	SENT_41	[p2l48t1161r356b1228],
2	of	IN	O	of	_	0	SENT_41	[p2l376t1161r437b1214],
3	the	DT	O	the	det	4	SENT_41	[p2l450t1161r545b1214],
4	efﬁcacy	NN	O	efﬁcacy	prep_of	1	SENT_41	[p2l566t1161r790b1228],
5	is	VBZ	O	be	auxpass	6	SENT_41	[p2l809t1162r852b1214],
6	manifested	VBN	O	manifest	_	0	SENT_41	[p2l874t1161r1201b1214],
7	through	IN	O	through	_	0	SENT_41	[p2l1222t1161r1460b1228],
8	differences	NNS	O	difference	prep_through	6	SENT_41	[p2l1480t1161r1801b1214],
9	in	IN	O	in	_	0	SENT_41	[p2l1824t1162r1880b1214],
10	the	DT	O	the	det	11	SENT_41	[p2l1899t1161r1994b1214],
11	dose	NN	O	dose	prep_in	8	SENT_41	[p2l2015t1161r2150b1214],
12	needed	VBN	O	need	partmod	11	SENT_41	[p2l51t1247r266b1301],
13	to	TO	O	to	aux	14	SENT_41	[p2l283t1255r340b1301],
14	maintain	VB	O	maintain	xcomp	12	SENT_41	[p2l358t1248r621b1301],
15	the	DT	O	the	det	16	SENT_41	[p2l638t1247r732b1301],
16	INR	NN	O	inr	dobj	14	SENT_41	[p2l750t1251r856b1300],
17	within	IN	O	within	_	0	SENT_41	[p2l869t1247r1063b1301],
18	the	DT	O	the	det	20	SENT_41	[p2l1079t1247r1173b1301],
19	therapeutic	JJ	O	therapeutic	amod	20	SENT_41	[p2l1191t1247r1529b1314],
20	range	NN	O	range	prep_within	14	SENT_41	[p2l1546t1263r1710b1314],
21	and	CC	O	and	_	0	SENT_41	[p2l1728t1247r1835b1301],
22	it	PRP	O	it	nsubjpass	24	SENT_41	[p2l1853t1248r1894b1301],
23	is	VBZ	O	be	auxpass	24	SENT_41	[p2l1909t1248r1953b1301],
24	determined	VBN	O	determine	conj_and	6	SENT_41	[p2l1971t1247r2149b1301, p2l51t1333r238b1387],
25	in	IN	O	in	_	0	SENT_41	[p2l260t1334r316b1386],
26	a	DT	O	a	det	28	SENT_41	[p2l336t1349r367b1387],
27	multi-factorial	JJ	O	multi-factorial	amod	28	SENT_41	[p2l388t1333r812b1387],
28	way	NN	O	way	prep_in	24	SENT_41	[p2l832t1349r957b1400],
29	that	WDT	O	that	nsubj	30	SENT_41	[p2l976t1333r1094b1387],
30	involves	VBZ	O	involve	rcmod	28	SENT_41	[p2l1114t1333r1356b1387],
31	both	DT	O	both	det	35	SENT_41	[p2l1378t1333r1512b1387],
32	genetic	JJ	O	genetic	amod	35	SENT_41	[p2l1533t1334r1747b1400],
33	and	CC	O	and	_	0	SENT_41	[p2l1767t1333r1875b1387],
34	environmental	JJ	O	environmental	conj_and	32	SENT_41	[p2l1897t1334r2150b1387, p2l51t1420r257b1473],
35	factors	NNS	O	factor	dobj	30	SENT_41	[p2l279t1420r489b1474],
36	.	.	O	.	_	0	SENT_41	[p2l279t1420r489b1474],

1	For	IN	O	for	_	0	SENT_42	[p2l512t1423r606b1473],
2	a	DT	O	a	det	4	SENT_42	[p2l626t1435r657b1473],
3	long	JJ	O	long	amod	4	SENT_42	[p2l679t1420r806b1486],
4	time	NN	O	time	prep_for	8	SENT_42	[p2l827t1421r960b1473],
5	environmental	JJ	O	environmental	amod	6	SENT_42	[p2l983t1420r1418b1473],
6	factors	NNS	O	factor	nsubjpass	8	SENT_42	[p2l1441t1420r1636b1473],
7	were	VBD	O	be	auxpass	8	SENT_42	[p2l1657t1435r1805b1473],
8	considered	VBN	O	consider	_	0	SENT_42	[p2l1827t1420r2149b1473],
9	as	IN	O	as	_	0	SENT_42	[p2l51t1521r109b1559],
10	the	DT	O	the	det	12	SENT_42	[p2l139t1506r233b1559],
11	main	JJ	O	main	amod	12	SENT_42	[p2l265t1507r413b1559],
12	cause	NN	O	cause	prep_as	8	SENT_42	[p2l445t1521r606b1559],
13	for	IN	O	for	_	0	SENT_42	[p2l637t1506r719b1559],
14	the	DT	O	the	det	15	SENT_42	[p2l748t1506r842b1559],
15	variations	NNS	O	variation	prep_for	12	SENT_42	[p2l871t1507r1163b1559],
16	in	IN	O	in	_	0	SENT_42	[p2l1195t1507r1249b1558],
17	oral	JJ	O	oral	amod	20	SENT_42	[p2l1280t1506r1391b1559],
18	anticoagulant	JJ	O	anticoagulant	amod	20	SENT_42	[p2l1423t1506r1826b1572],
19	treatment	NN	O	treatment	nn	20	SENT_42	[p2l1854t1514r2152b1559],
20	response	NN	O	response	prep_in	15	SENT_42	[p2l51t1607r328b1658],
21	.	.	O	.	_	0	SENT_42	[p2l51t1607r328b1658],

1	These	DT	O	these	det	2	SENT_43	[p2l348t1591r519b1644],
2	factors	NNS	O	factor	nsubj	3	SENT_43	[p2l543t1591r738b1644],
3	include	VBP	O	include	_	0	SENT_43	[p2l763t1591r995b1645],
4	:	:	O	:	_	0	SENT_43	[p2l763t1591r995b1645],
5	patient	NN	O	patient	poss	7	SENT_43	[p2l1024t1592r1274b1658],
6	's	POS	O	's	_	0	SENT_43	[p2l1024t1592r1274b1658],
7	characteristics	NNS	O	characteristic	dobj	3	SENT_43	[p2l1297t1591r1718b1644],
8	(	JJ	O	(	amod	9	SENT_43	[p2l1747t1591r1885b1658],
9	age	NN	O	age	dep	7	SENT_43	[p2l1747t1591r1885b1658],
10	,	,	O	,	_	0	SENT_43	[p2l1747t1591r1885b1658],
11	sex	NN	O	sex	dobj	3	SENT_43	[p2l1910t1607r2017b1653],
12	,	,	O	,	_	0	SENT_43	[p2l1910t1607r2017b1653],
13	and	CC	O	and	_	0	SENT_43	[p2l2041t1591r2148b1644],
14	body	NN	O	body	nn	16	SENT_43	[p2l50t1678r198b1744],
15	mass	NN	O	mass	nn	16	SENT_43	[p2l238t1693r384b1731],
16	index	NN	O	index	dobj	3	SENT_43	[p2l427t1678r632b1744],
17	)	CD	NUMBER	)	nsubj	25	SENT_43	[p2l427t1678r632b1744],
18	,	,	O	,	_	0	SENT_43	[p2l427t1678r632b1744],
19	vitamin	NN	O	vitamin	nn	22	SENT_43	[p2l673t1678r901b1731],
20	K	NN	O	k	nn	22	SENT_43	[p2l943t1681r983b1730],
21	food	NN	O	food	nn	22	SENT_43	[p2l1023t1677r1153b1731],
22	intake	NN	O	intake	appos	17	SENT_43	[p2l1195t1678r1390b1739],
23	,	,	O	,	_	0	SENT_43	[p2l1195t1678r1390b1739],
24	co-morbidities	NNS	O	co-morbidity	appos	22	SENT_43	[p2l1432t1678r1863b1731],
25	(	VBP	O	(	rcmod	16	SENT_43	[p2l1910t1678r2150b1744],
26	hepatic	JJ	O	hepatic	amod	27	SENT_43	[p2l1910t1678r2150b1744],
27	failure	NN	O	failure	nsubj	44	SENT_43	[p2l51t1763r252b1825],
28	,	,	O	,	_	0	SENT_43	[p2l51t1763r252b1825],
29	severe	JJ	O	severe	amod	31	SENT_43	[p2l279t1779r467b1817],
30	renal	JJ	O	renal	amod	31	SENT_43	[p2l493t1763r641b1817],
31	failure	NN	O	failure	appos	27	SENT_43	[p2l668t1763r868b1825],
32	,	,	O	,	_	0	SENT_43	[p2l668t1763r868b1825],
33	heart	NN	O	heart	nn	34	SENT_43	[p2l896t1763r1051b1817],
34	failure	NN	O	failure	appos	27	SENT_43	[p2l1075t1763r1275b1825],
35	,	,	O	,	_	0	SENT_43	[p2l1075t1763r1275b1825],
36	thyroid	NN	O	thyroid	nn	37	SENT_43	[p2l1301t1763r1517b1830],
37	diseases	NNS	O	disease	appos	27	SENT_43	[p2l1544t1763r1798b1825],
38	,	,	O	,	_	0	SENT_43	[p2l1544t1763r1798b1825],
39	etc.	FW	O	etc.	nn	40	SENT_43	[p2l1825t1764r1966b1830],
40	)	FW	O	)	appos	27	SENT_43	[p2l1825t1764r1966b1830],
41	,	,	O	,	_	0	SENT_43	[p2l1825t1764r1966b1830],
42	acute	JJ	O	acute	amod	43	SENT_43	[p2l1993t1771r2150b1817],
43	diseases	NNS	O	disease	appos	27	SENT_43	[p2l51t1850r290b1903],
44	(	VBP	O	(	ccomp	25	SENT_43	[p2l334t1850r520b1916],
45	fever	NN	O	fever	nsubj	60	SENT_43	[p2l334t1850r520b1916],
46	,	,	O	,	_	0	SENT_43	[p2l334t1850r520b1916],
47	sepsis	NN	O	sepsis	appos	45	SENT_43	[p2l560t1851r746b1916],
48	,	,	O	,	_	0	SENT_43	[p2l560t1851r746b1916],
49	decompensated	VBN	O	decompensate	partmod	45	SENT_43	[p2l785t1850r1251b1916],
50	heart	NN	O	heart	nn	51	SENT_43	[p2l1290t1850r1445b1903],
51	failure	NN	O	failure	dobj	49	SENT_43	[p2l1482t1850r1683b1911],
52	,	,	O	,	_	0	SENT_43	[p2l1482t1850r1683b1911],
53	diarrhea	NN	O	diarrhea	dobj	49	SENT_43	[p2l1723t1850r1983b1911],
54	,	,	O	,	_	0	SENT_43	[p2l1723t1850r1983b1911],
55	etc.	FW	O	etc.	nn	56	SENT_43	[p2l2022t1850r2145b1916],
56	)	FW	O	)	dobj	49	SENT_43	[p2l2022t1850r2145b1916],
57	and	CC	O	and	_	0	SENT_43	[p2l51t1936r158b1989],
58	concomitant	JJ	O	concomitant	amod	59	SENT_43	[p2l195t1937r566b1989],
59	treatments	NNS	O	treatment	dobj	49	SENT_43	[p2l599t1944r922b1989],
60	[	VBP	O	[	ccomp	44	SENT_43	[p2l962t1936r1104b2002],
61	2,3	CD	NUMBER	2,3	number	62	SENT_43	[p2l962t1936r1104b2002],
62	]	CD	NUMBER	]	dobj	60	SENT_43	[p2l962t1936r1104b2002],
63	.	.	O	.	_	0	SENT_43	[p2l962t1936r1104b2002],

1	After	IN	O	after	_	0	SENT_44	[p2l1138t1936r1287b1989],
2	uncovering	VBG	O	uncover	prepc_after	29	SENT_44	[p2l1321t1937r1654b2002],
3	the	DT	O	the	det	4	SENT_44	[p2l1687t1936r1781b1989],
4	role	NN	O	role	dobj	2	SENT_44	[p2l1818t1936r1929b1989],
5	of	IN	O	of	_	0	SENT_44	[p2l1966t1936r2028b1989],
6	the	DT	O	the	det	8	SENT_44	[p2l2055t1936r2149b1989],
7	genetic	JJ	O	genetic	amod	8	SENT_44	[p2l50t2022r264b2088],
8	polymorphisms	NNS	O	polymorphism	prep_of	4	SENT_44	[p2l286t2021r749b2088],
9	in	IN	O	in	_	0	SENT_44	[p2l772t2022r827b2074],
10	altering	VBG	O	alter	prepc_in	2	SENT_44	[p2l849t2021r1078b2088],
11	the	DT	O	the	det	12	SENT_44	[p2l1098t2021r1192b2074],
12	function	NN	O	function	dobj	10	SENT_44	[p2l1215t2021r1460b2074],
13	of	IN	O	of	_	0	SENT_44	[p2l1482t2021r1544b2074],
14	certain	JJ	O	certain	amod	16	SENT_44	[p2l1559t2022r1761b2074],
15	speciﬁc	NN	O	speciﬁc	nn	16	SENT_44	[p2l1785t2021r2003b2088],
16	proteins	NNS	O	protein	prep_of	12	SENT_44	[p2l2025t2037r2149b2088, p2l50t2108r205b2169],
17	,	,	O	,	_	0	SENT_44	[p2l2025t2037r2149b2088, p2l50t2108r205b2169],
18	the	DT	O	the	det	19	SENT_44	[p2l237t2107r331b2160],
19	variability	NN	O	variability	nsubjpass	29	SENT_44	[p2l360t2107r660b2174],
20	of	IN	O	of	_	0	SENT_44	[p2l689t2107r750b2160],
21	the	DT	O	the	det	22	SENT_44	[p2l774t2107r868b2160],
22	response	NN	O	response	prep_of	19	SENT_44	[p2l899t2123r1161b2174],
23	to	TO	O	to	_	0	SENT_44	[p2l1192t2115r1249b2160],
24	oral	JJ	O	oral	amod	26	SENT_44	[p2l1280t2107r1391b2160],
25	anticoagulant	JJ	O	anticoagulant	amod	26	SENT_44	[p2l1423t2107r1826b2174],
26	treatment	NN	O	treatment	prep_to	22	SENT_44	[p2l1854t2115r2151b2160],
27	was	VBD	O	be	auxpass	29	SENT_44	[p2l49t2209r165b2247],
28	partly	RB	O	partly	advmod	29	SENT_44	[p2l196t2194r370b2260],
29	attributed	VBN	O	attribute	_	0	SENT_44	[p2l398t2194r692b2247],
30	to	TO	O	to	_	0	SENT_44	[p2l723t2202r780b2247],
31	genetic	JJ	O	genetic	amod	32	SENT_44	[p2l810t2194r1024b2260],
32	factors	NNS	O	factor	prep_to	29	SENT_44	[p2l1054t2193r1264b2247],
33	.	.	O	.	_	0	SENT_44	[p2l1054t2193r1264b2247],

1	Among	IN	O	among	_	0	SENT_45	[p2l1291t2196r1508b2260],
2	these	DT	O	these	prep_among	16	SENT_45	[p2l1536t2194r1705b2255],
3	,	,	O	,	_	0	SENT_45	[p2l1536t2194r1705b2255],
4	the	DT	O	the	det	7	SENT_45	[p2l1737t2194r1831b2247],
5	CYP	NNP	O	CYP	nn	7	SENT_45	[p2l1861t2196r1974b2247],
6	P450	NN	O	p450	nn	7	SENT_45	[p2l2004t2196r2149b2247],
7	system	NN	O	system	nsubj	16	SENT_45	[p2l52t2287r259b2346],
8	metabolizing	VBG	O	metabolize	partmod	7	SENT_45	[p2l297t2279r683b2346],
9	enzymes	NNS	O	enzyme	dobj	8	SENT_45	[p2l721t2295r995b2346],
10	,	,	O	,	_	0	SENT_45	[p2l721t2295r995b2346],
11	highly	RB	O	highly	advmod	12	SENT_45	[p2l1035t2279r1220b2346],
12	polymorphic	JJ	O	polymorphic	amod	9	SENT_45	[p2l1258t2279r1636b2346],
13	in	IN	O	in	_	0	SENT_45	[p2l1675t2280r1729b2332],
14	humans	NNS	O	human	prep_in	12	SENT_45	[p2l1769t2279r2018b2341],
15	,	,	O	,	_	0	SENT_45	[p2l1769t2279r2018b2341],
16	are	VBP	O	be	_	0	SENT_45	[p2l2059t2295r2149b2333],

1	A.D.	NNP	O	A.D.	nn	2	SENT_46	[p2l313t2422r358b2443],
2	Buzoianu	NNP	O	Buzoianu	_	0	SENT_46	[p2l368t2421r476b2443],
3	et	FW	O	et	nn	4	SENT_46	[p2l486t2424r508b2443],
4	al.	FW	O	al.	dep	2	SENT_46	[p2l515t2421r540b2443],
5	/	:	O	/	punct	2	SENT_46	[p2l549t2422r559b2446],
6	Blood	NN	O	blood	nn	7	SENT_46	[p2l566t2421r631b2443],
7	Cells	NNS	O	cell	dep	2	SENT_46	[p2l641t2421r697b2446],
8	,	,	O	,	_	0	SENT_46	[p2l641t2421r697b2446],
9	Molecules	NNS	O	molecule	dep	2	SENT_46	[p2l707t2421r822b2443],
10	and	CC	O	and	_	0	SENT_46	[p2l831t2421r874b2443],
11	Diseases	NNS	O	disease	dep	2	SENT_46	[p2l882t2421r979b2443],
12	50	CD	NUMBER	50	number	13	SENT_46	[p2l988t2422r1017b2443],
13	(	CD	NUMBER	(	num	14	SENT_46	[p2l1027t2421r1106b2448],
14	2013	CD	DATE	2013	dep	7	SENT_46	[p2l1027t2421r1106b2448],
15	)	CD	NUMBER	)	number	16	SENT_46	[p2l1027t2421r1106b2448],
16	166-170 167	CD	NUMBER	166-170 167	num	14	SENT_46	[p2l1805t2422r1847b2443],[p2l1119t2422r1218b2443],

1	very	RB	O	very	advmod	2	SENT_47	[p2l7t2576r139b2629],
2	important	JJ	O	important	_	0	SENT_47	[p2l155t2561r469b2629],
3	.	.	O	.	_	0	SENT_47	[p2l155t2561r469b2629],

1	The	DT	O	the	det	4	SENT_48	[p2l484t2560r595b2615],
2	main	JJ	O	main	amod	4	SENT_48	[p2l613t2561r762b2615],
3	enzymatic	JJ	O	enzymatic	amod	4	SENT_48	[p2l779t2561r1087b2629],
4	subfamily	NN	O	subfamily	nsubj	10	SENT_48	[p2l1104t2560r1396b2629],
5	involved	VBN	O	involve	partmod	4	SENT_48	[p2l1412t2560r1667b2615],
6	in	IN	O	in	_	0	SENT_48	[p2l1685t2561r1741b2614],
7	metabolizing	VBG	O	metabolize	prepc_in	5	SENT_48	[p2l1758t2560r2147b2629],
8	acenocoumarol	NN	O	acenocoumarol	dobj	7	SENT_48	[p2l9t2649r465b2704],
9	is	VBZ	O	be	cop	10	SENT_48	[p2l485t2650r528b2704],
10	CYP2C9	NN	O	cyp2c9	_	0	SENT_48	[p2l548t2652r791b2705],
11	.	.	O	.	_	0	SENT_48	[p2l548t2652r791b2705],

1	The	DT	O	the	det	4	SENT_49	[p2l808t2649r919b2704],
2	CY	NN	MISC	cy	nn	4	SENT_49	[p2l938t2652r1017b2704],
3	P2C9	NN	O	p2c9	nn	4	SENT_49	[p2l1018t2652r1165b2704],
4	polymorphisms	NNS	O	polymorphism	nsubj	5	SENT_49	[p2l1185t2649r1653b2718],
5	identiﬁed	VBN	O	identiﬁed	dep	10	SENT_49	[p2l1673t2649r1957b2704],
6	about	IN	DATE	about	prep	5	SENT_49	[p2l1977t2649r2147b2704],
7	10	CD	DATE	10	num	8	SENT_49	[p2l12t2741r81b2793],
8	years	NNS	DATE	year	npadvmod	9	SENT_49	[p2l105t2754r262b2807],
9	ago	IN	DATE	ago	pcomp	6	SENT_49	[p2l306t2754r408b2807],
10	vary	VBP	O	vary	_	0	SENT_49	[p2l450t2754r582b2807],
11	with	IN	O	with	_	0	SENT_49	[p2l621t2738r759b2793],
12	race	NN	O	race	prep_with	10	SENT_49	[p2l802t2754r924b2793],
13	(	CD	NUMBER	(	num	19	SENT_49	[p2l971t2738r1303b2807],
14	Caucasian	JJ	MISC	caucasian	amod	19	SENT_49	[p2l971t2738r1303b2807],
15	,	,	O	,	_	0	SENT_49	[p2l971t2738r1303b2807],
16	African	JJ	MISC	african	conj_or	14	SENT_49	[p2l1345t2738r1558b2793],
17	or	CC	O	or	_	0	SENT_49	[p2l1601t2754r1663b2793],
18	Asian	JJ	MISC	asian	conj_or	14	SENT_49	[p2l1702t2739r1908b2807],
19	)	NN	O	)	nsubj	10	SENT_49	[p2l1702t2739r1908b2807],
20	.	.	O	.	_	0	SENT_49	[p2l1702t2739r1908b2807],

1	In	IN	O	in	_	0	SENT_50	[p2l1952t2742r2009b2793],
2	the	DT	O	the	det	4	SENT_50	[p2l2050t2738r2146b2793],
3	Caucasian	JJ	LOCATION	caucasian	amod	4	SENT_50	[p2l9t2828r303b2882],
4	population	NN	O	population	prep_in	13	SENT_50	[p2l331t2827r655b2896],
5	the	DT	O	the	det	9	SENT_50	[p2l683t2827r779b2882],
6	CYP2C9	NN	O	cyp2c9	nn	9	SENT_50	[p2l807t2827r1093b2882],
7	*	NN	O	*	nn	9	SENT_50	[p2l807t2827r1093b2882],
8	l	NN	O	l	nn	9	SENT_50	[p2l807t2827r1093b2882],
9	allele	NN	O	allele	nsubj	13	SENT_50	[p2l1129t2827r1284b2882],
10	is	VBZ	O	be	cop	13	SENT_50	[p2l1313t2828r1356b2882],
11	the	DT	O	the	det	13	SENT_50	[p2l1385t2827r1480b2882],
12	most	RBS	O	most	advmod	13	SENT_50	[p2l1509t2836r1658b2882],
13	frequent	JJ	O	frequent	_	0	SENT_50	[p2l1685t2827r1953b2896],
14	,	,	O	,	_	0	SENT_50	[p2l1685t2827r1953b2896],
15	being	VBG	O	be	auxpass	16	SENT_50	[p2l1982t2827r2147b2896],
16	considered	VBN	O	consider	partmod	13	SENT_50	[p2l9t2917r334b2972],
17	the	DT	O	the	det	19	SENT_50	[p2l365t2917r461b2972],
18	wild	JJ	O	wild	amod	19	SENT_50	[p2l491t2917r621b2972],
19	one	CD	NUMBER	one	dobj	16	SENT_50	[p2l654t2933r776b2972],
20	.	.	O	.	_	0	SENT_50	[p2l654t2933r776b2972],

1	Its	PRP$	O	its	poss	5	SENT_51	[p2l809t2920r876b2972],
2	most	RBS	O	most	advmod	3	SENT_51	[p2l909t2925r1057b2972],
3	frequent	JJ	O	frequent	amod	5	SENT_51	[p2l1088t2917r1344b2985],
4	polymorphic	JJ	O	polymorphic	amod	5	SENT_51	[p2l1373t2917r1755b2985],
5	variants	NNS	O	variant	_	0	SENT_51	[p2l1784t2918r2022b2972],
6	are	VBP	O	be	cop	8	SENT_51	[p2l2054t2933r2145b2972],
7	CYP2C9	NN	O	cyp2c9	nn	8	SENT_51	[p2l9t3005r301b3061],
8	*	NN	O	*	rcmod	5	SENT_51	[p2l9t3005r301b3061],
9	2	CD	NUMBER	2	number	10	SENT_51	[p2l9t3005r301b3061],
10	(	CD	NUMBER	(	dep	8	SENT_51	[p2l329t3006r458b3074],
11	Arg	NN	O	arg	dep	10	SENT_51	[p2l329t3006r458b3074],
12	144	CD	NUMBER	144	num	11	SENT_51	[p2l483t3006r744b3074],
13	.	.	O	.	_	0	SENT_51	[p2l483t3006r744b3074],

1	—	NN	O	—	_	0	SENT_52	[p2l483t3006r744b3074],
2	.	.	O	.	_	0	SENT_52	[p2l483t3006r744b3074],

1	Cys	NN	MISC	cy	nn	2	SENT_53	[p2l483t3006r744b3074],
2	)	NN	O	)	_	0	SENT_53	[p2l483t3006r744b3074],
3	and	CC	O	and	_	0	SENT_53	[p2l770t3006r879b3061],
4	CYP2C9	NN	O	cyp2c9	conj_and	2	SENT_53	[p2l903t3005r1193b3061],
5	*	CD	NUMBER	*	number	6	SENT_53	[p2l903t3005r1193b3061],
6	3	CD	NUMBER	3	num	8	SENT_53	[p2l903t3005r1193b3061],
7	(	NN	O	(	nn	8	SENT_53	[p2l1223t3006r1317b3074],
8	Ile	NN	O	ile	dep	2	SENT_53	[p2l1223t3006r1317b3074],
9	359	CD	NUMBER	359	dep	8	SENT_53	[p2l1338t3006r1606b3074],
10	.	.	O	.	_	0	SENT_53	[p2l1338t3006r1606b3074],

1	—	NN	O	—	_	0	SENT_54	[p2l1338t3006r1606b3074],
2	.	.	O	.	_	0	SENT_54	[p2l1338t3006r1606b3074],

1	Leu	NN	O	leu	npadvmod	3	SENT_55	[p2l1338t3006r1606b3074],
2	)	CD	NUMBER	)	num	1	SENT_55	[p2l1338t3006r1606b3074],
3	present	JJ	DATE	present	_	0	SENT_55	[p2l1633t3014r1859b3074],
4	in	IN	O	in	_	0	SENT_55	[p2l1880t3006r1935b3060],
5	8	CD	PERCENT	8	number	6	SENT_55	[p2l1957t3008r2147b3061],
6	—	CD	PERCENT	—	prep_in	3	SENT_55	[p2l1957t3008r2147b3061],
7	19	CD	PERCENT	19	num	8	SENT_55	[p2l1957t3008r2147b3061],
8	%	NN	PERCENT	%	dep	6	SENT_55	[p2l1957t3008r2147b3061],
9	and	CC	O	and	_	0	SENT_55	[p2l9t3094r119b3149],
10	6	CD	PERCENT	6	num	11	SENT_55	[p2l147t3097r335b3149],
11	—	NN	PERCENT	—	prep_in	3	SENT_55	[p2l147t3097r335b3149],
12	10	CD	PERCENT	10	number	13	SENT_55	[p2l147t3097r335b3149],
13	%	NN	PERCENT	%	amod	11	SENT_55	[p2l147t3097r335b3149],
14	of	IN	O	of	_	0	SENT_55	[p2l363t3094r425b3149],
15	the	DT	O	the	det	16	SENT_55	[p2l444t3094r540b3149],
16	population	NN	O	population	prep_of	11	SENT_55	[p2l568t3094r891b3163],
17	respectively	RB	O	respectively	advmod	16	SENT_55	[p2l919t3094r1289b3163],
18	,	,	O	,	_	0	SENT_55	[p2l919t3094r1289b3163],
19	having	VBG	O	have	dep	3	SENT_55	[p2l1319t3094r1520b3163],
20	at	IN	O	at	quantmod	22	SENT_55	[p2l1546t3102r1602b3149],
21	least	JJS	O	least	mwe	20	SENT_55	[p2l1628t3094r1766b3149],
22	one	CD	NUMBER	one	num	24	SENT_55	[p2l1791t3110r1900b3149],
23	mutant	JJ	O	mutant	amod	24	SENT_55	[p2l1928t3102r2148b3149],
24	allele	NN	O	allele	dobj	19	SENT_55	[p2l9t3183r177b3239],
25	.	.	O	.	_	0	SENT_55	[p2l9t3183r177b3239],

1	These	DT	O	these	det	2	SENT_56	[p2l207t3183r380b3238],
2	SNPs	NNS	O	snp	nsubj	3	SENT_56	[p2l412t3186r556b3238],
3	(	VBP	O	(	_	0	SENT_56	[p2l593t3183r790b3252],
4	single	JJ	O	single	amod	6	SENT_56	[p2l593t3183r790b3252],
5	nucleotide	NN	O	nucleotide	nn	6	SENT_56	[p2l823t3183r1135b3238],
6	polymorphisms	NNS	O	polymorphism	nsubjpass	19	SENT_56	[p2l1167t3183r1677b3252],
7	)	RB	O	)	advmod	6	SENT_56	[p2l1167t3183r1677b3252],
8	,	,	O	,	_	0	SENT_56	[p2l1167t3183r1677b3252],
9	CYP2C9	NN	O	cyp2c9	nn	10	SENT_56	[p2l1710t3183r2003b3238],
10	*	NN	O	*	appos	6	SENT_56	[p2l1710t3183r2003b3238],
11	2	CD	NUMBER	2	number	15	SENT_56	[p2l1710t3183r2003b3238],
12	and	CC	O	and	_	0	SENT_56	[p2l2036t3183r2146b3238],
13	CYP2C9	CD	NUMBER	cyp2c9	dep	10	SENT_56	[p2l9t3272r316b3336],
14	*	CD	NUMBER	*	number	15	SENT_56	[p2l9t3272r316b3336],
15	3	CD	NUMBER	3	dep	10	SENT_56	[p2l9t3272r316b3336],
16	,	,	O	,	_	0	SENT_56	[p2l9t3272r316b3336],
17	have	VBP	O	have	aux	19	SENT_56	[p2l336t3272r476b3327],
18	been	VBN	O	be	auxpass	19	SENT_56	[p2l495t3272r639b3327],
19	associated	VBN	O	associate	ccomp	3	SENT_56	[p2l659t3272r963b3327],
20	with	IN	O	with	_	0	SENT_56	[p2l981t3272r1119b3327],
21	a	DT	O	a	det	22	SENT_56	[p2l1138t3288r1169b3327],
22	decrease	NN	O	decrease	prep_with	19	SENT_56	[p2l1188t3272r1447b3327],
23	of	IN	O	of	_	0	SENT_56	[p2l1465t3272r1528b3327],
24	the	DT	O	the	det	26	SENT_56	[p2l1539t3272r1635b3327],
25	enzymatic	JJ	O	enzymatic	amod	26	SENT_56	[p2l1653t3273r1962b3341],
26	activity	NN	O	activity	prep_of	22	SENT_56	[p2l1980t3273r2145b3327, p3l9t18r86b85],

1	and	CC	O	and	cc	24	SENT_57	[p3l103t17r212b72],
2	implicitly	RB	O	implicitly	advmod	24	SENT_57	[p3l234t17r516b85],
3	with	IN	O	with	_	0	SENT_57	[p3l532t17r669b72],
4	an	DT	O	a	det	5	SENT_57	[p3l689t33r761b72],
5	increase	NN	O	increase	prep_with	24	SENT_57	[p3l780t18r1022b72],
6	in	IN	O	in	_	0	SENT_57	[p3l1044t18r1098b71],
7	acenocoumarol	NN	O	acenocoumarol	nn	8	SENT_57	[p3l1118t17r1575b72],
8	toxicity	NN	O	toxicity	prep_in	5	SENT_57	[p3l1594t18r1830b85],
9	,	,	O	,	_	0	SENT_57	[p3l1594t18r1830b85],
10	leading	VBG	O	lead	csubj	24	SENT_57	[p3l1851t17r2070b85],
11	to	TO	O	to	_	0	SENT_57	[p3l2087t25r2145b72],
12	the	DT	O	the	det	13	SENT_57	[p3l8t106r104b161],
13	need	NN	O	need	prep_to	10	SENT_57	[p3l125t105r269b161],
14	for	IN	O	for	_	0	SENT_57	[p3l291t105r374b161],
15	a	DT	O	a	det	17	SENT_57	[p3l394t121r425b161],
16	lower	JJR	O	lower	amod	17	SENT_57	[p3l446t106r618b161],
17	dose	NN	O	dose	prep_for	13	SENT_57	[p3l638t106r774b161],
18	in	IN	O	in	_	0	SENT_57	[p3l796t106r851b160],
19	the	DT	O	the	det	20	SENT_57	[p3l872t106r968b161],
20	carriers	NNS	O	carrier	prep_in	17	SENT_57	[p3l988t106r1210b161],
21	of	IN	O	of	_	0	SENT_57	[p3l1232t105r1295b161],
22	these	DT	O	these	det	23	SENT_57	[p3l1308t106r1466b161],
23	alleles	NNS	O	allele	prep_of	20	SENT_57	[p3l1488t106r1671b161],
24	[	VBP	O	[	_	0	SENT_57	[p3l1696t105r1840b174],
25	4,5	CD	NUMBER	4,5	number	26	SENT_57	[p3l1696t105r1840b174],
26	]	CD	NUMBER	]	dobj	24	SENT_57	[p3l1696t105r1840b174],
27	.	.	O	.	_	0	SENT_57	[p3l1696t105r1840b174],

1	Acenocoumarol	NNP	O	Acenocoumarol	nsubj	2	SENT_58	[p3l108t194r580b249],
2	exerts	VBZ	O	exert	_	0	SENT_58	[p3l605t202r786b249],
3	its	PRP$	O	its	poss	5	SENT_58	[p3l811t195r878b249],
4	anticoagulant	JJ	O	anticoagulant	amod	5	SENT_58	[p3l904t194r1314b263],
5	effect	NN	O	effect	dobj	2	SENT_58	[p3l1336t194r1501b249],
6	through	IN	O	through	_	0	SENT_58	[p3l1523t194r1764b263],
7	competitive	JJ	O	competitive	amod	8	SENT_58	[p3l1788t195r2145b263],
8	inhibition	NN	O	inhibition	prep_through	2	SENT_58	[p3l9t283r302b338],
9	of	IN	O	of	_	0	SENT_58	[p3l328t283r391b338],
10	epoxireductase	NN	O	epoxireductase	prep_of	8	SENT_58	[p3l411t283r880b352],
11	,	,	O	,	_	0	SENT_58	[p3l411t283r880b352],
12	the	DT	O	the	det	13	SENT_58	[p3l908t283r1004b338],
13	enzyme	NN	O	enzyme	appos	10	SENT_58	[p3l1031t299r1267b352],
14	responsible	JJ	O	responsible	amod	22	SENT_58	[p3l1294t283r1637b352],
15	for	IN	O	for	_	0	SENT_58	[p3l1665t283r1748b338],
16	the	DT	O	the	det	17	SENT_58	[p3l1773t283r1869b338],
17	gammacarboxylation	NN	O	gammacarboxylation	prep_for	14	SENT_58	[p3l1895t299r2145b352, p3l9t372r418b441],
18	of	IN	O	of	_	0	SENT_58	[p3l446t372r509b427],
19	the	DT	O	the	det	21	SENT_58	[p3l528t372r623b427],
20	glutamic	JJ	O	glutamic	amod	21	SENT_58	[p3l649t372r912b441],
21	acid	NN	O	acid	prep_of	17	SENT_58	[p3l938t372r1057b427],
22	residues	NNS	O	residue	dep	13	SENT_58	[p3l1085t372r1332b427],
23	during	IN	O	during	_	0	SENT_58	[p3l1361t372r1560b441],
24	the	DT	O	the	det	25	SENT_58	[p3l1585t372r1681b427],
25	synthesis	NN	O	synthesis	prep_during	2	SENT_58	[p3l1709t372r1984b441],
26	of	IN	O	of	_	0	SENT_58	[p3l2012t372r2075b427],
27	11	CD	NUMBER	11	prep_of	25	SENT_58	[p3l2095t376r2144b436],
28	,	,	O	,	_	0	SENT_58	[p3l2095t376r2144b436],
29	VII	NNP	O	VII	prep_of	25	SENT_58	[p3l6t465r102b525],
30	,	,	O	,	_	0	SENT_58	[p3l6t465r102b525],
31	IX	CD	NUMBER	ix	prep_of	25	SENT_58	[p3l140t465r202b516],
32	and	CC	O	and	_	0	SENT_58	[p3l235t461r345b516],
33	X	NN	O	x	nn	35	SENT_58	[p3l379t465r424b516],
34	coagulation	NN	O	coagulation	nn	35	SENT_58	[p3l458t461r806b530],
35	factors	NNS	O	factor	prep_of	25	SENT_58	[p3l842t461r1055b517],
36	.	.	O	.	_	0	SENT_58	[p3l842t461r1055b517],

1	Thus	RB	O	thus	advmod	13	SENT_59	[p3l1089t461r1247b525],
2	,	,	O	,	_	0	SENT_59	[p3l1089t461r1247b525],
3	the	DT	O	the	det	4	SENT_59	[p3l1284t461r1380b516],
4	formation	NN	O	formation	nsubjpass	13	SENT_59	[p3l1416t461r1713b516],
5	of	IN	O	of	_	0	SENT_59	[p3l1749t461r1811b516],
6	the	DT	O	the	det	8	SENT_59	[p3l1839t461r1934b516],
7	active	JJ	O	active	amod	8	SENT_59	[p3l1971t462r2145b516],
8	form	NN	O	form	prep_of	4	SENT_59	[p3l9t551r152b606],
9	of	IN	O	of	_	0	SENT_59	[p3l171t551r233b606],
10	K	NNP	O	K	nn	11	SENT_59	[p3l245t554r286b605],
11	vitamin	NN	O	vitamin	prep_of	8	SENT_59	[p3l301t552r533b606],
12	is	VBZ	O	be	auxpass	13	SENT_59	[p3l552t552r596b606],
13	inhibited	VBN	O	inhibit	_	0	SENT_59	[p3l615t551r899b614],
14	,	,	O	,	_	0	SENT_59	[p3l615t551r899b614],
15	leading	VBG	O	lead	xcomp	13	SENT_59	[p3l919t551r1138b619],
16	to	TO	O	to	_	0	SENT_59	[p3l1155t559r1213b606],
17	the	DT	O	the	det	18	SENT_59	[p3l1231t551r1327b606],
18	formation	NN	O	formation	prep_to	15	SENT_59	[p3l1346t551r1643b606],
19	of	IN	O	of	_	0	SENT_59	[p3l1663t551r1725b606],
20	proteins	NNS	O	protein	prep_of	18	SENT_59	[p3l1736t552r1982b619],
21	lacking	VBG	O	lack	partmod	20	SENT_59	[p3l2002t551r2145b606, p3l9t640r102b708],
22	anticoagulant	JJ	O	anticoagulant	amod	27	SENT_59	[p3l134t640r544b708],
23	biological	JJ	O	biological	amod	27	SENT_59	[p3l576t640r864b708],
24	activity	NN	O	activity	nn	27	SENT_59	[p3l897t640r1119b708],
25	(	CD	NUMBER	(	num	27	SENT_59	[p3l1155t640r1407b708],
26	PIVKA	NN	O	pivka	nn	27	SENT_59	[p3l1155t640r1407b708],
27	)	NN	O	)	dobj	21	SENT_59	[p3l1155t640r1407b708],
28	.	.	O	.	_	0	SENT_59	[p3l1155t640r1407b708],

1	Additionally	RB	O	additionally	advmod	5	SENT_60	[p3l1439t640r1823b708],
2	,	,	O	,	_	0	SENT_60	[p3l1439t640r1823b708],
3	oral	JJ	O	oral	amod	4	SENT_60	[p3l1858t640r1971b695],
4	anticoagulant	NN	O	anticoagulant	nsubj	5	SENT_60	[p3l2005t640r2145b695, p3l9t728r303b797],
5	inhibits	VBZ	O	inhibit	_	0	SENT_60	[p3l331t728r555b783],
6	the	DT	O	the	det	7	SENT_60	[p3l586t728r682b783],
7	formation	NN	O	formation	dobj	5	SENT_60	[p3l713t728r1010b783],
8	of	IN	O	of	_	0	SENT_60	[p3l1040t728r1103b783],
9	C	NN	O	c	nn	12	SENT_60	[p3l1127t731r1164b783],
10	and	CC	O	and	_	0	SENT_60	[p3l1193t728r1303b783],
11	S	NN	O	s	nn	12	SENT_60	[p3l1334t731r1364b783],
12	proteins	NNS	O	protein	prep_of	7	SENT_60	[p3l1396t729r1657b797],
13	,	,	O	,	_	0	SENT_60	[p3l1396t729r1657b797],
14	which	WDT	O	which	nsubj	15	SENT_60	[p3l1686t728r1873b783],
15	have	VBP	O	have	rcmod	12	SENT_60	[p3l1903t728r2044b783],
16	an	DT	O	a	det	18	SENT_60	[p3l2074t744r2146b783],
17	anticoagulant	JJ	O	anticoagulant	amod	18	SENT_60	[p3l9t817r420b886],
18	role	NN	O	role	dobj	15	SENT_60	[p3l443t817r571b873],
19	.	.	O	.	_	0	SENT_60	[p3l443t817r571b873],

1	The	DT	O	the	det	2	SENT_61	[p3l593t817r704b872],
2	enzyme	NN	O	enzyme	nsubj	4	SENT_61	[p3l730t833r965b886],
3	I	PRP	O	I	nsubj	4	SENT_61	[p3l990t817r1776b886],
4	(	VBP	O	(	_	0	SENT_61	[p3l990t817r1776b886],
5	.	.	O	.	_	0	SENT_61	[p3l990t817r1776b886],

1	—	NN	O	—	_	0	SENT_62	[p3l990t817r1776b886],
2	.	.	O	.	_	0	SENT_62	[p3l990t817r1776b886],

1	vitamin	NN	O	vitamin	_	0	SENT_63	[p3l990t817r1776b886],
2	.	.	O	.	_	0	SENT_63	[p3l990t817r1776b886],

1	—	NN	O	—	_	0	SENT_64	[p3l990t817r1776b886],
2	.	.	O	.	_	0	SENT_64	[p3l990t817r1776b886],

1	epoxireductase	NN	O	epoxireductase	nsubjpass	3	SENT_65	[p3l990t817r1776b886],
2	is	VBZ	O	be	auxpass	3	SENT_65	[p3l1802t818r1845b872],
3	coded	VBN	O	code	_	0	SENT_65	[p3l1871t817r2049b872],
4	by	IN	O	by	_	0	SENT_65	[p3l2074t817r2148b886],
5	the	DT	O	the	det	6	SENT_65	[p3l8t906r104b961],
6	subunit	NN	O	subunit	agent	3	SENT_65	[p3l127t906r353b961],
7	1	CD	NUMBER	1	num	6	SENT_65	[p3l376t909r400b961],
8	of	IN	O	of	_	0	SENT_65	[p3l429t906r493b961],
9	the	DT	O	the	det	11	SENT_65	[p3l506t906r601b961],
10	VKORC	NN	O	vkorc	nn	11	SENT_65	[p3l621t909r836b961],
11	gene	NN	O	gene	prep_of	6	SENT_65	[p3l855t922r1012b975],
12	.	.	O	.	_	0	SENT_65	[p3l855t922r1012b975],

1	The	DT	O	the	det	3	SENT_66	[p3l108t995r218b1050],
2	recent	JJ	O	recent	amod	3	SENT_66	[p3l251t1004r441b1050],
3	discovery	NN	O	discovery	nsubj	9	SENT_66	[p3l470t995r757b1064],
4	of	IN	O	of	_	0	SENT_66	[p3l788t995r850b1050],
5	the	DT	O	the	det	8	SENT_66	[p3l874t995r970b1050],
6	VKORC1	NN	O	vkorc1	nn	8	SENT_66	[p3l999t998r1243b1050],
7	gene	NN	O	gene	nn	8	SENT_66	[p3l1281t1011r1424b1064],
8	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_66	[p3l1457t995r1927b1064],
9	represents	VBZ	O	represent	_	0	SENT_66	[p3l1960t1011r2145b1064, p3l10t1093r161b1140],
10	a	DT	O	a	det	11	SENT_66	[p3l190t1101r221b1140],
11	step	NN	O	step	dobj	9	SENT_66	[p3l250t1093r372b1153],
12	forward	RB	O	forward	advmod	9	SENT_66	[p3l402t1085r639b1140],
13	in	IN	O	in	_	0	SENT_66	[p3l669t1086r724b1139],
14	understanding	VBG	O	understand	prepc_in	9	SENT_66	[p3l753t1085r1193b1153],
15	the	DT	O	the	det	19	SENT_66	[p3l1219t1085r1315b1140],
16	inter	NN	O	inter	nn	19	SENT_66	[p3l1344t1085r1816b1140],
17	—	NN	O	—	nn	19	SENT_66	[p3l1344t1085r1816b1140],
18	individual	JJ	O	individual	amod	19	SENT_66	[p3l1344t1085r1816b1140],
19	variability	NN	O	variability	dobj	14	SENT_66	[p3l1843t1085r2147b1153],
20	of	IN	O	of	_	0	SENT_66	[p3l9t1173r72b1229],
21	the	DT	O	the	det	25	SENT_66	[p3l87t1174r182b1229],
22	necessary	JJ	O	necessary	amod	25	SENT_66	[p3l206t1189r499b1242],
23	oral	JJ	O	oral	amod	25	SENT_66	[p3l521t1174r634b1229],
24	anticoagulant	JJ	O	anticoagulant	amod	25	SENT_66	[p3l658t1174r1067b1242],
25	dose	NN	O	dose	prep_of	19	SENT_66	[p3l1090t1174r1240b1237],
26	,	,	O	,	_	0	SENT_66	[p3l1090t1174r1240b1237],
27	and	CC	O	and	_	0	SENT_66	[p3l1264t1174r1373b1229],
28	recent	JJ	O	recent	amod	29	SENT_66	[p3l1398t1182r1588b1229],
29	studies	NNS	O	study	nsubj	30	SENT_66	[p3l1610t1174r1819b1229],
30	show	VBP	O	show	conj_and	9	SENT_66	[p3l1844t1174r2006b1229],
31	that	IN	O	that	complm	37	SENT_66	[p3l2026t1174r2148b1229],
32	the	DT	O	the	det	33	SENT_66	[p3l8t1262r104b1317],
33	presence	NN	O	presence	nsubj	37	SENT_66	[p3l121t1278r387b1331],
34	of	IN	O	of	_	0	SENT_66	[p3l404t1262r468b1317],
35	VKORC1	NN	O	vkorc1	nn	36	SENT_66	[p3l473t1265r716b1317],
36	SNPs	NNS	O	snp	prep_of	33	SENT_66	[p3l742t1265r886b1317],
37	inﬂuences	VBZ	O	inﬂuences	ccomp	30	SENT_66	[p3l905t1262r1209b1317],
38	the	DT	O	the	det	39	SENT_66	[p3l1226t1262r1321b1317],
39	body	NN	O	body	poss	41	SENT_66	[p3l1338t1262r1528b1331],
40	's	POS	O	's	_	0	SENT_66	[p3l1338t1262r1528b1331],
41	reactivity	NN	O	reactivity	dobj	37	SENT_66	[p3l1547t1263r1828b1331],
42	to	TO	O	to	_	0	SENT_66	[p3l1843t1270r1901b1317],
43	oral	JJ	O	oral	amod	45	SENT_66	[p3l1918t1262r2031b1317],
44	anticoagulant	JJ	O	anticoagulant	amod	45	SENT_66	[p3l2048t1278r2145b1317, p3l8t1351r345b1420],
45	treatment	NN	O	treatment	prep_to	37	SENT_66	[p3l370t1359r684b1407],
46	.	.	O	.	_	0	SENT_66	[p3l370t1359r684b1407],

1	Patients	NNS	O	patient	nsubj	6	SENT_67	[p3l714t1352r951b1406],
2	with	IN	O	with	_	0	SENT_67	[p3l978t1351r1117b1406],
3	congenital	JJ	O	congenital	amod	5	SENT_67	[p3l1145t1351r1457b1420],
4	VKORC1	NN	O	vkorc1	nn	5	SENT_67	[p3l1482t1354r1726b1406],
5	deﬁcits	NNS	O	deﬁcits	prep_with	1	SENT_67	[p3l1762t1351r1976b1406],
6	have	VBP	O	have	_	0	SENT_67	[p3l2004t1351r2145b1406],
7	coagulation	NN	O	coagulation	nn	8	SENT_67	[p3l9t1440r357b1509],
8	disorders	NNS	O	disorder	dobj	6	SENT_67	[p3l378t1440r656b1495],
9	or	CC	O	or	_	0	SENT_67	[p3l677t1456r741b1495],
10	resistance	NN	O	resistance	dobj	6	SENT_67	[p3l761t1441r1058b1495],
11	to	TO	O	to	_	0	SENT_67	[p3l1080t1448r1137b1495],
12	oral	JJ	O	oral	amod	17	SENT_67	[p3l1159t1440r1273b1495],
13	anticoagulant	JJ	O	anticoagulant	amod	17	SENT_67	[p3l1294t1440r1705b1509],
14	treatment	NN	O	treatment	nn	17	SENT_67	[p3l1724t1448r2027b1495],
15	[	NN	O	[	nn	17	SENT_67	[p3l2049t1440r2141b1509],
16	6	CD	NUMBER	6	num	17	SENT_67	[p3l2049t1440r2141b1509],
17	]	NN	O	]	prep_to	8	SENT_67	[p3l2049t1440r2141b1509],
18	.	.	O	.	_	0	SENT_67	[p3l2049t1440r2141b1509],

1	Twenty	CD	NUMBER	twenty	num	4	SENT_68	[p3l108t1529r518b1598],
2	—	CD	NUMBER	—	num	4	SENT_68	[p3l108t1529r518b1598],
3	eight	CD	NUMBER	eight	num	4	SENT_68	[p3l108t1529r518b1598],
4	polymorphisms	NNS	O	polymorphism	nsubjpass	11	SENT_68	[p3l564t1529r1034b1598],
5	of	IN	O	of	_	0	SENT_68	[p3l1082t1529r1145b1584],
6	the	DT	O	the	det	8	SENT_68	[p3l1185t1529r1280b1584],
7	VKORC1	NN	O	vkorc1	nn	8	SENT_68	[p3l1325t1532r1569b1584],
8	gene	NN	O	gene	prep_of	4	SENT_68	[p3l1623t1545r1766b1598],
9	have	VBP	O	have	aux	11	SENT_68	[p3l1814t1529r1954b1584],
10	been	VBN	O	be	auxpass	11	SENT_68	[p3l2001t1529r2145b1584],
11	described	VBN	O	describe	_	0	SENT_68	[p3l9t1619r310b1682],
12	,	,	O	,	_	0	SENT_68	[p3l9t1619r310b1682],
13	of	IN	O	of	dep	21	SENT_68	[p3l336t1619r398b1674],
14	which	WDT	O	which	pobj	13	SENT_68	[p3l412t1619r599b1674],
15	three	CD	NUMBER	three	nsubj	21	SENT_68	[p3l621t1619r778b1674],
16	of	IN	O	of	_	0	SENT_68	[p3l802t1619r864b1674],
17	the	DT	O	the	det	18	SENT_68	[p3l880t1619r976b1674],
18	haplotypes	NNS	O	haplotype	prep_of	15	SENT_68	[p3l1000t1619r1328b1687],
19	are	VBP	O	be	cop	21	SENT_68	[p3l1352t1635r1443b1674],
20	mainly	RB	O	mainly	advmod	21	SENT_68	[p3l1468t1619r1675b1687],
21	responsible	JJ	O	responsible	ccomp	11	SENT_68	[p3l1697t1619r2039b1687],
22	for	IN	O	for	_	0	SENT_68	[p3l2064t1619r2147b1674],
23	the	DT	O	the	det	26	SENT_68	[p3l8t1708r104b1763],
24	VKORC1	NN	O	vkorc1	nn	26	SENT_68	[p3l131t1710r375b1763],
25	genetic	JJ	O	genetic	amod	26	SENT_68	[p3l411t1708r630b1776],
26	variability	NN	O	variability	prep_for	21	SENT_68	[p3l656t1708r973b1776],
27	.	.	O	.	_	0	SENT_68	[p3l656t1708r973b1776],

1	VKORC1	NN	O	vkorc1	nn	2	SENT_69	[p3l1000t1710r1244b1763],
2	*	NN	O	*	nsubjpass	7	SENT_69	[p3l1256t1707r1316b1762],
3	2	CD	NUMBER	2	num	4	SENT_69	[p3l1256t1707r1316b1762],
4	haplotype	NN	O	haplotype	dep	2	SENT_69	[p3l1347t1708r1648b1776],
5	has	VBZ	O	have	aux	7	SENT_69	[p3l1678t1708r1776b1763],
6	been	VBN	O	be	auxpass	7	SENT_69	[p3l1806t1708r1950b1763],
7	made	VBN	O	make	_	0	SENT_69	[p3l1980t1707r2145b1763],
8	responsible	JJ	O	responsible	acomp	7	SENT_69	[p3l9t1796r352b1865],
9	for	IN	O	for	_	0	SENT_69	[p3l371t1796r455b1851],
10	most	JJS	O	most	prep_for	8	SENT_69	[p3l472t1804r621b1851],
11	of	IN	O	of	_	0	SENT_69	[p3l638t1796r701b1851],
12	the	DT	O	the	det	13	SENT_69	[p3l711t1796r807b1851],
13	variability	NN	O	variability	prep_of	10	SENT_69	[p3l824t1796r1129b1865],
14	of	IN	O	of	_	0	SENT_69	[p3l1146t1796r1208b1851],
15	the	DT	O	the	det	16	SENT_69	[p3l1218t1796r1314b1851],
16	response	NN	O	response	prep_of	13	SENT_69	[p3l1333t1812r1600b1865],
17	to	TO	O	to	_	0	SENT_69	[p3l1618t1804r1677b1851],
18	oral	JJ	O	oral	amod	22	SENT_69	[p3l1695t1796r1809b1851],
19	anticoagulant	JJ	O	anticoagulant	amod	22	SENT_69	[p3l1827t1797r2145b1865, p3l9t1885r124b1940],
20	[	NN	O	[	nn	22	SENT_69	[p3l146t1885r237b1954],
21	7	CD	NUMBER	7	num	22	SENT_69	[p3l146t1885r237b1954],
22	]	NN	O	]	prep_to	7	SENT_69	[p3l146t1885r237b1954],
23	.	.	O	.	_	0	SENT_69	[p3l146t1885r237b1954],

1	An	DT	O	a	det	3	SENT_70	[p3l257t1887r341b1939],
2	increased	VBN	O	increase	amod	3	SENT_70	[p3l361t1885r645b1940],
3	response	NN	O	response	nsubjpass	8	SENT_70	[p3l666t1901r932b1954],
4	to	TO	O	to	_	0	SENT_70	[p3l953t1893r1012b1940],
5	acenocoumarol	NN	O	acenocoumarol	prep_to	3	SENT_70	[p3l1032t1885r1491b1940],
6	has	VBZ	O	have	aux	8	SENT_70	[p3l1513t1885r1611b1940],
7	been	VBN	O	be	auxpass	8	SENT_70	[p3l1632t1885r1776b1940],
8	observed	VBN	O	observe	_	0	SENT_70	[p3l1797t1885r2068b1940],
9	in	IN	O	in	_	0	SENT_70	[p3l2090t1886r2145b1939],
10	healthy	JJ	O	healthy	amod	11	SENT_70	[p3l9t1974r235b2043],
11	subjects	NNS	O	subject	prep_in	8	SENT_70	[p3l261t1974r500b2043],
12	carrying	VBG	O	carry	xcomp	8	SENT_70	[p3l527t1975r774b2043],
13	c.-1639G	NN	O	c.-1639g	dep	14	SENT_70	[p3l800t1977r1166b2030],
14	>	JJR	O	>	dobj	12	SENT_70	[p3l800t1977r1166b2030],
15	A	DT	O	a	det	16	SENT_70	[p3l800t1977r1166b2030],
16	polymorphism	NN	O	polymorphism	dep	25	SENT_70	[p3l1191t1974r1647b2043],
17	,	,	O	,	_	0	SENT_70	[p3l1191t1974r1647b2043],
18	the	DT	O	the	det	19	SENT_70	[p3l1674t1974r1770b2029],
19	hallmark	NN	O	hallmark	appos	16	SENT_70	[p3l1797t1974r2066b2029],
20	of	IN	O	of	_	0	SENT_70	[p3l2090t1974r2154b2029],
21	VKORC1	NN	O	vkorc1	prep_of	16	SENT_70	[p3l6t2066r250b2118],
22	*	NN	O	*	dep	25	SENT_70	[p3l263t2063r321b2118],
23	2	CD	NUMBER	2	num	22	SENT_70	[p3l263t2063r321b2118],
24	haplotype	NN	O	haplotype	nn	25	SENT_70	[p3l346t2063r645b2132],
25	[	NN	O	[	dep	12	SENT_70	[p3l670t2063r762b2132],
26	8	CD	NUMBER	8	num	27	SENT_70	[p3l670t2063r762b2132],
27	]	NN	O	]	dep	25	SENT_70	[p3l670t2063r762b2132],
28	.	.	O	.	_	0	SENT_70	[p3l670t2063r762b2132],

1	According	VBG	O	accord	_	0	SENT_71	[p3l108t2153r413b2221],
2	to	TO	O	to	prepc_according_to	5	SENT_71	[p3l437t2161r496b2208],
3	several	JJ	O	several	amod	4	SENT_71	[p3l523t2153r731b2208],
4	authors	NNS	O	author	pobj	5	SENT_71	[p3l758t2153r984b2208],
5	[	VBP	O	[	_	0	SENT_71	[p3l1015t2153r1220b2221],
6	9	CD	NUMBER	9	num	7	SENT_71	[p3l1015t2153r1220b2221],
7	—	CD	NUMBER	—	dobj	5	SENT_71	[p3l1015t2153r1220b2221],
8	11	CD	NUMBER	11	num	9	SENT_71	[p3l1015t2153r1220b2221],
9	]	NN	O	]	nsubj	5	SENT_71	[p3l1015t2153r1220b2221],
10	,	,	O	,	_	0	SENT_71	[p3l1015t2153r1220b2221],
11	combined	JJ	O	combined	amod	12	SENT_71	[p3l1248t2153r1544b2208],
12	analysis	NN	O	analysis	appos	9	SENT_71	[p3l1572t2153r1807b2221],
13	of	IN	O	of	_	0	SENT_71	[p3l1835t2153r1897b2208],
14	CYP2C9	NN	O	cyp2c9	nn	17	SENT_71	[p3l1916t2156r2145b2208],
15	and	CC	O	and	_	0	SENT_71	[p3l9t2242r118b2297],
16	VKORC1	NN	O	vkorc1	nn	17	SENT_71	[p3l138t2244r382b2297],
17	polymorphisms	NNS	O	polymorphism	prep_of	12	SENT_71	[p3l411t2242r881b2310],
18	explains	VBZ	O	explain	dep	17	SENT_71	[p3l903t2242r1150b2310],
19	30	CD	NUMBER	30	number	21	SENT_71	[p3l1171t2244r1245b2297],
20	to	TO	O	to	dep	21	SENT_71	[p3l1266t2250r1324b2297],
21	40	CD	PERCENT	40	num	22	SENT_71	[p3l1344t2244r1461b2297],
22	%	NN	PERCENT	%	dobj	18	SENT_71	[p3l1344t2244r1461b2297],
23	of	IN	O	of	_	0	SENT_71	[p3l1481t2241r1544b2297],
24	the	DT	O	the	det	28	SENT_71	[p3l1557t2242r1653b2297],
25	inter	NN	O	inter	nn	28	SENT_71	[p3l1675t2241r2146b2297],
26	—	NN	O	—	nn	28	SENT_71	[p3l1675t2241r2146b2297],
27	individual	JJ	O	individual	amod	28	SENT_71	[p3l1675t2241r2146b2297],
28	variability	NN	O	variability	prep_of	22	SENT_71	[p3l7t2330r310b2399],
29	of	IN	O	of	_	0	SENT_71	[p3l326t2330r389b2385],
30	the	DT	O	the	det	31	SENT_71	[p3l398t2330r494b2385],
31	equilibrium	NN	O	equilibrium	prep_of	28	SENT_71	[p3l511t2330r863b2399],
32	oral	JJ	O	oral	amod	34	SENT_71	[p3l880t2330r993b2385],
33	anticoagulant	JJ	O	anticoagulant	amod	34	SENT_71	[p3l1010t2330r1419b2399],
34	dose	NN	O	dose	dep	22	SENT_71	[p3l1435t2330r1571b2385],
35	and	CC	O	and	_	0	SENT_71	[p3l1589t2330r1713b2393],
36	,	,	O	,	_	0	SENT_71	[p3l1589t2330r1713b2393],
37	consequently	RB	O	consequently	dep	22	SENT_71	[p3l1731t2330r2144b2399],
38	,	,	O	,	_	0	SENT_71	[p3l1731t2330r2144b2399],
39	the	DT	O	the	det	40	SENT_71	[p3l8t2419r104b2474],
40	response	NN	O	response	conj_and	22	SENT_71	[p3l126t2435r392b2488],
41	to	TO	O	to	_	0	SENT_71	[p3l413t2427r471b2474],
42	treatment	NN	O	treatment	prep_to	18	SENT_71	[p3l493t2427r795b2474],
43	and	CC	O	and	_	0	SENT_71	[p3l813t2419r923b2474],
44	its	PRP$	O	its	poss	45	SENT_71	[p3l946t2420r1013b2474],
45	safety	NN	O	safety	prep_to	18	SENT_71	[p3l1036t2419r1223b2488],
46	.	.	O	.	_	0	SENT_71	[p3l1036t2419r1223b2488],

1	The	DT	O	the	det	2	SENT_72	[p3l108t2508r220b2563],
2	study	NN	O	study	nsubj	3	SENT_72	[p3l244t2508r413b2577],
3	aims	VBZ	O	aim	_	0	SENT_72	[p3l434t2509r575b2563],
4	to	TO	O	to	aux	5	SENT_72	[p3l598t2516r657b2563],
5	investigate	VB	O	investigate	xcomp	3	SENT_72	[p3l681t2509r1014b2577],
6	the	DT	O	the	det	7	SENT_72	[p3l1037t2508r1134b2563],
7	association	NN	O	association	dobj	5	SENT_72	[p3l1157t2509r1495b2563],
8	between	IN	O	between	_	0	SENT_72	[p3l1517t2508r1783b2563],
9	the	DT	O	the	det	11	SENT_72	[p3l1805t2508r1902b2563],
10	genetic	JJ	O	genetic	amod	11	SENT_72	[p3l1924t2509r2147b2577],
11	status	NN	O	status	prep_between	7	SENT_72	[p3l10t2605r187b2652],
12	in	IN	O	in	_	0	SENT_72	[p3l223t2598r279b2652],
13	patients	NNS	O	patient	prep_in	5	SENT_72	[p3l314t2598r559b2666],
14	treated	VBN	O	treat	partmod	13	SENT_72	[p3l593t2597r812b2652],
15	with	IN	O	with	_	0	SENT_72	[p3l845t2597r986b2652],
16	acenocoumarol	NN	O	acenocoumarol	prep_with	14	SENT_72	[p3l1020t2597r1489b2652],
17	and	CC	O	and	_	0	SENT_72	[p3l1523t2597r1634b2652],
18	the	DT	O	the	det	20	SENT_72	[p3l1669t2597r1766b2652],
19	phenotypic	JJ	O	phenotypic	amod	20	SENT_72	[p3l1801t2597r2146b2666],
20	expression	NN	O	expression	prep_with	14	SENT_72	[p3l9t2687r339b2755],
21	represented	VBN	O	represent	partmod	20	SENT_72	[p3l376t2687r742b2755],
22	by	IN	O	by	_	0	SENT_72	[p3l778t2687r852b2755],
23	the	DT	O	the	det	26	SENT_72	[p3l887t2687r984b2742],
24	therapeutic	JJ	O	therapeutic	amod	26	SENT_72	[p3l1020t2687r1372b2755],
25	acenocoumarol	NN	O	acenocoumarol	nn	26	SENT_72	[p3l1408t2687r1876b2742],
26	dose	NN	O	dose	agent	21	SENT_72	[p3l1913t2687r2067b2742],
27	.	.	O	.	_	0	SENT_72	[p3l1913t2687r2067b2742],

1	It	PRP	O	it	nsubj	3	SENT_73	[p3l2105t2690r2147b2742],
2	also	RB	O	also	advmod	3	SENT_73	[p3l9t2775r126b2830],
3	aims	VBZ	O	aim	_	0	SENT_73	[p3l154t2776r295b2830],
4	to	TO	O	to	aux	5	SENT_73	[p3l322t2783r381b2830],
5	correlate	VB	O	correlate	xcomp	3	SENT_73	[p3l409t2775r679b2830],
6	the	DT	O	the	det	8	SENT_73	[p3l706t2775r803b2830],
7	genetic	JJ	O	genetic	amod	8	SENT_73	[p3l829t2776r1052b2844],
8	factors	NNS	O	factor	dobj	5	SENT_73	[p3l1078t2775r1281b2830],
9	with	IN	O	with	_	0	SENT_73	[p3l1307t2775r1448b2830],
10	the	DT	O	the	det	12	SENT_73	[p3l1474t2775r1572b2830],
11	clinical	JJ	O	clinical	amod	12	SENT_73	[p3l1599t2775r1812b2830],
12	ones	NNS	O	one	prep_with	5	SENT_73	[p3l1840t2791r1979b2830],
13	such	JJ	O	such	_	0	SENT_73	[p3l2008t2775r2146b2830],
14	as	IN	O	as	_	0	SENT_73	[p3l9t2880r68b2919],
15	age	NN	O	age	prep_such_as	12	SENT_73	[p3l99t2880r216b2933],
16	,	,	O	,	_	0	SENT_73	[p3l99t2880r216b2933],
17	sex	NN	O	sex	prep_such_as	12	SENT_73	[p3l247t2880r359b2928],
18	,	,	O	,	_	0	SENT_73	[p3l247t2880r359b2928],
19	and	CC	O	and	_	0	SENT_73	[p3l390t2864r501b2919],
20	concomitant	JJ	O	concomitant	amod	21	SENT_73	[p3l532t2865r917b2919],
21	medication	NN	O	medication	prep_such_as	12	SENT_73	[p3l945t2864r1302b2927],
22	,	,	O	,	_	0	SENT_73	[p3l945t2864r1302b2927],
23	in	IN	O	in	mark	26	SENT_73	[p3l1333t2865r1390b2918],
24	order	NN	O	order	dep	26	SENT_73	[p3l1420t2864r1586b2919],
25	to	TO	O	to	aux	26	SENT_73	[p3l1613t2872r1672b2919],
26	establish	VB	O	establish	purpcl	3	SENT_73	[p3l1703t2864r1972b2919],
27	their	PRP$	O	they	poss	28	SENT_73	[p3l2000t2864r2147b2919],
28	inﬂuence	NN	O	inﬂuence	dobj	26	SENT_73	[p3l9t2953r291b3008],
29	on	IN	O	on	_	0	SENT_73	[p3l315t2969r390b3008],
30	the	DT	O	the	det	32	SENT_73	[p3l414t2953r511b3008],
31	acenocoumarol	NN	O	acenocoumarol	nn	32	SENT_73	[p3l536t2953r1004b3008],
32	dose	NN	O	dose	prep_on	26	SENT_73	[p3l1029t2953r1183b3008],
33	.	.	O	.	_	0	SENT_73	[p3l1029t2953r1183b3008],

1	Material	NN	O	material	_	0	SENT_74	[p3l8t3131r279b3185],
2	and	CC	O	and	_	0	SENT_74	[p3l301t3131r421b3185],
3	methods	NNS	O	method	conj_and	1	SENT_74	[p3l444t3131r727b3185],

1	The	DT	O	the	det	2	SENT_75	[p3l108t3308r218b3363],
2	study	NN	O	study	nsubj	3	SENT_75	[p3l237t3308r402b3377],
3	included	VBD	O	include	_	0	SENT_75	[p3l419t3308r677b3363],
4	301	CD	NUMBER	301	num	6	SENT_75	[p3l694t3311r797b3363],
5	consecutive	JJ	O	consecutive	amod	6	SENT_75	[p3l823t3309r1175b3363],
6	patients	NNS	O	patient	dobj	3	SENT_75	[p3l1193t3309r1433b3377],
7	who	WP	O	who	nsubj	8	SENT_75	[p3l1450t3308r1583b3363],
8	required	VBD	O	require	rcmod	6	SENT_75	[p3l1601t3308r1856b3377],
9	oral	JJ	O	oral	amod	11	SENT_75	[p3l1874t3308r1987b3363],
10	anticoagulant	JJ	O	anticoagulant	amod	11	SENT_75	[p3l2005t3309r2145b3363, p3l9t3397r303b3466],
11	treatment	NN	O	treatment	dobj	8	SENT_75	[p3l319t3405r621b3452],
12	with	IN	O	with	_	0	SENT_75	[p3l637t3397r776b3452],
13	acenocoumarol	NN	O	acenocoumarol	prep_with	8	SENT_75	[p3l795t3397r1269b3461],
14	,	,	O	,	_	0	SENT_75	[p3l795t3397r1269b3461],
15	admitted	VBN	O	admit	partmod	13	SENT_75	[p3l1289t3397r1560b3452],
16	within	IN	O	within	_	0	SENT_75	[p3l1579t3397r1777b3452],
17	the	DT	O	the	det	19	SENT_75	[p3l1796t3397r1891b3452],
18	Internal	JJ	ORGANIZATION	internal	amod	19	SENT_75	[p3l1911t3397r2145b3452],
19	Medicine	NN	ORGANIZATION	medicine	prep_within	15	SENT_75	[p3l9t3486r286b3541],
20	and	CC	ORGANIZATION	and	_	0	SENT_75	[p3l321t3486r430b3541],
21	Cardiology	NNP	ORGANIZATION	Cardiology	nn	22	SENT_75	[p3l467t3486r789b3555],
22	Departments	NNP	ORGANIZATION	Departments	conj_and	19	SENT_75	[p3l823t3490r1214b3555],
23	of	IN	ORGANIZATION	of	_	0	SENT_75	[p3l1250t3486r1313b3541],
24	the	DT	ORGANIZATION	the	det	26	SENT_75	[p3l1340t3486r1436b3541],
25	Municipal	JJ	ORGANIZATION	municipal	amod	26	SENT_75	[p3l1472t3486r1771b3555],
26	Hospital	NN	ORGANIZATION	hospital	prep_of	22	SENT_75	[p3l1808t3486r2055b3555],
27	of	IN	ORGANIZATION	of	_	0	SENT_75	[p3l2091t3486r2153b3541],
28	Cluj	NNP	ORGANIZATION	Cluj	prep_of	26	SENT_75	[p3l9t3576r375b3644],
29	.	.	O	.	_	0	SENT_75	[p3l9t3576r375b3644],

1	—	NN	O	—	_	0	SENT_76	[p3l9t3576r375b3644],
2	.	.	O	.	_	0	SENT_76	[p3l9t3576r375b3644],

1	Napoca	NNP	PERSON	Napoca	_	0	SENT_77	[p3l9t3576r375b3644],
2	and	CC	O	and	_	0	SENT_77	[p3l413t3576r523b3631],
3	the	DT	O	the	det	5	SENT_77	[p3l563t3576r658b3631],
4	Cardiology	NNP	O	Cardiology	nn	5	SENT_77	[p3l699t3576r1020b3644],
5	Department	NNP	O	Department	conj_and	1	SENT_77	[p3l1059t3579r1424b3644],
6	of	IN	O	of	_	0	SENT_77	[p3l1461t3576r1524b3631],
7	the	DT	O	the	det	12	SENT_77	[p3l1555t3576r1650b3631],
8	Heart	NNP	ORGANIZATION	Heart	nn	12	SENT_77	[p3l1691t3579r1857b3631],
9	Institute	NNP	ORGANIZATION	Institute	nn	12	SENT_77	[p3l1896t3577r2145b3631],
10	“	NNP	O	“	nn	12	SENT_77	[p3l9t3665r259b3720],
11	Niculae	NNP	O	Niculae	nn	12	SENT_77	[p3l9t3665r259b3720],
12	Stancioiu	NNP	O	Stancioiu	prep_of	5	SENT_77	[p3l294t3666r595b3720],
13	”	NN	O	”	dep	1	SENT_77	[p3l294t3666r595b3720],
14	in	IN	O	in	_	0	SENT_77	[p3l632t3666r688b3719],
15	Cluj	NNP	LOCATION	Cluj	prep_in	13	SENT_77	[p3l723t3665r1089b3733],
16	.	.	O	.	_	0	SENT_77	[p3l723t3665r1089b3733],

1	—	NN	O	—	_	0	SENT_78	[p3l723t3665r1089b3733],
2	.	.	O	.	_	0	SENT_78	[p3l723t3665r1089b3733],

1	Napoca	NN	PERSON	napoca	_	0	SENT_79	[p3l723t3665r1089b3733],
2	between	IN	O	between	_	0	SENT_79	[p3l1121t3665r1381b3720],
3	October	NNP	DATE	October	prep_between	1	SENT_79	[p3l1416t3665r1654b3720],
4	2008	CD	DATE	2008	num	3	SENT_79	[p3l1686t3668r1833b3720],
5	and	CC	O	and	_	0	SENT_79	[p3l1870t3665r1979b3720],
6	June	NNP	DATE	June	prep_between	1	SENT_79	[p3l2007t3668r2145b3733],
7	2011	CD	DATE	2011	num	6	SENT_79	[p3l9t3756r171b3808],
8	.	.	O	.	_	0	SENT_79	[p3l9t3756r171b3808],

1	Informed	JJ	O	informed	amod	2	SENT_80	[p4l111t27r387b82],
2	consent	NN	O	consent	nsubjpass	4	SENT_80	[p4l419t35r653b82],
3	was	VBD	O	be	auxpass	4	SENT_80	[p4l681t43r798b82],
4	obtained	VBN	O	obtain	_	0	SENT_80	[p4l830t27r1092b82],
5	from	IN	O	from	_	0	SENT_80	[p4l1124t27r1268b82],
6	all	DT	O	all	predet	8	SENT_80	[p4l1298t27r1366b82],
7	the	DT	O	the	det	8	SENT_80	[p4l1397t27r1492b82],
8	participants	NNS	O	participant	prep_from	4	SENT_80	[p4l1524t28r1879b96],
9	prior	RB	O	prior	_	0	SENT_80	[p4l1911t28r2058b96],
10	to	TO	O	to	_	0	SENT_80	[p4l2087t35r2145b82],
11	their	PRP$	O	they	poss	12	SENT_80	[p4l8t116r152b171],
12	enrolment	NN	O	enrolment	prep_prior_to	8	SENT_80	[p4l171t116r488b171],
13	in	IN	O	in	_	0	SENT_80	[p4l507t117r562b171],
14	the	DT	O	the	det	15	SENT_80	[p4l583t116r679b171],
15	study	NN	O	study	prep_in	8	SENT_80	[p4l701t116r878b185],
16	,	,	O	,	_	0	SENT_80	[p4l701t116r878b185],
17	including	VBG	O	include	_	0	SENT_80	[p4l901t116r1182b185],
18	consent	NN	O	consent	prep_including	8	SENT_80	[p4l1202t124r1437b171],
19	on	IN	O	on	_	0	SENT_80	[p4l1456t132r1530b171],
20	genetic	JJ	O	genetic	amod	21	SENT_80	[p4l1550t117r1767b185],
21	evaluations	NNS	O	evaluation	prep_on	18	SENT_80	[p4l1788t116r2144b172],
22	.	.	O	.	_	0	SENT_80	[p4l1788t116r2144b172],

1	The	DT	O	the	det	3	SENT_81	[p4l108t205r220b260],
2	study	NN	O	study	nn	3	SENT_81	[p4l243t205r412b274],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_81	[p4l433t205r686b274],
4	was	VBD	O	be	auxpass	5	SENT_81	[p4l707t221r826b260],
5	submitted	VBN	O	submit	_	0	SENT_81	[p4l850t205r1160b260],
6	for	IN	O	for	_	0	SENT_81	[p4l1183t205r1268b260],
7	approval	NN	O	approval	prep_for	5	SENT_81	[p4l1288t205r1556b274],
8	to	TO	O	to	_	0	SENT_81	[p4l1578t213r1637b260],
9	the	DT	O	the	det	11	SENT_81	[p4l1659t205r1756b260],
10	Ethics	NNPS	ORGANIZATION	Ethics	nn	11	SENT_81	[p4l1779t205r1959b260],
11	Commission	NNP	ORGANIZATION	Commission	prep_to	5	SENT_81	[p4l1982t208r2145b260, p4l9t297r245b351],
12	of	IN	O	of	_	0	SENT_81	[p4l269t296r332b351],
13	“	CD	NUMBER	“	num	17	SENT_81	[p4l349t296r514b351],
14	luliu	NN	O	luliu	nn	17	SENT_81	[p4l349t296r514b351],
15	Hatieganu	NNP	O	Hatieganu	nn	17	SENT_81	[p4l538t297r878b366],
16	”	NNP	O	”	nn	17	SENT_81	[p4l538t297r878b366],
17	University	NNP	ORGANIZATION	University	prep_of	11	SENT_81	[p4l902t297r1220b364],
18	of	IN	ORGANIZATION	of	_	0	SENT_81	[p4l1242t296r1306b351],
19	Medicine	NNP	ORGANIZATION	Medicine	prep_of	11	SENT_81	[p4l1322t296r1604b351],
20	and	CC	O	and	_	0	SENT_81	[p4l1627t296r1739b351],
21	Pharmacy	NNP	O	Pharmacy	conj_and	19	SENT_81	[p4l1763t296r2067b364],
22	in	IN	O	in	_	0	SENT_81	[p4l2090t297r2146b350],
23	Cluj	NNP	LOCATION	Cluj	prep_in	5	SENT_81	[p4l9t384r396b452],
24	.	.	O	.	_	0	SENT_81	[p4l9t384r396b452],

1	—	NN	O	—	_	0	SENT_82	[p4l9t384r396b452],
2	.	.	O	.	_	0	SENT_82	[p4l9t384r396b452],

1	Napoca	NNP	PERSON	Napoca	_	0	SENT_83	[p4l9t384r396b452],
2	.	.	O	.	_	0	SENT_83	[p4l9t384r396b452],

1	The	DT	O	the	det	4	SENT_84	[p4l108t472r220b527],
2	following	VBG	O	follow	amod	4	SENT_84	[p4l245t472r535b541],
3	inclusion	NN	O	inclusion	nn	4	SENT_84	[p4l558t472r835b527],
4	criteria	NNS	O	criterion	nsubjpass	6	SENT_84	[p4l860t473r1077b527],
5	were	VBD	O	be	auxpass	6	SENT_84	[p4l1099t488r1253b527],
6	used	VBN	O	use	_	0	SENT_84	[p4l1277t472r1437b528],
7	:	:	O	:	_	0	SENT_84	[p4l1277t472r1437b528],

1	-	:	O	-	_	0	SENT_85	[p4l50t682r72b688],
2	age	NN	O	age	_	0	SENT_85	[p4l111t666r213b718],
3	over	IN	O	over	_	0	SENT_85	[p4l238t666r374b705],
4	18	CD	DURATION	18	num	5	SENT_85	[p4l399t653r467b705],
5	years	NNS	NUMBER	year	tmod	6	SENT_85	[p4l494t666r655b718],
6	—	RB	O	—	amod	7	SENT_85	[p4l50t771r72b777],
7	diagnosis	NN	O	diagnosis	prep_over	2	SENT_85	[p4l111t738r396b807],
8	of	IN	O	of	_	0	SENT_85	[p4l423t738r486b793],
9	acute	JJ	O	acute	amod	12	SENT_85	[p4l505t746r667b793],
10	deep	JJ	O	deep	amod	12	SENT_85	[p4l695t738r841b807],
11	venous	JJ	O	venous	amod	12	SENT_85	[p4l867t754r1085b793],
12	thrombosis	NN	O	thrombosis	prep_of	7	SENT_85	[p4l1111t738r1456b793],
13	of	IN	O	of	_	0	SENT_85	[p4l1484t738r1547b793],
14	the	DT	O	the	det	16	SENT_85	[p4l1566t738r1663b793],
15	lower	JJR	O	lower	amod	16	SENT_85	[p4l1690t738r1867b793],
16	limbs	NNS	O	limb	prep_of	12	SENT_85	[p4l1892t738r2057b793],
17	or	CC	O	or	_	0	SENT_85	[p4l2084t754r2147b793],
18	pulmonary	JJ	O	pulmonary	amod	21	SENT_85	[p4l111t828r449b896],
19	thrombo	NN	O	thrombo	nn	21	SENT_85	[p4l491t828r1106b891],
20	—	NN	O	—	nn	21	SENT_85	[p4l491t828r1106b891],
21	embolism	NN	O	embolism	conj_or	2	SENT_85	[p4l491t828r1106b891],
22	,	,	O	,	_	0	SENT_85	[p4l491t828r1106b891],
23	persistent	JJ	O	persistent	amod	21	SENT_85	[p4l1152t829r1456b896],
24	or	CC	O	or	_	0	SENT_85	[p4l1500t844r1563b883],
25	permanent	JJ	O	permanent	amod	21	SENT_85	[p4l1606t836r1946b896],
26	atrial	JJ	O	atrial	amod	27	SENT_85	[p4l1988t828r2145b883],
27	ﬁbrillation	NN	O	ﬁbrillation	dep	2	SENT_85	[p4l111t916r432b972],
28	or	CC	O	or	_	0	SENT_85	[p4l457t932r520b972],
29	heart	NN	O	heart	nn	31	SENT_85	[p4l543t917r703b972],
30	valve	NN	O	valve	nn	31	SENT_85	[p4l724t917r885b972],
31	prosthesis	NN	O	prosthesis	conj_or	27	SENT_85	[p4l910t917r1220b985],

1	—	RB	O	—	advmod	2	SENT_86	[p4l50t1038r72b1043],
2	no	DT	O	no	amod	3	SENT_86	[p4l111t1021r187b1060],
3	contraindications	NNS	O	contraindication	dep	23	SENT_86	[p4l223t1005r783b1060],
4	for	IN	O	for	_	0	SENT_86	[p4l819t1005r907b1060],
5	anticoagulant	JJ	O	anticoagulant	amod	8	SENT_86	[p4l941t1005r1380b1074],
6	treatment	NN	O	treatment	nn	8	SENT_86	[p4l1414t1013r1736b1060],
7	(	NN	O	(	nn	8	SENT_86	[p4l1773t1005r2047b1074],
8	heparin	NN	O	heparin	prep_for	3	SENT_86	[p4l1773t1005r2047b1074],
9	or	CC	O	or	_	0	SENT_86	[p4l2082t1021r2147b1060],
10	acenocoumarol	NN	O	acenocoumarol	nn	11	SENT_86	[p4l111t1094r567b1149],
11	allergy	NN	O	allergy	conj_or	8	SENT_86	[p4l584t1094r797b1163],
12	,	,	O	,	_	0	SENT_86	[p4l584t1094r797b1163],
13	active	JJ	O	active	amod	14	SENT_86	[p4l815t1095r988b1149],
14	hemorrhage	NN	O	hemorrhage	appos	8	SENT_86	[p4l1006t1094r1384b1163],
15	,	,	O	,	_	0	SENT_86	[p4l1006t1094r1384b1163],
16	active	JJ	O	active	amod	18	SENT_86	[p4l1402t1095r1575b1149],
17	peptic	JJ	O	peptic	amod	18	SENT_86	[p4l1593t1095r1776b1163],
18	ulcer	NN	O	ulcer	appos	14	SENT_86	[p4l1792t1094r1952b1158],
19	,	,	O	,	_	0	SENT_86	[p4l1792t1094r1952b1158],
20	ische	NN	O	ische	nn	21	SENT_86	[p4l1970t1094r2144b1149],
21	—	NN	O	—	dep	23	SENT_86	[p4l1970t1094r2144b1149],
22	mic	JJ	O	mic	amod	23	SENT_86	[p4l111t1184r219b1238],
23	stroke	NN	O	stroke	dep	64	SENT_86	[p4l236t1183r418b1238],
24	at	IN	O	at	_	0	SENT_86	[p4l435t1192r492b1238],
25	inclusion	NN	O	inclusion	prep_at	23	SENT_86	[p4l507t1183r775b1238],
26	or	CC	O	or	_	0	SENT_86	[p4l792t1199r854b1238],
27	in	IN	O	in	_	0	SENT_86	[p4l870t1184r925b1238],
28	the	DT	DATE	the	det	29	SENT_86	[p4l941t1183r1036b1238],
29	week	NN	DATE	week	npadvmod	48	SENT_86	[p4l1052t1183r1214b1238],
30	prior	RB	O	prior	advmod	29	SENT_86	[p4l1229t1184r1375b1252],
31	to	TO	O	to	_	0	SENT_86	[p4l1390t1191r1447b1238],
32	inclusion	NN	O	inclusion	prep_to	30	SENT_86	[p4l1465t1183r1747b1247],
33	,	,	O	,	_	0	SENT_86	[p4l1465t1183r1747b1247],
34	hemorrhagic	JJ	O	hemorrhagic	amod	35	SENT_86	[p4l1765t1183r2146b1252],
35	stroke	NN	O	stroke	appos	32	SENT_86	[p4l111t1272r294b1327],
36	in	IN	O	in	_	0	SENT_86	[p4l340t1273r395b1326],
37	the	DT	DURATION	the	det	39	SENT_86	[p4l440t1272r535b1327],
38	three	CD	DURATION	three	num	39	SENT_86	[p4l580t1272r736b1327],
39	months	NNS	NUMBER	month	prep_in	35	SENT_86	[p4l783t1272r1010b1327],
40	prior	RB	O	prior	_	0	SENT_86	[p4l1056t1273r1203b1341],
41	to	TO	O	to	_	0	SENT_86	[p4l1246t1280r1304b1327],
42	inclusion	NN	O	inclusion	prep_prior_to	48	SENT_86	[p4l1350t1272r1633b1336],
43	,	,	O	,	_	0	SENT_86	[p4l1350t1272r1633b1336],
44	elevated	JJ	O	elevated	amod	46	SENT_86	[p4l1679t1272r1931b1327],
45	blood	NN	O	blood	nn	46	SENT_86	[p4l1976t1272r2144b1327],
46	pressure	NN	O	pressure	appos	42	SENT_86	[p4l110t1377r366b1429],
47	—	CD	NUMBER	—	num	48	SENT_86	[p4l402t1394r450b1399],
48	systolic	NN	O	systolic	prep_in	23	SENT_86	[p4l486t1361r707b1430],
49	over	IN	O	over	_	0	SENT_86	[p4l740t1377r874b1416],
50	220	CD	NUMBER	220	num	52	SENT_86	[p4l905t1364r1015b1416],
51	mm	NN	O	mm	nn	52	SENT_86	[p4l1043t1377r1163b1415],
52	Hg	NN	O	hg	prep_over	48	SENT_86	[p4l1188t1364r1283b1430],
53	,	,	O	,	_	0	SENT_86	[p4l1188t1364r1283b1430],
54	diastolic	NN	O	diastolic	appos	48	SENT_86	[p4l1318t1361r1567b1416],
55	over	IN	O	over	_	0	SENT_86	[p4l1600t1377r1734b1416],
56	120	CD	NUMBER	120	num	58	SENT_86	[p4l1769t1364r1876b1416],
57	mm	NN	O	mm	nn	58	SENT_86	[p4l1903t1377r2023b1415],
58	Hg	NN	O	hg	prep_over	54	SENT_86	[p4l2048t1364r2143b1430],
59	,	,	O	,	_	0	SENT_86	[p4l2048t1364r2143b1430],
60	thrombocytopenia	NN	O	thrombocytopenia	appos	48	SENT_86	[p4l109t1450r1042b1519],
61	<	JJR	O	<	dep	60	SENT_86	[p4l109t1450r1042b1519],
62	100,000	CD	NUMBER	100,000	dep	23	SENT_86	[p4l109t1450r1042b1519],
63	/	:	O	/	punct	64	SENT_86	[p4l109t1450r1042b1519],
64	ﬂ	NN	O	ﬂ	_	0	SENT_86	[p4l109t1450r1042b1519],
65	,	,	O	,	_	0	SENT_86	[p4l109t1450r1042b1519],
66	antecedents	NNS	O	antecedent	appos	64	SENT_86	[p4l1104t1450r1466b1505],
67	of	IN	O	of	_	0	SENT_86	[p4l1528t1450r1591b1505],
68	heparin	NN	O	heparin	nn	69	SENT_86	[p4l1644t1450r2144b1519],
69	—	NN	O	—	prep_of	66	SENT_86	[p4l1644t1450r2144b1519],
70	induced	VBD	O	induce	partmod	69	SENT_86	[p4l1644t1450r2144b1519],
71	thrombocytopenia	NN	O	thrombocytopenia	dobj	70	SENT_86	[p4l109t1539r681b1608],
72	,	,	O	,	_	0	SENT_86	[p4l109t1539r681b1608],
73	and	CC	O	and	_	0	SENT_86	[p4l703t1539r812b1594],
74	hepatic	JJ	O	hepatic	amod	76	SENT_86	[p4l836t1539r1055b1608],
75	failure	NN	O	failure	nn	76	SENT_86	[p4l1076t1539r1308b1608],
76	)	NN	O	)	appos	64	SENT_86	[p4l1076t1539r1308b1608],
77	.	.	O	.	_	0	SENT_86	[p4l1076t1539r1308b1608],

1	Pregnant	JJ	O	pregnant	amod	2	SENT_87	[p4l110t1721r382b1786],
2	women	NNS	O	woman	nsubjpass	29	SENT_87	[p4l398t1733r641b1781],
3	,	,	O	,	_	0	SENT_87	[p4l398t1733r641b1781],
4	patients	NNS	O	patient	appos	2	SENT_87	[p4l662t1718r901b1786],
5	with	IN	O	with	_	0	SENT_87	[p4l921t1718r1060b1773],
6	a	DT	O	a	det	8	SENT_87	[p4l1079t1733r1110b1773],
7	life	NN	O	life	nn	8	SENT_87	[p4l1130t1717r1219b1773],
8	expectancy	NN	O	expectancy	prep_with	4	SENT_87	[p4l1240t1726r1580b1786],
9	of	IN	O	of	_	0	SENT_87	[p4l1598t1717r1661b1773],
10	less	JJR	DURATION	less	mwe	11	SENT_87	[p4l1674t1718r1781b1773],
11	than	IN	DURATION	than	quantmod	12	SENT_87	[p4l1801t1718r1937b1773],
12	1	CD	DURATION	1	num	13	SENT_87	[p4l1960t1721r1983b1772],
13	year	NN	NUMBER	year	prep_of	8	SENT_87	[p4l2015t1733r2147b1786],
14	due	JJ	O	due	amod	4	SENT_87	[p4l8t1806r118b1861],
15	to	TO	O	to	aux	16	SENT_87	[p4l143t1814r202b1861],
16	co	VB	O	co	xcomp	14	SENT_87	[p4l228t1806r666b1861],
17	—	NN	O	—	nn	18	SENT_87	[p4l228t1806r666b1861],
18	morbidities	NNS	O	morbidity	dobj	16	SENT_87	[p4l228t1806r666b1861],
19	and	CC	O	and	_	0	SENT_87	[p4l693t1806r802b1861],
20	patients	NNS	O	patient	amod	4	SENT_87	[p4l829t1807r1068b1875],
21	who	WP	O	who	nsubj	24	SENT_87	[p4l1094t1806r1226b1861],
22	had	VBD	O	have	aux	24	SENT_87	[p4l1253t1806r1362b1861],
23	not	RB	O	not	neg	24	SENT_87	[p4l1389t1814r1488b1861],
24	given	VBN	O	give	rcmod	20	SENT_87	[p4l1512t1807r1675b1875],
25	their	PRP$	O	they	poss	27	SENT_87	[p4l1701t1806r1844b1861],
26	informed	VBN	O	inform	amod	27	SENT_87	[p4l1868t1806r2144b1861],
27	consent	NN	O	consent	dobj	24	SENT_87	[p4l8t1903r242b1950],
28	were	VBD	O	be	auxpass	29	SENT_87	[p4l261t1911r411b1950],
29	excluded	VBN	O	exclude	_	0	SENT_87	[p4l434t1895r704b1950],
30	from	IN	O	from	_	0	SENT_87	[p4l727t1895r870b1950],
31	the	DT	O	the	det	32	SENT_87	[p4l891t1895r987b1950],
32	study	NN	O	study	prep_from	29	SENT_87	[p4l1009t1895r1187b1964],
33	.	.	O	.	_	0	SENT_87	[p4l1009t1895r1187b1964],

1	The	DT	O	the	det	3	SENT_88	[p4l107t1984r218b2039],
2	following	VBG	O	follow	amod	3	SENT_88	[p4l243t1984r527b2053],
3	data	NNS	O	datum	nsubjpass	5	SENT_88	[p4l550t1984r679b2039],
4	was	VBD	O	be	auxpass	5	SENT_88	[p4l701t2000r819b2039],
5	recorded	VBN	O	record	_	0	SENT_88	[p4l845t1984r1110b2039],
6	for	IN	O	for	_	0	SENT_88	[p4l1136t1984r1220b2039],
7	each	DT	O	each	det	8	SENT_88	[p4l1242t1984r1379b2039],
8	patient	NN	O	patient	prep_for	5	SENT_88	[p4l1403t1985r1632b2053],
9	:	:	O	:	_	0	SENT_88	[p4l1403t1985r1632b2053],
10	age	NN	O	age	nsubj	86	SENT_88	[p4l1662t2000r1777b2053],
11	,	,	O	,	_	0	SENT_88	[p4l1662t2000r1777b2053],
12	sex	NN	O	sex	appos	10	SENT_88	[p4l1803t2000r1912b2048],
13	,	,	O	,	_	0	SENT_88	[p4l1803t2000r1912b2048],
14	indication	NN	O	indication	appos	10	SENT_88	[p4l1939t1984r2145b2039, p4l7t2075r125b2129],
15	for	IN	O	for	_	0	SENT_88	[p4l150t2074r234b2129],
16	oral	JJ	O	oral	amod	18	SENT_88	[p4l256t2074r369b2129],
17	anticoagulant	JJ	O	anticoagulant	amod	18	SENT_88	[p4l394t2074r804b2142],
18	treatment	NN	O	treatment	prep_for	14	SENT_88	[p4l826t2082r1140b2137],
19	,	,	O	,	_	0	SENT_88	[p4l826t2082r1140b2137],
20	concomitant	JJ	O	concomitant	amod	21	SENT_88	[p4l1165t2075r1543b2129],
21	therapy	NN	O	therapy	appos	10	SENT_88	[p4l1565t2074r1799b2142],
22	potentially	RB	O	potentially	advmod	23	SENT_88	[p4l1822t2074r2146b2142],
23	inﬂuencing	VBG	O	inﬂuencing	partmod	10	SENT_88	[p4l9t2163r347b2231],
24	the	DT	O	the	det	25	SENT_88	[p4l366t2163r462b2218],
25	metabolization	NN	O	metabolization	dobj	23	SENT_88	[p4l484t2163r934b2218],
26	of	IN	O	of	_	0	SENT_88	[p4l956t2163r1019b2218],
27	oral	JJ	O	oral	amod	28	SENT_88	[p4l1032t2163r1145b2218],
28	anticoagulants	NNS	O	anticoagulant	prep_of	25	SENT_88	[p4l1168t2163r1604b2231],
29	by	IN	O	by	_	0	SENT_88	[p4l1626t2163r1699b2231],
30	the	DT	O	the	det	32	SENT_88	[p4l1718t2163r1814b2218],
31	enzymatic	JJ	O	enzymatic	amod	32	SENT_88	[p4l1836t2164r2145b2231],
32	system	NN	O	system	dep	37	SENT_88	[p4l9t2259r219b2320],
33	of	IN	O	of	_	0	SENT_88	[p4l244t2251r308b2306],
34	P450	NN	O	p450	prep_of	32	SENT_88	[p4l325t2254r473b2306],
35	cytochrome	NN	O	cytochrome	dep	37	SENT_88	[p4l499t2251r856b2320],
36	(	CD	NUMBER	(	num	35	SENT_88	[p4l886t2251r1285b2319],
37	amiodarone	NN	O	amiodarone	dep	47	SENT_88	[p4l886t2251r1285b2319],
38	,	,	O	,	_	0	SENT_88	[p4l886t2251r1285b2319],
39	statins	NNS	O	statin	dep	47	SENT_88	[p4l1313t2252r1521b2315],
40	,	,	O	,	_	0	SENT_88	[p4l1313t2252r1521b2315],
41	spironolactone	NN	O	spironolactone	dep	47	SENT_88	[p4l1549t2251r2007b2320],
42	,	,	O	,	_	0	SENT_88	[p4l1549t2251r2007b2320],
43	and	CC	O	and	_	0	SENT_88	[p4l2034t2251r2143b2306],
44	proton	NN	O	proton	nn	46	SENT_88	[p4l8t2348r210b2409],
45	pump	NN	O	pump	nn	46	SENT_88	[p4l230t2356r405b2409],
46	inhibitors	NNS	O	inhibitor	dep	47	SENT_88	[p4l426t2340r739b2408],
47	)	NN	O	)	agent	23	SENT_88	[p4l426t2340r739b2408],
48	and	CC	O	and	_	0	SENT_88	[p4l763t2340r872b2395],
49	by	IN	O	by	_	0	SENT_88	[p4l892t2340r965b2409],
50	the	DT	O	the	det	54	SENT_88	[p4l982t2340r1078b2395],
51	oral	JJ	O	oral	amod	54	SENT_88	[p4l1097t2340r1211b2395],
52	anticoagulant	JJ	O	anticoagulant	amod	54	SENT_88	[p4l1231t2340r1640b2409],
53	dose	NN	O	dose	nn	54	SENT_88	[p4l1658t2340r1795b2395],
54	(	NN	O	(	agent	23	SENT_88	[p4l1819t2340r2145b2409],
55	expressed	VBN	O	express	partmod	54	SENT_88	[p4l1819t2340r2145b2409],
56	in	IN	O	in	_	0	SENT_88	[p4l8t2430r64b2484],
57	mg/week	JJ	O	mg/week	amod	58	SENT_88	[p4l93t2429r397b2498],
58	)	NN	O	)	prep_in	55	SENT_88	[p4l93t2429r397b2498],
59	required	VBN	O	require	partmod	58	SENT_88	[p4l430t2429r685b2498],
60	to	TO	O	to	aux	61	SENT_88	[p4l713t2437r772b2484],
61	reach	VB	O	reach	xcomp	59	SENT_88	[p4l801t2429r963b2484],
62	a	DT	O	a	det	66	SENT_88	[p4l991t2445r1022b2484],
63	stable	JJ	O	stable	amod	66	SENT_88	[p4l1051t2429r1225b2484],
64	target	NN	O	target	nn	66	SENT_88	[p4l1253t2437r1430b2498],
65	INR	NN	O	inr	nn	66	SENT_88	[p4l1457t2433r1566b2484],
66	(	NN	O	(	dobj	61	SENT_88	[p4l1595t2429r1881b2498],
67	between	IN	O	between	_	0	SENT_88	[p4l1595t2429r1881b2498],
68	2	CD	NUMBER	2	prep_between	66	SENT_88	[p4l1908t2432r1941b2484],
69	and	CC	O	and	_	0	SENT_88	[p4l1971t2429r2080b2484],
70	3	CD	DATE	3	conj_and	68	SENT_88	[p4l2109t2432r2141b2484],
71	for	IN	O	for	_	0	SENT_88	[p4l8t2518r92b2573],
72	venous	JJ	O	venous	amod	73	SENT_88	[p4l128t2534r343b2573],
73	thrombosis	NN	O	thrombosis	prep_for	61	SENT_88	[p4l382t2518r720b2573],
74	and	CC	O	and	_	0	SENT_88	[p4l761t2518r871b2573],
75	atrial	JJ	O	atrial	amod	76	SENT_88	[p4l911t2518r1064b2573],
76	ﬁbrillation	NN	O	ﬁbrillation	conj_and	73	SENT_88	[p4l1104t2518r1417b2573],
77	and	CC	O	and	_	0	SENT_88	[p4l1457t2518r1567b2573],
78	between	IN	O	between	quantmod	79	SENT_88	[p4l1606t2518r1867b2573],
79	2.5	CD	NUMBER	2.5	conj_and	73	SENT_88	[p4l1907t2521r1992b2573],
80	and	CC	NUMBER	and	_	0	SENT_88	[p4l2034t2518r2144b2573],
81	3.5	CD	NUMBER	3.5	conj_and	73	SENT_88	[p4l7t2610r93b2662],
82	for	IN	O	for	_	0	SENT_88	[p4l129t2607r213b2662],
83	heart	NN	O	heart	nn	85	SENT_88	[p4l245t2607r402b2662],
84	valve	NN	O	valve	nn	85	SENT_88	[p4l432t2607r589b2662],
85	prostheses	NNS	O	prosthesis	prep_for	79	SENT_88	[p4l624t2607r968b2675],
86	)	VBP	O	)	parataxis	5	SENT_88	[p4l624t2607r968b2675],
87	at	IN	O	at	_	0	SENT_88	[p4l1006t2615r1062b2662],
88	three	CD	NUMBER	three	num	90	SENT_88	[p4l1093t2607r1251b2662],
89	consecutive	JJ	O	consecutive	amod	90	SENT_88	[p4l1284t2608r1636b2662],
90	determinations	NNS	O	determination	prep_at	86	SENT_88	[p4l1670t2607r2144b2662],
91	.	.	O	.	_	0	SENT_88	[p4l1670t2607r2144b2662],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_89	[p4l8t2696r245b2751],
2	were	VBD	O	be	auxpass	3	SENT_89	[p4l268t2711r419b2751],
3	divided	VBN	O	divide	dep	54	SENT_89	[p4l441t2696r664b2751],
4	in	IN	O	in	_	0	SENT_89	[p4l688t2696r744b2750],
5	three	CD	NUMBER	three	num	6	SENT_89	[p4l765t2696r922b2751],
6	groups	NNS	O	group	prep_in	3	SENT_89	[p4l944t2711r1149b2764],
7	according	VBG	O	accord	_	0	SENT_89	[p4l1172t2696r1465b2764],
8	to	TO	O	to	prepc_according_to	3	SENT_89	[p4l1486t2704r1543b2751],
9	the	DT	O	the	det	11	SENT_89	[p4l1566t2696r1662b2751],
10	acenocoumarol	NN	O	acenocoumarol	nn	11	SENT_89	[p4l1684t2696r2144b2751],
11	dose	NN	O	dose	pobj	3	SENT_89	[p4l8t2784r145b2839],
12	needed	VBN	O	need	partmod	11	SENT_89	[p4l185t2784r403b2839],
13	to	TO	O	to	aux	14	SENT_89	[p4l443t2792r501b2839],
14	reach	VB	O	reach	xcomp	12	SENT_89	[p4l541t2784r703b2839],
15	a	DT	O	a	det	17	SENT_89	[p4l743t2800r774b2839],
16	stable	JJ	O	stable	amod	17	SENT_89	[p4l814t2784r987b2839],
17	INR	NN	O	inr	dobj	14	SENT_89	[p4l1027t2787r1150b2840],
18	:	:	O	:	_	0	SENT_89	[p4l1027t2787r1150b2840],
19	patients	NNS	O	patient	pobj	3	SENT_89	[p4l1196t2785r1435b2853],
20	receiving	VBG	O	receive	partmod	19	SENT_89	[p4l1476t2785r1751b2853],
21	a	DT	O	a	det	24	SENT_89	[p4l1788t2800r1819b2839],
22	low	JJ	O	low	amod	24	SENT_89	[p4l1858t2784r1970b2839],
23	dose	NN	O	dose	nn	24	SENT_89	[p4l2008t2784r2145b2839],
24	(	NN	O	(	dobj	20	SENT_89	[p4l12t2873r130b2941],
25	:7	CD	NUMBER	:7	num	27	SENT_89	[p4l12t2873r130b2941],
26	mg/week	JJ	O	mg/week	amod	27	SENT_89	[p4l159t2873r481b2942],
27	)	NN	O	)	tmod	20	SENT_89	[p4l159t2873r481b2942],
28	,	,	O	,	_	0	SENT_89	[p4l159t2873r481b2942],
29	patients	NNS	O	patient	appos	27	SENT_89	[p4l536t2874r776b2942],
30	receiving	VBG	O	receive	partmod	29	SENT_89	[p4l831t2874r1105b2942],
31	a	DT	O	a	det	34	SENT_89	[p4l1157t2889r1188b2928],
32	medium	NN	O	medium	nn	34	SENT_89	[p4l1241t2873r1493b2928],
33	dose	NN	O	dose	nn	34	SENT_89	[p4l1547t2873r1684b2928],
34	(	NN	O	(	dep	35	SENT_89	[p4l1741t2873r1859b2941],
35	>	JJR	O	>	dobj	30	SENT_89	[p4l1741t2873r1859b2941],
36	7	CD	NUMBER	7	num	37	SENT_89	[p4l1741t2873r1859b2941],
37	mg	NN	O	mg	dep	35	SENT_89	[p4l1888t2889r1983b2942],
38	and	CC	O	and	_	0	SENT_89	[p4l2035t2873r2144b2928],
39	<	JJR	O	<	dobj	30	SENT_89	[p4l6t2965r125b3017],
40	28	CD	NUMBER	28	num	42	SENT_89	[p4l6t2965r125b3017],
41	mg/week	NN	O	mg/week	nn	42	SENT_89	[p4l152t2962r458b3031],
42	)	NN	O	)	dep	39	SENT_89	[p4l152t2962r458b3031],
43	and	CC	O	and	_	0	SENT_89	[p4l492t2962r601b3017],
44	patients	NNS	O	patient	pobj	3	SENT_89	[p4l632t2963r872b3031],
45	receiving	VBG	O	receive	partmod	44	SENT_89	[p4l903t2963r1178b3031],
46	a	DT	O	a	det	50	SENT_89	[p4l1207t2978r1238b3017],
47	high	JJ	O	high	amod	50	SENT_89	[p4l1268t2962r1401b3031],
48	acenocoumarol	NN	O	acenocoumarol	nn	50	SENT_89	[p4l1430t2962r1889b3017],
49	dose	NN	O	dose	nn	50	SENT_89	[p4l1920t2962r2140b3031],
50	(	NN	O	(	dobj	45	SENT_89	[p4l1920t2962r2140b3031],
51	s	VBZ	O	s	cop	54	SENT_89	[p4l1920t2962r2140b3031],
52	)	CD	NUMBER	)	number	53	SENT_89	[p4l1920t2962r2140b3031],
53	(	CD	NUMBER	(	npadvmod	54	SENT_89	[p4l12t3052r169b3120],
54	>	JJR	O	>	_	0	SENT_89	[p4l12t3052r169b3120],
55	28	CD	NUMBER	28	num	57	SENT_89	[p4l12t3052r169b3120],
56	mg/week	NN	O	mg/week	nn	57	SENT_89	[p4l196t3051r520b3120],
57	)	NN	O	)	nsubj	54	SENT_89	[p4l196t3051r520b3120],
58	.	.	O	.	_	0	SENT_89	[p4l196t3051r520b3120],

1	The	DT	O	the	det	3	SENT_90	[p4l107t3141r219b3196],
2	genetic	JJ	O	genetic	amod	3	SENT_90	[p4l239t3142r462b3209],
3	analysis	NN	O	analysis	nsubj	4	SENT_90	[p4l482t3141r723b3209],
4	consisted	VBD	O	consist	_	0	SENT_90	[p4l745t3141r1030b3196],
5	of	IN	O	of	_	0	SENT_90	[p4l1052t3141r1115b3196],
6	genotyping	VBG	O	genotype	prepc_of	4	SENT_90	[p4l1127t3142r1475b3209],
7	the	DT	O	the	det	9	SENT_90	[p4l1495t3141r1591b3196],
8	CYP2C9	NN	O	cyp2c9	nn	9	SENT_90	[p4l1613t3144r1846b3196],
9	gene	NN	O	gene	dobj	6	SENT_90	[p4l1866t3157r2012b3209],
10	and	CC	O	and	_	0	SENT_90	[p4l2033t3141r2144b3196],
11	the	DT	O	the	det	13	SENT_90	[p4l7t3230r104b3285],
12	VKORC1	NN	O	vkorc1	nn	13	SENT_90	[p4l137t3232r385b3285],
13	gene	NN	O	gene	dobj	6	SENT_90	[p4l427t3245r572b3298],
14	and	CC	O	and	_	0	SENT_90	[p4l607t3230r718b3285],
15	assessment	NN	O	assessment	dobj	6	SENT_90	[p4l754t3238r1103b3285],
16	of	IN	O	of	_	0	SENT_90	[p4l1138t3229r1201b3285],
17	the	DT	O	the	det	19	SENT_90	[p4l1228t3230r1325b3285],
18	CYP2C9	NN	O	cyp2c9	nn	19	SENT_90	[p4l1361t3229r1659b3285],
19	*	NN	O	*	prep_of	15	SENT_90	[p4l1361t3229r1659b3285],
20	2	CD	NUMBER	2	number	24	SENT_90	[p4l1361t3229r1659b3285],
21	and	CC	O	and	_	0	SENT_90	[p4l1696t3230r1807b3285],
22	CYP2C9	CD	NUMBER	cyp2c9	num	25	SENT_90	[p4l1844t3229r2141b3285],
23	*	CD	NUMBER	*	number	24	SENT_90	[p4l1844t3229r2141b3285],
24	3	CD	NUMBER	3	num	25	SENT_90	[p4l1844t3229r2141b3285],
25	polymorphisms	NNS	O	polymorphism	dobj	4	SENT_90	[p4l8t3318r504b3387],
26	.	.	O	.	_	0	SENT_90	[p4l8t3318r504b3387],

1	Genotyping	VBG	O	genotype	csubjpass	11	SENT_91	[p4l527t3319r884b3387],
2	for	IN	O	for	_	0	SENT_91	[p4l906t3318r991b3373],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_91	[p4l1012t3318r1310b3373],
4	*	NN	O	*	prep_for	1	SENT_91	[p4l1012t3318r1310b3373],
5	2	CD	NUMBER	2	number	9	SENT_91	[p4l1012t3318r1310b3373],
6	and	CC	O	and	_	0	SENT_91	[p4l1334t3318r1446b3373],
7	CYP2C9	CD	NUMBER	cyp2c9	dep	4	SENT_91	[p4l1469t3318r1766b3373],
8	*	CD	NUMBER	*	number	9	SENT_91	[p4l1469t3318r1766b3373],
9	3	CD	NUMBER	3	dep	4	SENT_91	[p4l1469t3318r1766b3373],
10	was	VBD	O	be	auxpass	11	SENT_91	[p4l1790t3334r1909b3373],
11	carried	VBN	O	carry	_	0	SENT_91	[p4l1932t3318r2144b3373],
12	out	RP	O	out	prt	11	SENT_91	[p4l8t3415r109b3462],
13	using	VBG	O	use	xcomp	11	SENT_91	[p4l129t3408r294b3476],
14	PCR	NN	O	pcr	dobj	13	SENT_91	[p4l315t3410r607b3462],
15	.	.	O	.	_	0	SENT_91	[p4l315t3410r607b3462],

1	—	NN	O	—	_	0	SENT_92	[p4l315t3410r607b3462],
2	.	.	O	.	_	0	SENT_92	[p4l315t3410r607b3462],

1	RFLP	NN	O	rflp	nn	2	SENT_93	[p4l315t3410r607b3462],
2	technique	NN	O	technique	nsubj	4	SENT_93	[p4l627t3407r931b3476],
3	(	CD	NUMBER	(	dep	2	SENT_93	[p4l959t3407r1339b3476],
4	polymerase	NN	O	polymerase	_	0	SENT_93	[p4l959t3407r1339b3476],
5	chain	NN	O	chain	nn	12	SENT_93	[p4l1362t3407r1526b3462],
6	reaction	NN	O	reaction	nn	12	SENT_93	[p4l1549t3408r2145b3462],
7	—	NN	O	—	nn	12	SENT_93	[p4l1549t3408r2145b3462],
8	restriction	NN	O	restriction	nn	12	SENT_93	[p4l1549t3408r2145b3462],
9	fragment	NN	O	fragment	nn	12	SENT_93	[p4l8t3496r290b3565],
10	length	NN	O	length	nn	12	SENT_93	[p4l314t3496r508b3565],
11	polymorphism	NN	O	polymorphism	nn	12	SENT_93	[p4l534t3496r1010b3565],
12	)	NN	O	)	dobj	4	SENT_93	[p4l534t3496r1010b3565],
13	as	IN	O	as	_	0	SENT_93	[p4l1041t3512r1100b3551],
14	described	VBN	O	describe	prepc_as	12	SENT_93	[p4l1127t3496r1421b3551],
15	in	IN	O	in	advmod	14	SENT_93	[p4l1448t3497r1504b3551],
16	1999	CD	DATE	1999	pobj	15	SENT_93	[p4l1534t3499r1681b3551],
17	by	IN	O	by	_	0	SENT_93	[p4l1707t3496r1781b3565],
18	Aynacioglu	NNP	PERSON	Aynacioglu	prep_by	15	SENT_93	[p4l1803t3496r2145b3565],
19	et	FW	O	et	nn	21	SENT_93	[p4l8t3594r66b3640],
20	al.	FW	O	al.	nn	21	SENT_93	[p4l94t3585r159b3641],
21	[	FW	O	[	dobj	14	SENT_93	[p4l194t3585r327b3654],
22	12	CD	NUMBER	12	num	23	SENT_93	[p4l194t3585r327b3654],
23	]	NN	O	]	dep	12	SENT_93	[p4l194t3585r327b3654],
24	.	.	O	.	_	0	SENT_93	[p4l194t3585r327b3654],

1	Genotyping	VBG	O	genotype	_	0	SENT_94	[p4l359t3586r716b3654],
2	for	IN	O	for	_	0	SENT_94	[p4l746t3585r831b3640],
3	polymorphism	NN	O	polymorphism	nn	5	SENT_94	[p4l860t3585r1311b3654],
4	VKORC1	NN	O	vkorc1	nn	5	SENT_94	[p4l1338t3588r1586b3640],
5	c.	NN	O	c.	prep_for	1	SENT_94	[p4l1625t3588r1998b3641],
6	.	.	O	.	_	0	SENT_94	[p4l1625t3588r1998b3641],

1	—	NN	O	—	_	0	SENT_95	[p4l1625t3588r1998b3641],
2	.	.	O	.	_	0	SENT_95	[p4l1625t3588r1998b3641],

1	l639G	NN	O	l639g	_	0	SENT_96	[p4l1625t3588r1998b3641],
2	>	JJR	O	>	dep	1	SENT_96	[p4l1625t3588r1998b3641],
3	A	DT	O	a	dep	2	SENT_96	[p4l1625t3588r1998b3641],
4	was	VBD	O	be	auxpass	5	SENT_96	[p4l2025t3601r2144b3640],
5	performed	VBN	O	perform	rcmod	1	SENT_96	[p5l8t17r332b85],
6	using	VBG	O	use	xcomp	5	SENT_96	[p5l355t18r519b85],
7	PCR	NN	O	pcr	dobj	6	SENT_96	[p5l541t20r833b72],
8	.	.	O	.	_	0	SENT_96	[p5l541t20r833b72],

1	—	NN	O	—	_	0	SENT_97	[p5l541t20r833b72],
2	.	.	O	.	_	0	SENT_97	[p5l541t20r833b72],

1	RFLP	NN	O	rflp	nn	2	SENT_98	[p5l541t20r833b72],
2	technique	NN	O	technique	_	0	SENT_98	[p5l853t17r1158b85],
3	as	IN	O	as	prep	2	SENT_98	[p5l1181t33r1240b72],
4	described	VBN	O	describe	dep	3	SENT_98	[p5l1264t17r1558b72],
5	by	IN	O	by	_	0	SENT_98	[p5l1580t17r1654b85],
6	Wen	NNP	PERSON	Wen	prep_by	4	SENT_98	[p5l1672t20r1818b72],
7	et	FW	O	et	nn	9	SENT_98	[p5l1841t25r1898b72],
8	al.	FW	O	al.	nn	9	SENT_98	[p5l1919t17r1984b72],
9	[	FW	O	[	dobj	4	SENT_98	[p5l2011t17r2144b85],
10	13	CD	NUMBER	13	num	11	SENT_98	[p5l2011t17r2144b85],
11	]	NN	O	]	dep	2	SENT_98	[p5l2011t17r2144b85],
12	.	.	O	.	_	0	SENT_98	[p5l2011t17r2144b85],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_99	[p5l110t106r397b161],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_99	[p5l424t106r659b174],
3	was	VBD	O	be	auxpass	4	SENT_99	[p5l685t121r803b161],
4	performed	VBN	O	perform	_	0	SENT_99	[p5l830t105r1146b174],
5	using	VBG	O	use	xcomp	4	SENT_99	[p5l1174t106r1336b174],
6	the	DT	O	the	det	8	SENT_99	[p5l1360t106r1456b161],
7	Statistical	JJ	O	statistical	amod	8	SENT_99	[p5l1483t106r1769b161],
8	Package	NN	O	package	dobj	5	SENT_99	[p5l1797t106r2036b174],
9	for	IN	O	for	_	0	SENT_99	[p5l2063t105r2146b161],
10	Social	NNP	ORGANIZATION	Social	nn	11	SENT_99	[p5l8t194r179b249],
11	Sciences	NNPS	ORGANIZATION	Sciences	prep_for	5	SENT_99	[p5l211t195r461b249],
12	(	CD	NUMBER	(	num	13	SENT_99	[p5l497t194r673b262],
13	SPSS	NNS	ORGANIZATION	spss	tmod	5	SENT_99	[p5l497t194r673b262],
14	,	,	O	,	_	0	SENT_99	[p5l497t194r673b262],
15	ver	NN	O	ver	appos	13	SENT_99	[p5l704t210r814b250],
16	.	.	O	.	_	0	SENT_99	[p5l704t210r814b250],

1	17	CD	NUMBER	17	_	0	SENT_100	[p5l849t197r933b258],
2	,	,	O	,	_	0	SENT_100	[p5l849t197r933b258],
3	Chicago	NNP	LOCATION	Chicago	appos	1	SENT_100	[p5l966t194r1213b263],
4	,	,	O	,	_	0	SENT_100	[p5l966t194r1213b263],
5	IL	NN	O	il	appos	1	SENT_100	[p5l1245t197r1308b257],
6	,	,	O	,	_	0	SENT_100	[p5l1245t197r1308b257],
7	USA	NNP	LOCATION	USA	appos	1	SENT_100	[p5l1339t194r1505b262],
8	)	CD	NUMBER	)	num	7	SENT_100	[p5l1339t194r1505b262],
9	.	.	O	.	_	0	SENT_100	[p5l1339t194r1505b262],

1	Deviations	NNS	O	deviation	_	0	SENT_101	[p5l1538t195r1854b249],
2	of	IN	O	of	_	0	SENT_101	[p5l1886t194r1950b249],
3	allelic	JJ	O	allelic	amod	4	SENT_101	[p5l1973t194r2145b249],
4	frequencies	NNS	O	frequency	prep_of	1	SENT_101	[p5l8t283r353b352],
5	from	IN	O	from	_	0	SENT_101	[p5l381t283r525b338],
6	Hardy	NNP	PERSON	Hardy	prep_from	1	SENT_101	[p5l552t283r1071b352],
7	.	.	O	.	_	0	SENT_101	[p5l552t283r1071b352],

1	—	NN	O	—	_	0	SENT_102	[p5l552t283r1071b352],
2	.	.	O	.	_	0	SENT_102	[p5l552t283r1071b352],

1	Weinberg	NNP	PERSON	Weinberg	nn	2	SENT_103	[p5l552t283r1071b352],
2	equilibrium	NN	O	equilibrium	nsubjpass	4	SENT_103	[p5l1098t283r1450b352],
3	were	VBD	O	be	auxpass	4	SENT_103	[p5l1475t299r1626b338],
4	computed	VBN	O	compute	_	0	SENT_103	[p5l1654t283r1956b352],
5	using	VBG	O	use	xcomp	4	SENT_103	[p5l1984t284r2146b352],
6	a	DT	O	a	det	10	SENT_103	[p5l8t388r39b427],
7	Chi	NNP	O	Chi	nn	10	SENT_103	[p5l67t372r391b441],
8	—	CD	NUMBER	—	num	10	SENT_103	[p5l67t372r391b441],
9	square	JJ	O	square	amod	10	SENT_103	[p5l67t372r391b441],
10	test	NN	O	test	dobj	5	SENT_103	[p5l420t380r542b428],
11	.	.	O	.	_	0	SENT_103	[p5l420t380r542b428],

1	Quantitative	JJ	O	quantitative	amod	2	SENT_104	[p5l572t373r943b438],
2	variables	NNS	O	variable	nsubjpass	4	SENT_104	[p5l970t372r1237b427],
3	were	VBD	O	be	auxpass	4	SENT_104	[p5l1265t388r1416b427],
4	tested	VBN	O	test	_	0	SENT_104	[p5l1445t372r1627b427],
5	for	IN	O	for	_	0	SENT_104	[p5l1657t372r1740b427],
6	normality	NN	O	normality	prep_for	4	SENT_104	[p5l1767t372r2063b441],
7	of	IN	O	of	_	0	SENT_104	[p5l2089t372r2153b427],
8	distribution	NN	O	distribution	prep_of	6	SENT_104	[p5l8t461r359b516],
9	using	VBG	O	use	xcomp	4	SENT_104	[p5l388t462r550b530],
10	the	DT	O	the	det	11	SENT_104	[p5l577t461r672b516],
11	I	PRP	O	I	nsubj	12	SENT_104	[p5l702t461r1363b530],
12	(	VBP	O	(	ccomp	9	SENT_104	[p5l702t461r1363b530],
13	olmogorov	NN	O	olmogorov	dobj	12	SENT_104	[p5l702t461r1363b530],
14	.	.	O	.	_	0	SENT_104	[p5l702t461r1363b530],

1	—	NN	O	—	_	0	SENT_105	[p5l702t461r1363b530],
2	.	.	O	.	_	0	SENT_105	[p5l702t461r1363b530],

1	Smirnov	NNP	PERSON	Smirnov	nsubj	2	SENT_106	[p5l702t461r1363b530],
2	test	NN	O	test	_	0	SENT_106	[p5l1391t470r1513b517],
3	.	.	O	.	_	0	SENT_106	[p5l1391t470r1513b517],

1	Descriptive	JJ	O	descriptive	amod	2	SENT_107	[p5l1543t462r1880b530],
2	analysis	NN	O	analysis	nsubj	3	SENT_107	[p5l1908t461r2144b530],
3	included	VBD	O	include	_	0	SENT_107	[p5l9t551r266b606],
4	frequencies	NNS	O	frequency	dobj	3	SENT_107	[p5l290t551r634b619],
5	for	IN	O	for	_	0	SENT_107	[p5l658t551r742b606],
6	ordinal	JJ	O	ordinal	amod	7	SENT_107	[p5l762t551r974b606],
7	variables	NNS	O	variable	prep_for	3	SENT_107	[p5l995t551r1264b606],
8	and	CC	O	and	_	0	SENT_107	[p5l1286t551r1396b606],
9	the	DT	O	the	det	10	SENT_107	[p5l1419t551r1515b606],
10	median	NN	O	median	conj_and	7	SENT_107	[p5l1538t551r1763b606],
11	for	IN	O	for	_	0	SENT_107	[p5l1786t551r1869b606],
12	continuous	JJ	O	continuous	amod	13	SENT_107	[p5l1890t552r2144b606, p5l8t655r110b695],
13	variables	NNS	O	variable	prep_for	3	SENT_107	[p5l126t640r409b695],
14	.	.	O	.	_	0	SENT_107	[p5l126t640r409b695],

1	Differences	NNS	O	difference	nsubjpass	8	SENT_108	[p5l428t639r762b695],
2	in	IN	O	in	_	0	SENT_108	[p5l782t640r837b694],
3	the	DT	O	the	det	4	SENT_108	[p5l854t640r951b695],
4	median	NN	O	median	prep_in	1	SENT_108	[p5l969t640r1194b695],
5	between	IN	O	between	_	0	SENT_108	[p5l1211t640r1471b695],
6	groups	NNS	O	group	prep_between	4	SENT_108	[p5l1488t655r1693b708],
7	were	VBD	O	be	auxpass	8	SENT_108	[p5l1710t655r1860b695],
8	analyzed	VBN	O	analyze	_	0	SENT_108	[p5l1879t640r2144b708],
9	using	VBG	O	use	xcomp	8	SENT_108	[p5l8t729r169b797],
10	the	DT	O	the	det	11	SENT_108	[p5l199t728r295b783],
11	Mann	NNP	O	Mann	dobj	9	SENT_108	[p5l327t728r803b797],
12	.	.	O	.	_	0	SENT_108	[p5l327t728r803b797],

1	—	NN	O	—	_	0	SENT_109	[p5l327t728r803b797],
2	.	.	O	.	_	0	SENT_109	[p5l327t728r803b797],

1	Whitney	NNP	PERSON	Whitney	_	0	SENT_110	[p5l327t728r803b797],
2	test	NN	O	test	dep	1	SENT_110	[p5l832t736r943b783],
3	or	CC	O	or	_	0	SENT_110	[p5l972t744r1035b783],
4	the	DT	O	the	det	7	SENT_110	[p5l1064t728r1160b783],
5	l	NN	O	l	nn	7	SENT_110	[p5l1191t728r1642b783],
6	(	NN	O	(	nn	7	SENT_110	[p5l1191t728r1642b783],
7	ruskal	NN	O	ruskal	conj_or	2	SENT_110	[p5l1191t728r1642b783],
8	.	.	O	.	_	0	SENT_110	[p5l1191t728r1642b783],

1	—	NN	O	—	_	0	SENT_111	[p5l1191t728r1642b783],
2	.	.	O	.	_	0	SENT_111	[p5l1191t728r1642b783],

1	Wallis	NNP	PERSON	Wallis	nn	2	SENT_112	[p5l1191t728r1642b783],
2	test	NN	O	test	_	0	SENT_112	[p5l1674t736r1796b791],
3	,	,	O	,	_	0	SENT_112	[p5l1674t736r1796b791],
4	whichever	WDT	O	whichever	nsubj	6	SENT_112	[p5l1827t728r2147b783],
5	was	VBD	O	be	cop	6	SENT_112	[p5l6t833r124b872],
6	appropriate	JJ	O	appropriate	rcmod	2	SENT_112	[p5l159t818r524b886],
7	.	.	O	.	_	0	SENT_112	[p5l159t818r524b886],

1	The	DT	O	the	det	2	SENT_113	[p5l557t817r668b872],
2	correlation	NN	O	correlation	nsubjpass	7	SENT_113	[p5l703t817r1029b872],
3	between	IN	O	between	_	0	SENT_113	[p5l1063t817r1323b872],
4	continuous	JJ	O	continuous	amod	5	SENT_113	[p5l1359t818r1691b872],
5	variables	NNS	O	variable	prep_between	2	SENT_113	[p5l1725t817r1992b872],
6	was	VBD	O	be	auxpass	7	SENT_113	[p5l2026t833r2143b872],
7	assessed	VBN	O	assess	_	0	SENT_113	[p5l8t906r262b961],
8	using	VBG	O	use	xcomp	7	SENT_113	[p5l284t907r446b975],
9	Spearman	NNP	PERSON	Spearman	poss	11	SENT_113	[p5l466t909r809b975],
10	's	POS	O	's	_	0	SENT_113	[p5l466t909r809b975],
11	rho	NN	O	rho	dobj	8	SENT_113	[p5l832t906r947b962],
12	.	.	O	.	_	0	SENT_113	[p5l832t906r947b962],

1	A	DT	O	a	det	5	SENT_114	[p5l967t909r1012b961],
2	Chi	NNP	O	Chi	nn	5	SENT_114	[p5l1031t906r1355b975],
3	—	CD	NUMBER	—	num	5	SENT_114	[p5l1031t906r1355b975],
4	square	JJ	O	square	amod	5	SENT_114	[p5l1031t906r1355b975],
5	test	NN	O	test	nsubjpass	7	SENT_114	[p5l1376t914r1486b961],
6	was	VBD	O	be	auxpass	7	SENT_114	[p5l1504t922r1622b961],
7	used	VBN	O	use	_	0	SENT_114	[p5l1644t906r1782b961],
8	to	TO	O	to	aux	9	SENT_114	[p5l1804t914r1862b961],
9	compare	VB	O	compare	xcomp	7	SENT_114	[p5l1884t922r2144b975],
10	categorical	JJ	O	categorical	amod	11	SENT_114	[p5l8t995r330b1064],
11	variables	NNS	O	variable	dobj	9	SENT_114	[p5l361t995r644b1051],
12	.	.	O	.	_	0	SENT_114	[p5l361t995r644b1051],

1	Variables	NNS	O	variable	nsubjpass	16	SENT_115	[p5l675t995r951b1050],
2	that	WDT	O	that	nsubj	3	SENT_115	[p5l984t995r1104b1050],
3	achieved	VBD	O	achieve	rcmod	1	SENT_115	[p5l1136t995r1400b1050],
4	the	DT	O	the	det	5	SENT_115	[p5l1433t995r1529b1050],
5	criterion	NN	O	criterion	dobj	3	SENT_115	[p5l1561t996r1817b1050],
6	of	IN	O	of	_	0	SENT_115	[p5l1850t995r1912b1050],
7	signiﬁcance	NN	O	signiﬁcance	prep_of	5	SENT_115	[p5l1938t995r2144b1064, p5l8t1100r174b1140],
8	at	IN	O	at	_	0	SENT_115	[p5l205t1093r262b1140],
9	p	NN	O	p	prep_at	3	SENT_115	[p5l289t1087r506b1153],
10	<	JJR	O	<	amod	9	SENT_115	[p5l289t1087r506b1153],
11	0.25	CD	NUMBER	0.25	dep	10	SENT_115	[p5l289t1087r506b1153],
12	in	IN	O	in	dep	11	SENT_115	[p5l539t1085r594b1139],
13	univariate	JJ	O	univariate	amod	14	SENT_115	[p5l624t1085r927b1140],
14	analysis	NN	O	analysis	pobj	12	SENT_115	[p5l957t1085r1192b1153],
15	were	VBD	O	be	auxpass	16	SENT_115	[p5l1222t1100r1373b1140],
16	included	VBN	O	include	_	0	SENT_115	[p5l1403t1085r1662b1140],
17	in	IN	O	in	_	0	SENT_115	[p5l1692t1085r1748b1139],
18	multivariate	JJ	O	multivariate	amod	19	SENT_115	[p5l1778t1085r2144b1140],
19	analysis	NN	O	analysis	prep_in	16	SENT_115	[p5l8t1173r258b1242],
20	.	.	O	.	_	0	SENT_115	[p5l8t1173r258b1242],

1	A	DT	O	a	det	4	SENT_116	[p5l277t1175r322b1227],
2	multinomial	JJ	O	multinomial	amod	4	SENT_116	[p5l340t1173r710b1228],
3	logistic	JJ	O	logistic	amod	4	SENT_116	[p5l730t1173r943b1242],
4	regression	NN	O	regression	nsubjpass	6	SENT_116	[p5l962t1174r1271b1242],
5	was	VBD	O	be	auxpass	6	SENT_116	[p5l1289t1189r1407b1228],
6	used	VBN	O	use	dep	14	SENT_116	[p5l1428t1173r1566b1228],
7	to	TO	O	to	aux	8	SENT_116	[p5l1586t1181r1645b1228],
8	assess	VB	O	assess	xcomp	6	SENT_116	[p5l1665t1189r1845b1228],
9	the	DT	O	the	det	10	SENT_116	[p5l1865t1173r1961b1228],
10	inﬂuence	NN	O	inﬂuence	dobj	8	SENT_116	[p5l1982t1173r2145b1228, p5l8t1278r144b1317],
11	of	IN	O	of	_	0	SENT_116	[p5l165t1262r228b1317],
12	certain	JJ	O	certain	amod	13	SENT_116	[p5l240t1263r446b1317],
13	parameters	NNS	O	parameter	prep_of	10	SENT_116	[p5l467t1270r807b1331],
14	(	VBP	O	(	_	0	SENT_116	[p5l832t1262r972b1331],
15	age	NN	O	age	nsubj	14	SENT_116	[p5l832t1262r972b1331],
16	,	,	O	,	_	0	SENT_116	[p5l832t1262r972b1331],
17	sex	NN	O	sex	nsubj	14	SENT_116	[p5l994t1278r1104b1326],
18	,	,	O	,	_	0	SENT_116	[p5l994t1278r1104b1326],
19	and	CC	O	and	_	0	SENT_116	[p5l1125t1262r1234b1317],
20	concomitant	JJ	O	concomitant	amod	21	SENT_116	[p5l1256t1263r1633b1317],
21	medication	NN	O	medication	nsubj	14	SENT_116	[p5l1652t1262r1989b1317],
22	such	JJ	O	such	_	0	SENT_116	[p5l2010t1262r2145b1317],
23	as	IN	O	as	_	0	SENT_116	[p5l8t1367r67b1406],
24	CYP2C9	NN	O	cyp2c9	nn	25	SENT_116	[p5l94t1354r324b1406],
25	inducers	NNS	O	inducer	prep_such_as	21	SENT_116	[p5l351t1351r606b1406],
26	or	CC	O	or	_	0	SENT_116	[p5l634t1367r697b1406],
27	inhibitors	NNS	O	inhibitor	conj_or	25	SENT_116	[p5l721t1351r1024b1415],
28	,	,	O	,	_	0	SENT_116	[p5l721t1351r1024b1415],
29	CYP2C9	NN	O	cyp2c9	nn	30	SENT_116	[p5l1052t1354r1281b1406],
30	genotypes	NNS	O	genotype	conj_or	25	SENT_116	[p5l1307t1359r1616b1420],
31	and	CC	O	and	_	0	SENT_116	[p5l1643t1351r1752b1406],
32	c.	NN	O	c.	conj_and	25	SENT_116	[p5l1780t1354r2147b1407],
33	.	.	O	.	_	0	SENT_116	[p5l1780t1354r2147b1407],

1	—	NN	O	—	_	0	SENT_117	[p5l1780t1354r2147b1407],
2	.	.	O	.	_	0	SENT_117	[p5l1780t1354r2147b1407],

1	1639G	NN	O	1639g	dep	2	SENT_118	[p5l1780t1354r2147b1407],
2	>	JJR	O	>	_	0	SENT_118	[p5l1780t1354r2147b1407],
3	A	DT	O	a	det	4	SENT_118	[p5l1780t1354r2147b1407],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_118	[p5l8t1440r452b1509],
5	of	IN	O	of	_	0	SENT_118	[p5l473t1440r535b1495],
6	the	DT	O	the	det	8	SENT_118	[p5l549t1440r645b1495],
7	VKORC1	NN	O	vkorc1	nn	8	SENT_118	[p5l664t1440r941b1509],
8	)	NN	O	)	prep_of	4	SENT_118	[p5l664t1440r941b1509],
9	on	IN	O	on	_	0	SENT_118	[p5l967t1456r1041b1495],
10	the	DT	O	the	det	11	SENT_118	[p5l1062t1440r1158b1495],
11	probability	NN	O	probability	prep_on	8	SENT_118	[p5l1180t1440r1510b1509],
12	that	IN	O	that	complm	16	SENT_118	[p5l1528t1440r1650b1495],
13	a	DT	O	a	det	14	SENT_118	[p5l1670t1456r1701b1495],
14	patient	NN	O	patient	nsubj	16	SENT_118	[p5l1722t1441r1936b1509],
15	would	MD	O	would	aux	16	SENT_118	[p5l1954t1440r2144b1495],
16	receive	VB	O	receive	dep	11	SENT_118	[p5l9t1531r220b1585],
17	a	DT	O	a	det	24	SENT_118	[p5l247t1546r279b1585],
18	low	JJ	O	low	amod	20	SENT_118	[p5l306t1530r429b1593],
19	,	,	O	,	_	0	SENT_118	[p5l306t1530r429b1593],
20	medium	NN	O	medium	nn	24	SENT_118	[p5l458t1530r709b1585],
21	or	CC	O	or	_	0	SENT_118	[p5l736t1546r799b1585],
22	a	DT	O	a	nn	24	SENT_118	[p5l824t1546r855b1585],
23	high	JJ	O	high	amod	24	SENT_118	[p5l882t1530r1013b1598],
24	dose	NN	O	dose	dobj	16	SENT_118	[p5l1040t1530r1177b1585],
25	of	IN	O	of	_	0	SENT_118	[p5l1204t1530r1267b1585],
26	acenocoumarol	NN	O	acenocoumarol	prep_of	24	SENT_118	[p5l1286t1530r1760b1585],
27	.	.	O	.	_	0	SENT_118	[p5l1286t1530r1760b1585],

1	The	DT	O	the	det	2	SENT_119	[p5l1785t1530r1895b1585],
2	level	NN	O	level	nsubjpass	7	SENT_119	[p5l1924t1530r2062b1585],
3	of	IN	O	of	_	0	SENT_119	[p5l2089t1530r2153b1585],
4	statistical	JJ	O	statistical	amod	5	SENT_119	[p5l9t1619r290b1674],
5	signiﬁcance	NN	O	signiﬁcance	prep_of	2	SENT_119	[p5l313t1618r662b1687],
6	was	VBD	O	be	auxpass	7	SENT_119	[p5l683t1634r800b1674],
7	set	VBN	O	set	_	0	SENT_119	[p5l823t1627r908b1674],
8	at	IN	O	at	_	0	SENT_119	[p5l928t1627r985b1674],
9	p	NN	O	p	prep_at	7	SENT_119	[p5l1005t1621r1237b1687],
10	<	JJR	O	<	dep	11	SENT_119	[p5l1005t1621r1237b1687],
11	0.05	CD	NUMBER	0.05	advmod	7	SENT_119	[p5l1005t1621r1237b1687],
12	.	.	O	.	_	0	SENT_119	[p5l1005t1621r1237b1687],

1	Results	NNS	O	result	_	0	SENT_120	[p5l7t1797r238b1852],

1	A	DT	O	a	det	2	SENT_121	[p5l107t1977r153b2029],
2	total	NN	O	total	nsubj	12	SENT_121	[p5l169t1975r304b2030],
3	of	IN	O	of	_	0	SENT_121	[p5l324t1975r387b2030],
4	301	CD	NUMBER	301	num	5	SENT_121	[p5l398t1978r500b2030],
5	patients	NNS	O	patient	prep_of	2	SENT_121	[p5l529t1976r766b2043],
6	(	IN	O	(	_	0	SENT_121	[p5l792t1975r927b2043],
7	146	CD	NUMBER	146	num	8	SENT_121	[p5l792t1975r927b2043],
8	men	NNS	O	man	prep_(	5	SENT_121	[p5l947t1991r1079b2030],
9	and	CC	O	and	_	0	SENT_121	[p5l1099t1975r1209b2030],
10	155	CD	NUMBER	155	num	11	SENT_121	[p5l1232t1978r1337b2030],
11	women	NNS	O	woman	conj_and	8	SENT_121	[p5l1357t1975r1611b2043],
12	)	VBP	O	)	_	0	SENT_121	[p5l1357t1975r1611b2043],
13	who	WP	O	who	nsubj	15	SENT_121	[p5l1632t1975r1765b2030],
14	had	VBD	O	have	aux	15	SENT_121	[p5l1785t1975r1893b2030],
15	met	VBN	O	meet	ccomp	12	SENT_121	[p5l1914t1983r2032b2030],
16	the	DT	O	the	det	18	SENT_121	[p5l2049t1975r2145b2030],
17	selection	NN	O	selection	nn	18	SENT_121	[p5l9t2064r271b2119],
18	criteria	NNS	O	criterion	nsubjpass	20	SENT_121	[p5l314t2065r524b2119],
19	were	VBD	O	be	auxpass	20	SENT_121	[p5l564t2080r714b2119],
20	included	VBN	O	include	ccomp	15	SENT_121	[p5l758t2064r1013b2119],
21	in	IN	O	in	_	0	SENT_121	[p5l1058t2065r1113b2118],
22	this	DT	O	this	det	23	SENT_121	[p5l1155t2064r1262b2119],
23	study	NN	O	study	prep_in	20	SENT_121	[p5l1307t2064r1483b2132],
24	.	.	O	.	_	0	SENT_121	[p5l1307t2064r1483b2132],

1	The	DT	O	the	det	3	SENT_122	[p5l1524t2064r1633b2119],
2	mean	NN	O	mean	nn	3	SENT_122	[p5l1677t2080r1844b2119],
3	age	NN	O	age	nsubj	6	SENT_122	[p5l1885t2080r1985b2132],
4	was	VBD	O	be	cop	6	SENT_122	[p5l2027t2080r2145b2119],
5	64	CD	DURATION	64	num	6	SENT_122	[p5l8t2155r81b2207],
6	years	NNS	NUMBER	year	_	0	SENT_122	[p5l104t2168r275b2221],
7	,	,	O	,	_	0	SENT_122	[p5l104t2168r275b2221],
8	and	CC	O	and	_	0	SENT_122	[p5l295t2152r405b2207],
9	the	DT	O	the	det	10	SENT_122	[p5l424t2152r520b2207],
10	median	NN	O	median	nsubj	13	SENT_122	[p5l539t2152r763b2207],
11	was	VBD	O	be	cop	13	SENT_122	[p5l780t2168r897b2207],
12	66	CD	DURATION	66	num	13	SENT_122	[p5l917t2155r989b2207],
13	years	NNS	NUMBER	year	conj_and	6	SENT_122	[p5l1013t2168r1185b2221],
14	.	.	O	.	_	0	SENT_122	[p5l1013t2168r1185b2221],

1	Age	NNP	O	Age	nsubj	2	SENT_123	[p5l1201t2155r1314b2221],
2	had	VBD	O	have	_	0	SENT_123	[p5l1334t2152r1443b2207],
3	a	DT	O	a	det	8	SENT_123	[p5l1462t2168r1493b2207],
4	non	JJ	O	non	amod	8	SENT_123	[p5l1512t2152r1870b2207],
5	—	NN	O	—	nn	8	SENT_123	[p5l1512t2152r1870b2207],
6	normal	JJ	O	normal	amod	8	SENT_123	[p5l1512t2152r1870b2207],
7	distribution	NN	O	distribution	nn	8	SENT_123	[p5l1889t2152r2144b2207, p5l7t2242r124b2296],
8	(	NN	O	(	dobj	2	SENT_123	[p5l148t2241r832b2310],
9	I	PRP	O	I	nsubj	10	SENT_123	[p5l148t2241r832b2310],
10	(	VBP	O	(	rcmod	8	SENT_123	[p5l148t2241r832b2310],
11	olmogorov	NN	O	olmogorov	dobj	10	SENT_123	[p5l148t2241r832b2310],
12	.	.	O	.	_	0	SENT_123	[p5l148t2241r832b2310],

1	—	NN	O	—	_	0	SENT_124	[p5l148t2241r832b2310],
2	.	.	O	.	_	0	SENT_124	[p5l148t2241r832b2310],

1	Smirnov	NNP	PERSON	Smirnov	nn	2	SENT_125	[p5l148t2241r832b2310],
2	test	NN	O	test	_	0	SENT_125	[p5l850t2249r975b2305],
3	;	:	O	;	_	0	SENT_125	[p5l850t2249r975b2305],
4	p	NN	O	p	dep	2	SENT_125	[p5l1001t2257r1036b2310],
5	=	JJ	O	=	amod	7	SENT_125	[p5l1052t2264r1105b2285],
6	0.02	CD	NUMBER	0.02	tmod	5	SENT_125	[p5l1122t2241r1290b2309],
7	)	NN	O	)	dep	4	SENT_125	[p5l1122t2241r1290b2309],
8	.	.	O	.	_	0	SENT_125	[p5l1122t2241r1290b2309],

1	Acute	JJ	O	acute	amod	4	SENT_126	[p5l1308t2243r1479b2296],
2	deep	JJ	O	deep	amod	4	SENT_126	[p5l1500t2241r1643b2310],
3	vein	NN	O	vein	nn	4	SENT_126	[p5l1662t2242r1789b2296],
4	thrombosis	NN	O	thrombosis	nsubj	9	SENT_126	[p5l1808t2241r2144b2296],
5	was	VBD	O	be	cop	9	SENT_126	[p5l6t2346r126b2385],
6	the	DT	O	the	det	9	SENT_126	[p5l162t2330r261b2385],
7	most	RBS	O	most	advmod	8	SENT_126	[p5l298t2338r452b2385],
8	frequent	JJ	O	frequent	amod	9	SENT_126	[p5l486t2330r754b2399],
9	pathology	NN	O	pathology	dep	10	SENT_126	[p5l788t2330r1101b2399],
10	encountered	VBD	O	encounter	_	0	SENT_126	[p5l1136t2330r1528b2385],
11	that	IN	O	that	complm	12	SENT_126	[p5l1565t2330r1690b2385],
12	required	VBN	O	require	ccomp	10	SENT_126	[p5l1724t2330r1989b2399],
13	oral	JJ	O	oral	amod	15	SENT_126	[p5l2027t2330r2144b2385],
14	anticoagulation	NN	O	anticoagulation	nn	15	SENT_126	[p5l8t2419r494b2488],
15	(	NN	O	(	dobj	12	SENT_126	[p5l531t2419r776b2488],
16	62.1	CD	PERCENT	62.1	number	17	SENT_126	[p5l531t2419r776b2488],
17	%	NN	PERCENT	%	amod	15	SENT_126	[p5l531t2419r776b2488],
18	)	CD	NUMBER	)	nsubj	10	SENT_126	[p5l531t2419r776b2488],
19	.	.	O	.	_	0	SENT_126	[p5l531t2419r776b2488],

1	Among	IN	O	among	_	0	SENT_127	[p5l808t2422r1033b2488],
2	the	DT	O	the	det	3	SENT_127	[p5l1065t2419r1163b2474],
3	medication	NN	O	medication	prep_among	16	SENT_127	[p5l1197t2419r1547b2474],
4	that	WDT	O	that	nsubj	6	SENT_127	[p5l1580t2419r1705b2474],
5	can	MD	O	can	aux	6	SENT_127	[p5l1736t2435r1841b2474],
6	interfere	VB	O	interfere	rcmod	3	SENT_127	[p5l1875t2419r2144b2474],
7	with	IN	O	with	_	0	SENT_127	[p5l6t2509r144b2564],
8	acenocoumarol	NN	O	acenocoumarol	nn	9	SENT_127	[p5l170t2509r626b2564],
9	metabolization	NN	O	metabolization	prep_with	6	SENT_127	[p5l654t2509r1114b2572],
10	,	,	O	,	_	0	SENT_127	[p5l654t2509r1114b2572],
11	statins	NNS	O	statin	nsubj	16	SENT_127	[p5l1142t2510r1334b2564],
12	were	VBD	O	be	cop	16	SENT_127	[p5l1360t2525r1510b2564],
13	the	DT	O	the	det	16	SENT_127	[p5l1536t2509r1632b2564],
14	most	RBS	O	most	advmod	16	SENT_127	[p5l1659t2517r1807b2564],
15	prescribed	JJ	O	prescribed	amod	16	SENT_127	[p5l1832t2509r2144b2577],
16	drugs	NNS	O	drug	_	0	SENT_127	[p5l8t2598r173b2666],
17	(	VBP	O	(	rcmod	16	SENT_127	[p5l212t2598r445b2666],
18	42.1	CD	PERCENT	42.1	num	19	SENT_127	[p5l212t2598r445b2666],
19	%	NN	PERCENT	%	dobj	17	SENT_127	[p5l212t2598r445b2666],
20	)	CD	NUMBER	)	tmod	17	SENT_127	[p5l212t2598r445b2666],
21	.	.	O	.	_	0	SENT_127	[p5l212t2598r445b2666],

1	The	DT	O	the	det	4	SENT_128	[p5l477t2598r588b2653],
2	lowest	JJS	O	lowest	amod	4	SENT_128	[p5l621t2598r820b2653],
3	acenocoumarol	NN	O	acenocoumarol	nn	4	SENT_128	[p5l851t2598r1307b2653],
4	dose	NN	O	dose	nsubj	10	SENT_128	[p5l1342t2598r1478b2653],
5	was	VBD	O	be	cop	7	SENT_128	[p5l1510t2614r1626b2653],
6	2	CD	NUMBER	2	num	7	SENT_128	[p5l1661t2601r1694b2652],
7	mg/week	NN	O	mg/week	dep	11	SENT_128	[p5l1722t2598r2003b2666],
8	and	CC	O	and	_	0	SENT_128	[p5l2035t2598r2145b2653],
9	the	DT	O	the	det	10	SENT_128	[p5l7t2686r102b2741],
10	highest	JJS	O	highest	dep	11	SENT_128	[p5l131t2686r351b2755],
11	was	VBD	O	be	_	0	SENT_128	[p5l375t2702r491b2741],
12	49	CD	NUMBER	49	num	13	SENT_128	[p5l519t2689r592b2741],
13	mg/week	NN	O	mg/week	nsubj	11	SENT_128	[p5l619t2686r912b2755],
14	.	.	O	.	_	0	SENT_128	[p5l619t2686r912b2755],

1	The	DT	O	the	det	3	SENT_129	[p5l937t2686r1048b2741],
2	mean	NN	O	mean	nn	3	SENT_129	[p5l1076t2702r1241b2741],
3	dose	NN	O	dose	nsubj	6	SENT_129	[p5l1270t2686r1405b2741],
4	was	VBD	O	be	cop	6	SENT_129	[p5l1432t2702r1548b2741],
5	17.3	CD	NUMBER	17.3	num	6	SENT_129	[p5l1581t2689r1699b2742],
6	mg/week	NN	O	mg/week	_	0	SENT_129	[p5l1728t2686r2009b2755],
7	and	CC	O	and	_	0	SENT_129	[p5l2035t2686r2145b2741],
8	the	DT	O	the	det	9	SENT_129	[p5l7t2775r102b2830],
9	median	NN	O	median	nsubj	12	SENT_129	[p5l138t2775r361b2830],
10	was	VBD	O	be	cop	12	SENT_129	[p5l395t2791r512b2830],
11	16	CD	NUMBER	16	num	12	SENT_129	[p5l551t2778r621b2830],
12	mg/week	NN	O	mg/week	conj_and	6	SENT_129	[p5l647t2775r938b2844],
13	.	.	O	.	_	0	SENT_129	[p5l647t2775r938b2844],

1	The	DT	O	the	det	4	SENT_130	[p5l972t2775r1083b2830],
2	weekly	JJ	SET	weekly	amod	4	SENT_130	[p5l1116t2775r1332b2844],
3	acenocoumarol	NN	O	acenocoumarol	nn	4	SENT_130	[p5l1365t2775r1822b2830],
4	dose	NN	O	dose	nsubj	7	SENT_130	[p5l1857t2775r1993b2830],
5	was	VBD	O	be	cop	7	SENT_130	[p5l2026t2791r2143b2830],
6	non	JJ	O	non	amod	7	SENT_130	[p5l8t2864r422b2933],
7	—	NN	O	—	_	0	SENT_130	[p5l8t2864r422b2933],
8	normally	RB	O	normally	advmod	9	SENT_130	[p5l8t2864r422b2933],
9	distributed	VBN	O	distribute	partmod	7	SENT_130	[p5l443t2864r782b2920],
10	.	.	O	.	_	0	SENT_130	[p5l443t2864r782b2920],

1	A	DT	O	a	det	5	SENT_131	[p5l803t2867r848b2919],
2	highly	RB	O	highly	advmod	3	SENT_131	[p5l869t2864r1056b2933],
3	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_131	[p5l1077t2864r1386b2933],
4	negative	JJ	O	negative	amod	5	SENT_131	[p5l1407t2865r1659b2933],
5	correlation	NN	O	correlation	nsubjpass	7	SENT_131	[p5l1682t2864r2006b2919],
6	was	VBD	O	be	auxpass	7	SENT_131	[p5l2027t2880r2145b2919],
7	found	VBN	O	find	_	0	SENT_131	[p5l8t2953r180b3008],
8	between	IN	O	between	_	0	SENT_131	[p5l208t2953r467b3008],
9	age	NN	O	age	prep_between	7	SENT_131	[p5l495t2969r595b3022],
10	and	CC	O	and	_	0	SENT_131	[p5l623t2953r732b3008],
11	the	DT	O	the	det	15	SENT_131	[p5l760t2953r855b3008],
12	acenocoumarol	NN	O	acenocoumarol	nn	15	SENT_131	[p5l883t2953r1340b3008],
13	weekly	JJ	SET	weekly	amod	15	SENT_131	[p5l1366t2953r1582b3022],
14	dose	NN	O	dose	nn	15	SENT_131	[p5l1609t2953r1744b3008],
15	(	NN	O	(	prep_between	7	SENT_131	[p5l1777t2954r2144b3022],
16	Spearman	NNP	PERSON	Spearman	poss	18	SENT_131	[p5l1777t2954r2144b3022],
17	's	POS	O	's	_	0	SENT_131	[p5l1777t2954r2144b3022],
18	rho	NN	O	rho	dep	15	SENT_131	[p5l9t3043r126b3106],
19	;	:	O	;	_	0	SENT_131	[p5l9t3043r126b3106],
20	r	NN	O	r	dep	15	SENT_131	[p5l159t3059r251b3097],
21	=	JJ	O	=	amod	20	SENT_131	[p5l159t3059r251b3097],
22	—	CD	NUMBER	—	number	23	SENT_131	[p5l273t3074r323b3078],
23	0.339	CD	NUMBER	0.339	dep	21	SENT_131	[p5l339t3046r519b3106],
24	;	:	O	;	_	0	SENT_131	[p5l339t3046r519b3106],
25	p	NN	O	p	dep	26	SENT_131	[p5l551t3058r633b3111],
26	<	JJR	O	<	dep	15	SENT_131	[p5l551t3058r633b3111],
27	0.001	CD	NUMBER	0.001	num	28	SENT_131	[p5l645t3043r850b3111],
28	)	NN	O	)	dep	26	SENT_131	[p5l645t3043r850b3111],
29	.	.	O	.	_	0	SENT_131	[p5l645t3043r850b3111],

1	The	DT	O	the	det	4	SENT_132	[p5l875t3043r986b3098],
2	weekly	JJ	SET	weekly	amod	4	SENT_132	[p5l1012t3043r1228b3111],
3	acenocoumarol	NN	O	acenocoumarol	nn	4	SENT_132	[p5l1254t3043r1710b3098],
4	dose	NN	O	dose	nsubjpass	7	SENT_132	[p5l1738t3043r1875b3098],
5	was	VBD	O	be	auxpass	7	SENT_132	[p5l1901t3059r2018b3098],
6	not	RB	O	not	neg	7	SENT_132	[p5l2047t3051r2146b3098],
7	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_132	[p5l8t3132r321b3187],
8	by	IN	O	by	_	0	SENT_132	[p5l350t3132r423b3200],
9	sex	NN	O	sex	agent	7	SENT_132	[p5l451t3148r548b3187],
10	(	CD	NUMBER	(	num	9	SENT_132	[p5l579t3132r1078b3200],
11	Mann	NNP	PERSON	Mann	dep	9	SENT_132	[p5l579t3132r1078b3200],
12	.	.	O	.	_	0	SENT_132	[p5l579t3132r1078b3200],

1	—	NN	O	—	_	0	SENT_133	[p5l579t3132r1078b3200],
2	.	.	O	.	_	0	SENT_133	[p5l579t3132r1078b3200],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_134	[p5l579t3132r1078b3200],
2	test	NN	O	test	_	0	SENT_134	[p5l1105t3140r1230b3195],
3	;	:	O	;	_	0	SENT_134	[p5l1105t3140r1230b3195],
4	p	NN	O	p	dep	2	SENT_134	[p5l1264t3132r1552b3200],
5	=	JJ	O	=	amod	14	SENT_134	[p5l1264t3132r1552b3200],
6	0.06	CD	NUMBER	0.06	num	7	SENT_134	[p5l1264t3132r1552b3200],
7	)	NN	O	)	tmod	5	SENT_134	[p5l1264t3132r1552b3200],
8	,	,	O	,	_	0	SENT_134	[p5l1264t3132r1552b3200],
9	by	IN	O	by	_	0	SENT_134	[p5l1582t3132r1655b3200],
10	treatment	NN	O	treatment	prep_by	7	SENT_134	[p5l1681t3140r1981b3187],
11	with	IN	O	with	_	0	SENT_134	[p5l2007t3132r2145b3187],
12	amiodarone	NN	O	amiodarone	prep_with	10	SENT_134	[p5l8t3220r366b3275],
13	(	CD	NUMBER	(	num	12	SENT_134	[p5l403t3220r901b3289],
14	Mann	NNP	PERSON	Mann	dep	4	SENT_134	[p5l403t3220r901b3289],
15	.	.	O	.	_	0	SENT_134	[p5l403t3220r901b3289],

1	—	NN	O	—	_	0	SENT_135	[p5l403t3220r901b3289],
2	.	.	O	.	_	0	SENT_135	[p5l403t3220r901b3289],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_136	[p5l403t3220r901b3289],
2	test	NN	O	test	_	0	SENT_136	[p5l932t3228r1057b3284],
3	;	:	O	;	_	0	SENT_136	[p5l932t3228r1057b3284],
4	p	NN	O	p	nsubj	12	SENT_136	[p5l1095t3220r1384b3289],
5	=	JJ	O	=	amod	4	SENT_136	[p5l1095t3220r1384b3289],
6	0.75	CD	NUMBER	0.75	num	7	SENT_136	[p5l1095t3220r1384b3289],
7	)	NN	O	)	tmod	5	SENT_136	[p5l1095t3220r1384b3289],
8	,	,	O	,	_	0	SENT_136	[p5l1095t3220r1384b3289],
9	proton	NN	O	proton	nn	11	SENT_136	[p5l1417t3228r1617b3289],
10	pump	NN	O	pump	nn	11	SENT_136	[p5l1650t3236r1825b3289],
11	inhibitors	NNS	O	inhibitor	appos	7	SENT_136	[p5l1859t3220r2144b3275],
12	(	VBP	O	(	dep	2	SENT_136	[p5l12t3309r511b3378],
13	Mann	NNP	PERSON	Mann	dobj	12	SENT_136	[p5l12t3309r511b3378],
14	.	.	O	.	_	0	SENT_136	[p5l12t3309r511b3378],

1	—	NN	O	—	_	0	SENT_137	[p5l12t3309r511b3378],
2	.	.	O	.	_	0	SENT_137	[p5l12t3309r511b3378],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_138	[p5l12t3309r511b3378],
2	test	NN	O	test	_	0	SENT_138	[p5l545t3317r669b3373],
3	;	:	O	;	_	0	SENT_138	[p5l545t3317r669b3373],
4	p	NN	O	p	dep	2	SENT_138	[p5l711t3309r963b3378],
5	=	JJ	O	=	amod	4	SENT_138	[p5l711t3309r963b3378],
6	0.9	CD	NUMBER	0.9	num	7	SENT_138	[p5l711t3309r963b3378],
7	)	NN	O	)	tmod	5	SENT_138	[p5l711t3309r963b3378],
8	,	,	O	,	_	0	SENT_138	[p5l711t3309r963b3378],
9	spironolactone	NN	O	spironolactone	nn	11	SENT_138	[p5l1000t3309r1441b3378],
10	(	CD	NUMBER	(	num	11	SENT_138	[p5l1482t3309r1980b3378],
11	Mann	NNP	PERSON	Mann	appos	7	SENT_138	[p5l1482t3309r1980b3378],
12	.	.	O	.	_	0	SENT_138	[p5l1482t3309r1980b3378],

1	—	NN	O	—	_	0	SENT_139	[p5l1482t3309r1980b3378],
2	.	.	O	.	_	0	SENT_139	[p5l1482t3309r1980b3378],

1	Whitney	NNP	PERSON	Whitney	nsubj	2	SENT_140	[p5l1482t3309r1980b3378],
2	test	NN	O	test	_	0	SENT_140	[p5l2015t3317r2140b3373],
3	;	:	O	;	_	0	SENT_140	[p5l2015t3317r2140b3373],
4	p	NN	O	p	nsubj	10	SENT_140	[p5l8t3414r43b3467],
5	=	JJ	O	=	dep	10	SENT_140	[p5l59t3422r113b3442],
6	0.43	CD	NUMBER	0.43	num	7	SENT_140	[p5l130t3399r278b3467],
7	)	CD	NUMBER	)	nsubj	10	SENT_140	[p5l130t3399r278b3467],
8	or	CC	O	or	_	0	SENT_140	[p5l305t3414r366b3454],
9	statins	NNS	O	statin	nsubj	10	SENT_140	[p5l387t3399r580b3454],
10	(	VBP	O	(	parataxis	2	SENT_140	[p5l606t3399r1105b3467],
11	Mann	NNP	PERSON	Mann	dobj	10	SENT_140	[p5l606t3399r1105b3467],
12	.	.	O	.	_	0	SENT_140	[p5l606t3399r1105b3467],

1	—	NN	O	—	_	0	SENT_141	[p5l606t3399r1105b3467],
2	.	.	O	.	_	0	SENT_141	[p5l606t3399r1105b3467],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_142	[p5l606t3399r1105b3467],
2	test	NN	O	test	_	0	SENT_142	[p5l1124t3407r1249b3462],
3	;	:	O	;	_	0	SENT_142	[p5l1124t3407r1249b3462],
4	p	NN	O	p	dep	2	SENT_142	[p5l1276t3414r1311b3467],
5	=	JJ	O	=	amod	7	SENT_142	[p5l1327t3422r1381b3442],
6	0.39	CD	NUMBER	0.39	tmod	5	SENT_142	[p5l1397t3399r1564b3467],
7	)	NN	O	)	dep	4	SENT_142	[p5l1397t3399r1564b3467],
8	.	.	O	.	_	0	SENT_142	[p5l1397t3399r1564b3467],

1	168	CD	DATE	168	_	0	SENT_143	[p5l314t3543r356b3564],
2	AD	NN	DATE	ad	dep	1	SENT_143	[p5l939t3543r985b3564],
3	.	.	O	.	_	0	SENT_143	[p5l939t3543r985b3564],

1	Buzoianu	NNP	MISC	Buzoianu	_	0	SENT_144	[p5l995t3542r1102b3564],
2	et	FW	O	et	nn	3	SENT_144	[p5l1112t3545r1134b3564],
3	al.	FW	O	al.	dep	1	SENT_144	[p5l1142t3542r1167b3564],
4	/	:	O	/	punct	1	SENT_144	[p5l1176t3543r1185b3567],
5	Blood	NN	O	blood	nn	6	SENT_144	[p5l1193t3542r1258b3564],
6	Cells	NNS	O	cell	dep	1	SENT_144	[p5l1267t3542r1323b3567],
7	,	,	O	,	_	0	SENT_144	[p5l1267t3542r1323b3567],
8	Molecules	NNS	O	molecule	dep	1	SENT_144	[p5l1333t3542r1448b3564],
9	and	CC	O	and	_	0	SENT_144	[p5l1457t3542r1500b3564],
10	Diseases	NNS	O	disease	dep	1	SENT_144	[p5l1509t3542r1606b3564],
11	50	CD	NUMBER	50	number	12	SENT_144	[p5l1615t3543r1644b3564],
12	(	CD	NUMBER	(	num	13	SENT_144	[p5l1654t3542r1732b3569],
13	2013	CD	DATE	2013	dep	6	SENT_144	[p5l1654t3542r1732b3569],
14	)	CD	NUMBER	)	number	15	SENT_144	[p5l1654t3542r1732b3569],
15	166-170	CD	NUMBER	166-170	num	13	SENT_144	[p5l1746t3543r1845b3564],

1	The	DT	O	the	det	2	SENT_145	[p6l109t63r221b118],
2	characteristics	NNS	O	characteristic	nsubjpass	16	SENT_145	[p6l258t63r697b118],
3	of	IN	O	of	_	0	SENT_145	[p6l735t63r799b118],
4	the	DT	O	the	det	5	SENT_145	[p6l828t63r925b118],
5	participants	NNS	O	participant	prep_of	2	SENT_145	[p6l962t64r1326b132],
6	according	VBG	O	accord	_	0	SENT_145	[p6l1364t63r1662b132],
7	to	TO	O	to	prepc_according_to	14	SENT_145	[p6l1698t71r1756b118],
8	the	DT	O	the	det	12	SENT_145	[p6l1794t63r1890b118],
9	weekly	JJ	SET	weekly	amod	12	SENT_145	[p6l1926t63r2148b132],
10	acenocoumarol	NN	O	acenocoumarol	nn	12	SENT_145	[p6l9t152r478b207],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_145	[p6l514t152r867b221],
12	dose	NN	O	dose	pobj	14	SENT_145	[p6l902t152r1042b207],
13	they	PRP	O	they	nsubj	14	SENT_145	[p6l1077t152r1213b221],
14	received	VBD	O	receive	rcmod	5	SENT_145	[p6l1249t152r1505b207],
15	are	VBP	O	be	auxpass	16	SENT_145	[p6l1542t168r1635b207],
16	summarized	VBN	O	summarize	_	0	SENT_145	[p6l1674t152r2052b207],
17	in	IN	O	in	_	0	SENT_145	[p6l2090t153r2146b206],
18	Table	NNP	O	Table	prep_in	16	SENT_145	[p6l7t241r171b296],
19	1	CD	NUMBER	1	num	18	SENT_145	[p6l199t244r245b296],
20	.	.	O	.	_	0	SENT_145	[p6l199t244r245b296],

1	Distribution	NN	O	distribution	nsubjpass	13	SENT_146	[p6l112t329r468b384],
2	of	IN	O	of	_	0	SENT_146	[p6l496t329r558b384],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_146	[p6l578t332r805b384],
4	genotypes	NNS	O	genotype	prep_of	1	SENT_146	[p6l832t338r1138b398],
5	according	VBG	O	accord	_	0	SENT_146	[p6l1166t329r1457b398],
6	to	TO	O	to	prepc_according_to	13	SENT_146	[p6l1482t337r1540b384],
7	the	DT	O	the	det	11	SENT_146	[p6l1567t329r1663b384],
8	acenocoumarol	NN	O	acenocoumarol	nn	11	SENT_146	[p6l1689t329r2146b384],
9	therapeutic	JJ	O	therapeutic	amod	11	SENT_146	[p6l9t419r351b487],
10	dose	NN	O	dose	nn	11	SENT_146	[p6l375t419r511b474],
11	groups	NNS	O	group	pobj	13	SENT_146	[p6l536t435r740b487],
12	is	VBZ	O	be	auxpass	13	SENT_146	[p6l766t420r809b474],
13	shown	VBN	O	show	_	0	SENT_146	[p6l836t419r1035b474],
14	in	IN	O	in	_	0	SENT_146	[p6l1060t420r1115b473],
15	Table	NNP	O	Table	prep_in	13	SENT_146	[p6l1138t419r1298b474],
16	2	CD	NUMBER	2	num	15	SENT_146	[p6l1324t422r1372b474],
17	.	.	O	.	_	0	SENT_146	[p6l1324t422r1372b474],

1	The	DT	O	the	det	3	SENT_147	[p6l1395t419r1506b474],
2	CYP2C9	NN	O	cyp2c9	nn	3	SENT_147	[p6l1531t419r1822b474],
3	*	NN	O	*	nsubj	11	SENT_147	[p6l1531t419r1822b474],
4	2	CD	NUMBER	2	num	5	SENT_147	[p6l1531t419r1822b474],
5	allele	NN	O	allele	nsubjpass	7	SENT_147	[p6l1850t419r2005b474],
6	was	VBD	O	be	auxpass	7	SENT_147	[p6l2028t435r2146b474],
7	found	VBN	O	find	rcmod	3	SENT_147	[p6l10t507r183b563],
8	in	IN	O	in	_	0	SENT_147	[p6l217t508r271b562],
9	63	CD	NUMBER	63	num	10	SENT_147	[p6l306t510r375b563],
10	cases	NNS	O	case	prep_in	7	SENT_147	[p6l411t523r563b563],
11	(	VBP	O	(	dep	25	SENT_147	[p6l602t508r817b576],
12	20.2	CD	PERCENT	20.2	num	13	SENT_147	[p6l602t508r817b576],
13	%	NN	PERCENT	%	nsubjpass	21	SENT_147	[p6l602t508r817b576],
14	)	CD	NUMBER	)	dep	13	SENT_147	[p6l602t508r817b576],
15	and	CC	O	and	_	0	SENT_147	[p6l855t508r964b563],
16	the	DT	O	the	det	18	SENT_147	[p6l997t508r1093b563],
17	CYP2C9	NN	O	cyp2c9	nn	18	SENT_147	[p6l1127t507r1417b563],
18	*	NN	O	*	nsubjpass	21	SENT_147	[p6l1127t507r1417b563],
19	3	CD	NUMBER	3	dep	18	SENT_147	[p6l1127t507r1417b563],
20	was	VBD	O	be	auxpass	21	SENT_147	[p6l1452t523r1570b563],
21	determined	VBN	O	determine	ccomp	11	SENT_147	[p6l1603t508r1950b563],
22	in	IN	O	in	_	0	SENT_147	[p6l1985t508r2040b562],
23	51	CD	NUMBER	51	num	24	SENT_147	[p6l2075t511r2138b563],
24	cases	NNS	O	case	prep_in	21	SENT_147	[p6l10t612r161b651],
25	(	VBP	O	(	_	0	SENT_147	[p6l188t596r420b664],
26	16.9	CD	PERCENT	16.9	num	27	SENT_147	[p6l188t596r420b664],
27	%	NN	PERCENT	%	dobj	25	SENT_147	[p6l188t596r420b664],
28	)	CD	NUMBER	)	nsubj	25	SENT_147	[p6l188t596r420b664],
29	.	.	O	.	_	0	SENT_147	[p6l188t596r420b664],

1	Allelic	JJ	O	allelic	amod	2	SENT_148	[p6l440t596r624b651],
2	frequencies	NNS	O	frequency	nsubj	3	SENT_148	[p6l644t596r986b665],
3	reached	VBD	O	reach	_	0	SENT_148	[p6l1009t596r1242b651],
4	the	DT	O	the	det	5	SENT_148	[p6l1264t596r1360b651],
5	Hardy	NNP	PERSON	Hardy	dobj	3	SENT_148	[p6l1381t596r1897b665],
6	.	.	O	.	_	0	SENT_148	[p6l1381t596r1897b665],

1	—	NN	O	—	_	0	SENT_149	[p6l1381t596r1897b665],
2	.	.	O	.	_	0	SENT_149	[p6l1381t596r1897b665],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_150	[p6l1381t596r1897b665],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_150	[p6l1917t596r2145b665, p6l10t686r165b741],
3	.	.	O	.	_	0	SENT_150	[p6l1917t596r2145b665, p6l10t686r165b741],

1	The	DT	O	the	det	2	SENT_151	[p6l190t685r300b740],
2	presence	NN	O	presence	_	0	SENT_151	[p6l325t701r590b754],
3	of	IN	O	of	_	0	SENT_151	[p6l616t685r678b740],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_151	[p6l696t685r989b740],
5	*	NN	O	*	prep_of	2	SENT_151	[p6l696t685r989b740],
6	2	CD	NUMBER	2	num	7	SENT_151	[p6l696t685r989b740],
7	allele	NN	O	allele	nsubjpass	11	SENT_151	[p6l1015t685r1170b740],
8	had	VBD	O	have	aux	11	SENT_151	[p6l1197t685r1305b740],
9	not	RB	O	not	neg	11	SENT_151	[p6l1332t694r1431b740],
10	been	VBN	O	be	auxpass	11	SENT_151	[p6l1454t685r1598b740],
11	associated	VBN	O	associate	rcmod	2	SENT_151	[p6l1623t685r1927b740],
12	with	IN	O	with	_	0	SENT_151	[p6l1952t685r2090b740],
13	a	DT	O	a	det	16	SENT_151	[p6l2115t701r2146b740],
14	speciﬁc	NN	O	speciﬁc	nn	16	SENT_151	[p6l10t774r230b843],
15	acenocoumarol	NN	O	acenocoumarol	nn	16	SENT_151	[p6l280t774r736b829],
16	dose	NN	O	dose	prep_with	11	SENT_151	[p6l788t774r924b829],
17	(	CD	NUMBER	(	num	18	SENT_151	[p6l979t774r1326b843],
18	Chi	NNP	O	Chi	dep	2	SENT_151	[p6l979t774r1326b843],
19	—	CD	NUMBER	—	num	18	SENT_151	[p6l979t774r1326b843],
20	square	JJ	O	square	amod	21	SENT_151	[p6l979t774r1326b843],
21	test	NN	O	test	dep	18	SENT_151	[p6l1377t782r1502b838],
22	;	:	O	;	_	0	SENT_151	[p6l1377t782r1502b838],
23	p	NN	O	p	dep	2	SENT_151	[p6l1558t775r1846b843],
24	=	JJ	O	=	amod	26	SENT_151	[p6l1558t775r1846b843],
25	0.36	CD	NUMBER	0.36	tmod	24	SENT_151	[p6l1558t775r1846b843],
26	)	NN	O	)	dep	23	SENT_151	[p6l1558t775r1846b843],
27	.	.	O	.	_	0	SENT_151	[p6l1558t775r1846b843],

1	In	IN	O	in	_	0	SENT_152	[p6l1899t778r1955b829],
2	tum	NN	O	tum	prep_in	12	SENT_152	[p6l2005t782r2146b838],
3	,	,	O	,	_	0	SENT_152	[p6l2005t782r2146b838],
4	patients	NNS	O	patient	nsubj	12	SENT_152	[p6l10t865r248b932],
5	with	IN	O	with	_	0	SENT_152	[p6l276t864r414b919],
6	CYP2C9	NN	O	cyp2c9	prep_with	4	SENT_152	[p6l444t864r735b919],
7	*	CD	NUMBER	*	number	8	SENT_152	[p6l444t864r735b919],
8	3	CD	NUMBER	3	num	9	SENT_152	[p6l444t864r735b919],
9	allele	NN	O	allele	dep	6	SENT_152	[p6l767t864r922b919],
10	were	VBD	O	be	cop	12	SENT_152	[p6l950t880r1100b919],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_152	[p6l1132t864r1495b932],
12	prone	JJ	O	prone	_	0	SENT_152	[p6l1523t880r1698b932],
13	to	TO	O	to	_	0	SENT_152	[p6l1726t872r1784b919],
14	receiving	VBG	O	receive	prepc_to	12	SENT_152	[p6l1815t865r2087b932],
15	a	DT	O	a	det	17	SENT_152	[p6l2115t880r2146b919],
16	lower	JJR	O	lower	amod	17	SENT_152	[p6l10t953r182b1008],
17	dose	NN	O	dose	dobj	14	SENT_152	[p6l202t953r338b1008],
18	of	IN	O	of	_	0	SENT_152	[p6l360t952r423b1008],
19	acenocoumarol	NN	O	acenocoumarol	nn	21	SENT_152	[p6l437t953r893b1008],
20	(	CD	NUMBER	(	num	21	SENT_152	[p6l920t953r1266b1021],
21	Chi	NNP	O	Chi	prep_of	17	SENT_152	[p6l920t953r1266b1021],
22	—	CD	NUMBER	—	num	24	SENT_152	[p6l920t953r1266b1021],
23	square	JJ	O	square	amod	24	SENT_152	[p6l920t953r1266b1021],
24	test	NN	O	test	dep	21	SENT_152	[p6l1288t961r1413b1016],
25	;	:	O	;	_	0	SENT_152	[p6l1288t961r1413b1016],
26	p	NN	O	p	dep	21	SENT_152	[p6l1440t968r1476b1021],
27	=	JJ	O	=	amod	29	SENT_152	[p6l1492t976r1545b996],
28	0.03	CD	NUMBER	0.03	tmod	27	SENT_152	[p6l1562t953r1729b1021],
29	)	NN	O	)	dep	26	SENT_152	[p6l1562t953r1729b1021],
30	.	.	O	.	_	0	SENT_152	[p6l1562t953r1729b1021],

1	The	DT	O	the	det	2	SENT_153	[p6l1749t953r1860b1008],
2	presence	NN	O	presence	_	0	SENT_153	[p6l1882t968r2146b1021],
3	of	IN	O	of	_	0	SENT_153	[p6l10t1041r72b1096],
4	any	DT	O	any	det	8	SENT_153	[p6l91t1057r198b1110],
5	CYP2C9	NN	O	cyp2c9	nn	8	SENT_153	[p6l224t1044r451b1096],
6	(	CD	NUMBER	(	num	8	SENT_153	[p6l483t1041r799b1109],
7	CYP2C9	NN	O	cyp2c9	nn	8	SENT_153	[p6l483t1041r799b1109],
8	*	NN	O	*	prep_of	2	SENT_153	[p6l483t1041r799b1109],
9	2	CD	NUMBER	2	dep	8	SENT_153	[p6l483t1041r799b1109],
10	+	CC	O	+	_	0	SENT_153	[p6l818t1049r869b1099],
11	CYP2C9	CD	NUMBER	cyp2c9	number	12	SENT_153	[p6l885t1041r1203b1109],
12	*	CD	NUMBER	*	conj_+	2	SENT_153	[p6l885t1041r1203b1109],
13	3	CD	NUMBER	3	num	15	SENT_153	[p6l885t1041r1203b1109],
14	)	NN	O	)	nn	15	SENT_153	[p6l885t1041r1203b1109],
15	allele	NN	O	allele	nsubjpass	17	SENT_153	[p6l1234t1041r1389b1096],
16	was	VBD	O	be	auxpass	17	SENT_153	[p6l1414t1057r1531b1096],
17	associated	VBN	O	associate	rcmod	12	SENT_153	[p6l1557t1041r1862b1096],
18	with	IN	O	with	_	0	SENT_153	[p6l1887t1041r2025b1096],
19	the	DT	O	the	det	20	SENT_153	[p6l2051t1041r2147b1096],
20	requirement	NN	O	requirement	prep_with	17	SENT_153	[p6l10t1131r386b1199],
21	of	IN	O	of	_	0	SENT_153	[p6l400t1130r463b1185],
22	a	DT	O	a	det	24	SENT_153	[p6l471t1146r503b1185],
23	low	JJ	O	low	amod	24	SENT_153	[p6l519t1130r630b1185],
24	dose	NN	O	dose	prep_of	20	SENT_153	[p6l645t1130r780b1185],
25	of	IN	O	of	_	0	SENT_153	[p6l798t1130r860b1185],
26	acenocoumarol	NN	O	acenocoumarol	nn	28	SENT_153	[p6l869t1130r1325b1185],
27	(	CD	NUMBER	(	num	28	SENT_153	[p6l1346t1130r1693b1199],
28	Chi	NNP	O	Chi	prep_of	24	SENT_153	[p6l1346t1130r1693b1199],
29	—	CD	NUMBER	—	num	31	SENT_153	[p6l1346t1130r1693b1199],
30	square	JJ	O	square	amod	31	SENT_153	[p6l1346t1130r1693b1199],
31	test	NN	O	test	dep	28	SENT_153	[p6l1710t1138r1835b1193],
32	;	:	O	;	_	0	SENT_153	[p6l1710t1138r1835b1193],
33	p	NN	O	p	dep	2	SENT_153	[p6l1857t1146r1892b1199],
34	=	JJ	O	=	amod	36	SENT_153	[p6l1908t1153r1962b1174],
35	0.03	CD	NUMBER	0.03	tmod	34	SENT_153	[p6l1978t1130r2145b1198],
36	)	NN	O	)	dep	33	SENT_153	[p6l1978t1130r2145b1198],
37	.	.	O	.	_	0	SENT_153	[p6l1978t1130r2145b1198],

1	Distribution	NN	O	distribution	nsubjpass	21	SENT_154	[p6l112t1219r480b1274],
2	of	IN	O	of	_	0	SENT_154	[p6l513t1219r577b1274],
3	genotypes	NNS	O	genotype	prep_of	1	SENT_154	[p6l602t1228r916b1288],
4	for	IN	O	for	_	0	SENT_154	[p6l952t1219r1037b1274],
5	the	DT	O	the	det	6	SENT_154	[p6l1068t1219r1165b1274],
6	c.-1639G	NN	O	c.-1639g	npadvmod	7	SENT_154	[p6l1199t1222r1574b1275],
7	>	JJR	O	>	amod	9	SENT_154	[p6l1199t1222r1574b1275],
8	A	DT	O	a	det	9	SENT_154	[p6l1199t1222r1574b1275],
9	polymorphism	NN	O	polymorphism	prep_for	3	SENT_154	[p6l1605t1219r2057b1288],
10	of	IN	O	of	_	0	SENT_154	[p6l2090t1219r2154b1274],
11	the	DT	O	the	det	12	SENT_154	[p6l9t1308r106b1363],
12	VKORC1	NN	O	vkorc1	prep_of	9	SENT_154	[p6l124t1311r372b1363],
13	according	VBG	O	accord	_	0	SENT_154	[p6l401t1308r699b1377],
14	to	TO	O	to	prepc_according_to	21	SENT_154	[p6l719t1316r777b1363],
15	the	DT	O	the	det	19	SENT_154	[p6l798t1308r895b1363],
16	acenocoumarol	NN	O	acenocoumarol	nn	19	SENT_154	[p6l916t1308r1385b1363],
17	therapeutic	JJ	O	therapeutic	amod	19	SENT_154	[p6l1406t1308r1758b1377],
18	dose	NN	O	dose	nn	19	SENT_154	[p6l1778t1308r1917b1363],
19	groups	NNS	O	group	pobj	21	SENT_154	[p6l1937t1324r2146b1377],
20	is	VBZ	O	be	auxpass	21	SENT_154	[p6l10t1399r54b1453],
21	summarized	VBN	O	summarize	_	0	SENT_154	[p6l75t1398r455b1453],
22	in	IN	O	in	_	0	SENT_154	[p6l475t1399r531b1452],
23	Table	NNP	O	Table	prep_in	21	SENT_154	[p6l548t1398r712b1453],
24	3	CD	NUMBER	3	num	23	SENT_154	[p6l731t1401r781b1453],
25	.	.	O	.	_	0	SENT_154	[p6l731t1401r781b1453],

1	The	DT	O	the	det	2	SENT_155	[p6l799t1398r911b1453],
2	frequencies	NNS	O	frequency	nsubj	16	SENT_155	[p6l931t1398r1283b1466],
3	of	IN	O	of	_	0	SENT_155	[p6l1304t1398r1367b1453],
4	the	DT	O	the	det	9	SENT_155	[p6l1379t1398r1476b1453],
5	VKORC1	NN	O	vkorc1	nn	9	SENT_155	[p6l1493t1401r1741b1453],
6	GG	NNS	O	gg	nn	9	SENT_155	[p6l1768t1401r1873b1461],
7	,	,	O	,	_	0	SENT_155	[p6l1768t1401r1873b1461],
8	VKORC1	NN	O	vkorc1	dep	9	SENT_155	[p6l1891t1401r2139b1453],
9	GA	NN	O	ga	prep_of	2	SENT_155	[p6l10t1489r99b1542],
10	and	CC	O	and	_	0	SENT_155	[p6l125t1487r236b1542],
11	VKORC1	NN	O	vkorc1	nn	13	SENT_155	[p6l262t1489r510b1542],
12	AA	NN	O	aa	nn	13	SENT_155	[p6l544t1489r633b1541],
13	genotypes	NNS	O	genotype	conj_and	9	SENT_155	[p6l658t1495r972b1555],
14	were	VBD	O	be	cop	16	SENT_155	[p6l999t1502r1152b1542],
15	32.5	CD	PERCENT	32.5	num	16	SENT_155	[p6l1179t1489r1365b1550],
16	%	NN	PERCENT	%	_	0	SENT_155	[p6l1179t1489r1365b1550],
17	,	,	O	,	_	0	SENT_155	[p6l1179t1489r1365b1550],
18	50.7	CD	PERCENT	50.7	num	19	SENT_155	[p6l1395t1489r1578b1550],
19	%	NN	PERCENT	%	conj_and	16	SENT_155	[p6l1395t1489r1578b1550],
20	,	,	O	,	_	0	SENT_155	[p6l1395t1489r1578b1550],
21	and	CC	O	and	_	0	SENT_155	[p6l1607t1487r1718b1542],
22	16.5	CD	PERCENT	16.5	num	23	SENT_155	[p6l1750t1489r1931b1542],
23	%	NN	PERCENT	%	conj_and	16	SENT_155	[p6l1750t1489r1931b1542],
24	.	.	O	.	_	0	SENT_155	[p6l1750t1489r1931b1542],

1	Allelic	JJ	O	allelic	amod	2	SENT_156	[p6l1957t1487r2147b1542],
2	frequencies	NNS	O	frequency	nsubj	3	SENT_156	[p6l10t1575r362b1644],
3	were	VBD	O	be	_	0	SENT_156	[p6l395t1591r548b1630],
4	in	IN	O	in	_	0	SENT_156	[p6l582t1576r638b1629],
5	Hardy	NNP	O	Hardy	prep_in	3	SENT_156	[p6l672t1575r1202b1644],
6	.	.	O	.	_	0	SENT_156	[p6l672t1575r1202b1644],

1	—	NN	O	—	_	0	SENT_157	[p6l672t1575r1202b1644],
2	.	.	O	.	_	0	SENT_157	[p6l672t1575r1202b1644],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_158	[p6l672t1575r1202b1644],
2	equilibrium	NN	O	equilibrium	dep	1	SENT_158	[p6l1234t1575r1607b1644],
3	.	.	O	.	_	0	SENT_158	[p6l1234t1575r1607b1644],

1	The	DT	O	the	det	2	SENT_159	[p6l1639t1575r1751b1630],
2	presence	NN	O	presence	_	0	SENT_159	[p6l1785t1591r2057b1644],
3	of	IN	O	of	_	0	SENT_159	[p6l2090t1575r2154b1630],
4	any	DT	O	any	prep_of	2	SENT_159	[p6l9t1680r120b1733],
5	of	IN	O	of	_	0	SENT_159	[p6l137t1664r201b1719],
6	the	DT	O	the	det	8	SENT_159	[p6l212t1664r310b1719],
7	A	NN	O	a	nn	8	SENT_159	[p6l327t1666r372b1718],
8	allele	NN	O	allele	prep_of	4	SENT_159	[p6l390t1664r550b1719],
9	of	IN	O	of	_	0	SENT_159	[p6l570t1664r633b1719],
10	c.	NN	O	c.	prep_of	2	SENT_159	[p6l645t1666r1018b1720],
11	.	.	O	.	_	0	SENT_159	[p6l645t1666r1018b1720],

1	—	NN	O	—	_	0	SENT_160	[p6l645t1666r1018b1720],
2	.	.	O	.	_	0	SENT_160	[p6l645t1666r1018b1720],

1	1639G	NN	O	1639g	_	0	SENT_161	[p6l645t1666r1018b1720],
2	>	JJR	O	>	amod	4	SENT_161	[p6l645t1666r1018b1720],
3	A	DT	O	a	det	4	SENT_161	[p6l645t1666r1018b1720],
4	polymorphism	NN	O	polymorphism	nsubj	7	SENT_161	[p6l1036t1664r1488b1733],
5	of	IN	O	of	_	0	SENT_161	[p6l1507t1664r1571b1719],
6	VKORC1	NN	O	vkorc1	prep_of	4	SENT_161	[p6l1580t1667r1828b1719],
7	increased	VBD	O	increase	rcmod	1	SENT_161	[p6l1856t1664r2146b1719],
8	the	DT	O	the	det	9	SENT_161	[p6l9t1753r106b1808],
9	probability	NN	O	probability	dobj	7	SENT_161	[p6l132t1753r468b1822],
10	of	IN	O	of	_	0	SENT_161	[p6l491t1753r555b1808],
11	a	DT	O	a	det	12	SENT_161	[p6l572t1769r603b1808],
12	patient	NN	O	patient	prep_of	9	SENT_161	[p6l628t1754r846b1822],
13	to	TO	O	to	aux	15	SENT_161	[p6l869t1762r927b1808],
14	be	VB	O	be	auxpass	15	SENT_161	[p6l952t1753r1022b1808],
15	included	VBN	O	include	infmod	12	SENT_161	[p6l1049t1753r1311b1808],
16	in	IN	O	in	_	0	SENT_161	[p6l1337t1754r1394b1808],
17	the	DT	O	the	det	21	SENT_161	[p6l1418t1753r1515b1808],
18	low	JJ	O	low	amod	21	SENT_161	[p6l1541t1753r1654b1808],
19	acenocoumarol	NN	O	acenocoumarol	nn	21	SENT_161	[p6l1677t1753r2146b1808],
20	dose	NN	O	dose	nn	21	SENT_161	[p6l10t1842r148b1897],
21	group	NN	O	group	prep_in	15	SENT_161	[p6l172t1858r352b1911],
22	(	CD	NUMBER	(	num	23	SENT_161	[p6l381t1842r737b1911],
23	Chi	NNP	O	Chi	dep	1	SENT_161	[p6l381t1842r737b1911],
24	—	CD	NUMBER	—	num	23	SENT_161	[p6l381t1842r737b1911],
25	square	JJ	O	square	amod	26	SENT_161	[p6l381t1842r737b1911],
26	test	NN	O	test	dep	23	SENT_161	[p6l762t1850r892b1906],
27	;	:	O	;	_	0	SENT_161	[p6l762t1850r892b1906],
28	p	NN	O	p	dep	29	SENT_161	[p6l921t1842r1226b1911],
29	<	JJR	O	<	dep	1	SENT_161	[p6l921t1842r1226b1911],
30	0.001	CD	NUMBER	0.001	num	31	SENT_161	[p6l921t1842r1226b1911],
31	)	NN	O	)	dep	29	SENT_161	[p6l921t1842r1226b1911],
32	.	.	O	.	_	0	SENT_161	[p6l921t1842r1226b1911],

1	In	IN	O	in	mark	4	SENT_162	[p6l112t1935r168b1986],
2	order	NN	O	order	dep	4	SENT_162	[p6l190t1932r351b1987],
3	to	TO	O	to	aux	4	SENT_162	[p6l371t1940r428b1987],
4	ﬁnd	VB	O	ﬁnd	dep	19	SENT_162	[p6l451t1932r566b1987],
5	out	RP	O	out	prt	4	SENT_162	[p6l588t1940r687b1987],
6	the	DT	O	the	det	8	SENT_162	[p6l706t1932r802b1987],
7	independent	JJ	O	independent	amod	8	SENT_162	[p6l824t1932r1204b2000],
8	inﬂuence	NN	O	inﬂuence	dobj	4	SENT_162	[p6l1225t1932r1498b1987],
9	of	IN	O	of	_	0	SENT_162	[p6l1520t1932r1582b1987],
10	the	DT	O	the	det	11	SENT_162	[p6l1596t1932r1692b1987],
11	parameters	NNS	O	parameter	prep_of	8	SENT_162	[p6l1713t1940r2050b2000],
12	on	IN	O	on	_	0	SENT_162	[p6l2072t1948r2146b1987],
13	acenocoumarol	NN	O	acenocoumarol	nn	14	SENT_162	[p6l9t2021r466b2076],
14	dose	NN	O	dose	prep_on	11	SENT_162	[p6l486t2021r621b2076],
15	a	DT	O	a	det	16	SENT_162	[p6l641t2036r672b2076],
16	model	NN	O	model	nsubjpass	19	SENT_162	[p6l692t2021r878b2076],
17	has	VBZ	O	have	aux	19	SENT_162	[p6l899t2021r997b2076],
18	been	VBN	O	be	auxpass	19	SENT_162	[p6l1017t2021r1160b2076],
19	constructed	VBN	O	construct	_	0	SENT_162	[p6l1180t2021r1530b2076],
20	using	VBG	O	use	xcomp	19	SENT_162	[p6l1550t2021r1711b2089],
21	a	DT	O	a	det	24	SENT_162	[p6l1729t2036r1760b2076],
22	multinomial	JJ	O	multinomial	amod	24	SENT_162	[p6l1779t2021r2146b2076],
23	logistic	JJ	O	logistic	amod	24	SENT_162	[p6l10t2109r219b2178],
24	regression	NN	O	regression	dobj	20	SENT_162	[p6l254t2110r574b2178],
25	.	.	O	.	_	0	SENT_162	[p6l254t2110r574b2178],

1	The	DT	O	the	det	3	SENT_163	[p6l607t2109r718b2164],
2	reference	NN	O	reference	nn	3	SENT_163	[p6l752t2109r1031b2164],
3	category	NN	O	category	nsubj	7	SENT_163	[p6l1065t2117r1321b2178],
4	was	VBD	O	be	cop	7	SENT_163	[p6l1353t2125r1469b2164],
5	the	DT	O	the	det	7	SENT_163	[p6l1505t2109r1601b2164],
6	medium	NN	O	medium	nn	7	SENT_163	[p6l1635t2109r1886b2164],
7	dose	NN	O	dose	_	0	SENT_163	[p6l1920t2109r2057b2164],
8	of	IN	O	of	_	0	SENT_163	[p6l2091t2109r2154b2164],
9	the	DT	O	the	det	11	SENT_163	[p6l9t2198r105b2253],
10	acenocoumarol	NN	O	acenocoumarol	nn	11	SENT_163	[p6l138t2198r594b2253],
11	group	NN	O	group	prep_of	7	SENT_163	[p6l628t2214r817b2267],
12	.	.	O	.	_	0	SENT_163	[p6l628t2214r817b2267],

1	We	PRP	O	we	nsubj	2	SENT_164	[p6l849t2201r952b2253],
2	dichotomized	VBD	O	dichotomize	_	0	SENT_164	[p6l987t2198r1395b2253],
3	the	DT	O	the	det	4	SENT_164	[p6l1429t2198r1525b2253],
4	age	NN	O	age	dobj	2	SENT_164	[p6l1558t2214r1658b2267],
5	using	VBG	O	use	xcomp	2	SENT_164	[p6l1693t2199r1853b2267],
6	a	DT	O	a	det	8	SENT_164	[p6l1886t2214r1917b2253],
7	cut	NN	O	cut	nn	8	SENT_164	[p6l1950t2198r2154b2253],
8	—	NN	O	—	dobj	5	SENT_164	[p6l1950t2198r2154b2253],
9	off	IN	O	off	_	0	SENT_164	[p6l1950t2198r2154b2253],
10	value	NN	O	value	prep_off	5	SENT_164	[p6l8t2287r167b2342],
11	of	IN	O	of	_	0	SENT_164	[p6l202t2287r265b2342],
12	65	CD	DURATION	65	num	13	SENT_164	[p6l291t2290r362b2342],
13	years	NNS	NUMBER	year	prep_of	10	SENT_164	[p6l388t2303r558b2356],
14	.	.	O	.	_	0	SENT_164	[p6l388t2303r558b2356],

1	The	DT	O	the	det	3	SENT_165	[p6l591t2287r702b2342],
2	suggested	VBN	O	suggest	amod	3	SENT_165	[p6l736t2287r1031b2356],
3	model	NN	O	model	nsubj	4	SENT_165	[p6l1066t2287r1253b2342],
4	explained	VBD	O	explain	_	0	SENT_165	[p6l1288t2287r1578b2356],
5	about	IN	O	about	_	0	SENT_165	[p6l1613t2287r1783b2342],
6	32	CD	PERCENT	32	num	7	SENT_165	[p6l1814t2290r1929b2342],
7	%	NN	PERCENT	%	prep_about	4	SENT_165	[p6l1814t2290r1929b2342],
8	of	IN	O	of	_	0	SENT_165	[p6l1963t2287r2025b2342],
9	the	DT	O	the	det	12	SENT_165	[p6l2051t2287r2147b2342],
10	acenocoumarol	NN	O	acenocoumarol	nn	12	SENT_165	[p6l9t2376r466b2431],
11	dose	NN	O	dose	nn	12	SENT_165	[p6l502t2376r638b2431],
12	variation	NN	O	variation	prep_of	7	SENT_165	[p6l672t2377r951b2432],
13	.	.	O	.	_	0	SENT_165	[p6l672t2377r951b2432],

1	We	PRP	O	we	nsubj	2	SENT_166	[p6l985t2380r1088b2431],
2	determined	VBD	O	determine	_	0	SENT_166	[p6l1124t2376r1471b2431],
3	that	IN	O	that	complm	12	SENT_166	[p6l1507t2376r1627b2431],
4	the	DT	O	the	det	5	SENT_166	[p6l1660t2376r1756b2431],
5	presence	NN	O	presence	nsubj	12	SENT_166	[p6l1792t2392r2056b2445],
6	of	IN	O	of	_	0	SENT_166	[p6l2091t2376r2154b2431],
7	the	DT	O	the	det	11	SENT_166	[p6l9t2466r105b2521],
8	CYP2C9	NN	O	cyp2c9	nn	11	SENT_166	[p6l143t2466r434b2521],
9	*	NN	O	*	nn	11	SENT_166	[p6l143t2466r434b2521],
10	3	CD	NUMBER	3	num	11	SENT_166	[p6l143t2466r434b2521],
11	allele	NN	O	allele	prep_of	5	SENT_166	[p6l476t2466r630b2521],
12	increases	VBZ	O	increase	ccomp	2	SENT_166	[p6l671t2467r941b2521],
13	the	DT	O	the	det	14	SENT_166	[p6l980t2466r1076b2521],
14	odds	NNS	O	odds	dobj	12	SENT_166	[p6l1115t2466r1256b2521],
15	of	IN	O	of	_	0	SENT_166	[p6l1295t2466r1357b2521],
16	receiving	VBG	O	receive	prepc_of	14	SENT_166	[p6l1389t2467r1662b2534],
17	a	DT	O	a	det	19	SENT_166	[p6l1698t2482r1730b2521],
18	low	JJ	O	low	amod	19	SENT_166	[p6l1768t2466r1879b2521],
19	dose	NN	O	dose	dobj	16	SENT_166	[p6l1916t2466r2052b2521],
20	of	IN	O	of	_	0	SENT_166	[p6l2091t2466r2154b2521],
21	acenocoumarol	NN	O	acenocoumarol	prep_of	19	SENT_166	[p6l9t2555r466b2610],
22	(	CD	NUMBER	(	num	23	SENT_166	[p6l487t2555r610b2623],
23	OR	NN	O	or	dep	21	SENT_166	[p6l487t2555r610b2623],
24	,	,	O	,	_	0	SENT_166	[p6l487t2555r610b2623],
25	3.4	CD	NUMBER	3.4	appos	23	SENT_166	[p6l628t2557r733b2618],
26	;	:	O	;	_	0	SENT_166	[p6l628t2557r733b2618],
27	p	NN	O	p	dep	23	SENT_166	[p6l755t2570r790b2623],
28	=	JJ	O	=	amod	27	SENT_166	[p6l807t2578r861b2598],
29	0.006	CD	NUMBER	0.006	tmod	28	SENT_166	[p6l877t2557r1057b2618],
30	;	:	O	;	_	0	SENT_166	[p6l877t2557r1057b2618],
31	95	CD	PERCENT	95	num	32	SENT_166	[p6l1079t2557r1268b2610],
32	%	NN	PERCENT	%	dep	23	SENT_166	[p6l1079t2557r1268b2610],
33	CI	NN	O	ci	dep	32	SENT_166	[p6l1079t2557r1268b2610],
34	:	:	O	:	_	0	SENT_166	[p6l1079t2557r1268b2610],
35	1.41	CD	NUMBER	1.41	dep	23	SENT_166	[p6l1293t2557r1407b2610],
36	-8.34	CD	NUMBER	-8.34	num	37	SENT_166	[p6l1419t2555r1624b2623],
37	)	NN	O	)	dep	35	SENT_166	[p6l1419t2555r1624b2623],
38	.	.	O	.	_	0	SENT_166	[p6l1419t2555r1624b2623],

1	The	DT	O	the	det	3	SENT_167	[p6l1638t2555r1749b2610],
2	GA	NNP	O	GA	nn	3	SENT_167	[p6l1766t2557r1855b2610],
3	genotype	NN	O	genotype	_	0	SENT_167	[p6l1868t2563r2145b2623],
4	of	IN	O	of	_	0	SENT_167	[p6l10t2643r72b2698],
5	c.	NN	O	c.	prep_of	3	SENT_167	[p6l87t2645r451b2699],
6	.	.	O	.	_	0	SENT_167	[p6l87t2645r451b2699],

1	—	NN	O	—	_	0	SENT_168	[p6l87t2645r451b2699],
2	.	.	O	.	_	0	SENT_168	[p6l87t2645r451b2699],

1	1639G	NN	O	1639g	_	0	SENT_169	[p6l87t2645r451b2699],
2	>	JJR	O	>	amod	4	SENT_169	[p6l87t2645r451b2699],
3	A	DT	O	a	det	4	SENT_169	[p6l87t2645r451b2699],
4	polymorphism	NN	O	polymorphism	nsubj	7	SENT_169	[p6l471t2643r912b2712],
5	of	IN	O	of	_	0	SENT_169	[p6l933t2643r995b2698],
6	VKORC1	NN	O	vkorc1	prep_of	4	SENT_169	[p6l1007t2646r1251b2698],
7	increased	VBD	O	increase	rcmod	1	SENT_169	[p6l1281t2643r1562b2698],
8	the	DT	O	the	det	9	SENT_169	[p6l1585t2643r1680b2698],
9	odds	NNS	O	odds	dobj	7	SENT_169	[p6l1702t2643r1842b2698],
10	of	IN	O	of	_	0	SENT_169	[p6l1865t2643r1928b2698],
11	receiving	VBG	O	receive	prepc_of	9	SENT_169	[p6l1943t2644r2145b2698, p6l10t2733r102b2801],
12	a	DT	O	a	det	14	SENT_169	[p6l123t2748r154b2787],
13	low	JJ	O	low	amod	14	SENT_169	[p6l177t2732r287b2787],
14	dose	NN	O	dose	dobj	11	SENT_169	[p6l308t2732r443b2787],
15	of	IN	O	of	_	0	SENT_169	[p6l466t2732r529b2787],
16	acenocoumarol	NN	O	acenocoumarol	prep_of	14	SENT_169	[p6l543t2732r1000b2787],
17	(	CD	NUMBER	(	num	18	SENT_169	[p6l1026t2732r1149b2800],
18	OR	NN	O	or	dep	1	SENT_169	[p6l1026t2732r1149b2800],
19	,	,	O	,	_	0	SENT_169	[p6l1026t2732r1149b2800],
20	6.5	CD	NUMBER	6.5	appos	18	SENT_169	[p6l1174t2735r1277b2796],
21	;	:	O	;	_	0	SENT_169	[p6l1174t2735r1277b2796],
22	p	NN	O	p	dep	1	SENT_169	[p6l1305t2748r1340b2801],
23	=	JJ	O	=	amod	22	SENT_169	[p6l1357t2755r1410b2776],
24	0.01	CD	NUMBER	0.01	tmod	23	SENT_169	[p6l1426t2735r1569b2795],
25	;	:	O	;	_	0	SENT_169	[p6l1426t2735r1569b2795],
26	95	CD	PERCENT	95	num	27	SENT_169	[p6l1596t2735r1785b2788],
27	%	NN	PERCENT	%	dep	1	SENT_169	[p6l1596t2735r1785b2788],
28	CI	NN	O	ci	dep	27	SENT_169	[p6l1596t2735r1785b2788],
29	:	:	O	:	_	0	SENT_169	[p6l1596t2735r1785b2788],
30	1.38	CD	NUMBER	1.38	number	31	SENT_169	[p6l1816t2732r2145b2800],
31	—	CD	NUMBER	—	dep	1	SENT_169	[p6l1816t2732r2145b2800],
32	30.5	CD	NUMBER	30.5	num	33	SENT_169	[p6l1816t2732r2145b2800],
33	)	NN	O	)	dep	31	SENT_169	[p6l1816t2732r2145b2800],
34	.	.	O	.	_	0	SENT_169	[p6l1816t2732r2145b2800],

1	The	DT	O	the	det	2	SENT_170	[p6l7t2821r118b2876],
2	presence	NN	O	presence	_	0	SENT_170	[p6l172t2837r436b2890],
3	of	IN	O	of	_	0	SENT_170	[p6l491t2821r554b2876],
4	AA	NN	O	aa	nn	5	SENT_170	[p6l598t2824r687b2876],
5	genotype	NN	O	genotype	prep_of	2	SENT_170	[p6l738t2829r1015b2890],
6	of	IN	O	of	_	0	SENT_170	[p6l1070t2821r1133b2876],
7	c.-1639G	NN	O	c.-1639g	prep_of	5	SENT_170	[p6l1180t2824r1544b2877],
8	>	JJR	O	>	amod	10	SENT_170	[p6l1180t2824r1544b2877],
9	A	DT	O	a	det	10	SENT_170	[p6l1180t2824r1544b2877],
10	polymorphism	NN	O	polymorphism	nsubj	14	SENT_170	[p6l1597t2821r2037b2890],
11	of	IN	O	of	_	0	SENT_170	[p6l2091t2821r2154b2876],
12	VKORC1	NN	O	vkorc1	prep_of	10	SENT_170	[p6l7t2913r250b2965],
13	further	RB	O	further	advmod	14	SENT_170	[p6l284t2910r494b2965],
14	increased	VBD	O	increase	rcmod	2	SENT_170	[p6l519t2910r800b2965],
15	the	DT	O	the	det	16	SENT_170	[p6l827t2910r923b2965],
16	odds	NNS	O	odds	dobj	14	SENT_170	[p6l949t2910r1089b2965],
17	of	IN	O	of	_	0	SENT_170	[p6l1117t2910r1179b2965],
18	receiving	VBG	O	receive	prepc_of	16	SENT_170	[p6l1199t2911r1472b2979],
19	a	DT	O	a	det	22	SENT_170	[p6l1496t2926r1527b2965],
20	low	JJ	O	low	amod	22	SENT_170	[p6l1554t2910r1664b2965],
21	acenocoumarol	NN	O	acenocoumarol	nn	22	SENT_170	[p6l1689t2910r2146b2965],
22	dose	NN	O	dose	dobj	18	SENT_170	[p6l10t3000r145b3055],
23	(	NN	O	(	nn	24	SENT_170	[p6l193t3000r316b3068],
24	OR	NN	O	or	dep	2	SENT_170	[p6l193t3000r316b3068],
25	,	,	O	,	_	0	SENT_170	[p6l193t3000r316b3068],
26	11.6	CD	NUMBER	11.6	appos	24	SENT_170	[p6l364t3003r504b3063],
27	;	:	O	;	_	0	SENT_170	[p6l364t3003r504b3063],
28	p	NN	O	p	dep	2	SENT_170	[p6l551t3003r852b3068],
29	=	JJ	O	=	amod	28	SENT_170	[p6l551t3003r852b3068],
30	0.003	CD	NUMBER	0.003	tmod	29	SENT_170	[p6l551t3003r852b3068],
31	;	:	O	;	_	0	SENT_170	[p6l551t3003r852b3068],
32	95	CD	PERCENT	95	number	33	SENT_170	[p6l901t3003r1090b3055],
33	%	NN	PERCENT	%	amod	34	SENT_170	[p6l901t3003r1090b3055],
34	CI	NN	O	ci	dep	2	SENT_170	[p6l901t3003r1090b3055],
35	:	:	O	:	_	0	SENT_170	[p6l901t3003r1090b3055],
36	2.26-59	CD	NUMBER	2.26-59	number	37	SENT_170	[p6l1139t3000r1508b3068],
37	.58	CD	NUMBER	.58	num	38	SENT_170	[p6l1139t3000r1508b3068],
38	)	NN	O	)	dep	34	SENT_170	[p6l1139t3000r1508b3068],
39	.	.	O	.	_	0	SENT_170	[p6l1139t3000r1508b3068],

1	Patients	NNS	O	patient	nsubj	8	SENT_171	[p6l1553t3001r1789b3055],
2	aged	VBN	O	age	partmod	1	SENT_171	[p6l1833t3000r1971b3068],
3	over	IN	O	over	_	0	SENT_171	[p6l2016t3016r2148b3055],
4	65	CD	DURATION	65	num	5	SENT_171	[p6l10t3091r80b3144],
5	years	NNS	NUMBER	year	prep_over	2	SENT_171	[p6l106t3104r262b3157],
6	were	VBD	O	be	cop	8	SENT_171	[p6l298t3104r448b3144],
7	more	RBR	O	more	advmod	8	SENT_171	[p6l485t3104r640b3144],
8	likely	JJ	O	likely	_	0	SENT_171	[p6l677t3089r837b3157],
9	to	TO	O	to	aux	10	SENT_171	[p6l872t3097r929b3144],
10	receive	VB	O	receive	xcomp	8	SENT_171	[p6l967t3089r1177b3144],
11	a	DT	O	a	det	13	SENT_171	[p6l1213t3104r1244b3144],
12	low	JJ	O	low	amod	13	SENT_171	[p6l1281t3089r1391b3144],
13	dose	NN	O	dose	dobj	10	SENT_171	[p6l1426t3089r1561b3144],
14	of	IN	O	of	_	0	SENT_171	[p6l1598t3088r1661b3144],
15	acenocoumarol	NN	O	acenocoumarol	prep_of	13	SENT_171	[p6l1689t3089r2145b3144],
16	(	CD	NUMBER	(	num	17	SENT_171	[p6l14t3177r137b3245],
17	OR	NN	O	or	dep	15	SENT_171	[p6l14t3177r137b3245],
18	,	,	O	,	_	0	SENT_171	[p6l14t3177r137b3245],
19	3.2	CD	NUMBER	3.2	appos	17	SENT_171	[p6l178t3180r283b3241],
20	;	:	O	;	_	0	SENT_171	[p6l178t3180r283b3241],
21	p	NN	O	p	dep	17	SENT_171	[p6l329t3180r594b3246],
22	=	JJ	O	=	amod	21	SENT_171	[p6l329t3180r594b3246],
23	0.01	CD	NUMBER	0.01	tmod	22	SENT_171	[p6l329t3180r594b3246],
24	;	:	O	;	_	0	SENT_171	[p6l329t3180r594b3246],
25	95	CD	PERCENT	95	num	26	SENT_171	[p6l638t3180r827b3233],
26	%	NN	PERCENT	%	dep	17	SENT_171	[p6l638t3180r827b3233],
27	CI	NN	O	ci	dep	26	SENT_171	[p6l638t3180r827b3233],
28	:	:	O	:	_	0	SENT_171	[p6l638t3180r827b3233],
29	1.24-8	CD	NUMBER	1.24-8	dep	17	SENT_171	[p6l876t3177r1206b3245],
30	.25	CD	NUMBER	.25	num	31	SENT_171	[p6l876t3177r1206b3245],
31	)	NN	O	)	dep	29	SENT_171	[p6l876t3177r1206b3245],
32	.	.	O	.	_	0	SENT_171	[p6l876t3177r1206b3245],

1	Elderly	JJ	O	elderly	amod	2	SENT_172	[p6l1248t3177r1456b3246],
2	patients	NNS	O	patient	_	0	SENT_172	[p6l1496t3178r1733b3246],
3	(	IN	O	(	_	0	SENT_172	[p6l1779t3177r1935b3245],
4	>	JJR	O	>	prep_(	10	SENT_172	[p6l1779t3177r1935b3245],
5	65	CD	DURATION	65	num	6	SENT_172	[p6l1779t3177r1935b3245],
6	years	NNS	NUMBER	year	tmod	4	SENT_172	[p6l1960t3177r2142b3246],
7	)	CD	NUMBER	)	nsubj	10	SENT_172	[p6l1960t3177r2142b3246],
8	were	VBD	O	be	cop	10	SENT_172	[p6l8t3282r158b3321],
9	less	RBR	O	less	advmod	10	SENT_172	[p6l186t3266r292b3321],
10	likely	JJ	O	likely	rcmod	2	SENT_172	[p6l321t3266r482b3335],
11	to	TO	O	to	aux	12	SENT_172	[p6l507t3274r565b3321],
12	receive	VB	O	receive	xcomp	10	SENT_172	[p6l593t3267r804b3321],
13	a	DT	O	a	det	16	SENT_172	[p6l832t3282r863b3321],
14	high	JJ	O	high	amod	16	SENT_172	[p6l890t3266r1021b3335],
15	acenocoumarol	NN	O	acenocoumarol	nn	16	SENT_172	[p6l1049t3266r1504b3321],
16	dose	NN	O	dose	dobj	12	SENT_172	[p6l1533t3266r1669b3321],
17	(	NN	O	(	nn	18	SENT_172	[p6l1701t3266r1824b3334],
18	OR	NN	O	or	dep	2	SENT_172	[p6l1701t3266r1824b3334],
19	,	,	O	,	_	0	SENT_172	[p6l1701t3266r1824b3334],
20	0.24	CD	NUMBER	0.24	appos	18	SENT_172	[p6l1853t3269r1995b3330],
21	;	:	O	;	_	0	SENT_172	[p6l1853t3269r1995b3330],
22	p	NN	O	p	dep	2	SENT_172	[p6l2028t3282r2132b3335],
23	:	:	O	:	_	0	SENT_172	[p6l2028t3282r2132b3335],
24	0.001	CD	NUMBER	0.001	dep	22	SENT_172	[p6l10t3358r189b3419],
25	;	:	O	;	_	0	SENT_172	[p6l10t3358r189b3419],
26	95	CD	PERCENT	95	num	27	SENT_172	[p6l219t3358r409b3411],
27	%	NN	PERCENT	%	dep	2	SENT_172	[p6l219t3358r409b3411],
28	CI	NN	O	ci	dep	27	SENT_172	[p6l219t3358r409b3411],
29	:	:	O	:	_	0	SENT_172	[p6l219t3358r409b3411],
30	0.1	CD	NUMBER	0.1	number	31	SENT_172	[p6l437t3355r732b3424],
31	—	CD	NUMBER	—	dep	2	SENT_172	[p6l437t3355r732b3424],
32	0.56	CD	NUMBER	0.56	num	33	SENT_172	[p6l437t3355r732b3424],
33	)	NN	O	)	dep	31	SENT_172	[p6l437t3355r732b3424],
34	.	.	O	.	_	0	SENT_172	[p6l437t3355r732b3424],

1	Patients	NNS	O	patient	nsubj	8	SENT_173	[p6l758t3356r993b3410],
2	with	IN	O	with	_	0	SENT_173	[p6l1017t3355r1155b3410],
3	the	DT	O	the	det	7	SENT_173	[p6l1178t3355r1274b3410],
4	GA	NN	O	ga	nn	7	SENT_173	[p6l1298t3358r1387b3410],
5	or	CC	O	or	_	0	SENT_173	[p6l1409t3371r1472b3410],
6	AA	NN	O	aa	nn	7	SENT_173	[p6l1491t3358r1580b3410],
7	genotype	NN	O	genotype	prep_with	1	SENT_173	[p6l1600t3363r1878b3424],
8	had	VBD	O	have	_	0	SENT_173	[p6l1903t3355r2012b3410],
9	low	JJ	O	low	amod	10	SENT_173	[p6l2037t3355r2148b3410],
10	odds	NNS	O	odds	dobj	8	SENT_173	[p6l10t3444r149b3499],
11	of	IN	O	of	_	0	SENT_173	[p6l187t3444r250b3499],
12	being	VBG	O	be	auxpass	13	SENT_173	[p6l279t3444r445b3513],
13	included	VBN	O	include	prepc_of	10	SENT_173	[p6l481t3444r736b3499],
14	in	IN	O	in	_	0	SENT_173	[p6l774t3445r829b3499],
15	the	DT	O	the	det	18	SENT_173	[p6l866t3444r962b3499],
16	high	JJ	O	high	amod	18	SENT_173	[p6l999t3444r1129b3513],
17	acenocoumarol	NN	O	acenocoumarol	nn	18	SENT_173	[p6l1166t3444r1622b3499],
18	group	NN	O	group	prep_in	13	SENT_173	[p6l1659t3460r1834b3513],
19	(	CD	NUMBER	(	num	20	SENT_173	[p6l1875t3444r1999b3513],
20	OR	NN	O	or	dep	18	SENT_173	[p6l1875t3444r1999b3513],
21	,	,	O	,	_	0	SENT_173	[p6l1875t3444r1999b3513],
22	0.2	CD	NUMBER	0.2	appos	20	SENT_173	[p6l2037t3447r2142b3508],
23	;	:	O	;	_	0	SENT_173	[p6l2037t3447r2142b3508],
24	p	NN	O	p	dep	25	SENT_173	[p6l10t3536r283b3602],
25	<	JJR	O	<	dep	20	SENT_173	[p6l10t3536r283b3602],
26	0.001	CD	NUMBER	0.001	dep	25	SENT_173	[p6l10t3536r283b3602],
27	;	:	O	;	_	0	SENT_173	[p6l10t3536r283b3602],
28	95CI	CD	PERCENT	95ci	num	29	SENT_173	[p6l323t3536r512b3589],
29	%	NN	PERCENT	%	dep	20	SENT_173	[p6l323t3536r512b3589],
30	:	:	O	:	_	0	SENT_173	[p6l323t3536r512b3589],
31	0.09-0	CD	NUMBER	0.09-0	number	32	SENT_173	[p6l552t3536r860b3597],
32	.45	CD	NUMBER	.45	dep	29	SENT_173	[p6l552t3536r860b3597],
33	;	:	O	;	_	0	SENT_173	[p6l552t3536r860b3597],
34	respectively	RB	O	respectively	advmod	35	SENT_173	[p6l901t3534r1260b3602],
35	OR	NN	O	or	dep	20	SENT_173	[p6l1293t3536r1391b3597],
36	,	,	O	,	_	0	SENT_173	[p6l1293t3536r1391b3597],
37	0.05	CD	NUMBER	0.05	appos	35	SENT_173	[p6l1427t3536r1570b3597],
38	;	:	O	;	_	0	SENT_173	[p6l1427t3536r1570b3597],
39	p	NN	O	p	dep	20	SENT_173	[p6l1610t3536r1912b3602],
40	=	JJ	O	=	amod	39	SENT_173	[p6l1610t3536r1912b3602],
41	0.006	CD	NUMBER	0.006	tmod	40	SENT_173	[p6l1610t3536r1912b3602],
42	;	:	O	;	_	0	SENT_173	[p6l1610t3536r1912b3602],
43	95	CD	PERCENT	95	num	44	SENT_173	[p6l1952t3536r2142b3589],
44	%	NN	PERCENT	%	dep	20	SENT_173	[p6l1952t3536r2142b3589],
45	CI	NN	O	ci	dep	44	SENT_173	[p6l1952t3536r2142b3589],
46	:	:	O	:	_	0	SENT_173	[p6l1952t3536r2142b3589],
47	0.007-0	CD	NUMBER	0.007-0	dep	20	SENT_173	[p6l10t3622r380b3690],
48	.43	CD	NUMBER	.43	num	49	SENT_173	[p6l10t3622r380b3690],
49	)	NN	O	)	dep	47	SENT_173	[p6l10t3622r380b3690],
50	.	.	O	.	_	0	SENT_173	[p6l10t3622r380b3690],

1	Discussion	NN	O	discussion	_	0	SENT_174	[p7l9t89r352b144],

1	Alongside	IN	O	alongside	_	0	SENT_175	[p7l109t267r412b335],
2	the	DT	O	the	det	3	SENT_175	[p7l440t267r537b322],
3	progress	NN	O	progress	prep_alongside	26	SENT_175	[p7l565t282r825b335],
4	of	IN	O	of	_	0	SENT_175	[p7l854t266r917b322],
5	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	3	SENT_175	[p7l937t267r1512b335],
6	,	,	O	,	_	0	SENT_175	[p7l937t267r1512b335],
7	the	DT	O	the	det	8	SENT_175	[p7l1540t267r1637b322],
8	hypothesis	NN	O	hypothesis	nsubj	26	SENT_175	[p7l1666t267r1997b335],
9	that	IN	O	that	complm	12	SENT_175	[p7l2025t267r2148b322],
10	genetic	JJ	O	genetic	amod	11	SENT_175	[p7l8t357r231b425],
11	variations	NNS	O	variation	nsubj	12	SENT_175	[p7l252t357r555b411],
12	could	MD	O	could	dep	8	SENT_175	[p7l581t356r746b411],
13	either	RB	O	either	advmod	12	SENT_175	[p7l771t356r953b411],
14	inﬂuence	RB	O	inﬂuence	advmod	26	SENT_175	[p7l975t356r1256b411],
15	drugs	NNS	O	drug	nsubj	26	SENT_175	[p7l1281t356r1465b425],
16	‘	CD	NUMBER	‘	num	17	SENT_175	[p7l1281t356r1465b425],
17	toxicity	NN	O	toxicity	dep	15	SENT_175	[p7l1490t357r1721b425],
18	or	CC	O	or	_	0	SENT_175	[p7l1743t372r1806b411],
19	determine	VB	O	determine	dep	15	SENT_175	[p7l1829t356r2146b411],
20	a	DT	O	a	det	22	SENT_175	[p7l9t461r40b500],
21	suboptimal	JJ	O	suboptimal	amod	22	SENT_175	[p7l65t445r408b514],
22	response	NN	O	response	dobj	19	SENT_175	[p7l434t461r706b514],
23	to	TO	O	to	_	0	SENT_175	[p7l729t453r788b500],
24	treatment	NN	O	treatment	prep_to	19	SENT_175	[p7l812t453r1121b500],
25	has	VBZ	O	have	aux	26	SENT_175	[p7l1144t445r1244b500],
26	become	VBN	O	become	_	0	SENT_175	[p7l1268t445r1506b500],
27	more	RBR	O	more	advmod	28	SENT_175	[p7l1532t461r1690b500],
28	attractive	JJ	O	attractive	acomp	26	SENT_175	[p7l1714t446r2019b501],
29	.	.	O	.	_	0	SENT_175	[p7l1714t446r2019b501],

1	Table	NNP	O	Table	nn	3	SENT_176	[p7l6t668r145b712],
2	1	CD	NUMBER	1	num	3	SENT_176	[p7l166t670r188b711],
3	Characteristics	NNS	O	characteristic	nsubj	8	SENT_176	[p7l9t738r368b782],
4	of	IN	O	of	_	0	SENT_176	[p7l389t738r440b782],
5	the	DT	O	the	det	7	SENT_176	[p7l453t738r530b782],
6	study	NN	O	study	nn	7	SENT_176	[p7l551t739r686b793],
7	participants	NNS	O	participant	prep_of	3	SENT_176	[p7l705t739r996b793],
8	divided	VBN	O	divide	_	0	SENT_176	[p7l1017t738r1199b782],
9	by	IN	O	by	_	0	SENT_176	[p7l1219t738r1278b793],
10	acenocoumarol	NN	O	acenocoumarol	nn	12	SENT_176	[p7l1296t738r1672b782],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_176	[p7l1692t738r1974b793],
12	dose	NN	O	dose	prep_by	8	SENT_176	[p7l1994t738r2117b782],
13	.	.	O	.	_	0	SENT_176	[p7l1994t738r2117b782],

1	Variable	JJ	O	variable	amod	2	SENT_177	[p7l58t879r260b923],
2	Acenocoumarol	NN	O	acenocoumarol	_	0	SENT_177	[p7l887t879r1273b923],
3	dose	NN	O	dose	nn	4	SENT_177	[p7l1293t879r1404b923],
4	p	NN	O	p	dep	2	SENT_177	[p7l1903t892r1931b934],

1	Low	JJ	O	low	_	0	SENT_178	[p7l890t1024r991b1065],
2	Medium	NNP	O	Medium	nn	3	SENT_178	[p7l1228t1021r1434b1065],
3	High	NNP	O	High	dep	1	SENT_178	[p7l1596t1021r1711b1075],

1	Patients	NNS	O	patient	dep	242	SENT_179	[p7l60t1163r255b1206],
2	(	CD	NUMBER	(	dep	242	SENT_179	[p7l279t1162r371b1216],
3	no	DT	O	no	dep	242	SENT_179	[p7l279t1162r371b1216],
4	,	,	O	,	_	0	SENT_179	[p7l279t1162r371b1216],
5	%	NN	O	%	dep	242	SENT_179	[p7l392t1162r442b1216],
6	)	CD	NUMBER	)	dep	242	SENT_179	[p7l392t1162r442b1216],
7	31	CD	NUMBER	31	dep	242	SENT_179	[p7l889t1164r942b1206],
8	(	NN	O	(	dep	242	SENT_179	[p7l972t1162r1148b1216],
9	10.3	CD	PERCENT	10.3	dep	242	SENT_179	[p7l972t1162r1148b1216],
10	%	NN	PERCENT	%	dep	242	SENT_179	[p7l972t1162r1148b1216],
11	)	CD	NUMBER	)	dep	242	SENT_179	[p7l972t1162r1148b1216],
12	231	CD	NUMBER	231	dep	242	SENT_179	[p7l1227t1164r1311b1206],
13	(	NN	O	(	dep	242	SENT_179	[p7l1340t1162r1518b1216],
14	76.7	CD	PERCENT	76.7	dep	242	SENT_179	[p7l1340t1162r1518b1216],
15	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1340t1162r1518b1216],
16	)	CD	PERCENT	)	dep	242	SENT_179	[p7l1340t1162r1518b1216],
17	39	CD	PERCENT	39	dep	242	SENT_179	[p7l1595t1164r1655b1206],
18	(	CD	PERCENT	(	dep	242	SENT_179	[p7l1678t1162r1811b1216],
19	13	CD	PERCENT	13	dep	242	SENT_179	[p7l1678t1162r1811b1216],
20	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1678t1162r1811b1216],
21	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1678t1162r1811b1216],
22	—	CD	NUMBER	—	dep	242	SENT_179	[p7l1903t1188r1929b1193],
23	Age	NNP	O	Age	dep	242	SENT_179	[p7l58t1235r149b1288],
24	(	CD	NUMBER	(	dep	242	SENT_179	[p7l173t1233r334b1288],
25	years	NNS	NUMBER	year	dep	242	SENT_179	[p7l173t1233r334b1288],
26	,	,	O	,	_	0	SENT_179	[p7l173t1233r334b1288],
27	median	JJ	O	median	dep	242	SENT_179	[p7l355t1233r558b1287],
28	)	NN	O	)	dep	242	SENT_179	[p7l355t1233r558b1287],
29	73	CD	NUMBER	73	dep	242	SENT_179	[p7l890t1235r946b1277],
30	67	CD	NUMBER	67	dep	242	SENT_179	[p7l1228t1235r1285b1277],
31	56	CD	NUMBER	56	dep	242	SENT_179	[p7l1597t1235r1655b1277],
32	<	JJR	O	<	dep	242	SENT_179	[p7l1901t1217r2099b1277],
33	0.001	CD	NUMBER	0.001	dep	242	SENT_179	[p7l1901t1217r2099b1277],
34	*	NN	O	*	dep	242	SENT_179	[p7l1901t1217r2099b1277],
35	Male	NN	O	male	dep	242	SENT_179	[p7l60t1305r178b1349],
36	(	CD	NUMBER	(	dep	242	SENT_179	[p7l202t1305r295b1360],
37	no	DT	O	no	dep	242	SENT_179	[p7l202t1305r295b1360],
38	,	,	O	,	_	0	SENT_179	[p7l202t1305r295b1360],
39	%	NN	O	%	dep	242	SENT_179	[p7l315t1305r366b1360],
40	)	CD	NUMBER	)	dep	242	SENT_179	[p7l315t1305r366b1360],
41	13	CD	NUMBER	13	dep	242	SENT_179	[p7l892t1307r946b1349],
42	(	NN	O	(	dep	242	SENT_179	[p7l972t1305r1117b1360],
43	4.3	CD	PERCENT	4.3	dep	242	SENT_179	[p7l972t1305r1117b1360],
44	%	NN	PERCENT	%	dep	242	SENT_179	[p7l972t1305r1117b1360],
45	)	CD	NUMBER	)	dep	242	SENT_179	[p7l972t1305r1117b1360],
46	108	CD	NUMBER	108	dep	242	SENT_179	[p7l1230t1307r1316b1349],
47	(	NN	O	(	dep	242	SENT_179	[p7l1340t1305r1518b1360],
48	35.8	CD	PERCENT	35.8	dep	242	SENT_179	[p7l1340t1305r1518b1360],
49	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1340t1305r1518b1360],
50	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1340t1305r1518b1360],
51	25	CD	NUMBER	25	dep	242	SENT_179	[p7l1596t1307r1653b1349],
52	(	NN	O	(	dep	242	SENT_179	[p7l1678t1305r1824b1360],
53	8.3	CD	PERCENT	8.3	dep	242	SENT_179	[p7l1678t1305r1824b1360],
54	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1678t1305r1824b1360],
55	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1678t1305r1824b1360],
56	0.09	CD	NUMBER	0.09	dep	242	SENT_179	[p7l1903t1289r2060b1350],
57	**	CD	NUMBER	**	dep	242	SENT_179	[p7l1903t1289r2060b1350],
58	Female	JJ	O	female	dep	242	SENT_179	[p7l60t1377r233b1421],
59	(	CD	NUMBER	(	dep	242	SENT_179	[p7l257t1377r350b1431],
60	no	DT	O	no	dep	242	SENT_179	[p7l257t1377r350b1431],
61	,	,	O	,	_	0	SENT_179	[p7l257t1377r350b1431],
62	%	NN	O	%	dep	242	SENT_179	[p7l370t1377r421b1431],
63	)	CD	NUMBER	)	dep	242	SENT_179	[p7l370t1377r421b1431],
64	18	CD	NUMBER	18	dep	242	SENT_179	[p7l892t1379r947b1421],
65	(	NN	O	(	dep	242	SENT_179	[p7l972t1377r1117b1431],
66	5.9	CD	PERCENT	5.9	dep	242	SENT_179	[p7l972t1377r1117b1431],
67	%	NN	PERCENT	%	dep	242	SENT_179	[p7l972t1377r1117b1431],
68	)	CD	NUMBER	)	dep	242	SENT_179	[p7l972t1377r1117b1431],
69	123	CD	NUMBER	123	dep	242	SENT_179	[p7l1230t1379r1315b1421],
70	(	NN	O	(	dep	242	SENT_179	[p7l1340t1377r1518b1431],
71	40.8	CD	PERCENT	40.8	dep	242	SENT_179	[p7l1340t1377r1518b1431],
72	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1340t1377r1518b1431],
73	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1340t1377r1518b1431],
74	14	CD	NUMBER	14	dep	242	SENT_179	[p7l1599t1379r1656b1420],
75	(	NN	O	(	dep	242	SENT_179	[p7l1678t1377r1824b1431],
76	4.6	CD	PERCENT	4.6	dep	242	SENT_179	[p7l1678t1377r1824b1431],
77	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1678t1377r1824b1431],
78	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1678t1377r1824b1431],
79	Atrial	JJ	O	atrial	dep	242	SENT_179	[p7l58t1448r193b1492],
80	ﬁbrillation	NN	O	ﬁbrillation	dep	242	SENT_179	[p7l214t1447r471b1492],
81	(	CD	NUMBER	(	dep	242	SENT_179	[p7l494t1448r587b1502],
82	no	DT	O	no	dep	242	SENT_179	[p7l494t1448r587b1502],
83	,	,	O	,	_	0	SENT_179	[p7l494t1448r587b1502],
84	%	NN	O	%	dep	242	SENT_179	[p7l607t1448r658b1502],
85	)	CD	NUMBER	)	dep	242	SENT_179	[p7l607t1448r658b1502],
86	13	CD	NUMBER	13	dep	242	SENT_179	[p7l892t1450r946b1492],
87	(	NN	O	(	dep	242	SENT_179	[p7l972t1448r1117b1503],
88	4.3	CD	PERCENT	4.3	dep	242	SENT_179	[p7l972t1448r1117b1503],
89	%	NN	PERCENT	%	dep	242	SENT_179	[p7l972t1448r1117b1503],
90	)	CD	PERCENT	)	dep	242	SENT_179	[p7l972t1448r1117b1503],
91	96	CD	PERCENT	96	dep	242	SENT_179	[p7l1227t1450r1286b1492],
92	(	NN	PERCENT	(	dep	242	SENT_179	[p7l1309t1448r1486b1503],
93	31.8	CD	PERCENT	31.8	dep	242	SENT_179	[p7l1309t1448r1486b1503],
94	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1309t1448r1486b1503],
95	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1309t1448r1486b1503],
96	12	CD	NUMBER	12	dep	242	SENT_179	[p7l1599t1450r1654b1492],
97	(	NN	O	(	dep	242	SENT_179	[p7l1678t1448r1824b1503],
98	3.3	CD	PERCENT	3.3	dep	242	SENT_179	[p7l1678t1448r1824b1503],
99	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1678t1448r1824b1503],
100	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1678t1448r1824b1503],
101	0.43	CD	NUMBER	0.43	dep	242	SENT_179	[p7l1903t1432r2060b1492],
102	**	CD	NUMBER	**	dep	242	SENT_179	[p7l1903t1432r2060b1492],
103	Deep	JJ	O	deep	dep	242	SENT_179	[p7l60t1523r183b1575],
104	vein	NN	O	vein	dep	242	SENT_179	[p7l202t1521r307b1564],
105	thrombosis	NN	O	thrombosis	dep	242	SENT_179	[p7l326t1520r603b1564],
106	(	CD	NUMBER	(	dep	242	SENT_179	[p7l627t1520r719b1575],
107	no	DT	O	no	dep	242	SENT_179	[p7l627t1520r719b1575],
108	,	,	O	,	_	0	SENT_179	[p7l627t1520r719b1575],
109	%	NN	O	%	dep	242	SENT_179	[p7l740t1520r790b1575],
110	)	CD	NUMBER	)	dep	242	SENT_179	[p7l740t1520r790b1575],
111	20	CD	NUMBER	20	dep	242	SENT_179	[p7l889t1522r948b1564],
112	(	NN	O	(	dep	242	SENT_179	[p7l972t1520r1117b1575],
113	6.6	CD	PERCENT	6.6	dep	242	SENT_179	[p7l972t1520r1117b1575],
114	%	NN	PERCENT	%	dep	242	SENT_179	[p7l972t1520r1117b1575],
115	)	CD	NUMBER	)	dep	242	SENT_179	[p7l972t1520r1117b1575],
116	140	CD	NUMBER	140	dep	242	SENT_179	[p7l1230t1522r1317b1564],
117	(	NN	O	(	dep	242	SENT_179	[p7l1340t1520r1518b1575],
118	46.5	CD	PERCENT	46.5	dep	242	SENT_179	[p7l1340t1520r1518b1575],
119	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1340t1520r1518b1575],
120	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1340t1520r1518b1575],
121	27	CD	NUMBER	27	dep	242	SENT_179	[p7l1596t1522r1654b1564],
122	(	NN	O	(	dep	242	SENT_179	[p7l1678t1520r1824b1575],
123	8.9	CD	PERCENT	8.9	dep	242	SENT_179	[p7l1678t1520r1824b1575],
124	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1678t1520r1824b1575],
125	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1678t1520r1824b1575],
126	0.56	CD	NUMBER	0.56	dep	242	SENT_179	[p7l1903t1505r2060b1565],
127	**	CD	NUMBER	**	dep	242	SENT_179	[p7l1903t1505r2060b1565],
128	Prosthetic	JJ	O	prosthetic	dep	242	SENT_179	[p7l60t1592r307b1637],
129	heart	NN	O	heart	dep	242	SENT_179	[p7l326t1592r454b1637],
130	valves	NNS	O	valve	dep	242	SENT_179	[p7l471t1593r623b1637],
131	(	VBP	O	(	dep	242	SENT_179	[p7l647t1592r740b1647],
132	no	RB	O	no	dep	242	SENT_179	[p7l647t1592r740b1647],
133	,	,	O	,	_	0	SENT_179	[p7l647t1592r740b1647],
134	%	NN	O	%	dep	242	SENT_179	[p7l760t1593r811b1647],
135	)	CD	NUMBER	)	dep	242	SENT_179	[p7l760t1593r811b1647],
136	3	CD	NUMBER	3	dep	242	SENT_179	[p7l889t1595r915b1637],
137	(	NN	O	(	dep	242	SENT_179	[p7l940t1593r1086b1647],
138	0.9	CD	PERCENT	0.9	dep	242	SENT_179	[p7l940t1593r1086b1647],
139	%	NN	PERCENT	%	dep	242	SENT_179	[p7l940t1593r1086b1647],
140	)	CD	NUMBER	)	dep	242	SENT_179	[p7l940t1593r1086b1647],
141	38	CD	NUMBER	38	dep	242	SENT_179	[p7l1227t1595r1285b1637],
142	(	NN	O	(	dep	242	SENT_179	[p7l1309t1592r1486b1647],
143	12.6	CD	PERCENT	12.6	dep	242	SENT_179	[p7l1309t1592r1486b1647],
144	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1309t1592r1486b1647],
145	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1309t1592r1486b1647],
146	5	CD	NUMBER	5	dep	242	SENT_179	[p7l1597t1595r1622b1637],
147	(	NN	O	(	dep	242	SENT_179	[p7l1647t1593r1793b1647],
148	1.6	CD	PERCENT	1.6	dep	242	SENT_179	[p7l1647t1593r1793b1647],
149	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1647t1593r1793b1647],
150	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1647t1593r1793b1647],
151	0.55	CD	NUMBER	0.55	dep	242	SENT_179	[p7l1903t1577r2060b1637],
152	**	CD	NUMBER	**	dep	242	SENT_179	[p7l1903t1577r2060b1637],
153	Amiodarone	NNP	O	Amiodarone	dep	242	SENT_179	[p7l58t1664r362b1708],
154	(	CD	NUMBER	(	dep	242	SENT_179	[p7l386t1664r478b1718],
155	no	DT	O	no	dep	242	SENT_179	[p7l386t1664r478b1718],
156	,	,	O	,	_	0	SENT_179	[p7l386t1664r478b1718],
157	%	NN	O	%	dep	242	SENT_179	[p7l498t1664r549b1719],
158	)	CD	NUMBER	)	dep	242	SENT_179	[p7l498t1664r549b1719],
159	1	CD	NUMBER	1	dep	242	SENT_179	[p7l892t1666r911b1707],
160	(	NN	O	(	dep	242	SENT_179	[p7l940t1664r1086b1718],
161	0.3	CD	PERCENT	0.3	dep	242	SENT_179	[p7l940t1664r1086b1718],
162	%	NN	PERCENT	%	dep	242	SENT_179	[p7l940t1664r1086b1718],
163	)	CD	NUMBER	)	dep	242	SENT_179	[p7l940t1664r1086b1718],
164	11	CD	NUMBER	11	dep	242	SENT_179	[p7l1230t1666r1280b1708],
165	(	NN	O	(	dep	242	SENT_179	[p7l1309t1664r1455b1719],
166	3.6	CD	PERCENT	3.6	dep	242	SENT_179	[p7l1309t1664r1455b1719],
167	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1309t1664r1455b1719],
168	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1309t1664r1455b1719],
169	o	NN	O	o	dep	242	SENT_179	[p7l1596t1666r1624b1708],
170	0.36	CD	NUMBER	0.36	dep	242	SENT_179	[p7l1903t1648r2060b1708],
171	**	CD	NUMBER	**	dep	242	SENT_179	[p7l1903t1648r2060b1708],
172	Proton	NNP	O	Proton	dep	242	SENT_179	[p7l60t1738r223b1780],
173	pump	NN	O	pump	dep	242	SENT_179	[p7l243t1749r386b1791],
174	inhibitor	NN	O	inhibitor	dep	242	SENT_179	[p7l406t1736r621b1780],
175	(	NN	O	(	dep	242	SENT_179	[p7l643t1736r736b1790],
176	no	RB	O	no	dep	242	SENT_179	[p7l643t1736r736b1790],
177	,	,	O	,	_	0	SENT_179	[p7l643t1736r736b1790],
178	%	NN	O	%	dep	242	SENT_179	[p7l756t1736r806b1790],
179	)	CD	NUMBER	)	dep	242	SENT_179	[p7l756t1736r806b1790],
180	3	CD	NUMBER	3	dep	242	SENT_179	[p7l889t1738r915b1780],
181	(	NN	O	(	dep	242	SENT_179	[p7l940t1736r1086b1790],
182	0.9	CD	PERCENT	0.9	dep	242	SENT_179	[p7l940t1736r1086b1790],
183	%	NN	PERCENT	%	dep	242	SENT_179	[p7l940t1736r1086b1790],
184	)	CD	NUMBER	)	dep	242	SENT_179	[p7l940t1736r1086b1790],
185	19	CD	NUMBER	19	dep	242	SENT_179	[p7l1230t1738r1285b1780],
186	(	NN	O	(	dep	242	SENT_179	[p7l1309t1736r1455b1791],
187	6.3	CD	PERCENT	6.3	dep	242	SENT_179	[p7l1309t1736r1455b1791],
188	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1309t1736r1455b1791],
189	)	CD	PERCENT	)	dep	242	SENT_179	[p7l1309t1736r1455b1791],
190	2	CD	PERCENT	2	dep	242	SENT_179	[p7l1596t1738r1622b1779],
191	(	CD	PERCENT	(	dep	242	SENT_179	[p7l1647t1736r1793b1791],
192	0.6	CD	PERCENT	0.6	dep	242	SENT_179	[p7l1647t1736r1793b1791],
193	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1647t1736r1793b1791],
194	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1647t1736r1793b1791],
195	0.75	CD	NUMBER	0.75	dep	242	SENT_179	[p7l1903t1720r2060b1780],
196	**	CD	NUMBER	**	dep	242	SENT_179	[p7l1903t1720r2060b1780],
197	Spironolactone	NN	O	spironolactone	dep	242	SENT_179	[p7l60t1808r429b1863],
198	(	CD	NUMBER	(	dep	242	SENT_179	[p7l453t1808r546b1863],
199	no	DT	O	no	dep	242	SENT_179	[p7l453t1808r546b1863],
200	,	,	O	,	_	0	SENT_179	[p7l453t1808r546b1863],
201	%	NN	O	%	dep	242	SENT_179	[p7l566t1808r617b1863],
202	)	CD	NUMBER	)	dep	242	SENT_179	[p7l566t1808r617b1863],
203	6	CD	NUMBER	6	dep	242	SENT_179	[p7l890t1810r917b1852],
204	(	NN	O	(	dep	242	SENT_179	[p7l940t1808r1086b1863],
205	1.9	CD	PERCENT	1.9	dep	242	SENT_179	[p7l940t1808r1086b1863],
206	%	NN	PERCENT	%	dep	242	SENT_179	[p7l940t1808r1086b1863],
207	)	CD	PERCENT	)	dep	242	SENT_179	[p7l940t1808r1086b1863],
208	50	CD	PERCENT	50	dep	242	SENT_179	[p7l1228t1810r1286b1852],
209	(	CD	PERCENT	(	dep	242	SENT_179	[p7l1309t1808r1486b1863],
210	16.6	CD	PERCENT	16.6	dep	242	SENT_179	[p7l1309t1808r1486b1863],
211	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1309t1808r1486b1863],
212	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1309t1808r1486b1863],
213	7	CD	NUMBER	7	dep	242	SENT_179	[p7l1597t1811r1623b1852],
214	(	NN	O	(	dep	242	SENT_179	[p7l1647t1808r1793b1863],
215	2.3	CD	PERCENT	2.3	dep	242	SENT_179	[p7l1647t1808r1793b1863],
216	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1647t1808r1793b1863],
217	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1647t1808r1793b1863],
218	0.84	CD	NUMBER	0.84	dep	242	SENT_179	[p7l1903t1792r2060b1853],
219	**	CD	NUMBER	**	dep	242	SENT_179	[p7l1903t1792r2060b1853],
220	Statins	NNS	O	statin	dep	242	SENT_179	[p7l60t1881r224b1925],
221	(	CD	NUMBER	(	dep	242	SENT_179	[p7l248t1880r341b1935],
222	no	DT	O	no	dep	242	SENT_179	[p7l248t1880r341b1935],
223	,	,	O	,	_	0	SENT_179	[p7l248t1880r341b1935],
224	%	NN	O	%	dep	242	SENT_179	[p7l361t1880r412b1935],
225	)	CD	NUMBER	)	dep	242	SENT_179	[p7l361t1880r412b1935],
226	12	CD	NUMBER	12	dep	242	SENT_179	[p7l892t1883r947b1924],
227	(	NN	O	(	dep	242	SENT_179	[p7l972t1880r1117b1935],
228	3.9	CD	PERCENT	3.9	dep	242	SENT_179	[p7l972t1880r1117b1935],
229	%	NN	PERCENT	%	dep	242	SENT_179	[p7l972t1880r1117b1935],
230	)	CD	PERCENT	)	dep	242	SENT_179	[p7l972t1880r1117b1935],
231	99	CD	PERCENT	99	dep	242	SENT_179	[p7l1227t1883r1286b1925],
232	(	CD	PERCENT	(	dep	242	SENT_179	[p7l1309t1880r1486b1935],
233	32.8	CD	PERCENT	32.8	dep	242	SENT_179	[p7l1309t1880r1486b1935],
234	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1309t1880r1486b1935],
235	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1309t1880r1486b1935],
236	16	CD	NUMBER	16	dep	242	SENT_179	[p7l1599t1883r1655b1925],
237	(	NN	O	(	dep	242	SENT_179	[p7l1678t1880r1824b1935],
238	5.3	CD	PERCENT	5.3	dep	242	SENT_179	[p7l1678t1880r1824b1935],
239	%	NN	PERCENT	%	dep	242	SENT_179	[p7l1678t1880r1824b1935],
240	)	CD	NUMBER	)	dep	242	SENT_179	[p7l1678t1880r1824b1935],
241	0.36	CD	NUMBER	0.36	dep	242	SENT_179	[p7l1903t1864r2060b1925],
242	**	NN	O	**	_	0	SENT_179	[p7l1903t1864r2060b1925],

1	*	NN	O	*	nn	2	SENT_180	[p7l50t2015r72b2041],
2	l	NN	O	l	_	0	SENT_180	[p7l111t2022r481b2065],
3	(	CD	NUMBER	(	num	4	SENT_180	[p7l111t2022r481b2065],
4	rusl	NN	O	rusl	dep	5	SENT_180	[p7l111t2022r481b2065],
5	<	JJR	O	<	dep	2	SENT_180	[p7l111t2022r481b2065],
6	al	NNP	O	al	dep	5	SENT_180	[p7l111t2022r481b2065],
7	.	.	O	.	_	0	SENT_180	[p7l111t2022r481b2065],

1	—	NN	O	—	_	0	SENT_181	[p7l111t2022r481b2065],
2	.	.	O	.	_	0	SENT_181	[p7l111t2022r481b2065],

1	Wallis	NNP	PERSON	Wallis	nsubj	2	SENT_182	[p7l111t2022r481b2065],
2	test	NN	O	test	_	0	SENT_182	[p7l501t2028r601b2066],
3	.	.	O	.	_	0	SENT_182	[p7l501t2028r601b2066],

1	**	NN	O	**	nsubj	5	SENT_183	[p7l22t2087r73b2112],
2	Chi	NNP	O	Chi	dep	5	SENT_183	[p7l111t2093r376b2147],
3	—	CD	NUMBER	—	num	5	SENT_183	[p7l111t2093r376b2147],
4	square	JJ	O	square	amod	5	SENT_183	[p7l111t2093r376b2147],
5	test	NN	O	test	_	0	SENT_183	[p7l396t2099r496b2137],
6	.	.	O	.	_	0	SENT_183	[p7l396t2099r496b2137],

1	Table	NNP	O	Table	_	0	SENT_184	[p7l6t2165r145b2208],
2	2	CD	NUMBER	2	num	4	SENT_184	[p7l163t2167r192b2208],
3	Genotype	NN	O	genotype	nn	4	SENT_184	[p7l8t2238r244b2291],
4	distribution	NN	O	distribution	dep	1	SENT_184	[p7l264t2236r553b2280],
5	of	IN	O	of	_	0	SENT_184	[p7l573t2236r624b2280],
6	CYP2C9	NN	O	cyp2c9	nn	7	SENT_184	[p7l637t2238r824b2280],
7	variants	NNS	O	variant	prep_of	4	SENT_184	[p7l843t2237r1052b2280],
8	.	.	O	.	_	0	SENT_184	[p7l843t2237r1052b2280],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_185	[p7l59t2378r246b2419],
2	genotype	NN	O	genotype	_	0	SENT_185	[p7l266t2382r493b2430],
3	Acenocoumarol	NNP	O	Acenocoumarol	dep	2	SENT_185	[p7l774t2376r1160b2419],
4	dose	NN	O	dose	dep	2	SENT_185	[p7l1181t2376r1292b2419],

1	Low	JJ	O	low	_	0	SENT_186	[p7l777t2518r878b2559],
2	Medium	NNP	O	Medium	nn	3	SENT_186	[p7l1291t2515r1497b2559],
3	High	NNP	O	High	dep	1	SENT_186	[p7l1867t2515r1982b2570],

1	*	NN	O	*	dep	134	SENT_187	[p7l60t2654r177b2705],
2	1	CD	NUMBER	1	dep	134	SENT_187	[p7l60t2654r177b2705],
3	/	:	O	/	dep	134	SENT_187	[p7l60t2654r177b2705],
4	*	CD	NUMBER	*	dep	134	SENT_187	[p7l60t2654r177b2705],
5	1	CD	NUMBER	1	dep	134	SENT_187	[p7l60t2654r177b2705],
6	(	CD	NUMBER	(	dep	134	SENT_187	[p7l206t2654r299b2708],
7	no	DT	O	no	dep	134	SENT_187	[p7l206t2654r299b2708],
8	,	,	O	,	_	0	SENT_187	[p7l206t2654r299b2708],
9	%	NN	O	%	dep	134	SENT_187	[p7l319t2654r370b2708],
10	)	CD	NUMBER	)	dep	134	SENT_187	[p7l319t2654r370b2708],
11	14	CD	NUMBER	14	dep	134	SENT_187	[p7l779t2656r836b2697],
12	(	NN	O	(	dep	134	SENT_187	[p7l858t2654r1004b2708],
13	4.6	CD	PERCENT	4.6	dep	134	SENT_187	[p7l858t2654r1004b2708],
14	%	NN	PERCENT	%	dep	134	SENT_187	[p7l858t2654r1004b2708],
15	)	CD	NUMBER	)	dep	134	SENT_187	[p7l858t2654r1004b2708],
16	152	CD	NUMBER	152	dep	134	SENT_187	[p7l1293t2656r1379b2698],
17	(	NN	O	(	dep	134	SENT_187	[p7l1404t2654r1537b2708],
18	50	CD	PERCENT	50	dep	134	SENT_187	[p7l1404t2654r1537b2708],
19	%	NN	PERCENT	%	dep	134	SENT_187	[p7l1404t2654r1537b2708],
20	)	CD	NUMBER	)	dep	134	SENT_187	[p7l1404t2654r1537b2708],
21	29	CD	NUMBER	29	dep	134	SENT_187	[p7l1867t2656r1925b2698],
22	(	NN	O	(	dep	134	SENT_187	[p7l1949t2654r2095b2708],
23	9.3	CD	PERCENT	9.3	dep	134	SENT_187	[p7l1949t2654r2095b2708],
24	%	NN	PERCENT	%	dep	134	SENT_187	[p7l1949t2654r2095b2708],
25	)	CD	NUMBER	)	dep	134	SENT_187	[p7l1949t2654r2095b2708],
26	*	NN	O	*	dep	134	SENT_187	[p7l60t2725r181b2776],
27	1	CD	NUMBER	1	dep	134	SENT_187	[p7l60t2725r181b2776],
28	/	:	O	/	dep	134	SENT_187	[p7l60t2725r181b2776],
29	*	CD	NUMBER	*	dep	134	SENT_187	[p7l60t2725r181b2776],
30	2	CD	NUMBER	2	dep	134	SENT_187	[p7l60t2725r181b2776],
31	(	CD	NUMBER	(	dep	134	SENT_187	[p7l206t2725r299b2779],
32	no	DT	O	no	dep	134	SENT_187	[p7l206t2725r299b2779],
33	,	,	O	,	_	0	SENT_187	[p7l206t2725r299b2779],
34	%	NN	O	%	dep	134	SENT_187	[p7l319t2725r370b2779],
35	)	CD	NUMBER	)	dep	134	SENT_187	[p7l319t2725r370b2779],
36	5	CD	NUMBER	5	dep	134	SENT_187	[p7l777t2728r802b2769],
37	(	NN	O	(	dep	134	SENT_187	[p7l828t2725r973b2779],
38	1.6	CD	PERCENT	1.6	dep	134	SENT_187	[p7l828t2725r973b2779],
39	%	NN	PERCENT	%	dep	134	SENT_187	[p7l828t2725r973b2779],
40	)	CD	NUMBER	)	dep	134	SENT_187	[p7l828t2725r973b2779],
41	42	CD	NUMBER	42	dep	134	SENT_187	[p7l1320t2727r1379b2768],
42	(	NN	O	(	dep	134	SENT_187	[p7l1404t2725r1581b2779],
43	13.9	CD	PERCENT	13.9	dep	134	SENT_187	[p7l1404t2725r1581b2779],
44	%	NN	PERCENT	%	dep	134	SENT_187	[p7l1404t2725r1581b2779],
45	)	CD	NUMBER	)	dep	134	SENT_187	[p7l1404t2725r1581b2779],
46	6	CD	NUMBER	6	dep	134	SENT_187	[p7l1867t2727r1895b2769],
47	(	NN	O	(	dep	134	SENT_187	[p7l1918t2725r2064b2779],
48	1.9	CD	PERCENT	1.9	dep	134	SENT_187	[p7l1918t2725r2064b2779],
49	%	NN	PERCENT	%	dep	134	SENT_187	[p7l1918t2725r2064b2779],
50	)	CD	NUMBER	)	dep	134	SENT_187	[p7l1918t2725r2064b2779],
51	*	NN	O	*	dep	134	SENT_187	[p7l60t2796r180b2847],
52	1	CD	NUMBER	1	dep	134	SENT_187	[p7l60t2796r180b2847],
53	/	:	O	/	dep	134	SENT_187	[p7l60t2796r180b2847],
54	*	CD	NUMBER	*	dep	134	SENT_187	[p7l60t2796r180b2847],
55	3	CD	NUMBER	3	dep	134	SENT_187	[p7l60t2796r180b2847],
56	(	CD	NUMBER	(	dep	134	SENT_187	[p7l206t2797r299b2851],
57	no	DT	O	no	dep	134	SENT_187	[p7l206t2797r299b2851],
58	,	,	O	,	_	0	SENT_187	[p7l206t2797r299b2851],
59	%	NN	O	%	dep	134	SENT_187	[p7l319t2797r370b2851],
60	)	CD	NUMBER	)	dep	134	SENT_187	[p7l319t2797r370b2851],
61	9	CD	NUMBER	9	dep	134	SENT_187	[p7l776t2799r804b2840],
62	(	NN	O	(	dep	134	SENT_187	[p7l828t2797r973b2851],
63	2.9	CD	PERCENT	2.9	dep	134	SENT_187	[p7l828t2797r973b2851],
64	%	NN	PERCENT	%	dep	134	SENT_187	[p7l828t2797r973b2851],
65	)	CD	NUMBER	)	dep	134	SENT_187	[p7l828t2797r973b2851],
66	28	CD	NUMBER	28	dep	134	SENT_187	[p7l1322t2799r1379b2840],
67	(	NN	O	(	dep	134	SENT_187	[p7l1404t2797r1550b2851],
68	9.3	CD	PERCENT	9.3	dep	134	SENT_187	[p7l1404t2797r1550b2851],
69	%	NN	PERCENT	%	dep	134	SENT_187	[p7l1404t2797r1550b2851],
70	)	CD	NUMBER	)	dep	134	SENT_187	[p7l1404t2797r1550b2851],
71	4	CD	NUMBER	4	dep	134	SENT_187	[p7l1866t2799r1895b2840],
72	(	NN	O	(	dep	134	SENT_187	[p7l1918t2797r2064b2851],
73	1.3	CD	PERCENT	1.3	dep	134	SENT_187	[p7l1918t2797r2064b2851],
74	%	NN	PERCENT	%	dep	134	SENT_187	[p7l1918t2797r2064b2851],
75	)	CD	NUMBER	)	dep	134	SENT_187	[p7l1918t2797r2064b2851],
76	*	NN	O	*	dep	134	SENT_187	[p7l60t2868r180b2919],
77	2	CD	NUMBER	2	dep	134	SENT_187	[p7l60t2868r180b2919],
78	/	:	O	/	dep	134	SENT_187	[p7l60t2868r180b2919],
79	*	CD	NUMBER	*	dep	134	SENT_187	[p7l60t2868r180b2919],
80	3	CD	NUMBER	3	dep	134	SENT_187	[p7l60t2868r180b2919],
81	(	CD	NUMBER	(	dep	134	SENT_187	[p7l206t2868r299b2922],
82	no	DT	O	no	dep	134	SENT_187	[p7l206t2868r299b2922],
83	,	,	O	,	_	0	SENT_187	[p7l206t2868r299b2922],
84	%	NN	O	%	dep	134	SENT_187	[p7l319t2868r370b2922],
85	)	CD	PERCENT	)	dep	134	SENT_187	[p7l319t2868r370b2922],
86	2	CD	PERCENT	2	dep	134	SENT_187	[p7l776t2870r803b2911],
87	(	CD	PERCENT	(	dep	134	SENT_187	[p7l828t2868r973b2922],
88	0.6	CD	PERCENT	0.6	dep	134	SENT_187	[p7l828t2868r973b2922],
89	%	NN	PERCENT	%	dep	134	SENT_187	[p7l828t2868r973b2922],
90	)	CD	NUMBER	)	dep	134	SENT_187	[p7l828t2868r973b2922],
91	6	CD	NUMBER	6	dep	134	SENT_187	[p7l1354t2870r1381b2912],
92	(	NN	O	(	dep	134	SENT_187	[p7l1404t2868r1550b2922],
93	1.9	CD	PERCENT	1.9	dep	134	SENT_187	[p7l1404t2868r1550b2922],
94	%	NN	PERCENT	%	dep	134	SENT_187	[p7l1404t2868r1550b2922],
95	)	CD	NUMBER	)	dep	134	SENT_187	[p7l1404t2868r1550b2922],
96	o	NN	O	o	dep	134	SENT_187	[p7l1867t2870r1895b2912],
97	*	NN	O	*	dep	134	SENT_187	[p7l60t2939r181b2990],
98	2	CD	NUMBER	2	dep	134	SENT_187	[p7l60t2939r181b2990],
99	/	:	O	/	dep	134	SENT_187	[p7l60t2939r181b2990],
100	*	CD	NUMBER	*	dep	134	SENT_187	[p7l60t2939r181b2990],
101	2	CD	NUMBER	2	dep	134	SENT_187	[p7l60t2939r181b2990],
102	(	CD	NUMBER	(	dep	134	SENT_187	[p7l206t2939r299b2993],
103	no	DT	O	no	dep	134	SENT_187	[p7l206t2939r299b2993],
104	,	,	O	,	_	0	SENT_187	[p7l206t2939r299b2993],
105	%	NN	O	%	dep	134	SENT_187	[p7l319t2939r370b2993],
106	)	CD	NUMBER	)	dep	134	SENT_187	[p7l319t2939r370b2993],
107	o	NN	O	o	dep	134	SENT_187	[p7l776t2941r804b2983],
108	2	CD	PERCENT	2	dep	134	SENT_187	[p7l1353t2941r1379b2982],
109	(	CD	PERCENT	(	dep	134	SENT_187	[p7l1404t2939r1550b2993],
110	0.6	CD	PERCENT	0.6	dep	134	SENT_187	[p7l1404t2939r1550b2993],
111	%	NN	PERCENT	%	dep	134	SENT_187	[p7l1404t2939r1550b2993],
112	)	CD	NUMBER	)	dep	134	SENT_187	[p7l1404t2939r1550b2993],
113	o	NN	O	o	dep	134	SENT_187	[p7l1867t2941r1895b2983],
114	*	CD	NUMBER	*	dep	134	SENT_187	[p7l60t3011r180b3062],
115	3	CD	NUMBER	3	dep	134	SENT_187	[p7l60t3011r180b3062],
116	/	:	O	/	dep	134	SENT_187	[p7l60t3011r180b3062],
117	*	CD	NUMBER	*	dep	134	SENT_187	[p7l60t3011r180b3062],
118	3	CD	NUMBER	3	dep	134	SENT_187	[p7l60t3011r180b3062],
119	(	CD	NUMBER	(	dep	134	SENT_187	[p7l206t3011r299b3065],
120	no	DT	O	no	dep	134	SENT_187	[p7l206t3011r299b3065],
121	,	,	O	,	_	0	SENT_187	[p7l206t3011r299b3065],
122	%	NN	O	%	dep	134	SENT_187	[p7l319t3011r370b3065],
123	)	CD	NUMBER	)	dep	134	SENT_187	[p7l319t3011r370b3065],
124	1	CD	NUMBER	1	dep	134	SENT_187	[p7l779t3013r798b3054],
125	(	NN	O	(	dep	134	SENT_187	[p7l828t3011r973b3065],
126	0.3	CD	PERCENT	0.3	dep	134	SENT_187	[p7l828t3011r973b3065],
127	%	NN	PERCENT	%	dep	134	SENT_187	[p7l828t3011r973b3065],
128	)	CD	NUMBER	)	dep	134	SENT_187	[p7l828t3011r973b3065],
129	1	CD	NUMBER	1	dep	134	SENT_187	[p7l1356t3013r1375b3054],
130	(	NN	O	(	dep	134	SENT_187	[p7l1404t3011r1550b3065],
131	0.3	CD	PERCENT	0.3	dep	134	SENT_187	[p7l1404t3011r1550b3065],
132	%	NN	PERCENT	%	dep	134	SENT_187	[p7l1404t3011r1550b3065],
133	)	CD	NUMBER	)	dep	134	SENT_187	[p7l1404t3011r1550b3065],
134	o	NN	O	o	_	0	SENT_187	[p7l1867t3013r1895b3055],

1	Although	IN	O	although	mark	7	SENT_188	[p7l108t3276r392b3344],
2	acenocoumarol	NN	O	acenocoumarol	nsubj	7	SENT_188	[p7l423t3276r891b3331],
3	is	VBZ	O	be	cop	7	SENT_188	[p7l923t3277r967b3331],
4	a	DT	O	a	det	7	SENT_188	[p7l999t3292r1030b3331],
5	frequently	RB	O	frequently	advmod	6	SENT_188	[p7l1060t3276r1380b3344],
6	used	VBN	O	use	amod	7	SENT_188	[p7l1409t3276r1549b3331],
7	drug	NN	O	drug	advcl	12	SENT_188	[p7l1581t3276r1736b3344],
8	,	,	O	,	_	0	SENT_188	[p7l1581t3276r1736b3344],
9	it	PRP	O	it	nsubj	12	SENT_188	[p7l1768t3277r1809b3331],
10	remains	VBZ	O	remain	cop	12	SENT_188	[p7l1839t3277r2084b3331],
11	a	DT	O	a	det	12	SENT_188	[p7l2115t3292r2146b3331],
12	hard	JJ	O	hard	_	0	SENT_188	[p7l9t3365r147b3420],
13	to	TO	O	to	aux	14	SENT_188	[p7l168t3373r227b3420],
14	maneuver	VB	O	maneuver	xcomp	12	SENT_188	[p7l248t3380r559b3420],
15	one	CD	NUMBER	one	dobj	14	SENT_188	[p7l577t3380r687b3420],
16	in	IN	O	in	_	0	SENT_188	[p7l709t3365r765b3419],
17	daily	JJ	SET	daily	amod	18	SENT_188	[p7l786t3365r934b3433],
18	practice	NN	O	practice	prep_in	14	SENT_188	[p7l954t3365r1210b3433],
19	.	.	O	.	_	0	SENT_188	[p7l954t3365r1210b3433],

1	Because	IN	O	because	_	0	SENT_189	[p7l1232t3368r1474b3420],
2	of	IN	O	of	prepc_because_of	24	SENT_189	[p7l1495t3364r1559b3420],
3	its	PRP$	O	its	poss	6	SENT_189	[p7l1572t3365r1640b3420],
4	low	JJ	O	low	amod	6	SENT_189	[p7l1663t3365r1776b3420],
5	therapeutic	JJ	O	therapeutic	amod	6	SENT_189	[p7l1794t3365r2146b3433],
6	index	NN	O	index	pobj	24	SENT_189	[p7l9t3453r180b3508],
7	and	CC	O	and	_	0	SENT_189	[p7l214t3453r325b3508],
8	of	IN	O	of	conj_and	24	SENT_189	[p7l361t3453r425b3508],
9	the	DT	O	the	det	13	SENT_189	[p7l452t3453r549b3508],
10	inter	NN	O	inter	nn	13	SENT_189	[p7l586t3453r1068b3508],
11	—	NN	O	—	nn	13	SENT_189	[p7l586t3453r1068b3508],
12	individual	JJ	O	individual	amod	13	SENT_189	[p7l586t3453r1068b3508],
13	variability	NN	O	variability	pobj	8	SENT_189	[p7l1103t3453r1415b3522],
14	of	IN	O	of	_	0	SENT_189	[p7l1449t3453r1512b3508],
15	the	DT	O	the	det	17	SENT_189	[p7l1539t3453r1636b3508],
16	therapeutic	JJ	O	therapeutic	amod	17	SENT_189	[p7l1672t3453r2025b3522],
17	response	NN	O	response	prep_of	13	SENT_189	[p7l2060t3469r2145b3508, p7l10t3558r233b3611],
18	,	,	O	,	_	0	SENT_189	[p7l2060t3469r2145b3508, p7l10t3558r233b3611],
19	patients	NNS	O	patient	nsubj	24	SENT_189	[p7l261t3543r506b3611],
20	under	IN	O	under	_	0	SENT_189	[p7l533t3542r715b3597],
21	such	PDT	O	such	predet	23	SENT_189	[p7l741t3542r878b3597],
22	a	DT	O	a	det	23	SENT_189	[p7l904t3558r935b3597],
23	treatment	NN	O	treatment	prep_under	19	SENT_189	[p7l961t3550r1270b3597],
24	require	VBP	O	require	_	0	SENT_189	[p7l1295t3543r1515b3611],
25	regular	JJ	O	regular	amod	27	SENT_189	[p7l1542t3542r1761b3611],
26	medical	JJ	O	medical	amod	27	SENT_189	[p7l1786t3542r2025b3597],
27	supervision	NN	O	supervision	dobj	24	SENT_189	[p7l2053t3558r2144b3597, p7l9t3632r293b3700],
28	in	IN	O	in	mark	31	SENT_189	[p7l341t3632r397b3686],
29	order	NN	O	order	dep	31	SENT_189	[p7l445t3631r612b3686],
30	to	TO	O	to	aux	31	SENT_189	[p7l657t3639r716b3686],
31	reach	VB	O	reach	purpcl	24	SENT_189	[p7l764t3631r930b3686],
32	the	DT	O	the	det	34	SENT_189	[p7l977t3631r1074b3686],
33	target	NN	O	target	nn	34	SENT_189	[p7l1122t3639r1304b3700],
34	INR	NN	O	inr	dobj	31	SENT_189	[p7l1350t3635r1472b3687],
35	.	.	O	.	_	0	SENT_189	[p7l1350t3635r1472b3687],

1	Failure	NN	O	failure	nsubj	31	SENT_190	[p7l1521t3631r1727b3686],
2	to	TO	O	to	aux	4	SENT_190	[p7l1775t3639r1833b3686],
3	carefully	RB	O	carefully	advmod	4	SENT_190	[p7l1882t3631r2148b3700],
4	monitor	VB	O	monitor	infmod	1	SENT_190	[p7l9t3721r258b3775],
5	the	DT	O	the	det	6	SENT_190	[p7l295t3720r393b3775],
6	patient	NN	O	patient	dobj	4	SENT_190	[p7l434t3721r651b3789],
7	may	MD	O	may	aux	8	SENT_190	[p7l690t3736r821b3789],
8	lead	VB	O	lead	rcmod	6	SENT_190	[p7l859t3720r983b3775],
9	either	CC	O	either	dep	8	SENT_190	[p7l1025t3720r1206b3775],
10	to	TO	O	to	_	0	SENT_190	[p7l1244t3728r1303b3775],
11	excessive	JJ	O	excessive	amod	12	SENT_190	[p7l1343t3721r1630b3775],
12	anticoagulation	NN	O	anticoagulation	prep_to	8	SENT_190	[p7l1670t3720r2145b3789],
13	with	IN	O	with	_	0	SENT_190	[p8l7t17r148b72],
14	an	DT	O	a	det	16	SENT_190	[p8l176t33r247b72],
15	increased	VBN	O	increase	amod	16	SENT_190	[p8l275t17r565b72],
16	risk	NN	O	risk	prep_with	8	SENT_190	[p8l593t17r705b72],
17	for	IN	O	for	_	0	SENT_190	[p8l731t17r816b72],
18	hemorrhagic	JJ	O	hemorrhagic	amod	19	SENT_190	[p8l842t17r1234b85],
19	events	NNS	O	event	prep_for	16	SENT_190	[p8l1261t25r1474b80],
20	,	,	O	,	_	0	SENT_190	[p8l1261t25r1474b80],
21	or	CC	O	or	_	0	SENT_190	[p8l1502t33r1565b72],
22	to	TO	O	to	_	0	SENT_190	[p8l1590t25r1649b72],
23	the	DT	O	the	det	25	SENT_190	[p8l1677t17r1773b72],
24	suboptimal	JJ	O	suboptimal	amod	25	SENT_190	[p8l1802t17r2145b85],
25	anticoagulation	NN	O	anticoagulation	prep_to	8	SENT_190	[p8l9t106r498b174],
26	,	,	O	,	_	0	SENT_190	[p8l9t106r498b174],
27	which	WDT	O	which	nsubj	28	SENT_190	[p8l524t106r713b161],
28	could	MD	O	could	rcmod	25	SENT_190	[p8l739t106r904b161],
29	in	IN	O	in	_	0	SENT_190	[p8l931t106r987b160],
30	turn	NN	O	turn	prep_in	4	SENT_190	[p8l1013t114r1143b161],
31	lead	VBP	O	lead	_	0	SENT_190	[p8l1169t106r1294b161],
32	to	TO	O	to	_	0	SENT_190	[p8l1320t114r1379b161],
33	an	DT	O	a	det	36	SENT_190	[p8l1406t121r1478b161],
34	increased	VBN	O	increase	amod	36	SENT_190	[p8l1504t106r1794b161],
35	stroke	NN	O	stroke	nn	36	SENT_190	[p8l1821t106r2009b161],
36	risk	NN	O	risk	prep_to	31	SENT_190	[p8l2035t106r2147b161],
37	or	CC	O	or	_	0	SENT_190	[p8l9t210r72b248],
38	to	TO	O	to	_	0	SENT_190	[p8l94t202r153b248],
39	other	JJ	O	other	amod	41	SENT_190	[p8l178t194r343b248],
40	thrombo-embolic	JJ	O	thrombo-embolic	amod	41	SENT_190	[p8l364t194r906b248],
41	events	NNS	O	event	prep_to	31	SENT_190	[p8l929t202r1142b249],
42	.	.	O	.	_	0	SENT_190	[p8l929t202r1142b249],

1	The	DT	O	the	det	2	SENT_191	[p8l108t282r218b337],
2	study	NN	O	study	nsubj	3	SENT_191	[p8l241t282r407b351],
3	aims	VBZ	O	aim	_	0	SENT_191	[p8l425t283r565b337],
4	to	TO	O	to	aux	5	SENT_191	[p8l586t290r645b337],
5	establish	VB	O	establish	xcomp	3	SENT_191	[p8l666t282r929b337],
6	the	DT	O	the	det	7	SENT_191	[p8l950t282r1046b337],
7	link	NN	O	link	dobj	5	SENT_191	[p8l1067t282r1181b336],
8	between	IN	O	between	_	0	SENT_191	[p8l1199t282r1459b337],
9	the	DT	O	the	det	10	SENT_191	[p8l1480t282r1576b337],
10	polymorphisms	NNS	O	polymorphism	prep_between	7	SENT_191	[p8l1598t282r2068b351],
11	of	IN	O	of	_	0	SENT_191	[p8l2090t282r2154b337],
12	the	DT	O	the	det	13	SENT_191	[p8l8t371r104b426],
13	genes	NNS	O	gene	prep_of	10	SENT_191	[p8l124t387r295b440],
14	involved	VBN	O	involve	partmod	13	SENT_191	[p8l317t371r573b426],
15	in	IN	O	in	_	0	SENT_191	[p8l595t372r651b426],
16	the	DT	O	the	det	23	SENT_191	[p8l672t371r768b426],
17	oral	JJ	O	oral	amod	23	SENT_191	[p8l788t371r902b426],
18	anticoagulant	JJ	O	anticoagulant	amod	23	SENT_191	[p8l923t371r1332b440],
19	metabolism	NN	O	metabolism	nn	23	SENT_191	[p8l1352t371r1707b426],
20	(	CD	NUMBER	(	num	23	SENT_191	[p8l1730t371r1835b440],
21	CY	NN	O	cy	nn	23	SENT_191	[p8l1730t371r1835b440],
22	P2C9	NN	O	p2c9	nn	23	SENT_191	[p8l1837t372r2028b440],
23	)	NN	O	)	prep_in	14	SENT_191	[p8l1837t372r2028b440],
24	,	,	O	,	_	0	SENT_191	[p8l1837t372r2028b440],
25	the	DT	O	the	det	27	SENT_191	[p8l2049t371r2145b426],
26	gene	NN	O	gene	nn	27	SENT_191	[p8l8t476r150b529],
27	VKORC1	NN	O	vkorc1	conj_and	23	SENT_191	[p8l181t463r425b515],
28	(	CD	NUMBER	(	dep	27	SENT_191	[p8l470t460r591b529],
29	the	DT	O	the	det	33	SENT_191	[p8l470t460r591b529],
30	oral	JJ	O	oral	amod	33	SENT_191	[p8l624t460r738b515],
31	anticoagulant	JJ	O	anticoagulant	amod	33	SENT_191	[p8l771t460r1182b529],
32	target	NN	O	target	nn	33	SENT_191	[p8l1212t460r1432b529],
33	)	NN	O	)	dep	27	SENT_191	[p8l1212t460r1432b529],
34	,	,	O	,	_	0	SENT_191	[p8l1212t460r1432b529],
35	and	CC	O	and	_	0	SENT_191	[p8l1465t460r1574b515],
36	the	DT	O	the	det	38	SENT_191	[p8l1608t460r1704b515],
37	anticoagulant	JJ	O	anticoagulant	amod	38	SENT_191	[p8l1737t460r2147b529],
38	doses	NNS	O	dose	conj_and	23	SENT_191	[p8l9t550r174b605],
39	required	VBN	O	require	partmod	38	SENT_191	[p8l196t550r452b618],
40	to	TO	O	to	aux	41	SENT_191	[p8l472t558r531b605],
41	maintain	VB	O	maintain	xcomp	39	SENT_191	[p8l553t551r821b605],
42	the	DT	O	the	det	44	SENT_191	[p8l841t550r937b605],
43	target	NN	O	target	nn	44	SENT_191	[p8l958t558r1136b618],
44	INR	NN	O	inr	dobj	41	SENT_191	[p8l1155t553r1275b605],
45	.	.	O	.	_	0	SENT_191	[p8l1155t553r1275b605],

1	In	IN	O	in	_	0	SENT_192	[p8l1297t553r1355b604],
2	addition	NN	O	addition	prep_in	24	SENT_192	[p8l1375t550r1638b613],
3	,	,	O	,	_	0	SENT_192	[p8l1375t550r1638b613],
4	the	DT	O	the	det	5	SENT_192	[p8l1660t550r1756b605],
5	implications	NNS	O	implication	nsubjpass	24	SENT_192	[p8l1777t550r2145b618],
6	of	IN	O	of	_	0	SENT_192	[p8l9t638r72b694],
7	age	NN	O	age	prep_of	5	SENT_192	[p8l85t654r200b707],
8	,	,	O	,	_	0	SENT_192	[p8l85t654r200b707],
9	sex	NN	O	sex	prep_of	5	SENT_192	[p8l223t654r320b694],
10	and	CC	O	and	_	0	SENT_192	[p8l340t639r449b694],
11	co-medication	NN	O	co-medication	prep_of	5	SENT_192	[p8l472t639r903b694],
12	upon	IN	O	upon	_	0	SENT_192	[p8l924t654r1077b707],
13	the	DT	O	the	det	15	SENT_192	[p8l1098t639r1193b694],
14	acenocoumarol	NN	O	acenocoumarol	nn	15	SENT_192	[p8l1215t639r1675b694],
15	dose	NN	O	dose	prep_upon	5	SENT_192	[p8l1696t639r1833b694],
16	necessary	JJ	O	necessary	amod	15	SENT_192	[p8l1855t654r2147b707],
17	to	TO	O	to	aux	18	SENT_192	[p8l8t735r66b781],
18	maintain	VB	O	maintain	xcomp	16	SENT_192	[p8l89t728r357b781],
19	a	DT	O	a	det	21	SENT_192	[p8l378t743r409b781],
20	stable	JJ	O	stable	amod	21	SENT_192	[p8l431t727r605b781],
21	INR	NN	O	inr	dobj	18	SENT_192	[p8l627t730r736b781],
22	have	VBP	O	have	aux	24	SENT_192	[p8l755t727r896b781],
23	been	VBN	O	be	auxpass	24	SENT_192	[p8l917t727r1062b781],
24	studied	VBN	O	study	_	0	SENT_192	[p8l1084t727r1319b782],
25	.	.	O	.	_	0	SENT_192	[p8l1084t727r1319b782],

1	The	DT	O	the	det	2	SENT_193	[p8l108t815r220b870],
2	study	NN	O	study	nsubj	8	SENT_193	[p8l240t815r409b884],
3	of	IN	O	of	_	0	SENT_193	[p8l426t815r490b870],
4	the	DT	O	the	det	7	SENT_193	[p8l500t815r598b870],
5	CYP2C9	NN	O	cyp2c9	nn	7	SENT_193	[p8l617t818r850b870],
6	gene	NN	O	gene	nn	7	SENT_193	[p8l869t831r1014b884],
7	alleles	NNS	O	allele	prep_of	2	SENT_193	[p8l1033t815r1222b870],
8	showed	VBD	O	show	_	0	SENT_193	[p8l1243t815r1480b870],
9	a	DT	O	a	det	44	SENT_193	[p8l1499t831r1530b870],
10	20.2	CD	PERCENT	20.2	num	11	SENT_193	[p8l1549t818r1719b871],
11	%	NN	PERCENT	%	amod	44	SENT_193	[p8l1549t818r1719b871],
12	frequency	NN	O	frequency	dep	11	SENT_193	[p8l1738t815r2045b884],
13	for	IN	O	for	_	0	SENT_193	[p8l2063t815r2147b870],
14	the	DT	O	the	det	18	SENT_193	[p8l8t903r105b958],
15	CYP2C9	NN	O	cyp2c9	nn	18	SENT_193	[p8l136t903r434b958],
16	*	NN	O	*	nn	18	SENT_193	[p8l136t903r434b958],
17	2	CD	NUMBER	2	num	18	SENT_193	[p8l136t903r434b958],
18	allele	NN	O	allele	prep_for	12	SENT_193	[p8l466t903r642b966],
19	,	,	O	,	_	0	SENT_193	[p8l466t903r642b966],
20	a	DT	O	a	det	21	SENT_193	[p8l673t919r704b958],
21	result	NN	O	result	appos	12	SENT_193	[p8l734t903r908b958],
22	that	WDT	O	that	nsubj	24	SENT_193	[p8l936t903r1059b958],
23	is	VBZ	O	be	cop	24	SENT_193	[p8l1088t904r1132b958],
24	consistent	JJ	O	consistent	rcmod	21	SENT_193	[p8l1163t904r1477b958],
25	with	IN	O	with	_	0	SENT_193	[p8l1503t903r1645b958],
26	the	DT	O	the	det	27	SENT_193	[p8l1674t903r1771b958],
27	data	NNS	O	datum	prep_with	24	SENT_193	[p8l1802t903r1932b958],
28	in	IN	O	in	_	0	SENT_193	[p8l1962t904r2018b957],
29	the	DT	O	the	det	31	SENT_193	[p8l2048t903r2145b958],
30	current	JJ	DATE	current	amod	31	SENT_193	[p8l9t999r234b1046],
31	literature	NN	O	literature	prep_in	27	SENT_193	[p8l255t991r540b1046],
32	on	IN	O	on	_	0	SENT_193	[p8l563t1007r638b1046],
33	the	DT	O	the	det	34	SENT_193	[p8l660t991r756b1046],
34	frequency	NN	O	frequency	prep_on	31	SENT_193	[p8l780t991r1087b1060],
35	of	IN	O	of	_	0	SENT_193	[p8l1107t991r1171b1046],
36	this	DT	O	this	det	37	SENT_193	[p8l1185t991r1296b1046],
37	allele	NN	O	allele	prep_of	34	SENT_193	[p8l1319t991r1479b1046],
38	within	IN	O	within	_	0	SENT_193	[p8l1500t991r1702b1046],
39	the	DT	O	the	det	41	SENT_193	[p8l1724t991r1821b1046],
40	Caucasian	JJ	LOCATION	caucasian	amod	41	SENT_193	[p8l1843t992r2146b1046],
41	population	NN	O	population	prep_within	37	SENT_193	[p8l9t1081r342b1149],
42	(	CD	NUMBER	(	number	43	SENT_193	[p8l370t1081r614b1149],
43	8	CD	PERCENT	8	num	44	SENT_193	[p8l370t1081r614b1149],
44	—	NN	PERCENT	—	dobj	8	SENT_193	[p8l370t1081r614b1149],
45	20	CD	PERCENT	20	number	46	SENT_193	[p8l370t1081r614b1149],
46	%	NN	PERCENT	%	amod	44	SENT_193	[p8l370t1081r614b1149],
47	)	CD	NUMBER	)	number	48	SENT_193	[p8l370t1081r614b1149],
48	[	CD	NUMBER	[	dep	44	SENT_193	[p8l646t1081r741b1149],
49	9	CD	NUMBER	9	num	50	SENT_193	[p8l646t1081r741b1149],
50	]	NN	O	]	dep	48	SENT_193	[p8l646t1081r741b1149],
51	.	.	O	.	_	0	SENT_193	[p8l646t1081r741b1149],

1	CYP2C9	NN	O	cyp2c9	nsubjpass	6	SENT_194	[p8l111t1170r404b1225],
2	*	CD	NUMBER	*	num	1	SENT_194	[p8l111t1170r404b1225],
3	3	CD	NUMBER	3	num	4	SENT_194	[p8l111t1170r404b1225],
4	allele	NN	O	allele	dep	1	SENT_194	[p8l432t1170r588b1225],
5	was	VBD	O	be	auxpass	6	SENT_194	[p8l612t1186r730b1225],
6	found	VBN	O	find	_	0	SENT_194	[p8l756t1170r929b1225],
7	in	IN	O	in	_	0	SENT_194	[p8l956t1171r1012b1224],
8	16.9	CD	PERCENT	16.9	num	9	SENT_194	[p8l1040t1173r1204b1225],
9	%	NN	PERCENT	%	prep_in	6	SENT_194	[p8l1040t1173r1204b1225],
10	of	IN	O	of	_	0	SENT_194	[p8l1229t1170r1292b1225],
11	the	DT	O	the	det	12	SENT_194	[p8l1309t1170r1405b1225],
12	patients	NNS	O	patient	prep_of	9	SENT_194	[p8l1431t1171r1685b1238],
13	,	,	O	,	_	0	SENT_194	[p8l1431t1171r1685b1238],
14	a	DT	O	a	det	15	SENT_194	[p8l1711t1186r1742b1225],
15	value	NN	O	value	npadvmod	16	SENT_194	[p8l1765t1170r1926b1225],
16	higher	JJR	O	higher	advmod	6	SENT_194	[p8l1953t1170r2147b1238],
17	than	IN	O	than	mark	20	SENT_194	[p8l8t1258r143b1313],
18	the	DT	O	the	det	19	SENT_194	[p8l161t1258r257b1313],
19	average	NN	O	average	nsubj	20	SENT_194	[p8l275t1274r507b1327],
20	reported	VBD	O	report	dep	16	SENT_194	[p8l526t1258r784b1327],
21	frequency	NN	O	frequency	dobj	20	SENT_194	[p8l803t1258r1104b1327],
22	for	IN	O	for	_	0	SENT_194	[p8l1121t1258r1205b1313],
23	this	DT	O	this	det	24	SENT_194	[p8l1220t1258r1328b1313],
24	allele	NN	O	allele	prep_for	20	SENT_194	[p8l1347t1258r1503b1313],
25	within	IN	O	within	_	0	SENT_194	[p8l1520t1258r1718b1313],
26	the	DT	O	the	det	28	SENT_194	[p8l1735t1258r1831b1313],
27	Caucasian	JJ	LOCATION	caucasian	amod	28	SENT_194	[p8l1850t1259r2146b1313],
28	population	NN	O	population	prep_within	20	SENT_194	[p8l9t1347r334b1416],
29	(	CD	NUMBER	(	number	30	SENT_194	[p8l361t1347r600b1415],
30	6	CD	NUMBER	6	num	31	SENT_194	[p8l361t1347r600b1415],
31	—	NN	O	—	dep	28	SENT_194	[p8l361t1347r600b1415],
32	10	CD	PERCENT	10	num	33	SENT_194	[p8l361t1347r600b1415],
33	%	NN	PERCENT	%	dep	28	SENT_194	[p8l361t1347r600b1415],
34	)	CD	NUMBER	)	number	35	SENT_194	[p8l361t1347r600b1415],
35	[	CD	NUMBER	[	num	33	SENT_194	[p8l629t1347r721b1416],
36	9	CD	NUMBER	9	num	37	SENT_194	[p8l629t1347r721b1416],
37	]	NN	O	]	dep	33	SENT_194	[p8l629t1347r721b1416],
38	.	.	O	.	_	0	SENT_194	[p8l629t1347r721b1416],

1	GG	NNS	O	gg	nn	2	SENT_195	[p8l111t1439r201b1491],
2	genotype	NN	O	genotype	nsubj	10	SENT_195	[p8l226t1444r506b1505],
3	of	IN	O	of	_	0	SENT_195	[p8l532t1436r595b1491],
4	the	DT	O	the	det	6	SENT_195	[p8l613t1436r708b1491],
5	polymorphism	NN	O	polymorphism	nn	6	SENT_195	[p8l736t1436r1180b1505],
6	c.-1639G	NN	O	c.-1639g	prep_of	2	SENT_195	[p8l1205t1439r1571b1492],
7	>	JJR	O	>	dep	2	SENT_195	[p8l1205t1439r1571b1492],
8	A	DT	O	a	dep	2	SENT_195	[p8l1205t1439r1571b1492],
9	was	VBD	O	be	cop	10	SENT_195	[p8l1594t1452r1712b1491],
10	present	JJ	DATE	present	_	0	SENT_195	[p8l1739t1444r1966b1505],
11	in	IN	O	in	_	0	SENT_195	[p8l1991t1437r2046b1491],
12	98	CD	NUMBER	98	num	13	SENT_195	[p8l2073t1439r2144b1491],
13	patients	NNS	O	patient	prep_in	10	SENT_195	[p8l9t1526r248b1594],
14	(	IN	O	(	_	0	SENT_195	[p8l292t1525r527b1594],
15	32.5	CD	PERCENT	32.5	num	16	SENT_195	[p8l292t1525r527b1594],
16	%	NN	PERCENT	%	prep_(	13	SENT_195	[p8l292t1525r527b1594],
17	)	CD	NUMBER	)	tmod	10	SENT_195	[p8l292t1525r527b1594],
18	.	.	O	.	_	0	SENT_195	[p8l292t1525r527b1594],

1	GA	NN	O	ga	nn	2	SENT_196	[p8l568t1528r657b1580],
2	genotype	NN	O	genotype	nsubjpass	4	SENT_196	[p8l692t1533r972b1594],
3	was	VBD	O	be	auxpass	4	SENT_196	[p8l1010t1541r1128b1580],
4	found	VBN	O	find	_	0	SENT_196	[p8l1167t1525r1341b1580],
5	in	IN	O	in	_	0	SENT_196	[p8l1381t1526r1437b1580],
6	153	CD	NUMBER	153	num	7	SENT_196	[p8l1479t1528r1584b1580],
7	patients	NNS	O	patient	prep_in	4	SENT_196	[p8l1626t1526r1865b1594],
8	(	IN	O	(	_	0	SENT_196	[p8l1909t1525r2144b1594],
9	50.8	CD	PERCENT	50.8	number	10	SENT_196	[p8l1909t1525r2144b1594],
10	%	NN	PERCENT	%	num	11	SENT_196	[p8l1909t1525r2144b1594],
11	)	CD	NUMBER	)	prep_(	4	SENT_196	[p8l1909t1525r2144b1594],
12	.	.	O	.	_	0	SENT_196	[p8l1909t1525r2144b1594],

1	Tatarunas	NNP	O	Tatarunas	nsubj	4	SENT_197	[p8l6t1618r302b1670],
2	et	FW	O	et	nn	3	SENT_197	[p8l337t1623r394b1670],
3	al.	FW	O	al.	dep	1	SENT_197	[p8l426t1615r489b1670],
4	reported	VBN	O	report	_	0	SENT_197	[p8l526t1615r784b1683],
5	frequencies	NNS	O	frequency	dobj	4	SENT_197	[p8l819t1615r1163b1683],
6	of	IN	O	of	_	0	SENT_197	[p8l1199t1615r1261b1670],
7	38.6	CD	PERCENT	38.6	num	8	SENT_197	[p8l1287t1618r1468b1678],
8	%	NN	PERCENT	%	prep_of	5	SENT_197	[p8l1287t1618r1468b1678],
9	,	,	O	,	_	0	SENT_197	[p8l1287t1618r1468b1678],
10	54.4	CD	PERCENT	54.4	number	14	SENT_197	[p8l1505t1618r1670b1670],
11	%	NN	PERCENT	%	dep	14	SENT_197	[p8l1505t1618r1670b1670],
12	and	CC	O	and	_	0	SENT_197	[p8l1704t1615r1813b1670],
13	7.2	CD	PERCENT	7.2	appos	8	SENT_197	[p8l1850t1618r1978b1670],
14	%	NN	PERCENT	%	appos	8	SENT_197	[p8l1850t1618r1978b1670],
15	[	CD	NUMBER	[	num	17	SENT_197	[p8l2015t1615r2144b1683],
16	14	CD	NUMBER	14	num	17	SENT_197	[p8l2015t1615r2144b1683],
17	]	NN	O	]	dep	14	SENT_197	[p8l2015t1615r2144b1683],
18	.	.	O	.	_	0	SENT_197	[p8l2015t1615r2144b1683],

1	Montes	NNP	O	Montes	nsubj	4	SENT_198	[p8l9t1707r232b1759],
2	et	FW	O	et	nn	3	SENT_198	[p8l257t1712r314b1759],
3	al.	FW	O	al.	dep	1	SENT_198	[p8l336t1704r399b1759],
4	found	VBN	O	find	_	0	SENT_198	[p8l425t1703r599b1759],
5	GG	NNS	O	gg	nn	6	SENT_198	[p8l624t1706r714b1759],
6	genotype	NN	O	genotype	dobj	4	SENT_198	[p8l737t1712r1017b1772],
7	in	IN	O	in	_	0	SENT_198	[p8l1042t1704r1097b1758],
8	27.6	CD	PERCENT	27.6	num	9	SENT_198	[p8l1121t1706r1289b1759],
9	%	NN	PERCENT	%	prep_in	6	SENT_198	[p8l1121t1706r1289b1759],
10	of	IN	O	of	_	0	SENT_198	[p8l1313t1703r1375b1759],
11	the	DT	O	the	det	12	SENT_198	[p8l1392t1704r1488b1759],
12	cases	NNS	O	case	prep_of	9	SENT_198	[p8l1512t1719r1680b1767],
13	,	,	O	,	_	0	SENT_198	[p8l1512t1719r1680b1767],
14	GA	NN	O	ga	prep_in	6	SENT_198	[p8l1706t1706r1794b1759],
15	in	IN	O	in	_	0	SENT_198	[p8l1817t1704r1873b1758],
16	40	CD	PERCENT	40	num	17	SENT_198	[p8l1895t1706r2011b1759],
17	%	NN	PERCENT	%	prep_in	14	SENT_198	[p8l1895t1706r2011b1759],
18	and	CC	O	and	_	0	SENT_198	[p8l2035t1704r2145b1759],
19	AA	NN	O	aa	prep_in	6	SENT_198	[p8l6t1794r95b1847],
20	in	IN	O	in	_	0	SENT_198	[p8l118t1793r173b1846],
21	32.3	CD	PERCENT	32.3	num	22	SENT_198	[p8l197t1795r365b1848],
22	%	NN	PERCENT	%	prep_in	19	SENT_198	[p8l197t1795r365b1848],
23	[	CD	NUMBER	[	number	24	SENT_198	[p8l393t1792r522b1861],
24	15	CD	NUMBER	15	num	25	SENT_198	[p8l393t1792r522b1861],
25	]	NN	O	]	dep	19	SENT_198	[p8l393t1792r522b1861],
26	.	.	O	.	_	0	SENT_198	[p8l393t1792r522b1861],

1	Sipeky	NNP	O	Sipeky	nsubj	4	SENT_199	[p8l548t1792r746b1861],
2	et	FW	O	et	nn	3	SENT_199	[p8l769t1800r826b1847],
3	al.	FW	O	al.	dep	1	SENT_199	[p8l849t1792r912b1848],
4	reported	VBD	O	report	_	0	SENT_199	[p8l938t1792r1197b1861],
5	the	DT	O	the	det	7	SENT_199	[p8l1222t1792r1318b1847],
6	following	VBG	O	follow	amod	7	SENT_199	[p8l1342t1792r1627b1861],
7	percentages	NNS	O	percentage	dobj	4	SENT_199	[p8l1650t1800r2009b1861],
8	in	IN	O	in	_	0	SENT_199	[p8l2035t1793r2090b1846],
9	a	DT	O	a	det	11	SENT_199	[p8l2115t1808r2146b1847],
10	Hungarian	JJ	LOCATION	hungarian	amod	11	SENT_199	[p8l9t1882r324b1950],
11	population	NN	O	population	prep_in	7	SENT_199	[p8l346t1881r690b1950],
12	:	:	O	:	_	0	SENT_199	[p8l346t1881r690b1950],
13	GG	NNS	PERCENT	gg	dobj	4	SENT_199	[p8l716t1884r805b1936],
14	35.3	CD	PERCENT	35.3	num	15	SENT_199	[p8l826t1884r1007b1944],
15	%	NN	PERCENT	%	dep	13	SENT_199	[p8l826t1884r1007b1944],
16	,	,	O	,	_	0	SENT_199	[p8l826t1884r1007b1944],
17	GA	NN	O	ga	conj_and	7	SENT_199	[p8l1030t1883r1120b1936],
18	51.4	CD	PERCENT	51.4	num	19	SENT_199	[p8l1140t1884r1306b1937],
19	%	NN	PERCENT	%	dep	17	SENT_199	[p8l1140t1884r1306b1937],
20	and	CC	O	and	_	0	SENT_199	[p8l1326t1881r1436b1936],
21	AA	NN	O	aa	conj_and	7	SENT_199	[p8l1456t1883r1545b1936],
22	13.3	CD	PERCENT	13.3	num	23	SENT_199	[p8l1568t1884r1731b1937],
23	%	NN	PERCENT	%	dep	21	SENT_199	[p8l1568t1884r1731b1937],
24	[	CD	NUMBER	[	number	25	SENT_199	[p8l1756t1881r1885b1950],
25	16	CD	NUMBER	16	num	26	SENT_199	[p8l1756t1881r1885b1950],
26	]	NN	O	]	dep	23	SENT_199	[p8l1756t1881r1885b1950],
27	.	.	O	.	_	0	SENT_199	[p8l1756t1881r1885b1950],

1	The	DT	O	the	det	3	SENT_200	[p8l108t1970r223b2025],
2	negative	JJ	O	negative	amod	3	SENT_200	[p8l274t1971r545b2039],
3	correlation	NN	O	correlation	nsubj	13	SENT_200	[p8l594t1970r946b2025],
4	between	IN	O	between	_	0	SENT_200	[p8l995t1970r1270b2025],
5	a	DT	O	a	det	6	SENT_200	[p8l1320t1986r1351b2025],
6	patient	NN	O	patient	poss	8	SENT_200	[p8l1401t1971r1673b2039],
7	's	POS	O	's	_	0	SENT_200	[p8l1401t1971r1673b2039],
8	age	NN	O	age	prep_between	3	SENT_200	[p8l1724t1986r1830b2039],
9	and	CC	O	and	_	0	SENT_200	[p8l1880t1970r1994b2025],
10	the	DT	O	the	det	12	SENT_200	[p8l2045t1970r2145b2025],
11	acenocoumarol	NN	O	acenocoumarol	nn	12	SENT_200	[p8l9t2059r468b2114],
12	dose	NN	O	dose	prep_between	3	SENT_200	[p8l487t2059r623b2114],
13	indicates	VBZ	O	indicate	_	0	SENT_200	[p8l643t2059r908b2114],
14	that	IN	O	that	complm	20	SENT_200	[p8l926t2059r1048b2114],
15	patients	NNS	O	patient	nsubj	20	SENT_200	[p8l1064t2060r1303b2128],
16	aged	VBN	O	age	amod	15	SENT_200	[p8l1323t2059r1463b2128],
17	65	CD	NUMBER	65	dep	16	SENT_200	[p8l1482t2062r1552b2114],
18	or	CC	O	or	_	0	SENT_200	[p8l1573t2075r1635b2114],
19	more	JJR	O	more	dep	16	SENT_200	[p8l1652t2075r1808b2114],
20	have	VBP	O	have	ccomp	13	SENT_200	[p8l1827t2059r1967b2114],
21	a	DT	O	a	det	25	SENT_200	[p8l1986t2075r2018b2114],
22	statistically	RB	O	statistically	advmod	24	SENT_200	[p8l2036t2067r2145b2114, p8l8t2149r261b2217],
23	signiﬁcant	NN	O	signiﬁcant	npadvmod	24	SENT_200	[p8l282t2149r593b2217],
24	higher	JJR	O	higher	amod	25	SENT_200	[p8l613t2149r808b2217],
25	probability	NN	O	probability	dobj	20	SENT_200	[p8l827t2149r1157b2217],
26	to	TO	O	to	aux	27	SENT_200	[p8l1176t2157r1234b2204],
27	receive	VB	O	receive	infmod	25	SENT_200	[p8l1257t2150r1470b2204],
28	a	DT	O	a	det	31	SENT_200	[p8l1492t2165r1523b2204],
29	lower	JJR	O	lower	dep	30	SENT_200	[p8l1544t2149r1717b2204],
30	anticoagulant	JJ	O	anticoagulant	amod	31	SENT_200	[p8l1737t2149r2148b2217],
31	dose	NN	O	dose	dobj	27	SENT_200	[p8l9t2237r159b2301],
32	,	,	O	,	_	0	SENT_200	[p8l9t2237r159b2301],
33	which	WDT	O	which	nsubj	35	SENT_200	[p8l177t2237r363b2292],
34	is	VBZ	O	be	cop	35	SENT_200	[p8l380t2238r424b2292],
35	consistent	JJ	O	consistent	rcmod	31	SENT_200	[p8l443t2238r749b2292],
36	with	IN	O	with	_	0	SENT_200	[p8l763t2237r902b2292],
37	the	DT	O	the	det	38	SENT_200	[p8l919t2237r1015b2292],
38	data	NNS	O	datum	prep_with	35	SENT_200	[p8l1032t2237r1161b2292],
39	from	IN	O	from	_	0	SENT_200	[p8l1178t2237r1322b2292],
40	the	DT	O	the	det	45	SENT_200	[p8l1338t2237r1434b2292],
41	relevant	JJ	O	relevant	amod	45	SENT_200	[p8l1452t2237r1699b2292],
42	literature	NN	O	literature	nn	45	SENT_200	[p8l1716t2237r1993b2292],
43	[	NN	O	[	nn	45	SENT_200	[p8l2015t2237r2144b2306],
44	17	CD	NUMBER	17	num	45	SENT_200	[p8l2015t2237r2144b2306],
45	]	NN	O	]	prep_from	38	SENT_200	[p8l2015t2237r2144b2306],
46	.	.	O	.	_	0	SENT_200	[p8l2015t2237r2144b2306],

1	This	DT	O	this	det	3	SENT_201	[p8l108t2326r228b2381],
2	inverse	JJ	O	inverse	amod	3	SENT_201	[p8l247t2327r457b2381],
3	correlation	NN	O	correlation	nsubj	5	SENT_201	[p8l475t2326r792b2381],
4	is	VBZ	O	be	cop	5	SENT_201	[p8l810t2327r852b2381],
5	independent	JJ	O	independent	_	0	SENT_201	[p8l871t2326r1244b2395],
6	from	IN	O	from	_	0	SENT_201	[p8l1261t2326r1402b2381],
7	variations	NNS	O	variation	prep_from	5	SENT_201	[p8l1416t2327r1705b2381],
8	in	IN	O	in	_	0	SENT_201	[p8l1723t2327r1778b2380],
9	CYP2C9	NN	O	cyp2c9	nn	12	SENT_201	[p8l1795t2329r2019b2381],
10	and	CC	O	and	_	0	SENT_201	[p8l2037t2326r2145b2381],
11	VKORC1	NN	O	vkorc1	nn	12	SENT_201	[p8l6t2418r245b2470],
12	genotypes	NNS	O	genotype	prep_in	7	SENT_201	[p8l279t2423r579b2484],
13	and	CC	O	and	_	0	SENT_201	[p8l608t2415r715b2470],
14	from	IN	O	from	_	0	SENT_201	[p8l745t2415r885b2470],
15	the	DT	O	the	det	16	SENT_201	[p8l911t2415r1005b2470],
16	use	NN	O	use	nsubj	22	SENT_201	[p8l1033t2431r1130b2470],
17	of	IN	O	of	_	0	SENT_201	[p8l1158t2415r1220b2470],
18	CYP2C9	NN	O	cyp2c9	nn	19	SENT_201	[p8l1240t2415r1748b2484],
19	—	NN	O	—	prep_of	16	SENT_201	[p8l1240t2415r1748b2484],
20	inducing	VBG	O	induce	conj_and	7	SENT_201	[p8l1240t2415r1748b2484],
21	or	CC	O	or	_	0	SENT_201	[p8l1774t2431r1836b2470],
22	inhibiting	VBG	O	inhibit	conj_and	7	SENT_201	[p8l1862t2415r2146b2484],
23	medication	NN	O	medication	dobj	20	SENT_201	[p8l9t2504r349b2560],
24	.	.	O	.	_	0	SENT_201	[p8l9t2504r349b2560],

1	Patients	NNS	O	patient	nsubj	9	SENT_202	[p8l374t2505r605b2559],
2	aged	VBN	O	age	partmod	1	SENT_202	[p8l629t2504r765b2573],
3	over	IN	O	over	_	0	SENT_202	[p8l790t2520r920b2559],
4	65	CD	NUMBER	65	prep_over	2	SENT_202	[p8l942t2507r1011b2559],
5	were	VBD	O	be	cop	9	SENT_202	[p8l1035t2520r1184b2559],
6	3.2	CD	NUMBER	3.2	num	7	SENT_202	[p8l1206t2507r1291b2560],
7	times	NNS	O	time	npadvmod	8	SENT_202	[p8l1316t2505r1477b2559],
8	more	RBR	O	more	advmod	9	SENT_202	[p8l1501t2520r1654b2559],
9	likely	JJ	O	likely	_	0	SENT_202	[p8l1679t2504r1836b2573],
10	to	TO	O	to	aux	11	SENT_202	[p8l1857t2512r1914b2559],
11	receive	VB	O	receive	xcomp	9	SENT_202	[p8l1938t2505r2145b2559],
12	a	DT	O	a	det	13	SENT_202	[p8l9t2610r40b2649],
13	dose	NN	O	dose	dobj	11	SENT_202	[p8l65t2594r199b2649],
14	of	IN	O	of	_	0	SENT_202	[p8l226t2594r288b2649],
15	acenocoumarol	NN	O	acenocoumarol	prep_of	13	SENT_202	[p8l306t2594r754b2649],
16	lower	JJR	O	lower	advmod	11	SENT_202	[p8l781t2594r950b2649],
17	than	IN	O	than	_	0	SENT_202	[p8l974t2594r1106b2649],
18	7	CD	NUMBER	7	num	19	SENT_202	[p8l1134t2597r1166b2648],
19	mg/week	NN	O	mg/week	prep_than	11	SENT_202	[p8l1193t2594r1480b2662],
20	,	,	O	,	_	0	SENT_202	[p8l1193t2594r1480b2662],
21	compared	VBN	O	compare	_	0	SENT_202	[p8l1508t2594r1801b2662],
22	to	TO	O	to	prepc_compared_to	11	SENT_202	[p8l1827t2602r1885b2649],
23	patients	NNS	O	patient	dep	24	SENT_202	[p8l1912t2595r2144b2662],
24	younger	JJR	O	younger	pobj	11	SENT_202	[p8l7t2699r252b2751],
25	than	IN	O	than	_	0	SENT_202	[p8l273t2683r405b2738],
26	65	CD	DURATION	65	num	27	SENT_202	[p8l429t2686r498b2738],
27	years	NNS	NUMBER	year	prep_than	24	SENT_202	[p8l524t2699r691b2751],
28	.	.	O	.	_	0	SENT_202	[p8l524t2699r691b2751],

1	Furthermore	RB	O	furthermore	advmod	20	SENT_203	[p8l715t2683r1100b2746],
2	,	,	O	,	_	0	SENT_203	[p8l715t2683r1100b2746],
3	the	DT	O	the	det	4	SENT_203	[p8l1123t2683r1217b2738],
4	probability	NN	O	probability	nsubj	20	SENT_203	[p8l1241t2683r1560b2751],
5	of	IN	O	of	_	0	SENT_203	[p8l1581t2683r1642b2738],
6	older	JJR	O	older	amod	7	SENT_203	[p8l1658t2683r1810b2738],
7	patients	NNS	O	patient	prep_of	4	SENT_203	[p8l1831t2684r2064b2751],
8	to	TO	O	to	aux	9	SENT_203	[p8l2087t2691r2144b2738],
9	receive	VB	O	receive	infmod	7	SENT_203	[p8l9t2772r216b2826],
10	an	DT	O	a	det	12	SENT_203	[p8l237t2787r307b2826],
11	acenocoumarol	NN	O	acenocoumarol	nn	12	SENT_203	[p8l328t2771r776b2826],
12	dose	NN	O	dose	dobj	9	SENT_203	[p8l798t2771r931b2826],
13	higher	JJR	O	higher	advmod	9	SENT_203	[p8l953t2771r1143b2840],
14	than	IN	O	than	_	0	SENT_203	[p8l1162t2771r1295b2826],
15	28	CD	NUMBER	28	num	16	SENT_203	[p8l1316t2774r1386b2826],
16	rng/week	NN	O	rng/week	prep_than	9	SENT_203	[p8l1413t2771r1690b2840],
17	was	VBD	O	be	cop	20	SENT_203	[p8l1708t2787r1823b2826],
18	76	CD	PERCENT	76	num	19	SENT_203	[p8l1846t2774r1957b2826],
19	%	NN	PERCENT	%	npadvmod	20	SENT_203	[p8l1846t2774r1957b2826],
20	lower	JJR	O	lower	_	0	SENT_203	[p8l1978t2771r2147b2826],
21	than	IN	O	than	_	0	SENT_203	[p8l8t2860r143b2915],
22	that	DT	O	that	prep_than	20	SENT_203	[p8l177t2860r297b2915],
23	of	IN	O	of	_	0	SENT_203	[p8l330t2860r393b2915],
24	younger	JJR	O	younger	amod	25	SENT_203	[p8l417t2876r668b2929],
25	patients	NNS	O	patient	prep_of	22	SENT_203	[p8l700t2861r955b2929],
26	.	.	O	.	_	0	SENT_203	[p8l700t2861r955b2929],

1	Loebstein	NNP	O	Loebstein	nsubj	5	SENT_204	[p8l989t2860r1275b2915],
2	et	FW	O	et	nn	3	SENT_204	[p8l1309t2868r1366b2915],
3	al.	FW	O	al.	dep	1	SENT_204	[p8l1397t2860r1461b2916],
4	initially	RB	O	initially	advmod	5	SENT_204	[p8l1496t2860r1723b2929],
5	thought	VBD	O	think	_	0	SENT_204	[p8l1755t2860r1995b2929],
6	that	IN	O	that	complm	8	SENT_204	[p8l2026t2860r2148b2915],
7	there	EX	O	there	expl	8	SENT_204	[p8l8t2949r165b3004],
8	were	VBD	O	be	ccomp	5	SENT_204	[p8l199t2965r350b3004],
9	two	CD	NUMBER	two	num	11	SENT_204	[p8l385t2958r500b3004],
10	major	JJ	O	major	amod	11	SENT_204	[p8l537t2950r714b3018],
11	determinants	NNS	O	determinant	nsubj	8	SENT_204	[p8l748t2949r1150b3004],
12	of	IN	O	of	_	0	SENT_204	[p8l1187t2949r1250b3004],
13	the	DT	O	the	det	15	SENT_204	[p8l1277t2949r1372b3004],
14	maintenance	NN	O	maintenance	nn	15	SENT_204	[p8l1409t2950r1797b3004],
15	dose	NN	O	dose	prep_of	11	SENT_204	[p8l1833t2949r1970b3004],
16	once	RB	DATE	once	advmod	21	SENT_204	[p8l2006t2965r2145b3004],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_204	[p8l8t3038r353b3107],
18	INR	NN	O	inr	nsubjpass	21	SENT_204	[p8l378t3042r486b3093],
19	has	VBZ	O	have	aux	21	SENT_204	[p8l511t3038r609b3093],
20	been	VBN	O	be	auxpass	21	SENT_204	[p8l635t3038r780b3093],
21	reached	VBN	O	reach	dep	8	SENT_204	[p8l806t3038r1061b3094],
22	:	:	O	:	_	0	SENT_204	[p8l806t3038r1061b3094],
23	age	NN	O	age	dobj	5	SENT_204	[p8l1091t3054r1192b3107],
24	over	IN	O	over	_	0	SENT_204	[p8l1218t3054r1352b3093],
25	65	CD	NUMBER	65	prep_over	23	SENT_204	[p8l1376t3041r1447b3093],
26	and	CC	O	and	_	0	SENT_204	[p8l1474t3038r1584b3093],
27	CYP2C9	NN	O	cyp2c9	nn	28	SENT_204	[p8l1611t3041r1840b3093],
28	genotype	NN	O	genotype	dobj	5	SENT_204	[p8l1865t3046r2146b3107],
29	[	CD	NUMBER	[	number	30	SENT_204	[p8l12t3128r141b3196],
30	17	CD	NUMBER	17	num	31	SENT_204	[p8l12t3128r141b3196],
31	]	NN	O	]	dep	28	SENT_204	[p8l12t3128r141b3196],
32	.	.	O	.	_	0	SENT_204	[p8l12t3128r141b3196],

1	Montes	NNP	O	Montes	nsubj	5	SENT_205	[p8l174t3131r396b3183],
2	et	FW	O	et	nn	3	SENT_205	[p8l428t3136r486b3183],
3	al.	FW	O	al.	dep	1	SENT_205	[p8l515t3128r578b3183],
4	also	RB	O	also	advmod	5	SENT_205	[p8l610t3128r726b3183],
5	ﬁnd	VBD	O	ﬁnd	_	0	SENT_205	[p8l758t3128r875b3183],
6	an	DT	O	a	det	8	SENT_205	[p8l905t3144r977b3183],
7	inverse	JJ	O	inverse	amod	8	SENT_205	[p8l1008t3129r1224b3183],
8	correlation	NN	O	correlation	dobj	5	SENT_205	[p8l1255t3128r1582b3183],
9	between	IN	O	between	_	0	SENT_205	[p8l1612t3128r1873b3183],
10	age	NN	O	age	prep_between	8	SENT_205	[p8l1903t3144r2004b3196],
11	and	CC	O	and	_	0	SENT_205	[p8l2035t3128r2145b3183],
12	acenocoumarol	NN	O	acenocoumarol	nn	14	SENT_205	[p8l9t3217r468b3272],
13	dose	NN	O	dose	nn	14	SENT_205	[p8l490t3217r626b3272],
14	[	NN	O	[	dobj	5	SENT_205	[p8l652t3217r781b3285],
15	15	CD	NUMBER	15	num	16	SENT_205	[p8l652t3217r781b3285],
16	]	NN	O	]	dep	14	SENT_205	[p8l652t3217r781b3285],
17	.	.	O	.	_	0	SENT_205	[p8l652t3217r781b3285],

1	Table	NNP	O	Table	_	0	SENT_206	[p8l6t3439r145b3482],
2	3	CD	NUMBER	3	num	3	SENT_206	[p8l162t3441r191b3482],
3	Distribution	NN	O	distribution	dep	1	SENT_206	[p8l9t3510r303b3554],
4	of	IN	O	of	_	0	SENT_206	[p8l323t3510r374b3554],
5	genotypes	NNS	O	genotype	prep_of	3	SENT_206	[p8l387t3517r638b3565],
6	for	IN	O	for	_	0	SENT_206	[p8l660t3510r728b3554],
7	the	DT	O	the	det	8	SENT_206	[p8l745t3510r823b3554],
8	c.-1639G	NN	O	c.-1639g	prep_for	5	SENT_206	[p8l843t3512r1143b3554],
9	>	JJR	O	>	amod	11	SENT_206	[p8l843t3512r1143b3554],
10	A	DT	O	a	det	11	SENT_206	[p8l843t3512r1143b3554],
11	polymorphism	NN	O	polymorphism	dep	1	SENT_206	[p8l1161t3510r1523b3565],
12	of	IN	O	of	_	0	SENT_206	[p8l1543t3510r1594b3554],
13	the	DT	O	the	det	16	SENT_206	[p8l1606t3510r1684b3554],
14	VI	NNP	O	VI	nn	16	SENT_206	[p8l1702t3512r1919b3554],
15	(	CD	NUMBER	(	num	16	SENT_206	[p8l1702t3512r1919b3554],
16	ORC1	NN	O	orc1	prep_of	11	SENT_206	[p8l1702t3512r1919b3554],
17	.	.	O	.	_	0	SENT_206	[p8l1702t3512r1919b3554],

1	c.-1639G	NN	O	c.-1639g	_	0	SENT_207	[p8l59t3636r358b3678],
2	>	JJR	O	>	amod	4	SENT_207	[p8l59t3636r358b3678],
3	A	DT	O	a	det	4	SENT_207	[p8l59t3636r358b3678],
4	polymorphism	NN	O	polymorphism	dep	1	SENT_207	[p8l377t3634r739b3689],
5	of	IN	O	of	_	0	SENT_207	[p8l759t3634r810b3678],
6	the	DT	O	the	det	10	SENT_207	[p8l823t3634r901b3678],
7	Acenocoumarol	NNP	O	Acenocoumarol	nn	10	SENT_207	[p8l1046t3634r1431b3678],
8	dose	NN	O	dose	nn	10	SENT_207	[p8l1452t3634r1563b3678],
9	VKORC1	NN	O	vkorc1	nn	10	SENT_207	[p8l57t3709r256b3750],
10	genotypes	NNS	O	genotype	prep_of	4	SENT_207	[p8l265t3713r516b3761],
11	LOW	RB	O	low	advmod	10	SENT_207	[p8l1048t3747r1149b3788],
12	Medium	NNP	O	Medium	nn	13	SENT_207	[p8l1427t3745r1632b3788],
13	High	NNP	O	High	dep	1	SENT_207	[p8l1867t3745r1982b3799],

1	GG	NNS	O	gg	dep	29	SENT_208	[p9l59t54r131b96],
2	(	CD	NUMBER	(	dep	1	SENT_208	[p9l154t52r247b106],
3	no	DT	O	no	dep	2	SENT_208	[p9l154t52r247b106],
4	,	,	O	,	_	0	SENT_208	[p9l154t52r247b106],
5	%	NN	O	%	appos	3	SENT_208	[p9l267t52r318b106],
6	)	CD	PERCENT	)	number	5	SENT_208	[p9l267t52r318b106],
7	2	CD	PERCENT	2	number	5	SENT_208	[p9l1079t54r1105b95],
8	(	CD	PERCENT	(	number	5	SENT_208	[p9l1130t52r1276b106],
9	0.6	CD	PERCENT	0.6	num	10	SENT_208	[p9l1130t52r1276b106],
10	%	NN	PERCENT	%	dep	5	SENT_208	[p9l1130t52r1276b106],
11	)	CD	NUMBER	)	number	12	SENT_208	[p9l1130t52r1276b106],
12	69	CD	NUMBER	69	num	13	SENT_208	[p9l1458t54r1516b96],
13	(	NN	O	(	dep	5	SENT_208	[p9l1539t52r1716b106],
14	22.9	CD	PERCENT	22.9	number	15	SENT_208	[p9l1539t52r1716b106],
15	%	NN	PERCENT	%	amod	13	SENT_208	[p9l1539t52r1716b106],
16	)	CD	NUMBER	)	num	18	SENT_208	[p9l1539t52r1716b106],
17	27	CD	NUMBER	27	num	18	SENT_208	[p9l1867t54r1925b95],
18	(	NN	O	(	dep	13	SENT_208	[p9l1949t52r2095b106],
19	8.9	CD	PERCENT	8.9	number	20	SENT_208	[p9l1949t52r2095b106],
20	%	NN	PERCENT	%	amod	18	SENT_208	[p9l1949t52r2095b106],
21	)	CD	NUMBER	)	dep	22	SENT_208	[p9l1949t52r2095b106],
22	GA	NN	O	ga	advmod	18	SENT_208	[p9l59t141r131b183],
23	(	CD	NUMBER	(	num	24	SENT_208	[p9l152t139r245b193],
24	no	DT	O	no	dep	18	SENT_208	[p9l152t139r245b193],
25	,	,	O	,	_	0	SENT_208	[p9l152t139r245b193],
26	%	NN	O	%	dep	29	SENT_208	[p9l266t139r316b193],
27	)	CD	NUMBER	)	num	26	SENT_208	[p9l266t139r316b193],
28	19	CD	NUMBER	19	num	29	SENT_208	[p9l1050t141r1106b183],
29	(	NN	O	(	dep	36	SENT_208	[p9l1130t139r1276b193],
30	6.3	CD	PERCENT	6.3	num	31	SENT_208	[p9l1130t139r1276b193],
31	%	NN	PERCENT	%	dep	29	SENT_208	[p9l1130t139r1276b193],
32	)	CD	NUMBER	)	number	33	SENT_208	[p9l1130t139r1276b193],
33	123	CD	NUMBER	123	num	34	SENT_208	[p9l1429t141r1514b183],
34	(	NN	O	(	dep	31	SENT_208	[p9l1539t139r1716b193],
35	40.8	CD	PERCENT	40.8	num	36	SENT_208	[p9l1539t139r1716b193],
36	%	NN	PERCENT	%	dep	43	SENT_208	[p9l1539t139r1716b193],
37	)	CD	NUMBER	)	number	38	SENT_208	[p9l1539t139r1716b193],
38	11	CD	NUMBER	11	num	39	SENT_208	[p9l1870t142r1920b182],
39	(	NN	O	(	dep	36	SENT_208	[p9l1949t139r2095b193],
40	3.6	CD	PERCENT	3.6	number	41	SENT_208	[p9l1949t139r2095b193],
41	%	NN	PERCENT	%	amod	39	SENT_208	[p9l1949t139r2095b193],
42	)	CD	NUMBER	)	num	43	SENT_208	[p9l1949t139r2095b193],
43	AA	NN	O	aa	dep	44	SENT_208	[p9l57t229r129b270],
44	(	CD	NUMBER	(	dep	52	SENT_208	[p9l150t227r243b281],
45	no	DT	O	no	dep	44	SENT_208	[p9l150t227r243b281],
46	,	,	O	,	_	0	SENT_208	[p9l150t227r243b281],
47	%	NN	O	%	appos	45	SENT_208	[p9l263t227r314b281],
48	)	CD	NUMBER	)	number	49	SENT_208	[p9l263t227r314b281],
49	10	CD	NUMBER	10	num	50	SENT_208	[p9l1050t229r1106b270],
50	(	NN	O	(	dep	47	SENT_208	[p9l1130t227r1276b281],
51	3.3	CD	PERCENT	3.3	num	52	SENT_208	[p9l1130t227r1276b281],
52	%	NN	PERCENT	%	dep	63	SENT_208	[p9l1130t227r1276b281],
53	)	CD	NUMBER	)	number	54	SENT_208	[p9l1130t227r1276b281],
54	39	CD	NUMBER	39	num	55	SENT_208	[p9l1457t229r1516b270],
55	(	NN	O	(	dep	52	SENT_208	[p9l1539t227r1716b281],
56	12.9	CD	PERCENT	12.9	number	57	SENT_208	[p9l1539t227r1716b281],
57	%	NN	PERCENT	%	amod	55	SENT_208	[p9l1539t227r1716b281],
58	)	CD	NUMBER	)	number	59	SENT_208	[p9l1539t227r1716b281],
59	1	CD	NUMBER	1	dep	60	SENT_208	[p9l1901t229r1920b270],
60	(	NN	O	(	dep	55	SENT_208	[p9l1949t227r2095b281],
61	0.3	CD	PERCENT	0.3	number	62	SENT_208	[p9l1949t227r2095b281],
62	%	NN	PERCENT	%	amod	55	SENT_208	[p9l1949t227r2095b281],
63	)	CD	NUMBER	)	_	0	SENT_208	[p9l1949t227r2095b281],

1	A.D.	NNP	O	A.D.	nn	2	SENT_209	[p9l313t383r358b404],
2	Buzoianu	NNP	O	Buzoianu	_	0	SENT_209	[p9l368t382r476b404],
3	et	FW	O	et	nn	4	SENT_209	[p9l486t385r508b404],
4	al.	FW	O	al.	dep	2	SENT_209	[p9l515t382r540b404],
5	/	:	O	/	punct	2	SENT_209	[p9l549t383r559b407],
6	Blood	NN	O	blood	nn	7	SENT_209	[p9l567t382r631b404],
7	Cells	NNS	O	cell	dep	2	SENT_209	[p9l641t382r697b407],
8	,	,	O	,	_	0	SENT_209	[p9l641t382r697b407],
9	Molecules	NNS	O	molecule	dep	2	SENT_209	[p9l707t382r822b404],
10	and	CC	O	and	_	0	SENT_209	[p9l831t382r874b404],
11	Diseases	NNS	O	disease	dep	2	SENT_209	[p9l882t382r979b404],
12	50	CD	NUMBER	50	number	13	SENT_209	[p9l988t383r1017b404],
13	(	CD	NUMBER	(	num	14	SENT_209	[p9l1027t382r1106b409],
14	2013	CD	DATE	2013	dep	7	SENT_209	[p9l1027t382r1106b409],
15	)	CD	NUMBER	)	number	16	SENT_209	[p9l1027t382r1106b409],
16	166-170 169	CD	NUMBER	166-170 169	num	14	SENT_209	[p9l1805t383r1847b404],[p9l1119t383r1219b404],

1	Although	IN	O	although	mark	4	SENT_210	[p9l107t521r392b590],
2	several	JJ	O	several	amod	3	SENT_210	[p9l415t521r628b576],
3	studies	NNS	O	study	nsubj	4	SENT_210	[p9l652t521r866b576],
4	revealed	VBD	O	reveal	advcl	24	SENT_210	[p9l889t521r1149b576],
5	that	IN	O	that	dep	6	SENT_210	[p9l1171t521r1295b576],
6	patients	NNS	O	patient	dep	4	SENT_210	[p9l1315t522r1575b590],
7	‘	CD	NUMBER	‘	num	9	SENT_210	[p9l1315t522r1575b590],
8	gender	NN	O	gender	nn	9	SENT_210	[p9l1598t521r1813b590],
9	inﬂuences	NNS	O	inﬂuences	dep	6	SENT_210	[p9l1833t521r2144b576],
10	the	DT	O	the	det	12	SENT_210	[p9l7t610r104b665],
11	response	NN	O	response	nn	12	SENT_210	[p9l131t626r403b679],
12	variability	NN	O	variability	dobj	4	SENT_210	[p9l426t610r739b679],
13	to	TO	O	to	_	0	SENT_210	[p9l761t618r820b665],
14	oral	JJ	O	oral	amod	18	SENT_210	[p9l846t610r961b665],
15	anticoagulant	JJ	O	anticoagulant	amod	18	SENT_210	[p9l987t610r1406b679],
16	[	NN	O	[	nn	18	SENT_210	[p9l1433t610r1659b679],
17	17,18	CD	NUMBER	17,18	num	18	SENT_210	[p9l1433t610r1659b679],
18	]	NN	O	]	prep_to	12	SENT_210	[p9l1433t610r1659b679],
19	,	,	O	,	_	0	SENT_210	[p9l1433t610r1659b679],
20	our	PRP$	O	we	poss	21	SENT_210	[p9l1685t626r1789b665],
21	study	NN	O	study	nsubj	24	SENT_210	[p9l1813t610r1982b679],
22	does	VBZ	O	do	aux	24	SENT_210	[p9l2005t610r2144b665],
23	not	RB	O	not	neg	24	SENT_210	[p9l8t707r109b754],
24	show	VB	O	show	_	0	SENT_210	[p9l151t699r314b754],
25	any	DT	O	any	det	27	SENT_210	[p9l356t715r466b768],
26	signiﬁcant	JJ	O	signiﬁcant	amod	27	SENT_210	[p9l508t699r825b768],
27	differences	NNS	O	difference	dobj	24	SENT_210	[p9l867t699r1202b754],
28	regarding	VBG	O	regard	_	0	SENT_210	[p9l1246t699r1542b768],
29	the	DT	O	the	det	30	SENT_210	[p9l1583t699r1680b754],
30	link	NN	O	link	prep_regarding	27	SENT_210	[p9l1724t699r1839b754],
31	between	IN	O	between	_	0	SENT_210	[p9l1880t699r2145b754],
32	patient	NN	O	patient	nn	33	SENT_210	[p9l8t789r226b857],
33	gender	NN	O	gender	prep_between	30	SENT_210	[p9l247t788r463b857],
34	and	CC	O	and	_	0	SENT_210	[p9l485t788r596b843],
35	the	DT	O	the	det	38	SENT_210	[p9l620t788r717b843],
36	efﬁcient	JJ	O	efﬁcient	amod	38	SENT_210	[p9l742t788r992b843],
37	acenocoumarol	NN	O	acenocoumarol	nn	38	SENT_210	[p9l1014t788r1482b843],
38	dose	NN	O	dose	prep_between	30	SENT_210	[p9l1508t788r1661b844],
39	.	.	O	.	_	0	SENT_210	[p9l1508t788r1661b844],

1	No	DT	O	no	det	4	SENT_211	[p9l110t881r191b933],
2	statistically	RB	O	statistically	advmod	3	SENT_211	[p9l221t878r554b946],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_211	[p9l581t878r888b946],
4	association	NN	O	association	nsubjpass	7	SENT_211	[p9l915t879r1242b933],
5	has	VBZ	O	have	aux	7	SENT_211	[p9l1270t878r1367b933],
6	been	VBN	O	be	auxpass	7	SENT_211	[p9l1396t878r1539b933],
7	found	VBN	O	find	_	0	SENT_211	[p9l1568t878r1739b933],
8	between	IN	O	between	_	0	SENT_211	[p9l1767t878r2025b933],
9	comedication	NN	O	comedication	prep_between	7	SENT_211	[p9l2053t894r2143b933, p9l8t967r341b1022],
10	with	IN	O	with	_	0	SENT_211	[p9l359t967r497b1022],
11	drugs	NNS	O	drug	prep_with	7	SENT_211	[p9l516t967r681b1035],
12	known	VBN	O	know	partmod	11	SENT_211	[p9l701t967r908b1022],
13	to	TO	O	to	_	0	SENT_211	[p9l926t975r983b1022],
14	inﬂuence	NN	O	inﬂuence	prep_to	12	SENT_211	[p9l1004t966r1277b1022],
15	oral	JJ	O	oral	amod	16	SENT_211	[p9l1296t967r1408b1022],
16	anticoagulant	NN	O	anticoagulant	poss	20	SENT_211	[p9l1427t967r1874b1035],
17	's	POS	O	's	_	0	SENT_211	[p9l1427t967r1874b1035],
18	metabolism	NN	O	metabolism	nn	20	SENT_211	[p9l1895t967r2144b1022, p9l8t1055r132b1110],
19	(	NN	O	(	nn	20	SENT_211	[p9l157t1055r382b1124],
20	proton	NN	O	proton	dep	11	SENT_211	[p9l157t1055r382b1124],
21	pump	NN	O	pump	nn	22	SENT_211	[p9l404t1071r578b1124],
22	inhibitors	NNS	O	inhibitor	dep	11	SENT_211	[p9l601t1055r899b1118],
23	,	,	O	,	_	0	SENT_211	[p9l601t1055r899b1118],
24	spironolactone	NN	O	spironolactone	appos	22	SENT_211	[p9l923t1055r1376b1124],
25	,	,	O	,	_	0	SENT_211	[p9l923t1055r1376b1124],
26	statins	NNS	O	statin	appos	24	SENT_211	[p9l1400t1056r1605b1118],
27	,	,	O	,	_	0	SENT_211	[p9l1400t1056r1605b1118],
28	and	CC	O	and	_	0	SENT_211	[p9l1628t1055r1738b1110],
29	amiodarone	NN	O	amiodarone	nn	30	SENT_211	[p9l1759t1055r2140b1123],
30	)	NN	O	)	conj_and	11	SENT_211	[p9l1759t1055r2140b1123],
31	and	CC	O	and	_	0	SENT_211	[p9l8t1144r118b1199],
32	the	DT	O	the	det	36	SENT_211	[p9l143t1144r238b1199],
33	daily	JJ	SET	daily	amod	36	SENT_211	[p9l266t1144r410b1213],
34	oral	JJ	O	oral	amod	36	SENT_211	[p9l435t1144r547b1199],
35	anticoagulant	JJ	O	anticoagulant	amod	36	SENT_211	[p9l575t1144r980b1213],
36	dose	NN	O	dose	conj_and	11	SENT_211	[p9l1007t1144r1155b1200],
37	.	.	O	.	_	0	SENT_211	[p9l1007t1144r1155b1200],

1	The	DT	O	the	det	2	SENT_212	[p9l1181t1144r1291b1199],
2	results	NNS	O	result	nsubj	8	SENT_212	[p9l1318t1144r1513b1199],
3	of	IN	O	of	_	0	SENT_212	[p9l1540t1144r1603b1199],
4	this	DT	O	this	det	5	SENT_212	[p9l1622t1144r1729b1199],
5	study	NN	O	study	prep_of	2	SENT_212	[p9l1758t1144r1922b1213],
6	do	VBP	O	do	aux	8	SENT_212	[p9l1947t1144r2019b1199],
7	not	RB	O	not	neg	8	SENT_212	[p9l2047t1152r2146b1199],
8	conﬁrm	VB	O	conﬁrm	_	0	SENT_212	[p9l8t1233r241b1288],
9	the	DT	O	the	det	10	SENT_212	[p9l258t1233r353b1288],
10	data	NNS	O	datum	dobj	8	SENT_212	[p9l371t1233r498b1288],
11	from	IN	O	from	_	0	SENT_212	[p9l517t1233r660b1288],
12	the	DT	O	the	det	13	SENT_212	[p9l676t1233r772b1288],
13	literature	NN	O	literature	prep_from	8	SENT_212	[p9l791t1233r1065b1288],
14	regarding	VBG	O	regard	_	0	SENT_212	[p9l1084t1233r1371b1302],
15	the	DT	O	the	det	16	SENT_212	[p9l1388t1233r1483b1288],
16	inﬂuence	NN	O	inﬂuence	prep_regarding	13	SENT_212	[p9l1502t1233r1776b1288],
17	of	IN	O	of	_	0	SENT_212	[p9l1794t1233r1856b1288],
18	the	DT	O	the	det	19	SENT_212	[p9l1866t1233r1962b1288],
19	treatment	NN	O	treatment	prep_of	16	SENT_212	[p9l1979t1241r2144b1288, p9l8t1331r165b1378],
20	with	IN	O	with	_	0	SENT_212	[p9l186t1323r324b1378],
21	certain	JJ	O	certain	amod	22	SENT_212	[p9l349t1324r553b1378],
22	classes	NNS	O	class	prep_with	19	SENT_212	[p9l577t1323r776b1378],
23	of	IN	O	of	_	0	SENT_212	[p9l802t1323r864b1378],
24	drugs	NNS	O	drug	prep_of	22	SENT_212	[p9l882t1323r1046b1391],
25	on	IN	O	on	_	0	SENT_212	[p9l1072t1339r1146b1378],
26	the	DT	O	the	det	28	SENT_212	[p9l1170t1323r1265b1378],
27	acenocoumarol	NN	O	acenocoumarol	nn	28	SENT_212	[p9l1290t1323r1745b1378],
28	dose	NN	O	dose	prep_on	24	SENT_212	[p9l1771t1323r1920b1378],
29	.	.	O	.	_	0	SENT_212	[p9l1771t1323r1920b1378],

1	Statins	NNS	O	statin	nsubjpass	3	SENT_213	[p9l1946t1324r2143b1378],
2	are	VBP	O	be	auxpass	3	SENT_213	[p9l8t1427r98b1467],
3	known	VBN	O	know	_	0	SENT_213	[p9l120t1412r327b1467],
4	to	TO	O	to	aux	5	SENT_213	[p9l348t1420r405b1467],
5	inﬂuence	VB	O	inﬂuence	xcomp	3	SENT_213	[p9l428t1411r702b1467],
6	the	DT	O	the	det	8	SENT_213	[p9l722t1412r816b1467],
7	plasma	NN	O	plasma	nn	8	SENT_213	[p9l839t1412r1051b1480],
8	concentration	NN	O	concentration	dobj	5	SENT_213	[p9l1071t1412r1482b1467],
9	of	IN	O	of	_	0	SENT_213	[p9l1504t1411r1567b1467],
10	the	DT	O	the	det	15	SENT_213	[p9l1580t1412r1674b1467],
11	oral	JJ	O	oral	amod	15	SENT_213	[p9l1696t1411r1808b1467],
12	anticoagulant	JJ	O	anticoagulant	amod	15	SENT_213	[p9l1829t1412r2144b1480, p9l8t1500r122b1555],
13	[	NN	O	[	nn	15	SENT_213	[p9l151t1500r279b1569],
14	19	CD	NUMBER	19	num	15	SENT_213	[p9l151t1500r279b1569],
15	]	NN	O	]	prep_of	8	SENT_213	[p9l151t1500r279b1569],
16	.	.	O	.	_	0	SENT_213	[p9l151t1500r279b1569],

1	Despite	IN	O	despite	_	0	SENT_214	[p9l310t1501r531b1569],
2	an	DT	O	a	det	4	SENT_214	[p9l559t1516r630b1555],
3	increased	VBN	O	increase	amod	4	SENT_214	[p9l658t1500r938b1555],
4	number	NN	O	number	prep_despite	16	SENT_214	[p9l968t1500r1205b1555],
5	of	IN	O	of	_	0	SENT_214	[p9l1231t1500r1293b1555],
6	patients	NNS	O	patient	prep_of	4	SENT_214	[p9l1314t1501r1550b1569],
7	simultaneously	RB	O	simultaneously	advmod	8	SENT_214	[p9l1581t1500r2034b1569],
8	receiving	VBG	O	receive	partmod	6	SENT_214	[p9l2061t1516r2144b1555, p9l8t1590r219b1658],
9	statins	NNS	O	statin	dobj	8	SENT_214	[p9l250t1590r442b1644],
10	and	CC	O	and	_	0	SENT_214	[p9l475t1589r585b1644],
11	acenocoumarol	NN	O	acenocoumarol	dobj	8	SENT_214	[p9l616t1589r1086b1652],
12	,	,	O	,	_	0	SENT_214	[p9l616t1589r1086b1652],
13	statins	NNS	O	statin	nsubj	16	SENT_214	[p9l1120t1590r1312b1644],
14	did	VBD	O	do	aux	16	SENT_214	[p9l1344t1589r1437b1644],
15	not	RB	O	not	neg	16	SENT_214	[p9l1470t1597r1569b1644],
16	inﬂuence	VB	O	inﬂuence	_	0	SENT_214	[p9l1600t1589r1873b1644],
17	the	DT	O	the	det	20	SENT_214	[p9l1905t1589r2000b1644],
18	oral	JJ	O	oral	amod	20	SENT_214	[p9l2032t1589r2144b1644],
19	anticoagulant	JJ	O	anticoagulant	amod	20	SENT_214	[p9l8t1678r414b1747],
20	dose	NN	O	dose	dobj	16	SENT_214	[p9l429t1678r578b1734],
21	.	.	O	.	_	0	SENT_214	[p9l429t1678r578b1734],

1	Proton	NNP	O	Proton	nn	3	SENT_215	[p9l597t1682r795b1733],
2	pump	NN	O	pump	nn	3	SENT_215	[p9l812t1694r988b1747],
3	inhibitors	NNS	O	inhibitor	nsubj	4	SENT_215	[p9l1005t1678r1290b1733],
4	(	VBP	O	(	_	0	SENT_215	[p9l1312t1679r1452b1747],
5	PPI	NNP	O	PPI	nsubj	8	SENT_215	[p9l1312t1679r1452b1747],
6	)	CD	NUMBER	)	num	5	SENT_215	[p9l1312t1679r1452b1747],
7	are	VBP	O	be	cop	8	SENT_215	[p9l1473t1694r1564b1733],
8	drugs	NNS	O	drug	ccomp	4	SENT_215	[p9l1582t1678r1746b1747],
9	known	VBN	O	know	partmod	8	SENT_215	[p9l1765t1678r1971b1733],
10	to	TO	O	to	aux	11	SENT_215	[p9l1988t1686r2045b1733],
11	increase	VB	O	increase	xcomp	9	SENT_215	[p9l2063t1679r2144b1733, p9l8t1783r192b1822],
12	the	DT	O	the	det	15	SENT_215	[p9l217t1767r311b1822],
13	oral	JJ	O	oral	amod	15	SENT_215	[p9l337t1767r449b1822],
14	anticoagulant	JJ	O	anticoagulant	amod	15	SENT_215	[p9l475t1767r880b1836],
15	effect	NN	O	effect	dobj	11	SENT_215	[p9l903t1767r1078b1823],
16	.	.	O	.	_	0	SENT_215	[p9l903t1767r1078b1823],

1	Because	IN	O	because	_	0	SENT_216	[p9l1104t1771r1340b1822],
2	of	IN	O	of	_	0	SENT_216	[p9l1366t1767r1428b1822],
3	the	DT	O	the	det	5	SENT_216	[p9l1445t1767r1540b1822],
4	reduced	VBN	O	reduce	amod	5	SENT_216	[p9l1565t1767r1803b1822],
5	number	NN	O	number	prep_because_of	28	SENT_216	[p9l1830t1767r2067b1822],
6	of	IN	O	of	_	0	SENT_216	[p9l2090t1767r2152b1822],
7	patients	NNS	O	patient	prep_of	5	SENT_216	[p9l8t1858r245b1925],
8	treated	VBN	O	treat	partmod	7	SENT_216	[p9l262t1857r473b1912],
9	simultaneously	RB	O	simultaneously	advmod	8	SENT_216	[p9l491t1857r945b1925],
10	with	IN	O	with	_	0	SENT_216	[p9l958t1857r1096b1912],
11	oral	JJ	O	oral	amod	12	SENT_216	[p9l1112t1857r1224b1912],
12	anticoagulant	JJ	O	anticoagulant	prep_with	8	SENT_216	[p9l1241t1857r1648b1925],
13	and	CC	O	and	_	0	SENT_216	[p9l1661t1857r1770b1912],
14	amiodarone	NN	O	amiodarone	conj_and	12	SENT_216	[p9l1787t1857r2144b1912],
15	or	CC	O	or	_	0	SENT_216	[p9l8t1961r70b2001],
16	PPI	NNP	O	PPI	conj_or	12	SENT_216	[p9l85t1949r174b2000],
17	(	CD	NUMBER	(	num	18	SENT_216	[p9l194t1946r293b2014],
18	24	CD	NUMBER	24	dep	16	SENT_216	[p9l194t1946r293b2014],
19	and	CC	O	and	_	0	SENT_216	[p9l308t1946r417b2001],
20	12	CD	NUMBER	12	num	21	SENT_216	[p9l437t1948r504b2000],
21	patients	NNS	O	patient	conj_and	18	SENT_216	[p9l522t1946r801b2014],
22	)	RB	O	)	advmod	8	SENT_216	[p9l522t1946r801b2014],
23	,	,	O	,	_	0	SENT_216	[p9l522t1946r801b2014],
24	no	DT	O	no	det	25	SENT_216	[p9l819t1961r892b2001],
25	association	NN	O	association	nsubjpass	28	SENT_216	[p9l908t1946r1235b2001],
26	has	VBZ	O	have	aux	28	SENT_216	[p9l1252t1946r1349b2001],
27	been	VBN	O	be	auxpass	28	SENT_216	[p9l1365t1946r1509b2001],
28	found	VBN	O	find	_	0	SENT_216	[p9l1525t1945r1698b2001],
29	between	IN	O	between	_	0	SENT_216	[p9l1713t1946r1971b2001],
30	these	DT	O	these	det	31	SENT_216	[p9l1986t1945r2144b2001],
31	treatments	NNS	O	treatment	prep_between	28	SENT_216	[p9l7t2042r332b2089],
32	and	CC	O	and	_	0	SENT_216	[p9l354t2034r463b2089],
33	the	DT	O	the	det	36	SENT_216	[p9l485t2034r579b2089],
34	oral	JJ	O	oral	amod	36	SENT_216	[p9l601t2034r713b2089],
35	anticoagulant	JJ	O	anticoagulant	amod	36	SENT_216	[p9l735t2034r1141b2103],
36	dose	NN	O	dose	prep_between	28	SENT_216	[p9l1160t2034r1310b2090],
37	.	.	O	.	_	0	SENT_216	[p9l1160t2034r1310b2090],

1	Apart	RB	O	apart	_	0	SENT_217	[p9l107t2125r275b2192],
2	from	IN	O	from	_	0	SENT_217	[p9l294t2123r437b2178],
3	the	DT	O	the	det	5	SENT_217	[p9l456t2123r552b2178],
4	above	JJ	O	above	amod	5	SENT_217	[p9l571t2123r1104b2178],
5	—	NN	O	—	prep_apart_from	6	SENT_217	[p9l571t2123r1104b2178],
6	mentioned	VBD	O	mention	_	0	SENT_217	[p9l571t2123r1104b2178],
7	factors	NNS	O	factor	dobj	6	SENT_217	[p9l1124t2123r1323b2178],
8	(	CD	NUMBER	(	num	9	SENT_217	[p9l1347t2123r1487b2192],
9	age	NN	O	age	nsubj	6	SENT_217	[p9l1347t2123r1487b2192],
10	,	,	O	,	_	0	SENT_217	[p9l1347t2123r1487b2192],
11	sex	NN	O	sex	appos	9	SENT_217	[p9l1509t2139r1618b2186],
12	,	,	O	,	_	0	SENT_217	[p9l1509t2139r1618b2186],
13	and	CC	O	and	_	0	SENT_217	[p9l1639t2123r1748b2178],
14	concomitant	JJ	O	concomitant	amod	15	SENT_217	[p9l1769t2124r2147b2178],
15	medication	NN	O	medication	appos	9	SENT_217	[p9l8t2212r369b2281],
16	)	IN	O	)	mark	35	SENT_217	[p9l8t2212r369b2281],
17	the	DT	O	the	det	18	SENT_217	[p9l391t2212r487b2267],
18	inﬂuence	NN	O	inﬂuence	nsubjpass	35	SENT_217	[p9l505t2212r781b2267],
19	of	IN	O	of	_	0	SENT_217	[p9l799t2212r862b2267],
20	genetic	JJ	O	genetic	amod	21	SENT_217	[p9l872t2213r1090b2281],
21	factors	NNS	O	factor	prep_of	18	SENT_217	[p9l1107t2212r1305b2267],
22	on	IN	O	on	_	0	SENT_217	[p9l1324t2228r1398b2267],
23	the	DT	O	the	det	27	SENT_217	[p9l1416t2212r1512b2267],
24	required	VBN	O	require	amod	27	SENT_217	[p9l1530t2212r1785b2281],
25	oral	JJ	O	oral	amod	27	SENT_217	[p9l1804t2212r1918b2267],
26	anticoagulant	JJ	O	anticoagulant	amod	27	SENT_217	[p9l1936t2213r2144b2267, p9l8t2301r232b2370],
27	dose	NN	O	dose	prep_on	21	SENT_217	[p9l252t2301r389b2356],
28	for	IN	O	for	_	0	SENT_217	[p9l411t2301r495b2356],
29	an	DT	O	a	det	31	SENT_217	[p9l514t2317r586b2356],
30	effective	JJ	O	effective	amod	31	SENT_217	[p9l607t2301r860b2356],
31	anticoagulation	NN	O	anticoagulation	prep_for	27	SENT_217	[p9l881t2301r1346b2370],
32	has	VBZ	O	have	aux	35	SENT_217	[p9l1368t2301r1466b2356],
33	also	RB	O	also	advmod	35	SENT_217	[p9l1489t2301r1604b2356],
34	been	VBN	O	be	auxpass	35	SENT_217	[p9l1625t2301r1769b2356],
35	studied	VBN	O	study	dep	6	SENT_217	[p9l1793t2301r2027b2357],
36	.	.	O	.	_	0	SENT_217	[p9l1793t2301r2027b2357],

1	The	DT	O	the	det	2	SENT_218	[p9l107t2391r217b2446],
2	presence	NN	O	presence	_	0	SENT_218	[p9l237t2407r503b2459],
3	of	IN	O	of	_	0	SENT_218	[p9l522t2391r586b2446],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_218	[p9l597t2391r889b2446],
5	*	NN	O	*	prep_of	2	SENT_218	[p9l597t2391r889b2446],
6	2	CD	NUMBER	2	num	7	SENT_218	[p9l597t2391r889b2446],
7	allele	NN	O	allele	nsubj	10	SENT_218	[p9l911t2391r1066b2446],
8	did	VBD	O	do	aux	10	SENT_218	[p9l1086t2391r1180b2446],
9	not	RB	O	not	neg	10	SENT_218	[p9l1200t2399r1300b2446],
10	inﬂuence	VB	O	inﬂuence	rcmod	5	SENT_218	[p9l1318t2391r1593b2446],
11	the	DT	O	the	det	12	SENT_218	[p9l1612t2391r1708b2446],
12	assignment	NN	O	assignment	dobj	10	SENT_218	[p9l1727t2392r2072b2459],
13	of	IN	O	of	_	0	SENT_218	[p9l2090t2391r2152b2446],
14	patients	NNS	O	patient	prep_of	12	SENT_218	[p9l8t2480r248b2548],
15	to	TO	O	to	_	0	SENT_218	[p9l267t2488r325b2535],
16	one	CD	NUMBER	one	prep_to	10	SENT_218	[p9l345t2495r454b2535],
17	of	IN	O	of	_	0	SENT_218	[p9l473t2479r537b2535],
18	the	DT	O	the	det	20	SENT_218	[p9l548t2480r644b2535],
19	three	CD	NUMBER	three	num	20	SENT_218	[p9l662t2480r820b2535],
20	groups	NNS	O	group	prep_of	2	SENT_218	[p9l838t2495r1043b2548],
21	deﬁned	VBN	O	deﬁned	partmod	2	SENT_218	[p9l1063t2479r1288b2535],
22	by	IN	O	by	_	0	SENT_218	[p9l1308t2479r1381b2548],
23	the	DT	O	the	det	25	SENT_218	[p9l1398t2480r1494b2535],
24	acenocoumarol	NN	O	acenocoumarol	nn	25	SENT_218	[p9l1513t2480r1973b2535],
25	dose	NN	O	dose	agent	21	SENT_218	[p9l1993t2479r2143b2535],
26	.	.	O	.	_	0	SENT_218	[p9l1993t2479r2143b2535],

1	Importantly	RB	O	importantly	advmod	7	SENT_219	[p9l8t2568r380b2637],
2	,	,	O	,	_	0	SENT_219	[p9l8t2568r380b2637],
3	none	NN	O	none	nsubj	7	SENT_219	[p9l410t2584r558b2623],
4	of	IN	O	of	_	0	SENT_219	[p9l587t2568r649b2623],
5	the	DT	O	the	det	6	SENT_219	[p9l669t2568r766b2623],
6	patients	NNS	O	patient	prep_of	3	SENT_219	[p9l794t2569r1033b2637],
7	included	VBD	O	include	dep	11	SENT_219	[p9l1063t2568r1320b2623],
8	in	IN	O	in	_	0	SENT_219	[p9l1350t2569r1406b2623],
9	the	DT	O	the	det	10	SENT_219	[p9l1433t2568r1530b2623],
10	study	NN	O	study	prep_in	7	SENT_219	[p9l1558t2568r1724b2637],
11	proved	VBD	O	prove	_	0	SENT_219	[p9l1751t2568r1960b2637],
12	to	TO	O	to	aux	15	SENT_219	[p9l1988t2576r2046b2623],
13	be	VB	O	be	cop	15	SENT_219	[p9l2074t2568r2145b2623],
14	CYP2C9	NN	O	cyp2c9	nn	15	SENT_219	[p9l8t2657r392b2721],
15	*	NN	O	*	xcomp	11	SENT_219	[p9l8t2657r392b2721],
16	2	CD	NUMBER	2	nsubj	25	SENT_219	[p9l8t2657r392b2721],
17	/	:	O	/	punct	20	SENT_219	[p9l8t2657r392b2721],
18	*	CD	NUMBER	*	number	19	SENT_219	[p9l8t2657r392b2721],
19	2	CD	NUMBER	2	num	20	SENT_219	[p9l8t2657r392b2721],
20	homozygous	JJ	O	homozygous	dep	16	SENT_219	[p9l419t2657r815b2726],
21	,	,	O	,	_	0	SENT_219	[p9l419t2657r815b2726],
22	all	PDT	O	all	predet	24	SENT_219	[p9l841t2657r909b2712],
23	the	DT	O	the	det	24	SENT_219	[p9l934t2657r1030b2712],
24	patients	NNS	O	patient	appos	20	SENT_219	[p9l1056t2658r1295b2726],
25	presenting	VBG	O	present	rcmod	15	SENT_219	[p9l1322t2658r1644b2726],
26	CYP2C9	NN	O	cyp2c9	nn	27	SENT_219	[p9l1667t2657r1960b2712],
27	*	NN	O	*	dobj	25	SENT_219	[p9l1667t2657r1960b2712],
28	2	CD	NUMBER	2	num	29	SENT_219	[p9l1667t2657r1960b2712],
29	allele	NN	O	allele	nsubj	11	SENT_219	[p9l1988t2657r2144b2712],
30	being	VBG	O	be	cop	31	SENT_219	[p9l7t2746r170b2815],
31	heterozygous	JJ	O	heterozygous	dep	11	SENT_219	[p9l190t2746r596b2815],
32	.	.	O	.	_	0	SENT_219	[p9l190t2746r596b2815],

1	Literature	NN	O	literature	nsubj	2	SENT_220	[p9l620t2747r902b2801],
2	results	VBZ	O	result	_	0	SENT_220	[p9l925t2746r1116b2801],
3	concerning	VBG	O	concern	xcomp	2	SENT_220	[p9l1139t2747r1464b2815],
4	the	DT	O	the	det	5	SENT_220	[p9l1485t2746r1578b2801],
5	effect	NN	O	effect	dobj	3	SENT_220	[p9l1600t2746r1760b2801],
6	of	IN	O	of	_	0	SENT_220	[p9l1780t2746r1842b2801],
7	CYP2C9	NN	O	cyp2c9	nn	8	SENT_220	[p9l1856t2746r2142b2801],
8	*	NN	O	*	prep_of	5	SENT_220	[p9l1856t2746r2142b2801],
9	2	CD	NUMBER	2	num	10	SENT_220	[p9l1856t2746r2142b2801],
10	allele	NN	O	allele	nsubj	19	SENT_220	[p9l8t2835r159b2890],
11	on	IN	O	on	_	0	SENT_220	[p9l180t2851r253b2890],
12	the	DT	O	the	det	14	SENT_220	[p9l274t2835r367b2890],
13	daily	JJ	SET	daily	amod	14	SENT_220	[p9l389t2835r530b2904],
14	dose	NN	O	dose	prep_on	10	SENT_220	[p9l550t2835r684b2890],
15	of	IN	O	of	_	0	SENT_220	[p9l705t2835r767b2890],
16	acenocoumarol	NN	O	acenocoumarol	prep_of	14	SENT_220	[p9l780t2835r1227b2890],
17	are	VBP	O	be	cop	19	SENT_220	[p9l1249t2851r1338b2890],
18	not	RB	O	not	neg	19	SENT_220	[p9l1360t2843r1457b2890],
19	straightforward	JJ	O	straightforward	rcmod	5	SENT_220	[p9l1477t2835r1947b2904],
20	.	.	O	.	_	0	SENT_220	[p9l1477t2835r1947b2904],

1	Saraeva	NNP	O	Saraeva	nsubj	7	SENT_221	[p9l110t2928r339b2980],
2	et	FW	O	et	dep	1	SENT_221	[p9l355t2933r412b2980],
3	al.	FW	O	al.	nn	4	SENT_221	[p9l427t2925r490b2980],
4	[	FW	O	[	dep	1	SENT_221	[p9l510t2925r622b2993],
5	20	CD	NUMBER	20	num	6	SENT_221	[p9l510t2925r622b2993],
6	]	NN	O	]	dep	4	SENT_221	[p9l510t2925r622b2993],
7	showed	VBD	O	show	_	0	SENT_221	[p9l643t2925r875b2980],
8	in	IN	O	in	_	0	SENT_221	[p9l893t2926r948b2979],
9	a	DT	O	a	det	11	SENT_221	[p9l965t2941r996b2980],
10	recent	JJ	O	recent	amod	11	SENT_221	[p9l1012t2933r1201b2980],
11	study	NN	O	study	prep_in	7	SENT_221	[p9l1216t2925r1381b2993],
12	on	IN	O	on	_	0	SENT_221	[p9l1396t2941r1469b2980],
13	96	CD	NUMBER	96	num	14	SENT_221	[p9l1486t2928r1558b2980],
14	patients	NNS	O	patient	prep_on	11	SENT_221	[p9l1575t2926r1814b2993],
15	that	IN	O	that	complm	27	SENT_221	[p9l1831t2925r1951b2980],
16	a	DT	O	a	det	18	SENT_221	[p9l1966t2941r1997b2980],
17	high	JJ	O	high	amod	18	SENT_221	[p9l2013t2925r2144b2993],
18	number	NN	O	number	nsubj	27	SENT_221	[p9l8t3014r246b3069],
19	of	IN	O	of	_	0	SENT_221	[p9l266t3013r330b3069],
20	carriers	NNS	O	carrier	prep_of	18	SENT_221	[p9l343t3014r566b3069],
21	of	IN	O	of	_	0	SENT_221	[p9l588t3013r651b3069],
22	the	DT	O	the	det	26	SENT_221	[p9l665t3014r761b3069],
23	CYP2C9	NN	O	cyp2c9	nn	26	SENT_221	[p9l783t3013r1076b3069],
24	*	NN	O	*	nn	26	SENT_221	[p9l783t3013r1076b3069],
25	2	CD	NUMBER	2	num	26	SENT_221	[p9l783t3013r1076b3069],
26	allele	NN	O	allele	prep_of	20	SENT_221	[p9l1099t3014r1254b3069],
27	required	VBN	O	require	ccomp	7	SENT_221	[p9l1277t3014r1531b3082],
28	low	JJ	O	low	amod	30	SENT_221	[p9l1554t3014r1665b3069],
29	acenocoumarol	NN	O	acenocoumarol	nn	30	SENT_221	[p9l1686t3014r2144b3069],
30	doses	NNS	O	dose	dobj	27	SENT_221	[p9l8t3102r187b3166],
31	,	,	O	,	_	0	SENT_221	[p9l8t3102r187b3166],
32	while	IN	O	while	mark	35	SENT_221	[p9l211t3102r379b3157],
33	other	JJ	O	other	amod	34	SENT_221	[p9l403t3102r564b3157],
34	authors	NNS	O	author	nsubj	35	SENT_221	[p9l587t3102r813b3157],
35	showed	VBD	O	show	advcl	27	SENT_221	[p9l839t3102r1071b3157],
36	that	IN	O	that	complm	45	SENT_221	[p9l1096t3102r1218b3157],
37	the	DT	O	the	det	38	SENT_221	[p9l1239t3102r1335b3157],
38	presence	NN	O	presence	nsubj	45	SENT_221	[p9l1360t3118r1626b3171],
39	of	IN	O	of	_	0	SENT_221	[p9l1650t3102r1713b3157],
40	the	DT	O	the	det	44	SENT_221	[p9l1729t3102r1825b3157],
41	CYP2C9	NN	O	cyp2c9	nn	44	SENT_221	[p9l1850t3102r2143b3157],
42	*	NN	O	*	nn	44	SENT_221	[p9l1850t3102r2143b3157],
43	2	CD	NUMBER	2	num	44	SENT_221	[p9l1850t3102r2143b3157],
44	allele	NN	O	allele	prep_of	38	SENT_221	[p9l8t3191r171b3245],
45	has	VBZ	O	have	ccomp	35	SENT_221	[p9l207t3191r308b3245],
46	little	JJ	O	little	amod	49	SENT_221	[p9l344t3191r486b3245],
47	or	CC	O	or	_	0	SENT_221	[p9l522t3207r586b3245],
48	no	DT	O	no	amod	49	SENT_221	[p9l619t3207r694b3245],
49	inﬂuence	NN	O	inﬂuence	dobj	45	SENT_221	[p9l729t3191r1015b3245],
50	at	IN	O	at	_	0	SENT_221	[p9l1050t3199r1108b3245],
51	all	DT	O	all	prep_at	49	SENT_221	[p9l1141t3191r1212b3245],
52	on	IN	O	on	_	0	SENT_221	[p9l1247t3207r1323b3245],
53	the	DT	O	the	det	57	SENT_221	[p9l1357t3191r1455b3245],
54	acenocoumarol	NN	O	acenocoumarol	nn	57	SENT_221	[p9l1491t3191r1968b3245],
55	dose	NN	O	dose	nn	57	SENT_221	[p9l2003t3191r2144b3245],
56	[	NN	O	[	nn	57	SENT_221	[p9l11t3279r266b3348],
57	21-24L	NN	O	21-24l	prep_on	51	SENT_221	[p9l11t3279r266b3348],

1	Unlike	IN	O	unlike	_	0	SENT_222	[p9l109t3368r303b3423],
2	the	DT	O	the	det	4	SENT_222	[p9l328t3368r424b3423],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_222	[p9l450t3368r744b3423],
4	*	NN	O	*	prep_unlike	15	SENT_222	[p9l450t3368r744b3423],
5	2	CD	NUMBER	2	number	6	SENT_222	[p9l450t3368r744b3423],
6	heterozygous	JJ	O	heterozygous	amod	4	SENT_222	[p9l771t3368r1188b3437],
7	,	,	O	,	_	0	SENT_222	[p9l771t3368r1188b3437],
8	carriers	NNS	O	carrier	nsubj	15	SENT_222	[p9l1215t3369r1438b3423],
9	of	IN	O	of	_	0	SENT_222	[p9l1465t3368r1528b3423],
10	the	DT	O	the	det	14	SENT_222	[p9l1545t3368r1641b3423],
11	CYP2C9	NN	O	cyp2c9	nn	14	SENT_222	[p9l1667t3368r1959b3423],
12	*	NN	O	*	nn	14	SENT_222	[p9l1667t3368r1959b3423],
13	3	CD	NUMBER	3	num	14	SENT_222	[p9l1667t3368r1959b3423],
14	allele	NN	O	allele	prep_of	8	SENT_222	[p9l1988t3368r2144b3423],
15	required	VBN	O	require	_	0	SENT_222	[p10l8t17r263b85],
16	low	JJ	O	low	amod	18	SENT_222	[p10l293t17r404b72],
17	acenocoumarol	NN	O	acenocoumarol	nn	18	SENT_222	[p10l432t17r890b72],
18	doses	NNS	O	dose	dobj	15	SENT_222	[p10l920t17r1100b80],
19	,	,	O	,	_	0	SENT_222	[p10l920t17r1100b80],
20	the	DT	O	the	det	21	SENT_222	[p10l1129t17r1225b72],
21	results	NNS	O	result	appos	18	SENT_222	[p10l1254t17r1451b72],
22	being	VBG	O	be	cop	23	SENT_222	[p10l1480t17r1647b85],
23	consistent	JJ	O	consistent	partmod	21	SENT_222	[p10l1674t18r1981b72],
24	with	IN	O	with	_	0	SENT_222	[p10l2006t17r2144b72],
25	the	DT	O	the	det	27	SENT_222	[p10l7t106r103b161],
26	relevant	JJ	O	relevant	amod	27	SENT_222	[p10l125t106r372b161],
27	literature	NN	O	literature	prep_with	23	SENT_222	[p10l392t106r670b161],
28	[	CD	NUMBER	[	number	29	SENT_222	[p10l695t105r916b174],
29	14,20	CD	NUMBER	14,20	num	30	SENT_222	[p10l695t105r916b174],
30	]	NN	O	]	dep	23	SENT_222	[p10l695t105r916b174],
31	.	.	O	.	_	0	SENT_222	[p10l695t105r916b174],

1	The	DT	O	the	det	2	SENT_223	[p10l936t106r1046b161],
2	patients	NNS	O	patient	nsubj	13	SENT_223	[p10l1069t106r1308b174],
3	having	VBG	O	have	partmod	2	SENT_223	[p10l1331t106r1534b174],
4	the	DT	O	the	det	8	SENT_223	[p10l1553t106r1650b161],
5	CYP2C9	NN	O	cyp2c9	nn	8	SENT_223	[p10l1671t105r1964b161],
6	*	NN	O	*	nn	8	SENT_223	[p10l1671t105r1964b161],
7	3	CD	NUMBER	3	num	8	SENT_223	[p10l1671t105r1964b161],
8	allele	NN	O	allele	dobj	3	SENT_223	[p10l1988t106r2144b161],
9	were	VBD	O	be	cop	13	SENT_223	[p10l6t210r157b249],
10	3.4	CD	NUMBER	3.4	num	11	SENT_223	[p10l174t197r264b250],
11	times	NNS	O	time	npadvmod	12	SENT_223	[p10l279t195r443b249],
12	more	RBR	O	more	advmod	13	SENT_223	[p10l462t210r619b249],
13	likely	JJ	O	likely	_	0	SENT_223	[p10l636t194r798b263],
14	to	TO	O	to	aux	15	SENT_223	[p10l813t202r872b249],
15	receive	VB	O	receive	xcomp	13	SENT_223	[p10l890t195r1102b249],
16	less	JJR	O	less	mwe	17	SENT_223	[p10l1120t194r1228b249],
17	than	IN	O	than	quantmod	18	SENT_223	[p10l1245t194r1381b249],
18	7	CD	NUMBER	7	num	20	SENT_223	[p10l1399t197r1431b248],
19	mg	NN	O	mg	nn	20	SENT_223	[p10l1459t210r1553b263],
20	acenocoumarol	NN	O	acenocoumarol	dobj	15	SENT_223	[p10l1570t194r2029b249],
21	per	IN	O	per	_	0	SENT_223	[p10l2047t210r2146b263],
22	week	NN	DURATION	week	prep_per	20	SENT_223	[p10l6t283r169b338],
23	compared	VBN	O	compare	_	0	SENT_223	[p10l186t283r486b352],
24	to	TO	O	to	prepc_compared_to	15	SENT_223	[p10l504t291r562b338],
25	those	DT	O	those	pobj	15	SENT_223	[p10l580t283r743b338],
26	not	RB	O	not	neg	27	SENT_223	[p10l761t291r861b338],
27	having	VBG	O	have	rcmod	25	SENT_223	[p10l878t283r1081b352],
28	this	DT	O	this	det	29	SENT_223	[p10l1097t283r1205b338],
29	allele	NN	O	allele	dobj	27	SENT_223	[p10l1225t283r1395b339],
30	.	.	O	.	_	0	SENT_223	[p10l1225t283r1395b339],

1	This	DT	O	this	nsubj	3	SENT_224	[p10l1412t283r1534b338],
2	was	VBD	O	be	cop	3	SENT_224	[p10l1552t299r1670b338],
3	independent	JJ	O	independent	_	0	SENT_224	[p10l1689t283r2072b352],
4	of	IN	O	of	_	0	SENT_224	[p10l2090t283r2152b338],
5	the	DT	O	the	det	6	SENT_224	[p10l7t372r103b427],
6	presence	NN	O	presence	prep_of	3	SENT_224	[p10l127t388r393b441],
7	of	IN	O	of	_	0	SENT_224	[p10l417t372r479b427],
8	other	JJ	O	other	amod	9	SENT_224	[p10l496t372r657b427],
9	mutations	NNS	O	mutation	prep_of	6	SENT_224	[p10l679t373r997b428],
10	.	.	O	.	_	0	SENT_224	[p10l679t373r997b428],

1	Studies	NNS	O	study	nsubj	5	SENT_225	[p10l1022t372r1237b427],
2	published	VBN	O	publish	partmod	1	SENT_225	[p10l1262t372r1555b441],
3	so	RB	O	so	advmod	4	SENT_225	[p10l1580t388r1643b427],
4	far	RB	O	far	advmod	2	SENT_225	[p10l1667t372r1747b427],
5	showed	VBD	O	show	_	0	SENT_225	[p10l1769t372r2002b427],
6	that	IN	O	that	complm	15	SENT_225	[p10l2025t372r2147b427],
7	the	DT	O	the	det	8	SENT_225	[p10l7t461r103b516],
8	patients	NNS	O	patient	nsubj	15	SENT_225	[p10l125t462r363b530],
9	carrying	VBG	O	carry	partmod	8	SENT_225	[p10l386t462r633b530],
10	the	DT	O	the	det	14	SENT_225	[p10l653t461r749b516],
11	CYP2C9	NN	O	cyp2c9	nn	14	SENT_225	[p10l770t461r1062b516],
12	*	NN	O	*	nn	14	SENT_225	[p10l770t461r1062b516],
13	3	CD	NUMBER	3	num	14	SENT_225	[p10l770t461r1062b516],
14	allele	NN	O	allele	dobj	9	SENT_225	[p10l1086t461r1242b516],
15	require	VBP	O	require	ccomp	5	SENT_225	[p10l1265t462r1480b530],
16	a	DT	O	a	det	27	SENT_225	[p10l1501t477r1532b516],
17	low	JJ	O	low	amod	27	SENT_225	[p10l1554t461r1666b516],
18	acenocoumarol	NN	O	acenocoumarol	nn	19	SENT_225	[p10l1685t461r2144b516],
19	dose	NN	O	dose	dep	17	SENT_225	[p10l8t551r145b606],
20	to	TO	O	to	aux	21	SENT_225	[p10l166t559r224b606],
21	reach	VB	O	reach	infmod	19	SENT_225	[p10l247t551r410b606],
22	the	DT	O	the	det	24	SENT_225	[p10l430t551r526b606],
23	anticoagulation	NN	O	anticoagulation	nn	24	SENT_225	[p10l548t551r1012b619],
24	target	NN	O	target	dobj	21	SENT_225	[p10l1033t559r1211b619],
25	[	CD	NUMBER	[	number	26	SENT_225	[p10l1235t550r1455b619],
26	21,24	CD	NUMBER	21,24	num	27	SENT_225	[p10l1235t550r1455b619],
27	]	NN	O	]	dobj	15	SENT_225	[p10l1235t550r1455b619],
28	.	.	O	.	_	0	SENT_225	[p10l1235t550r1455b619],

1	Another	DT	O	another	det	3	SENT_226	[p10l107t639r355b694],
2	important	JJ	O	important	amod	3	SENT_226	[p10l374t640r677b708],
3	determinant	NN	O	determinant	nsubjpass	12	SENT_226	[p10l696t639r1073b694],
4	of	IN	O	of	_	0	SENT_226	[p10l1091t639r1154b694],
5	the	DT	O	the	det	10	SENT_226	[p10l1166t639r1262b694],
6	oral	JJ	O	oral	amod	10	SENT_226	[p10l1282t639r1395b694],
7	anticoagulant	JJ	O	anticoagulant	amod	10	SENT_226	[p10l1416t639r1826b708],
8	treatment	NN	O	treatment	nn	10	SENT_226	[p10l1844t647r2147b694],
9	response	NN	O	response	nn	10	SENT_226	[p10l8t744r274b797],
10	variability	NN	O	variability	prep_of	3	SENT_226	[p10l314t728r618b797],
11	is	VBZ	O	be	auxpass	12	SENT_226	[p10l658t729r701b783],
12	represented	VBN	O	represent	_	0	SENT_226	[p10l743t728r1103b797],
13	by	IN	O	by	_	0	SENT_226	[p10l1143t728r1217b797],
14	the	DT	O	the	det	17	SENT_226	[p10l1254t728r1350b783],
15	VKORC1	NN	O	vkorc1	nn	17	SENT_226	[p10l1389t731r1633b783],
16	gene	NN	O	gene	nn	17	SENT_226	[p10l1680t744r1823b797],
17	polymorphisms	NNS	O	polymorphism	agent	12	SENT_226	[p10l1864t728r2144b797, p10l8t817r235b886],
18	.	.	O	.	_	0	SENT_226	[p10l1864t728r2144b797, p10l8t817r235b886],

1	This	DT	O	this	nsubj	2	SENT_227	[p10l260t817r383b872],
2	is	VBZ	O	be	_	0	SENT_227	[p10l410t818r453b872],
3	why	WRB	O	why	advmod	7	SENT_227	[p10l479t817r613b886],
4	the	DT	O	the	det	6	SENT_227	[p10l636t817r731b872],
5	current	JJ	DATE	current	amod	6	SENT_227	[p10l758t825r978b872],
6	study	NN	O	study	nsubj	7	SENT_227	[p10l1004t817r1169b886],
7	assessed	VBN	O	assess	advcl	2	SENT_227	[p10l1193t817r1446b872],
8	c.	NN	O	c.	dobj	7	SENT_227	[p10l1473t820r1840b873],
9	.	.	O	.	_	0	SENT_227	[p10l1473t820r1840b873],

1	—	NN	O	—	_	0	SENT_228	[p10l1473t820r1840b873],
2	.	.	O	.	_	0	SENT_228	[p10l1473t820r1840b873],

1	1639G	NN	O	1639g	_	0	SENT_229	[p10l1473t820r1840b873],
2	>	JJR	O	>	amod	4	SENT_229	[p10l1473t820r1840b873],
3	A	DT	O	a	det	4	SENT_229	[p10l1473t820r1840b873],
4	polymorphism	NN	O	polymorphism	dep	1	SENT_229	[p10l1864t817r2144b886, p10l8t906r195b975],
5	of	IN	O	of	_	0	SENT_229	[p10l226t906r289b961],
6	the	DT	O	the	det	8	SENT_229	[p10l313t906r408b961],
7	VKORC1	NN	O	vkorc1	nn	8	SENT_229	[p10l439t909r682b961],
8	gene	NN	O	gene	prep_of	4	SENT_229	[p10l722t922r865b975],
9	and	CC	O	and	_	0	SENT_229	[p10l897t906r1007b961],
10	its	PRP$	O	its	poss	11	SENT_229	[p10l1040t907r1107b961],
11	inﬂuence	NN	O	inﬂuence	dep	1	SENT_229	[p10l1142t906r1417b961],
12	on	IN	O	on	_	0	SENT_229	[p10l1450t922r1525b961],
13	the	DT	O	the	det	15	SENT_229	[p10l1556t906r1652b961],
14	acenocoumarol	NN	O	acenocoumarol	nn	15	SENT_229	[p10l1685t906r2144b961],
15	dose	NN	O	dose	prep_on	11	SENT_229	[p10l8t996r158b1051],
16	.	.	O	.	_	0	SENT_229	[p10l8t996r158b1051],

1	The	DT	O	the	det	2	SENT_230	[p10l176t996r286b1051],
2	research	NN	O	research	_	0	SENT_230	[p10l306t996r559b1051],
3	on	IN	O	on	_	0	SENT_230	[p10l577t1012r651b1051],
4	the	DT	O	the	det	5	SENT_230	[p10l670t996r766b1051],
5	prevalence	NN	O	prevalence	prep_on	2	SENT_230	[p10l785t996r1110b1064],
6	of	IN	O	of	_	0	SENT_230	[p10l1130t996r1192b1051],
7	the	DT	O	the	det	8	SENT_230	[p10l1203t996r1299b1051],
8	c.	NN	O	c.	prep_of	2	SENT_230	[p10l1319t998r1685b1051],
9	.	.	O	.	_	0	SENT_230	[p10l1319t998r1685b1051],

1	—	NN	O	—	_	0	SENT_231	[p10l1319t998r1685b1051],
2	.	.	O	.	_	0	SENT_231	[p10l1319t998r1685b1051],

1	1639G	NN	O	1639g	nsubj	8	SENT_232	[p10l1319t998r1685b1051],
2	>	JJR	O	>	dep	1	SENT_232	[p10l1319t998r1685b1051],
3	A	DT	O	a	det	4	SENT_232	[p10l1319t998r1685b1051],
4	polymorphism	NN	O	polymorphism	dep	1	SENT_232	[p10l1702t996r2146b1064],
5	of	IN	O	of	_	0	SENT_232	[p10l8t1084r71b1140],
6	the	DT	O	the	det	7	SENT_232	[p10l85t1085r181b1140],
7	VKORC1	NN	O	vkorc1	prep_of	4	SENT_232	[p10l201t1087r445b1140],
8	showed	VBD	O	show	_	0	SENT_232	[p10l477t1084r710b1140],
9	a	DT	O	a	det	10	SENT_232	[p10l733t1100r764b1140],
10	difference	NN	O	difference	dobj	8	SENT_232	[p10l786t1084r1085b1140],
11	between	IN	O	between	_	0	SENT_232	[p10l1107t1085r1367b1140],
12	the	DT	O	the	det	14	SENT_232	[p10l1389t1085r1485b1140],
13	three	CD	NUMBER	three	num	14	SENT_232	[p10l1508t1085r1664b1140],
14	subgroups	NNS	O	subgroup	prep_between	10	SENT_232	[p10l1689t1085r2013b1153],
15	.	.	O	.	_	0	SENT_232	[p10l1689t1085r2013b1153],

1	The	DT	O	the	det	2	SENT_233	[p10l2034t1085r2144b1140],
2	carriers	NNS	O	carrier	_	0	SENT_233	[p10l8t1174r231b1228],
3	of	IN	O	of	_	0	SENT_233	[p10l258t1173r320b1228],
4	the	DT	O	the	det	6	SENT_233	[p10l338t1173r434b1228],
5	AA	NNP	O	AA	nn	6	SENT_233	[p10l457t1175r547b1227],
6	genotype	NN	O	genotype	prep_of	2	SENT_233	[p10l569t1181r848b1242],
7	of	IN	O	of	_	0	SENT_233	[p10l874t1173r938b1228],
8	c.	NN	O	c.	prep_of	2	SENT_233	[p10l955t1175r1322b1229],
9	.	.	O	.	_	0	SENT_233	[p10l955t1175r1322b1229],

1	—	NN	O	—	_	0	SENT_234	[p10l955t1175r1322b1229],
2	.	.	O	.	_	0	SENT_234	[p10l955t1175r1322b1229],

1	1639G	NN	O	1639g	nsubj	7	SENT_235	[p10l955t1175r1322b1229],
2	>	JJR	O	>	dep	1	SENT_235	[p10l955t1175r1322b1229],
3	A	DT	O	a	det	4	SENT_235	[p10l955t1175r1322b1229],
4	polymorphism	NN	O	polymorphism	dep	1	SENT_235	[p10l1346t1173r1789b1242],
5	of	IN	O	of	_	0	SENT_235	[p10l1814t1173r1877b1228],
6	VKORC1	NN	O	vkorc1	prep_of	4	SENT_235	[p10l1893t1176r2137b1228],
7	received	VBD	O	receive	_	0	SENT_235	[p10l8t1262r259b1317],
8	lower	JJR	O	lower	amod	9	SENT_235	[p10l283t1262r456b1317],
9	doses	NNS	O	dose	dobj	7	SENT_235	[p10l476t1262r641b1317],
10	of	IN	O	of	_	0	SENT_235	[p10l664t1262r727b1317],
11	acenocoumarol	NN	O	acenocoumarol	prep_of	9	SENT_235	[p10l741t1262r1214b1318],
12	.	.	O	.	_	0	SENT_235	[p10l741t1262r1214b1318],

1	This	DT	O	this	det	2	SENT_236	[p10l1235t1262r1358b1317],
2	genotype	NN	O	genotype	nsubj	3	SENT_236	[p10l1380t1270r1659b1331],
3	had	VBD	O	have	_	0	SENT_236	[p10l1682t1262r1791b1317],
4	the	DT	O	the	det	22	SENT_236	[p10l1813t1262r1909b1317],
5	greater	JJR	O	greater	amod	8	SENT_236	[p10l1930t1270r2146b1331],
6	impact	NN	O	impact	nn	8	SENT_236	[p10l8t1352r215b1420],
7	(	CD	NUMBER	(	num	8	SENT_236	[p10l251t1352r364b1420],
8	OR	NN	O	or	dep	22	SENT_236	[p10l251t1352r364b1420],
9	—	CD	NUMBER	—	number	10	SENT_236	[p10l396t1384r444b1390],
10	11.6	CD	NUMBER	11.6	num	11	SENT_236	[p10l483t1351r630b1420],
11	)	NN	O	)	dobj	8	SENT_236	[p10l483t1351r630b1420],
12	on	IN	O	on	_	0	SENT_236	[p10l667t1367r742b1406],
13	the	DT	O	the	det	14	SENT_236	[p10l774t1351r870b1406],
14	probability	NN	O	probability	prep_on	11	SENT_236	[p10l904t1351r1233b1420],
15	of	IN	O	of	_	0	SENT_236	[p10l1265t1351r1328b1406],
16	a	DT	O	a	det	17	SENT_236	[p10l1354t1367r1385b1406],
17	patient	NN	O	patient	prep_of	14	SENT_236	[p10l1418t1352r1631b1420],
18	receiving	VBG	O	receive	xcomp	8	SENT_236	[p10l1664t1352r1938b1420],
19	a	DT	O	a	det	21	SENT_236	[p10l1970t1367r2001b1406],
20	low	JJ	O	low	amod	21	SENT_236	[p10l2035t1351r2146b1406],
21	acenocoumarol	NN	O	acenocoumarol	dobj	18	SENT_236	[p10l8t1440r467b1495],
22	dose	NN	O	dose	dobj	3	SENT_236	[p10l496t1440r647b1496],
23	.	.	O	.	_	0	SENT_236	[p10l496t1440r647b1496],

1	Patients	NNS	O	patient	nsubj	10	SENT_237	[p10l676t1441r913b1495],
2	having	VBG	O	have	partmod	1	SENT_237	[p10l943t1440r1146b1509],
3	the	DT	O	the	det	5	SENT_237	[p10l1172t1440r1268b1495],
4	AA	NN	O	aa	nn	5	SENT_237	[p10l1294t1443r1384b1495],
5	genotype	NN	O	genotype	dobj	2	SENT_237	[p10l1408t1448r1688b1509],
6	were	VBD	O	be	cop	10	SENT_237	[p10l1715t1456r1866b1495],
7	95	CD	PERCENT	95	num	8	SENT_237	[p10l1894t1443r2009b1495],
8	%	NN	PERCENT	%	npadvmod	9	SENT_237	[p10l1894t1443r2009b1495],
9	less	RBR	O	less	advmod	10	SENT_237	[p10l2037t1440r2144b1495],
10	likely	JJ	O	likely	_	0	SENT_237	[p10l8t1530r170b1598],
11	to	TO	O	to	aux	12	SENT_237	[p10l195t1538r254b1585],
12	receive	VB	O	receive	xcomp	10	SENT_237	[p10l282t1531r494b1585],
13	a	DT	O	a	det	16	SENT_237	[p10l522t1546r553b1585],
14	higher	JJR	O	higher	amod	16	SENT_237	[p10l581t1530r775b1598],
15	acenocoumarol	NN	O	acenocoumarol	nn	16	SENT_237	[p10l800t1530r1260b1585],
16	dose	NN	O	dose	dobj	12	SENT_237	[p10l1288t1530r1425b1585],
17	than	IN	O	than	_	0	SENT_237	[p10l1452t1530r1588b1585],
18	28	CD	NUMBER	28	num	19	SENT_237	[p10l1615t1533r1685b1585],
19	mg/week	NN	O	mg/week	prep_than	12	SENT_237	[p10l1714t1530r2008b1598],
20	.	.	O	.	_	0	SENT_237	[p10l1714t1530r2008b1598],

1	The	DT	O	the	det	2	SENT_238	[p10l2034t1530r2144b1585],
2	presence	NN	O	presence	nsubj	7	SENT_238	[p10l8t1634r274b1687],
3	of	IN	O	of	_	0	SENT_238	[p10l305t1618r368b1674],
4	a	DT	O	a	det	6	SENT_238	[p10l391t1634r422b1674],
5	GA	NN	O	ga	nn	6	SENT_238	[p10l452t1621r540b1674],
6	genotype	NN	O	genotype	prep_of	2	SENT_238	[p10l568t1627r848b1687],
7	increased	VBN	O	increase	_	0	SENT_238	[p10l879t1619r1162b1674],
8	by	IN	O	by	_	0	SENT_238	[p10l1193t1619r1267b1687],
9	6	CD	NUMBER	6	num	10	SENT_238	[p10l1295t1621r1329b1674],
10	fold	NN	O	fold	prep_by	7	SENT_238	[p10l1361t1618r1473b1674],
11	the	DT	O	the	det	12	SENT_238	[p10l1504t1619r1600b1674],
12	probability	NN	O	probability	dobj	7	SENT_238	[p10l1630t1619r1959b1687],
13	of	IN	O	of	_	0	SENT_238	[p10l1988t1618r2051b1674],
14	an	DT	O	a	det	15	SENT_238	[p10l2073t1634r2145b1674],
15	individual	NN	O	individual	prep_of	12	SENT_238	[p10l8t1707r309b1762],
16	being	VBG	O	be	auxpass	17	SENT_238	[p10l346t1707r513b1776],
17	assigned	VBN	O	assign	partmod	15	SENT_238	[p10l548t1707r805b1776],
18	to	TO	O	to	_	0	SENT_238	[p10l843t1715r901b1762],
19	the	DT	O	the	det	20	SENT_238	[p10l938t1707r1034b1762],
20	subgroup	NN	O	subgroup	prep_to	17	SENT_238	[p10l1073t1707r1354b1776],
21	of	IN	O	of	_	0	SENT_238	[p10l1392t1707r1454b1762],
22	patients	NNS	O	patient	prep_of	20	SENT_238	[p10l1485t1708r1724b1776],
23	receiving	VBG	O	receive	partmod	22	SENT_238	[p10l1763t1708r2038b1776],
24	an	DT	O	a	det	26	SENT_238	[p10l2073t1723r2145b1762],
25	acenocoumarol	NN	O	acenocoumarol	nn	26	SENT_238	[p10l8t1796r467b1851],
26	dose	NN	O	dose	dobj	23	SENT_238	[p10l508t1796r646b1851],
27	lower	JJR	O	lower	advmod	23	SENT_238	[p10l686t1796r860b1851],
28	than	IN	O	than	_	0	SENT_238	[p10l897t1796r1034b1851],
29	7	CD	NUMBER	7	num	30	SENT_238	[p10l1074t1799r1106b1850],
30	mg/week	NN	O	mg/week	prep_than	23	SENT_238	[p10l1135t1796r1417b1865],
31	and	CC	O	and	_	0	SENT_238	[p10l1456t1796r1565b1851],
32	also	RB	O	also	advmod	33	SENT_238	[p10l1606t1796r1722b1851],
33	lowered	VBD	O	lower	conj_and	17	SENT_238	[p10l1763t1796r2007b1851],
34	the	DT	O	the	det	35	SENT_238	[p10l2048t1796r2144b1851],
35	probability	NN	O	probability	dobj	33	SENT_238	[p10l8t1885r337b1954],
36	to	TO	O	to	aux	38	SENT_238	[p10l363t1894r422b1940],
37	be	VB	O	be	auxpass	38	SENT_238	[p10l450t1885r520b1940],
38	assigned	VBN	O	assign	infmod	35	SENT_238	[p10l548t1885r805b1954],
39	to	TO	O	to	_	0	SENT_238	[p10l835t1893r892b1940],
40	the	DT	O	the	det	41	SENT_238	[p10l921t1885r1016b1940],
41	subgroup	NN	O	subgroup	prep_to	38	SENT_238	[p10l1047t1885r1328b1954],
42	of	IN	O	of	_	0	SENT_238	[p10l1357t1885r1420b1940],
43	patients	NNS	O	patient	prep_of	41	SENT_238	[p10l1441t1886r1680b1954],
44	receiving	VBG	O	receive	xcomp	38	SENT_238	[p10l1711t1886r1985b1954],
45	high	JJ	O	high	amod	47	SENT_238	[p10l2013t1885r2144b1954],
46	acenocoumarol	NN	O	acenocoumarol	nn	47	SENT_238	[p10l8t1974r467b2029],
47	doses	NNS	O	dose	dobj	44	SENT_238	[p10l487t1974r652b2029],
48	by	IN	O	by	_	0	SENT_238	[p10l671t1974r745b2043],
49	80	CD	PERCENT	80	num	50	SENT_238	[p10l762t1977r889b2030],
50	%	NN	PERCENT	%	prep_by	44	SENT_238	[p10l762t1977r889b2030],
51	.	.	O	.	_	0	SENT_238	[p10l762t1977r889b2030],

1	These	DT	O	these	det	2	SENT_239	[p10l906t1974r1081b2029],
2	results	NNS	O	result	nsubj	3	SENT_239	[p10l1100t1974r1297b2029],
3	conﬁrm	VBP	O	conﬁrm	_	0	SENT_239	[p10l1318t1974r1552b2029],
4	the	DT	O	the	det	5	SENT_239	[p10l1570t1974r1666b2029],
5	ﬁndings	NNS	O	ﬁndings	dobj	3	SENT_239	[p10l1686t1974r1926b2043],
6	of	IN	O	of	_	0	SENT_239	[p10l1946t1974r2009b2029],
7	previous	JJ	O	previous	amod	8	SENT_239	[p10l2021t1990r2144b2043, p10l6t2065r165b2119],
8	research	NN	O	research	prep_of	5	SENT_239	[p10l191t2064r445b2119],
9	on	IN	O	on	_	0	SENT_239	[p10l470t2080r544b2119],
10	the	DT	O	the	det	11	SENT_239	[p10l570t2064r665b2119],
11	variability	NN	O	variability	prep_on	8	SENT_239	[p10l689t2064r994b2132],
12	of	IN	O	of	_	0	SENT_239	[p10l1018t2064r1081b2119],
13	the	DT	O	the	det	14	SENT_239	[p10l1098t2064r1194b2119],
14	response	NN	O	response	prep_of	11	SENT_239	[p10l1220t2080r1487b2132],
15	to	TO	O	to	_	0	SENT_239	[p10l1513t2072r1570b2119],
16	oral	JJ	O	oral	amod	18	SENT_239	[p10l1597t2064r1710b2119],
17	anticoagulant	JJ	O	anticoagulant	amod	18	SENT_239	[p10l1736t2064r2146b2132],
18	treatment	NN	O	treatment	prep_to	3	SENT_239	[p10l7t2161r310b2208],
19	[	CD	NUMBER	[	number	20	SENT_239	[p10l330t2153r461b2221],
20	25	CD	NUMBER	25	num	21	SENT_239	[p10l330t2153r461b2221],
21	]	NN	O	]	dep	18	SENT_239	[p10l330t2153r461b2221],
22	.	.	O	.	_	0	SENT_239	[p10l330t2153r461b2221],

1	Bodin	NNP	PERSON	Bodin	nsubj	4	SENT_240	[p10l482t2153r654b2208],
2	et	FW	O	et	nn	3	SENT_240	[p10l674t2161r731b2208],
3	al.	FW	O	al.	dep	1	SENT_240	[p10l749t2153r813b2208],
4	argued	VBD	O	argue	_	0	SENT_240	[p10l834t2153r1040b2221],
5	that	IN	O	that	_	0	SENT_240	[p10l1060t2153r1181b2208],
6	the	DT	O	the	det	9	SENT_240	[p10l1198t2153r1295b2208],
7	VKORCT	NNP	O	VKORCT	nn	9	SENT_240	[p10l1312t2156r1556b2208],
8	genotype	NN	O	genotype	nn	9	SENT_240	[p10l1582t2161r1862b2221],
9	accounts	NNS	O	account	prep_that	4	SENT_240	[p10l1882t2161r2144b2208],
10	for	IN	O	for	_	0	SENT_240	[p10l8t2241r91b2296],
11	37	CD	PERCENT	37	num	12	SENT_240	[p10l110t2244r225b2296],
12	%	NN	PERCENT	%	prep_for	4	SENT_240	[p10l110t2244r225b2296],
13	of	IN	O	of	_	0	SENT_240	[p10l247t2241r310b2296],
14	this	DT	O	this	det	18	SENT_240	[p10l323t2241r431b2296],
15	variability	NN	O	variability	nn	18	SENT_240	[p10l452t2241r757b2310],
16	[	NN	O	[	nn	18	SENT_240	[p10l780t2241r871b2310],
17	8	CD	NUMBER	8	num	18	SENT_240	[p10l780t2241r871b2310],
18	]	NN	O	]	prep_of	12	SENT_240	[p10l780t2241r871b2310],
19	.	.	O	.	_	0	SENT_240	[p10l780t2241r871b2310],

1	The	DT	O	the	det	2	SENT_241	[p10l107t2330r219b2384],
2	results	NNS	O	result	nsubj	7	SENT_241	[p10l241t2330r443b2384],
3	of	IN	O	of	_	0	SENT_241	[p10l465t2330r529b2384],
4	this	DT	O	this	det	5	SENT_241	[p10l542t2330r653b2384],
5	research	NN	O	research	prep_of	2	SENT_241	[p10l675t2330r934b2384],
6	are	VBP	O	be	cop	7	SENT_241	[p10l955t2346r1048b2384],
7	consistent	JJ	O	consistent	_	0	SENT_241	[p10l1070t2331r1383b2384],
8	with	IN	O	with	_	0	SENT_241	[p10l1401t2330r1542b2384],
9	the	DT	O	the	det	10	SENT_241	[p10l1563t2330r1660b2384],
10	results	NNS	O	result	prep_with	7	SENT_241	[p10l1682t2330r1884b2384],
11	of	IN	O	of	_	0	SENT_241	[p10l1906t2330r1969b2384],
12	some	DT	O	some	prep_of	10	SENT_241	[p10l1984t2346r2144b2384],
13	of	IN	O	of	_	0	SENT_241	[p10l8t2418r72b2473],
14	the	DT	O	the	det	17	SENT_241	[p10l84t2418r181b2473],
15	latest	JJS	O	latest	amod	17	SENT_241	[p10l203t2418r368b2473],
16	relevant	JJ	O	relevant	amod	17	SENT_241	[p10l388t2418r641b2473],
17	literature	NN	O	literature	prep_of	12	SENT_241	[p10l660t2418r945b2473],
18	in	IN	O	in	_	0	SENT_241	[p10l966t2419r1022b2473],
19	the	DT	O	the	det	20	SENT_241	[p10l1043t2418r1140b2473],
20	ﬁeld	NN	O	ﬁeld	prep_in	17	SENT_241	[p10l1161t2418r1308b2474],
21	.	.	O	.	_	0	SENT_241	[p10l1161t2418r1308b2474],

1	Using	VBG	O	use	partmod	10	SENT_242	[p10l1329t2419r1502b2487],
2	a	DT	O	a	det	5	SENT_242	[p10l1522t2434r1553b2473],
3	complex	JJ	O	complex	amod	5	SENT_242	[p10l1573t2418r1836b2487],
4	statistical	JJ	O	statistical	amod	5	SENT_242	[p10l1856t2418r2144b2473],
5	analysis	NN	O	analysis	dobj	1	SENT_242	[p10l8t2507r264b2576],
6	,	,	O	,	_	0	SENT_242	[p10l8t2507r264b2576],
7	Skov	NNP	PERSON	Skov	nsubj	10	SENT_242	[p10l292t2507r437b2562],
8	et	FW	O	et	nn	9	SENT_242	[p10l463t2515r520b2562],
9	al.	FW	O	al.	dep	7	SENT_242	[p10l546t2507r611b2563],
10	showed	VBD	O	show	_	0	SENT_242	[p10l639t2507r876b2562],
11	that	IN	O	that	complm	22	SENT_242	[p10l903t2507r1027b2562],
12	the	DT	O	the	det	14	SENT_242	[p10l1052t2507r1148b2562],
13	major	JJ	O	major	amod	14	SENT_242	[p10l1177t2508r1357b2576],
14	determinants	NNS	O	determinant	nsubj	22	SENT_242	[p10l1382t2507r1793b2562],
15	of	IN	O	of	_	0	SENT_242	[p10l1821t2507r1885b2562],
16	the	DT	O	the	det	19	SENT_242	[p10l1904t2507r2001b2562],
17	oral	JJ	O	oral	amod	19	SENT_242	[p10l2029t2507r2144b2562],
18	anticoagulant	JJ	O	anticoagulant	amod	19	SENT_242	[p10l8t2597r427b2665],
19	dose	NN	O	dose	prep_of	14	SENT_242	[p10l459t2597r598b2652],
20	are	VBP	O	be	cop	22	SENT_242	[p10l633t2613r745b2652],
21	:	:	O	:	_	0	SENT_242	[p10l633t2613r745b2652],
22	VKORC1	NN	O	vkorc1	ccomp	10	SENT_242	[p10l781t2600r1029b2652],
23	and	CC	O	and	_	0	SENT_242	[p10l1071t2597r1182b2652],
24	CYP2C9	NN	O	cyp2c9	nn	26	SENT_242	[p10l1217t2600r1450b2652],
25	gene	NN	O	gene	nn	26	SENT_242	[p10l1484t2613r1629b2665],
26	polymorphisms	NNS	O	polymorphism	ccomp	10	SENT_242	[p10l1664t2597r2144b2665],
27	and	CC	O	and	_	0	SENT_242	[p10l8t2686r119b2741],
28	age	NN	O	age	ccomp	10	SENT_242	[p10l144t2701r246b2754],
29	[	CD	NUMBER	[	number	30	SENT_242	[p10l274t2685r407b2754],
30	26	CD	NUMBER	26	num	31	SENT_242	[p10l274t2685r407b2754],
31	]	NN	O	]	dep	28	SENT_242	[p10l274t2685r407b2754],
32	.	.	O	.	_	0	SENT_242	[p10l274t2685r407b2754],

1	This	DT	O	this	det	2	SENT_243	[p10l107t2774r233b2829],
2	study	NN	O	study	nsubj	7	SENT_243	[p10l255t2774r423b2843],
3	was	VBD	O	be	cop	7	SENT_243	[p10l440t2790r559b2829],
4	not	RB	O	not	neg	7	SENT_243	[p10l580t2782r681b2829],
5	a	DT	O	a	det	7	SENT_243	[p10l699t2790r731b2829],
6	randomized	JJ	O	randomized	amod	7	SENT_243	[p10l751t2774r1117b2829],
7	trial	NN	O	trial	_	0	SENT_243	[p10l1138t2774r1275b2830],
8	.	.	O	.	_	0	SENT_243	[p10l1138t2774r1275b2830],

1	The	DT	O	the	det	3	SENT_244	[p10l1293t2774r1405b2829],
2	genetic	JJ	O	genetic	amod	3	SENT_244	[p10l1425t2775r1648b2843],
3	analysis	NN	O	analysis	nsubj	6	SENT_244	[p10l1667t2774r1908b2843],
4	did	VBD	O	do	aux	6	SENT_244	[p10l1929t2774r2024b2829],
5	not	RB	O	not	neg	6	SENT_244	[p10l2045t2782r2146b2829],
6	account	VB	O	account	_	0	SENT_244	[p10l8t2871r248b2918],
7	for	IN	O	for	_	0	SENT_244	[p10l271t2863r355b2918],
8	mutations	NNS	O	mutation	prep_for	6	SENT_244	[p10l378t2864r689b2918],
9	which	WDT	O	which	nsubj	10	SENT_244	[p10l712t2863r901b2918],
10	generate	VBP	O	generate	rcmod	8	SENT_244	[p10l924t2871r1191b2932],
11	resistance	NN	O	resistance	dobj	10	SENT_244	[p10l1216t2864r1521b2918],
12	to	TO	O	to	_	0	SENT_244	[p10l1545t2871r1604b2918],
13	acenocoumarol	NN	O	acenocoumarol	prep_to	10	SENT_244	[p10l1629t2863r2112b2919],
14	.	.	O	.	_	0	SENT_244	[p10l1629t2863r2112b2919],

1	Conclusion	NN	O	conclusion	_	0	SENT_245	[p10l8t2964r366b3018],

1	Our	PRP$	O	we	poss	2	SENT_246	[p10l111t3144r228b3196],
2	study	NN	O	study	nsubj	3	SENT_246	[p10l266t3141r441b3210],
3	demonstrated	VBD	O	demonstrate	_	0	SENT_246	[p10l479t3141r926b3196],
4	that	IN	O	that	complm	25	SENT_246	[p10l966t3141r1094b3196],
5	the	DT	O	the	det	8	SENT_246	[p10l1131t3141r1231b3196],
6	stable	JJ	O	stable	amod	8	SENT_246	[p10l1272t3141r1457b3196],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_246	[p10l1497t3141r1867b3210],
8	dose	NN	O	dose	nsubj	25	SENT_246	[p10l1905t3141r2049b3196],
9	of	IN	O	of	_	0	SENT_246	[p10l2088t3141r2154b3196],
10	acenocoumarol	NN	O	acenocoumarol	prep_of	8	SENT_246	[p10l9t3230r498b3285],
11	is	VBZ	O	be	cop	25	SENT_246	[p10l529t3231r574b3285],
12	dependent	JJ	O	dependent	amod	25	SENT_246	[p10l604t3230r948b3299],
13	of	IN	O	of	_	0	SENT_246	[p10l975t3230r1040b3285],
14	patient	NN	O	patient	poss	16	SENT_246	[p10l1062t3231r1336b3299],
15	's	POS	O	's	_	0	SENT_246	[p10l1062t3231r1336b3299],
16	age	NN	O	age	prep_of	12	SENT_246	[p10l1365t3246r1487b3299],
17	,	,	O	,	_	0	SENT_246	[p10l1365t3246r1487b3299],
18	the	DT	O	the	det	19	SENT_246	[p10l1517t3230r1617b3285],
19	presence	NN	O	presence	appos	16	SENT_246	[p10l1647t3246r1930b3299],
20	of	IN	O	of	_	0	SENT_246	[p10l1959t3230r2025b3285],
21	the	DT	O	the	det	23	SENT_246	[p10l2045t3230r2146b3285],
22	CYP2C9	NN	O	cyp2c9	nn	23	SENT_246	[p10l9t3319r318b3375],
23	*	NN	O	*	prep_of	19	SENT_246	[p10l9t3319r318b3375],
24	3	CD	NUMBER	3	tmod	12	SENT_246	[p10l9t3319r318b3375],
25	allele	NN	O	allele	ccomp	3	SENT_246	[p10l379t3320r548b3375],
26	and	CC	O	and	_	0	SENT_246	[p10l606t3320r720b3375],
27	c.	NN	O	c.	ccomp	3	SENT_246	[p10l779t3322r1168b3375],
28	.	.	O	.	_	0	SENT_246	[p10l779t3322r1168b3375],

1	—	NN	O	—	_	0	SENT_247	[p10l779t3322r1168b3375],
2	.	.	O	.	_	0	SENT_247	[p10l779t3322r1168b3375],

1	1639G	NN	O	1639g	_	0	SENT_248	[p10l779t3322r1168b3375],
2	>	JJR	O	>	amod	4	SENT_248	[p10l779t3322r1168b3375],
3	A	DT	O	a	det	4	SENT_248	[p10l779t3322r1168b3375],
4	polymorphism	NN	O	polymorphism	dep	1	SENT_248	[p10l1224t3320r1695b3388],
5	of	IN	O	of	_	0	SENT_248	[p10l1752t3319r1817b3375],
6	VKORC1	NN	O	vkorc1	prep_of	4	SENT_248	[p10l1865t3322r2145b3375],
7	.	.	O	.	_	0	SENT_248	[p10l1865t3322r2145b3375],

1	Acenocoumarol	NNP	O	Acenocoumarol	nn	2	SENT_249	[p10l6t3409r478b3464],
2	dose	NN	O	dose	nsubjpass	5	SENT_249	[p10l506t3409r644b3464],
3	was	VBD	O	be	auxpass	5	SENT_249	[p10l670t3424r788b3464],
4	not	RB	O	not	neg	5	SENT_249	[p10l817t3417r916b3464],
5	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_249	[p10l943t3408r1258b3464],
6	by	IN	O	by	_	0	SENT_249	[p10l1286t3409r1359b3477],
7	the	DT	O	the	det	9	SENT_249	[p10l1385t3409r1481b3464],
8	other	JJ	O	other	amod	9	SENT_249	[p10l1509t3409r1670b3464],
9	medication	NN	O	medication	agent	5	SENT_249	[p10l1697t3409r2033b3464],
10	received	VBN	O	receive	partmod	9	SENT_249	[p10l2061t3424r2145b3464, p10l9t3497r200b3552],
11	by	IN	O	by	_	0	SENT_249	[p10l221t3497r295b3566],
12	patients	NNS	O	patient	agent	10	SENT_249	[p10l314t3498r554b3566],
13	or	CC	O	or	_	0	SENT_249	[p10l576t3513r640b3552],
14	the	DT	O	the	det	15	SENT_249	[p10l658t3497r754b3552],
15	presence	NN	O	presence	agent	10	SENT_249	[p10l776t3513r1042b3566],
16	of	IN	O	of	_	0	SENT_249	[p10l1064t3497r1128b3552],
17	the	DT	O	the	det	21	SENT_249	[p10l1140t3497r1236b3552],
18	CYP2C9	NN	O	cyp2c9	nn	21	SENT_249	[p10l1258t3497r1552b3552],
19	*	NN	O	*	nn	21	SENT_249	[p10l1258t3497r1552b3552],
20	2	CD	NUMBER	2	num	21	SENT_249	[p10l1258t3497r1552b3552],
21	allele	NN	O	allele	prep_of	15	SENT_249	[p10l1575t3497r1745b3553],
22	.	.	O	.	_	0	SENT_249	[p10l1575t3497r1745b3553],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_250	[p10l6t3720r609b3788],

1	This	DT	O	this	det	2	SENT_251	[p11l108t94r239b149],
2	study	NN	O	study	nsubjpass	4	SENT_251	[p11l292t94r467b163],
3	was	VBD	O	be	auxpass	4	SENT_251	[p11l515t110r637b149],
4	supported	VBN	O	support	_	0	SENT_251	[p11l690t94r1014b163],
5	by	IN	O	by	_	0	SENT_251	[p11l1066t94r1142b163],
6	research	NN	O	research	nn	7	SENT_251	[p11l1192t94r1461b149],
7	grant	NN	O	grant	agent	4	SENT_251	[p11l1511t102r1681b163],
8	42-127/2008	CD	NUMBER	42-127/2008	number	9	SENT_251	[p11l1729t97r2144b158],
9	“	CD	NUMBER	“	dep	7	SENT_251	[p11l10t183r461b247],
10	Trombo	NNP	O	Trombo	dep	9	SENT_251	[p11l10t183r461b247],
11	.	.	O	.	_	0	SENT_251	[p11l10t183r461b247],

1	—	NN	O	—	_	0	SENT_252	[p11l10t183r461b247],
2	.	.	O	.	_	0	SENT_252	[p11l10t183r461b247],

1	Gen	NN	O	gen	nn	2	SENT_253	[p11l10t183r461b247],
2	”	NN	O	”	_	0	SENT_253	[p11l10t183r461b247],
3	,	,	O	,	_	0	SENT_253	[p11l10t183r461b247],
4	from	IN	O	from	dep	2	SENT_253	[p11l494t183r637b238],
5	the	DT	O	the	det	7	SENT_253	[p11l667t183r762b238],
6	National	NNP	ORGANIZATION	National	nn	7	SENT_253	[p11l795t183r1047b238],
7	Center	NNP	ORGANIZATION	Center	pobj	4	SENT_253	[p11l1078t186r1275b238],
8	for	IN	ORGANIZATION	for	_	0	SENT_253	[p11l1305t183r1389b238],
9	Programs	NNP	ORGANIZATION	Programs	nn	10	SENT_253	[p11l1418t186r1702b252],
10	Management	NNP	ORGANIZATION	Management	prep_for	7	SENT_253	[p11l1734t186r2144b252],
11	,	,	O	,	_	0	SENT_253	[p11l1734t186r2144b252],
12	Romanian	NNP	ORGANIZATION	Romanian	nn	13	SENT_253	[p11l9t273r313b327],
13	Ministry	NNP	ORGANIZATION	Ministry	appos	10	SENT_253	[p11l334t273r589b341],
14	of	IN	ORGANIZATION	of	_	0	SENT_253	[p11l608t272r671b327],
15	Education	NNP	ORGANIZATION	Education	prep_of	13	SENT_253	[p11l685t272r983b327],
16	and	CC	ORGANIZATION	and	_	0	SENT_253	[p11l1005t272r1114b327],
17	Research	NNP	ORGANIZATION	Research	conj_and	15	SENT_253	[p11l1137t272r1417b328],
18	.	.	O	.	_	0	SENT_253	[p11l1137t272r1417b328],

1	Contributors	NNS	O	contributor	nsubj	9	SENT_254	[p11l111t361r496b416],
2	Anca	NNP	PERSON	Anca	nn	4	SENT_254	[p11l108t452r259b505],
3	D.	NNP	PERSON	D.	nn	4	SENT_254	[p11l291t453r349b505],
4	Buzoianu	NNP	PERSON	Buzoianu	dep	1	SENT_254	[p11l383t451r666b505],
5	designed	VBD	O	design	_	0	SENT_254	[p11l698t450r971b518],
6	the	DT	O	the	det	7	SENT_254	[p11l1004t450r1100b505],
7	research	NN	O	research	dobj	5	SENT_254	[p11l1134t450r1406b513],
8	,	,	O	,	_	0	SENT_254	[p11l1134t450r1406b513],
9	analyzed	VBD	O	analyze	conj_and	5	SENT_254	[p11l1439t450r1710b518],
10	the	DT	O	the	det	11	SENT_254	[p11l1742t450r1839b505],
11	data	NNS	O	datum	dobj	9	SENT_254	[p11l1872t450r2003b505],
12	and	CC	O	and	_	0	SENT_254	[p11l2033t450r2145b505],
13	revised	VBD	O	revise	conj_and	5	SENT_254	[p11l9t539r224b594],
14	the	DT	O	the	det	15	SENT_254	[p11l254t539r350b594],
15	manuscript	NN	O	manuscript	dobj	13	SENT_254	[p11l380t539r738b607],
16	;	:	O	;	_	0	SENT_254	[p11l380t539r738b607],
17	Florentina	NNP	PERSON	Florentina	nn	19	SENT_254	[p11l773t539r1078b594],
18	C.	NNP	PERSON	C.	nn	19	SENT_254	[p11l1107t541r1157b594],
19	Militaru	NNP	PERSON	Militaru	nsubj	24	SENT_254	[p11l1188t539r1428b594],
20	analyzed	VBD	O	analyze	parataxis	5	SENT_254	[p11l1457t539r1722b607],
21	the	DT	O	the	det	22	SENT_254	[p11l1753t539r1848b594],
22	data	NNS	O	datum	dobj	20	SENT_254	[p11l1878t539r2006b594],
23	and	CC	O	and	_	0	SENT_254	[p11l2035t539r2145b594],
24	wrote	VBD	O	write	conj_and	20	SENT_254	[p11l7t635r185b682],
25	the	DT	O	the	det	26	SENT_254	[p11l212t627r308b682],
26	manuscript	NN	O	manuscript	dobj	24	SENT_254	[p11l335t628r693b696],
27	;	:	O	;	_	0	SENT_254	[p11l335t628r693b696],
28	Stefan	NNP	PERSON	Stefan	nn	30	SENT_254	[p11l725t627r910b697],
29	C.	NNP	PERSON	C.	nn	30	SENT_254	[p11l937t630r987b683],
30	Vesa	NNP	PERSON	Vesa	nsubj	35	SENT_254	[p11l1012t630r1153b682],
31	collected	VBD	O	collect	parataxis	5	SENT_254	[p11l1180t627r1445b682],
32	the	DT	O	the	det	33	SENT_254	[p11l1472t627r1568b682],
33	samples	NNS	O	sample	dobj	31	SENT_254	[p11l1596t627r1852b696],
34	,	,	O	,	_	0	SENT_254	[p11l1596t627r1852b696],
35	analyzed	VBD	O	analyze	parataxis	5	SENT_254	[p11l1880t627r2145b696],
36	the	DT	O	the	det	37	SENT_254	[p11l8t716r104b771],
37	data	NNS	O	datum	dobj	35	SENT_254	[p11l125t716r253b771],
38	and	CC	O	and	_	0	SENT_254	[p11l273t716r382b771],
39	wrote	VBD	O	write	parataxis	5	SENT_254	[p11l402t724r580b771],
40	the	DT	O	the	det	41	SENT_254	[p11l600t716r696b771],
41	manuscript	NN	O	manuscript	dobj	39	SENT_254	[p11l717t717r1075b785],
42	;	:	O	;	_	0	SENT_254	[p11l717t717r1075b785],
43	Adrian	NNP	PERSON	Adrian	nn	44	SENT_254	[p11l1098t716r1301b771],
44	Trifa	NNP	PERSON	Trifa	nsubj	54	SENT_254	[p11l1318t716r1455b771],
45	performed	VBD	O	perform	parataxis	5	SENT_254	[p11l1476t716r1793b785],
46	the	DT	O	the	det	48	SENT_254	[p11l1813t716r1909b771],
47	genetic	JJ	O	genetic	amod	48	SENT_254	[p11l1929t717r2146b785],
48	analyses	NNS	O	analysis	dobj	45	SENT_254	[p11l9t805r274b874],
49	,	,	O	,	_	0	SENT_254	[p11l9t805r274b874],
50	analyzed	VBD	O	analyze	parataxis	5	SENT_254	[p11l308t805r574b874],
51	the	DT	O	the	det	52	SENT_254	[p11l607t805r703b860],
52	data	NNS	O	datum	dobj	50	SENT_254	[p11l736t805r864b860],
53	and	CC	O	and	_	0	SENT_254	[p11l896t805r1005b860],
54	wrote	VBD	O	write	parataxis	5	SENT_254	[p11l1038t814r1216b860],
55	the	DT	O	the	det	56	SENT_254	[p11l1248t805r1344b860],
56	manuscript	NN	O	manuscript	dobj	54	SENT_254	[p11l1378t806r1735b874],
57	;	:	O	;	_	0	SENT_254	[p11l1378t806r1735b874],
58	Sorin	NNP	PERSON	Sorin	nn	59	SENT_254	[p11l1773t806r1928b860],
59	Crisan	NNP	PERSON	Crisan	nsubj	60	SENT_254	[p11l1961t806r2146b876],
60	collected	VBD	O	collect	parataxis	5	SENT_254	[p11l9t894r274b949],
61	the	DT	O	the	det	62	SENT_254	[p11l297t894r392b949],
62	samples	NNS	O	sample	dobj	60	SENT_254	[p11l415t894r656b963],
63	and	CC	O	and	_	0	SENT_254	[p11l678t894r788b949],
64	analyzed	VBD	O	analyze	parataxis	5	SENT_254	[p11l810t894r1075b963],
65	the	DT	O	the	det	66	SENT_254	[p11l1097t894r1193b949],
66	data	NNS	O	datum	dobj	64	SENT_254	[p11l1215t894r1357b950],
67	.	.	O	.	_	0	SENT_254	[p11l1215t894r1357b950],

1	Conﬂict	NN	O	conﬂict	nsubj	6	SENT_255	[p11l111t984r346b1038],
2	of	IN	O	of	_	0	SENT_255	[p11l369t984r432b1038],
3	interest	NN	O	interest	prep_of	1	SENT_255	[p11l449t985r685b1038],
4	The	DT	O	the	det	5	SENT_255	[p11l108t1072r220b1126],
5	authors	NNS	O	author	dep	3	SENT_255	[p11l245t1072r476b1126],
6	conﬁrm	VBP	O	conﬁrm	_	0	SENT_255	[p11l501t1071r740b1126],
7	that	IN	O	that	complm	9	SENT_255	[p11l763t1072r886b1126],
8	there	EX	O	there	expl	9	SENT_255	[p11l909t1072r1069b1126],
9	are	VBP	O	be	ccomp	6	SENT_255	[p11l1093t1087r1186b1126],
10	no	DT	O	no	det	11	SENT_255	[p11l1211t1087r1285b1126],
11	conﬂicts	NNS	O	conﬂicts	nsubj	9	SENT_255	[p11l1311t1071r1564b1126],
12	of	IN	O	of	_	0	SENT_255	[p11l1589t1071r1653b1126],
13	interest	NN	O	interest	prep_of	11	SENT_255	[p11l1670t1072r1918b1126],
14	.	.	O	.	_	0	SENT_255	[p11l1670t1072r1918b1126],

1	Disclosure	NN	O	disclosure	nsubj	5	SENT_256	[p11l111t1159r426b1213],
2	All	DT	O	all	det	3	SENT_256	[p11l108t1247r190b1301],
3	authors	NNS	O	author	dep	1	SENT_256	[p11l215t1247r446b1302],
4	have	VBP	O	have	aux	5	SENT_256	[p11l472t1247r615b1302],
5	approved	VBN	O	approve	_	0	SENT_256	[p11l639t1247r928b1316],
6	the	DT	O	the	det	8	SENT_256	[p11l952t1247r1049b1302],
7	ﬁnal	JJ	O	ﬁnal	amod	8	SENT_256	[p11l1074t1247r1206b1302],
8	form	NN	O	form	dobj	5	SENT_256	[p11l1232t1247r1378b1302],
9	of	IN	O	of	_	0	SENT_256	[p11l1402t1247r1465b1302],
10	this	DT	O	this	det	11	SENT_256	[p11l1481t1247r1592b1302],
11	article	NN	O	article	prep_of	8	SENT_256	[p11l1617t1247r1822b1303],
12	.	.	O	.	_	0	SENT_256	[p11l1617t1247r1822b1303],

1	References	NNS	O	reference	_	0	SENT_257	[p11l8t1470r357b1524],

1	[	NN	O	[	nn	5	SENT_258	[p11l42t1675r103b1729],
2	1	CD	NUMBER	1	num	5	SENT_258	[p11l42t1675r103b1729],
3	]	CD	NUMBER	]	num	5	SENT_258	[p11l42t1675r103b1729],
4	D.	NNP	PERSON	D.	nn	5	SENT_258	[p11l144t1678r190b1719],
5	Tomalil	NNP	PERSON	Tomalil	_	0	SENT_258	[p11l212t1675r629b1725],
6	<	JJR	O	<	dep	5	SENT_258	[p11l212t1675r629b1725],
7	.	.	O	.	_	0	SENT_258	[p11l212t1675r629b1725],

1	—	NN	O	—	_	0	SENT_259	[p11l212t1675r629b1725],
2	.	.	O	.	_	0	SENT_259	[p11l212t1675r629b1725],

1	Scharte	NNP	O	Scharte	_	0	SENT_260	[p11l212t1675r629b1725],
2	,	,	O	,	_	0	SENT_260	[p11l212t1675r629b1725],
3	A.	NNP	PERSON	A.	nn	4	SENT_260	[p11l652t1677r698b1719],
4	Lazar	NNP	PERSON	Lazar	appos	1	SENT_260	[p11l722t1678r861b1725],
5	,	,	O	,	_	0	SENT_260	[p11l722t1678r861b1725],
6	U.	NNP	PERSON	U.	nn	7	SENT_260	[p11l885t1678r932b1719],
7	Fuhr	NNP	PERSON	Fuhr	appos	1	SENT_260	[p11l957t1675r1079b1725],
8	,	,	O	,	_	0	SENT_260	[p11l957t1675r1079b1725],
9	J.	NNP	PERSON	J.	nn	10	SENT_260	[p11l1097t1678r1128b1729],
10	Kirchheiner	NNP	PERSON	Kirchheiner	appos	1	SENT_260	[p11l1153t1675r1453b1725],
11	,	,	O	,	_	0	SENT_260	[p11l1153t1675r1453b1725],
12	The	DT	O	the	det	14	SENT_260	[p11l1475t1675r1565b1719],
13	clinical	JJ	O	clinical	amod	14	SENT_260	[p11l1589t1675r1760b1719],
14	role	NN	O	role	appos	1	SENT_260	[p11l1784t1675r1877b1719],
15	of	IN	O	of	_	0	SENT_260	[p11l1901t1675r1952b1719],
16	genetic	JJ	O	genetic	amod	17	SENT_260	[p11l1968t1676r2146b1729],
17	polymorphisms	NNS	O	polymorphism	prep_of	14	SENT_260	[p11l143t1741r539b1795],
18	in	IN	O	in	_	0	SENT_260	[p11l558t1741r605b1784],
19	drug-metabolizing	JJ	O	drug-metabolizing	amod	20	SENT_260	[p11l624t1741r1097b1795],
20	enzymes	NNS	O	enzyme	prep_in	17	SENT_260	[p11l1115t1753r1349b1795],
21	,	,	O	,	_	0	SENT_260	[p11l1115t1753r1349b1795],
22	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	23	SENT_260	[p11l1369t1741r1860b1795],
23	J.	NNP	O	J.	appos	1	SENT_260	[p11l1874t1743r1906b1795],
24	8	CD	NUMBER	8	number	25	SENT_260	[p11l1926t1743r1952b1784],
25	(	CD	NUMBER	(	dep	23	SENT_260	[p11l1975t1741r2142b1795],
26	2008	CD	DATE	2008	dep	1	SENT_260	[p11l1975t1741r2142b1795],
27	)	CD	NUMBER	)	num	28	SENT_260	[p11l1975t1741r2142b1795],
28	4-15	CD	NUMBER	4-15	dep	26	SENT_260	[p11l142t1810r280b1852],
29	.	.	O	.	_	0	SENT_260	[p11l142t1810r280b1852],

1	[	NN	O	[	nn	6	SENT_261	[p11l42t1873r103b1928],
2	2	CD	NUMBER	2	num	6	SENT_261	[p11l42t1873r103b1928],
3	]	CD	NUMBER	]	num	6	SENT_261	[p11l42t1873r103b1928],
4	F.J.	NNP	PERSON	F.J.	nn	6	SENT_261	[p11l144t1876r206b1928],
5	Penning-van	NNP	PERSON	Penning-van	nn	6	SENT_261	[p11l221t1874r525b1928],
6	Beest	NNP	PERSON	Beest	_	0	SENT_261	[p11l539t1876r676b1924],
7	,	,	O	,	_	0	SENT_261	[p11l539t1876r676b1924],
8	E.	NNP	PERSON	E.	nn	10	SENT_261	[p11l691t1876r730b1917],
9	van	NNP	PERSON	van	nn	10	SENT_261	[p11l742t1886r829b1917],
10	Meegen	NNP	PERSON	Meegen	conj_and	6	SENT_261	[p11l844t1876r1045b1928],
11	,	,	O	,	_	0	SENT_261	[p11l844t1876r1045b1928],
12	F.R.	NNP	PERSON	F.R.	nn	13	SENT_261	[p11l1060t1876r1139b1917],
13	Rosendaal	NNP	PERSON	Rosendaal	conj_and	6	SENT_261	[p11l1154t1873r1408b1924],
14	,	,	O	,	_	0	SENT_261	[p11l1154t1873r1408b1924],
15	B.H.	NNP	PERSON	B.H.	nn	16	SENT_261	[p11l1423t1876r1514b1917],
16	Stricker	NNP	PERSON	Stricker	conj_and	6	SENT_261	[p11l1529t1873r1723b1924],
17	,	,	O	,	_	0	SENT_261	[p11l1529t1873r1723b1924],
18	Characteristics	NNS	O	characteristic	conj_and	6	SENT_261	[p11l1738t1873r2088b1917],
19	of	IN	O	of	_	0	SENT_261	[p11l2102t1873r2153b1917],
20	anticoagulant	JJ	O	anticoagulant	amod	21	SENT_261	[p11l143t1940r471b1994],
21	therapy	NN	O	therapy	prep_of	18	SENT_261	[p11l498t1940r685b1994],
22	and	CC	O	and	_	0	SENT_261	[p11l713t1940r801b1983],
23	comorbidity	NN	O	comorbidity	conj_and	6	SENT_261	[p11l831t1940r1125b1994],
24	related	JJ	O	related	amod	6	SENT_261	[p11l1153t1940r1319b1983],
25	to	TO	O	to	_	0	SENT_261	[p11l1349t1946r1395b1983],
26	overanticoagulation	NN	O	overanticoagulation	prep_to	24	SENT_261	[p11l1425t1940r1915b1994],
27	,	,	O	,	_	0	SENT_261	[p11l1425t1940r1915b1994],
28	Thromb	NNP	O	Thromb	appos	26	SENT_261	[p11l1943t1940r2146b1984],
29	.	.	O	.	_	0	SENT_261	[p11l1943t1940r2146b1984],

1	Haemost	NNP	O	Haemost	_	0	SENT_262	[p11l144t2009r367b2050],
2	.	.	O	.	_	0	SENT_262	[p11l144t2009r367b2050],

1	86	CD	NUMBER	86	_	0	SENT_263	[p11l385t2008r443b2050],
2	(	CD	NUMBER	(	num	3	SENT_263	[p11l463t2006r623b2060],
3	2001	CD	DATE	2001	dep	1	SENT_263	[p11l463t2006r623b2060],
4	)	CD	NUMBER	)	num	5	SENT_263	[p11l463t2006r623b2060],
5	569-574	CD	NUMBER	569-574	dep	3	SENT_263	[p11l644t2008r865b2050],
6	.	.	O	.	_	0	SENT_263	[p11l644t2008r865b2050],

1	[	NN	O	[	_	0	SENT_264	[p11l42t2072r103b2126],
2	3	CD	NUMBER	3	num	4	SENT_264	[p11l42t2072r103b2126],
3	]	NN	O	]	nn	4	SENT_264	[p11l42t2072r103b2126],
4	LE	NN	O	le	dep	1	SENT_264	[p11l144t2075r216b2116],
5	.	.	O	.	_	0	SENT_264	[p11l144t2075r216b2116],

1	Visser	NNP	PERSON	Visser	_	0	SENT_265	[p11l230t2072r379b2122],
2	,	,	O	,	_	0	SENT_265	[p11l230t2072r379b2122],
3	F.J.	NNP	PERSON	F.J.	nn	7	SENT_265	[p11l395t2075r454b2126],
4	Penning	NNP	PERSON	Penning	nn	7	SENT_265	[p11l469t2073r764b2126],
5	—	NNP	PERSON	—	nn	7	SENT_265	[p11l469t2073r764b2126],
6	van	NNP	PERSON	van	nn	7	SENT_265	[p11l469t2073r764b2126],
7	Beest	NNP	PERSON	Beest	appos	1	SENT_265	[p11l778t2075r911b2122],
8	,	,	O	,	_	0	SENT_265	[p11l778t2075r911b2122],
9	A.A.	NNP	PERSON	A.A.	nn	10	SENT_265	[p11l923t2074r1012b2116],
10	Kasbegen	NNP	PERSON	Kasbegen	appos	1	SENT_265	[p11l1028t2072r1259b2126],
11	,	,	O	,	_	0	SENT_265	[p11l1028t2072r1259b2126],
12	P.A.	NNP	LOCATION	P.A.	nn	14	SENT_265	[p11l1275t2074r1356b2116],
13	De	NNP	LOCATION	De	nn	14	SENT_265	[p11l1372t2075r1433b2115],
14	Smet	NNP	LOCATION	Smet	appos	1	SENT_265	[p11l1448t2074r1575b2122],
15	,	,	O	,	_	0	SENT_265	[p11l1448t2074r1575b2122],
16	A.G.	NNP	PERSON	A.G.	nn	17	SENT_265	[p11l1588t2074r1679b2116],
17	Vulto	NNP	PERSON	Vulto	appos	1	SENT_265	[p11l1692t2072r1829b2122],
18	,	,	O	,	_	0	SENT_265	[p11l1692t2072r1829b2122],
19	A.	NNP	PERSON	A.	nn	21	SENT_265	[p11l1842t2074r1887b2116],
20	Hofman	NNP	PERSON	Hofman	nn	21	SENT_265	[p11l1902t2072r2088b2115],
21	A	NNP	O	A	appos	1	SENT_265	[p11l2101t2074r2145b2122],
22	,	,	O	,	_	0	SENT_265	[p11l2101t2074r2145b2122],
23	et	FW	O	et	nn	24	SENT_265	[p11l143t2144r188b2181],
24	al.	FW	O	al.	appos	1	SENT_265	[p11l203t2138r262b2188],
25	,	,	O	,	_	0	SENT_265	[p11l203t2138r262b2188],
26	Overanticoagulation	NN	O	overanticoagulation	appos	1	SENT_265	[p11l281t2138r768b2192],
27	associated	VBN	O	associate	partmod	1	SENT_265	[p11l785t2138r1031b2181],
28	with	IN	O	with	_	0	SENT_265	[p11l1047t2138r1158b2181],
29	combined	VBN	O	combine	amod	30	SENT_265	[p11l1176t2138r1413b2181],
30	use	NN	O	use	prep_with	27	SENT_265	[p11l1431t2150r1511b2181],
31	of	IN	O	of	_	0	SENT_265	[p11l1529t2138r1579b2181],
32	antibacterial	JJ	O	antibacterial	amod	33	SENT_265	[p11l1590t2138r1888b2181],
33	drugs	NNS	O	drug	prep_of	30	SENT_265	[p11l1906t2138r2040b2192],
34	and	CC	O	and	_	0	SENT_265	[p11l2058t2138r2145b2181],
35	acenocoumarol	NN	O	acenocoumarol	nn	38	SENT_265	[p11l143t2204r540b2247],
36	or	CC	O	or	_	0	SENT_265	[p11l575t2216r628b2247],
37	phenprocoumon	NN	O	phenprocoumon	nn	38	SENT_265	[p11l662t2204r1092b2258],
38	anticoagulants	NNS	O	anticoagulant	conj_and	30	SENT_265	[p11l1127t2204r1522b2258],
39	,	,	O	,	_	0	SENT_265	[p11l1127t2204r1522b2258],
40	Thromb	NNP	O	Thromb	appos	38	SENT_265	[p11l1555t2204r1772b2248],
41	.	.	O	.	_	0	SENT_265	[p11l1555t2204r1772b2248],

1	Haemost	NNP	O	Haemost	_	0	SENT_266	[p11l1809t2206r2050b2248],
2	.	.	O	.	_	0	SENT_266	[p11l1809t2206r2050b2248],

1	88	CD	NUMBER	88	_	0	SENT_267	[p11l2085t2206r2144b2247],
2	(	CD	NUMBER	(	num	3	SENT_267	[p11l146t2270r318b2324],
3	2002	CD	DATE	2002	dep	1	SENT_267	[p11l146t2270r318b2324],
4	)	CD	NUMBER	)	num	5	SENT_267	[p11l146t2270r318b2324],
5	705-710	CD	NUMBER	705-710	dep	3	SENT_267	[p11l342t2272r579b2314],
6	.	.	O	.	_	0	SENT_267	[p11l342t2272r579b2314],

1	[	NN	O	[	_	0	SENT_268	[p11l42t2336r103b2391],
2	4	CD	NUMBER	4	num	5	SENT_268	[p11l42t2336r103b2391],
3	]	CD	NUMBER	]	num	5	SENT_268	[p11l42t2336r103b2391],
4	Y.	NNP	PERSON	Y.	nn	5	SENT_268	[p11l141t2339r185b2380],
5	Tong	NNP	PERSON	Tong	dep	1	SENT_268	[p11l203t2339r337b2391],
6	,	,	O	,	_	0	SENT_268	[p11l203t2339r337b2391],
7	M.	NNP	PERSON	M.	nn	8	SENT_268	[p11l357t2339r416b2380],
8	Toshiyuki	NNP	PERSON	Toshiyuki	dep	1	SENT_268	[p11l434t2336r685b2391],
9	,	,	O	,	_	0	SENT_268	[p11l434t2336r685b2391],
10	Warfarin	NNP	MISC	Warfarin	nn	11	SENT_268	[p11l704t2336r925b2380],
11	dose	NN	O	dose	conj_and	5	SENT_268	[p11l945t2336r1056b2380],
12	and	CC	O	and	_	0	SENT_268	[p11l1076t2336r1166b2380],
13	the	DT	O	the	det	14	SENT_268	[p11l1185t2336r1263b2380],
14	pharmacogenomics	NNS	O	pharmacogenomic	conj_and	5	SENT_268	[p11l1283t2336r1764b2391],
15	of	IN	O	of	_	0	SENT_268	[p11l1784t2336r1835b2380],
16	CYP2C9	NN	O	cyp2c9	prep_of	14	SENT_268	[p11l1849t2338r2036b2380],
17	and	CC	O	and	cc	14	SENT_268	[p11l2056t2336r2145b2380],

1	VI	NNP	O	VI	nn	3	SENT_269	[p11l141t2404r389b2445],
2	(	CD	NUMBER	(	num	3	SENT_269	[p11l141t2404r389b2445],
3	ORC1	NN	O	orc1	_	0	SENT_269	[p11l141t2404r389b2445],
4	—	CD	NUMBER	—	num	5	SENT_269	[p11l141t2404r389b2445],
5	rationale	NN	O	rationale	dep	3	SENT_269	[p11l411t2402r627b2445],
6	and	CC	O	and	_	0	SENT_269	[p11l647t2401r737b2445],
7	perspectives	NNS	O	perspective	dep	3	SENT_269	[p11l757t2402r1075b2456],
8	,	,	O	,	_	0	SENT_269	[p11l757t2402r1075b2456],
9	Thromb	NNP	LOCATION	Thromb	appos	7	SENT_269	[p11l1093t2401r1300b2445],
10	.	.	O	.	_	0	SENT_269	[p11l1093t2401r1300b2445],

1	Res	NNP	O	Res	_	0	SENT_270	[p11l1321t2404r1414b2445],
2	.	.	O	.	_	0	SENT_270	[p11l1321t2404r1414b2445],

1	120	CD	NUMBER	120	_	0	SENT_271	[p11l1438t2404r1525b2445],
2	(	CD	NUMBER	(	num	3	SENT_271	[p11l1548t2402r1710b2455],
3	2007	CD	DATE	2007	dep	1	SENT_271	[p11l1548t2402r1710b2455],
4	)	CD	NUMBER	)	num	5	SENT_271	[p11l1548t2402r1710b2455],
5	1-10	CD	NUMBER	1-10	dep	3	SENT_271	[p11l1736t2404r1867b2445],
6	.	.	O	.	_	0	SENT_271	[p11l1736t2404r1867b2445],

1	[	NN	O	[	nn	5	SENT_272	[p11l42t2468r103b2522],
2	5	CD	NUMBER	5	num	5	SENT_272	[p11l42t2468r103b2522],
3	]	CD	NUMBER	]	num	5	SENT_272	[p11l42t2468r103b2522],
4	J.	NNP	PERSON	J.	nn	5	SENT_272	[p11l137t2471r168b2522],
5	Kirchheiner	NNP	PERSON	Kirchheiner	_	0	SENT_272	[p11l202t2468r502b2518],
6	,	,	O	,	_	0	SENT_272	[p11l202t2468r502b2518],
7	J.	NNP	PERSON	J.	nn	8	SENT_272	[p11l531t2471r562b2522],
8	Brockmoller	NNP	PERSON	Brockmoller	appos	5	SENT_272	[p11l596t2468r907b2518],
9	,	,	O	,	_	0	SENT_272	[p11l596t2468r907b2518],
10	Clinical	JJ	O	clinical	amod	11	SENT_272	[p11l942t2468r1120b2512],
11	consequences	NNS	O	consequence	appos	5	SENT_272	[p11l1153t2481r1493b2522],
12	of	IN	O	of	_	0	SENT_272	[p11l1528t2468r1579b2512],
13	cytochrome	NN	O	cytochrome	nn	14	SENT_272	[p11l1606t2468r1896b2522],
14	P4502C9	NN	O	p4502c9	prep_of	11	SENT_272	[p11l1931t2470r2145b2512],

1	polymorphisms	NNS	O	polymorphism	_	0	SENT_273	[p11l144t2534r540b2588],
2	,	,	O	,	_	0	SENT_273	[p11l144t2534r540b2588],
3	Clin	NNP	PERSON	Clin	appos	1	SENT_273	[p11l562t2534r666b2578],
4	.	.	O	.	_	0	SENT_273	[p11l562t2534r666b2578],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_274	[p11l688t2534r958b2578],
2	.	.	O	.	_	0	SENT_274	[p11l688t2534r958b2578],

1	Ther	NNP	O	Ther	_	0	SENT_275	[p11l977t2534r1100b2578],
2	.	.	O	.	_	0	SENT_275	[p11l977t2534r1100b2578],

1	77	CD	NUMBER	77	_	0	SENT_276	[p11l1122t2536r1179b2577],
2	(	CD	NUMBER	(	num	3	SENT_276	[p11l1203t2534r1365b2588],
3	2005	CD	DATE	2005	dep	1	SENT_276	[p11l1203t2534r1365b2588],
4	)	CD	NUMBER	)	num	5	SENT_276	[p11l1203t2534r1365b2588],
5	1-16	CD	NUMBER	1-16	dep	3	SENT_276	[p11l1391t2536r1522b2578],
6	.	.	O	.	_	0	SENT_276	[p11l1391t2536r1522b2578],

1	[	NN	O	[	nn	5	SENT_277	[p11l42t2600r103b2654],
2	6	CD	NUMBER	6	num	5	SENT_277	[p11l42t2600r103b2654],
3	]	CD	NUMBER	]	num	5	SENT_277	[p11l42t2600r103b2654],
4	S.	NNP	PERSON	S.	nn	5	SENT_277	[p11l143t2602r180b2644],
5	Rost	NNP	PERSON	Rost	dep	42	SENT_277	[p11l206t2603r321b2650],
6	,	,	O	,	_	0	SENT_277	[p11l206t2603r321b2650],
7	A.	NNP	PERSON	A.	nn	8	SENT_277	[p11l346t2602r392b2644],
8	Fregin	NNP	PERSON	Fregin	appos	5	SENT_277	[p11l418t2600r582b2654],
9	,	,	O	,	_	0	SENT_277	[p11l418t2600r582b2654],
10	V.	NNP	PERSON	V.	nn	11	SENT_277	[p11l606t2603r652b2644],
11	Ivaskevicius	NNP	PERSON	Ivaskevicius	appos	5	SENT_277	[p11l678t2600r984b2650],
12	,	,	O	,	_	0	SENT_277	[p11l678t2600r984b2650],
13	E.	NNP	PERSON	E.	nn	14	SENT_277	[p11l1012t2603r1050b2644],
14	Conzelmann	NNP	PERSON	Conzelmann	appos	5	SENT_277	[p11l1076t2600r1394b2650],
15	,	,	O	,	_	0	SENT_277	[p11l1076t2600r1394b2650],
16	K.	NNP	PERSON	K.	nn	17	SENT_277	[p11l1420t2603r1463b2644],
17	Hortnagel	NNP	PERSON	Hortnagel	appos	5	SENT_277	[p11l1490t2600r1745b2654],
18	,	,	O	,	_	0	SENT_277	[p11l1490t2600r1745b2654],
19	H.J.	NNP	PERSON	H.J.	nn	20	SENT_277	[p11l1771t2603r1849b2654],
20	Pelz	NNP	PERSON	Pelz	appos	5	SENT_277	[p11l1875t2600r1984b2650],
21	,	,	O	,	_	0	SENT_277	[p11l1875t2600r1984b2650],
22	et	FW	O	et	nn	23	SENT_277	[p11l2011t2606r2057b2643],
23	al.	FW	O	al.	appos	5	SENT_277	[p11l2080t2600r2145b2650],
24	,	,	O	,	_	0	SENT_277	[p11l2080t2600r2145b2650],
25	Mutations	NNS	O	mutation	appos	5	SENT_277	[p11l144t2666r392b2709],
26	in	IN	O	in	_	0	SENT_277	[p11l415t2666r460b2709],
27	VKORC1	NN	O	vkorc1	nn	28	SENT_277	[p11l480t2668r678b2709],
28	cause	NN	O	cause	prep_in	25	SENT_277	[p11l706t2678r840b2709],
29	Warfarin	NNP	MISC	Warfarin	nn	30	SENT_277	[p11l861t2665r1071b2709],
30	resistance	NN	O	resistance	dep	28	SENT_277	[p11l1093t2666r1337b2709],
31	and	CC	O	and	_	0	SENT_277	[p11l1359t2665r1448b2709],
32	multiple	JJ	O	multiple	amod	36	SENT_277	[p11l1471t2665r1677b2720],
33	coagulation	NN	O	coagulation	nn	36	SENT_277	[p11l1699t2666r1984b2720],
34	factor	NN	O	factor	nn	36	SENT_277	[p11l2006t2665r2147b2709],
35	deﬁciency	NN	O	deﬁciency	nn	36	SENT_277	[p11l143t2731r393b2786],
36	type	NN	O	type	conj_and	28	SENT_277	[p11l411t2738r517b2786],
37	2	CD	NUMBER	2	dep	36	SENT_277	[p11l537t2734r577b2782],
38	,	,	O	,	_	0	SENT_277	[p11l537t2734r577b2782],
39	Nature	NNP	O	Nature	appos	5	SENT_277	[p11l598t2734r763b2775],
40	427	CD	NUMBER	427	num	39	SENT_277	[p11l782t2734r873b2775],
41	(	CD	NUMBER	(	num	42	SENT_277	[p11l897t2732r1059b2786],
42	2004	CD	DATE	2004	_	0	SENT_277	[p11l897t2732r1059b2786],
43	)	CD	NUMBER	)	num	44	SENT_277	[p11l897t2732r1059b2786],
44	537-541	CD	NUMBER	537-541	dep	42	SENT_277	[p11l1083t2734r1309b2776],
45	.	.	O	.	_	0	SENT_277	[p11l1083t2734r1309b2776],

1	[	NN	O	[	nn	5	SENT_278	[p11l42t2798r103b2853],
2	7	CD	NUMBER	7	num	5	SENT_278	[p11l42t2798r103b2853],
3	]	CD	NUMBER	]	num	5	SENT_278	[p11l42t2798r103b2853],
4	C.	NNP	PERSON	C.	nn	5	SENT_278	[p11l143t2800r184b2842],
5	Geisen	NNP	PERSON	Geisen	_	0	SENT_278	[p11l216t2799r391b2848],
6	,	,	O	,	_	0	SENT_278	[p11l216t2799r391b2848],
7	M.	NNP	PERSON	M.	nn	8	SENT_278	[p11l423t2801r482b2842],
8	Watzka	NNP	PERSON	Watzka	appos	5	SENT_278	[p11l511t2798r710b2848],
9	,	,	O	,	_	0	SENT_278	[p11l511t2798r710b2848],
10	K.	NNP	PERSON	K.	nn	11	SENT_278	[p11l743t2801r786b2842],
11	Sittinger	NNP	PERSON	Sittinger	appos	5	SENT_278	[p11l818t2799r1038b2853],
12	,	,	O	,	_	0	SENT_278	[p11l818t2799r1038b2853],
13	M.	NNP	PERSON	M.	nn	14	SENT_278	[p11l1071t2801r1129b2842],
14	Steffens	NNP	PERSON	Steffens	conj_and	11	SENT_278	[p11l1161t2798r1366b2848],
15	,	,	O	,	_	0	SENT_278	[p11l1161t2798r1366b2848],
16	L.	NNP	PERSON	L.	nn	17	SENT_278	[p11l1398t2801r1433b2842],
17	Daugela	NNP	PERSON	Daugela	conj_and	11	SENT_278	[p11l1465t2798r1673b2853],
18	,	,	O	,	_	0	SENT_278	[p11l1465t2798r1673b2853],
19	E.	NNP	PERSON	E.	nn	20	SENT_278	[p11l1706t2801r1744b2842],
20	Seifried	NNP	PERSON	Seifried	conj_and	11	SENT_278	[p11l1776t2798r1973b2848],
21	,	,	O	,	_	0	SENT_278	[p11l1776t2798r1973b2848],
22	et	FW	O	et	nn	23	SENT_278	[p11l2005t2805r2051b2842],
23	al.	FW	O	al.	conj_and	11	SENT_278	[p11l2080t2798r2145b2848],
24	,	,	O	,	_	0	SENT_278	[p11l2080t2798r2145b2848],
25	VKORC1	NN	O	vkorc1	nn	26	SENT_278	[p11l141t2866r340b2907],
26	haplotypes	NNS	O	haplotype	appos	5	SENT_278	[p11l369t2864r638b2918],
27	and	CC	O	and	_	0	SENT_278	[p11l662t2864r751b2907],
28	their	PRP$	O	they	poss	29	SENT_278	[p11l774t2864r892b2907],
29	impact	NN	O	impact	conj_and	11	SENT_278	[p11l914t2864r1082b2918],
30	on	IN	O	on	_	0	SENT_278	[p11l1104t2876r1164b2907],
31	the	DT	O	the	det	33	SENT_278	[p11l1187t2864r1265b2907],
32	inter	NN	O	inter	nn	33	SENT_278	[p11l1288t2865r1405b2907],
33	individual	NN	O	individual	prep_on	29	SENT_278	[p11l1427t2864r1673b2907],
34	and	CC	O	and	_	0	SENT_278	[p11l1696t2864r1786b2907],
35	inter	NN	O	inter	prep_on	29	SENT_278	[p11l1809t2864r2145b2907],
36	—	CD	NUMBER	—	num	38	SENT_278	[p11l1809t2864r2145b2907],
37	ethnical	JJ	O	ethnical	amod	38	SENT_278	[p11l1809t2864r2145b2907],
38	variability	NN	O	variability	dep	5	SENT_278	[p11l142t2930r392b2984],
39	of	IN	O	of	_	0	SENT_278	[p11l411t2930r462b2973],
40	oral	JJ	O	oral	amod	41	SENT_278	[p11l475t2930r568b2973],
41	anticoagulation	NN	O	anticoagulation	prep_of	38	SENT_278	[p11l587t2930r980b2984],
42	,	,	O	,	_	0	SENT_278	[p11l587t2930r980b2984],
43	Thromb	NNP	O	Thromb	appos	5	SENT_278	[p11l999t2930r1206b2974],
44	.	.	O	.	_	0	SENT_278	[p11l999t2930r1206b2974],

1	Haemost	NNP	O	Haemost	_	0	SENT_279	[p11l1227t2933r1455b2974],
2	.	.	O	.	_	0	SENT_279	[p11l1227t2933r1455b2974],

1	94	CD	NUMBER	94	_	0	SENT_280	[p11l1476t2932r1535b2973],
2	(	CD	NUMBER	(	num	3	SENT_280	[p11l1558t2930r1720b2984],
3	2004	CD	DATE	2004	dep	1	SENT_280	[p11l1558t2930r1720b2984],
4	)	CD	NUMBER	)	num	5	SENT_280	[p11l1558t2930r1720b2984],
5	773-779	CD	NUMBER	773-779	dep	3	SENT_280	[p11l1745t2932r1970b2974],
6	.	.	O	.	_	0	SENT_280	[p11l1745t2932r1970b2974],

1	[	NN	O	[	_	0	SENT_281	[p11l42t2995r103b3050],
2	8	CD	NUMBER	8	num	1	SENT_281	[p11l42t2995r103b3050],
3	]	NNP	O	]	nn	5	SENT_281	[p11l42t2995r103b3050],
4	L.	NNP	PERSON	L.	nn	5	SENT_281	[p11l144t2998r178b3040],
5	Bodin	NNP	PERSON	Bodin	dep	1	SENT_281	[p11l196t2996r348b3046],
6	,	,	O	,	_	0	SENT_281	[p11l196t2996r348b3046],
7	C.	NNP	PERSON	C.	nn	8	SENT_281	[p11l365t2998r406b3040],
8	Verstuyft	NNP	PERSON	Verstuyft	conj_and	5	SENT_281	[p11l421t2995r660b3050],
9	,	,	O	,	_	0	SENT_281	[p11l421t2995r660b3050],
10	D.A.	NNP	PERSON	D.A.	nn	11	SENT_281	[p11l678t2997r773b3040],
11	Tregouet	NNP	PERSON	Tregouet	conj_and	5	SENT_281	[p11l788t2998r1019b3050],
12	,	,	O	,	_	0	SENT_281	[p11l788t2998r1019b3050],
13	A.	NN	PERSON	a.	nn	14	SENT_281	[p11l1034t2998r1081b3040],
14	Robert	NNP	PERSON	Robert	conj_and	5	SENT_281	[p11l1098t2996r1271b3046],
15	,	,	O	,	_	0	SENT_281	[p11l1098t2996r1271b3046],
16	L.	NNP	PERSON	L.	nn	17	SENT_281	[p11l1290t2998r1324b3040],
17	Dubert	NNP	PERSON	Dubert	dep	1	SENT_281	[p11l1342t2996r1522b3046],
18	,	,	O	,	_	0	SENT_281	[p11l1342t2996r1522b3046],
19	C.	NNP	PERSON	C.	nn	20	SENT_281	[p11l1539t2998r1580b3040],
20	Funck-Brentano	NNP	PERSON	Funck-Brentano	dep	1	SENT_281	[p11l1598t2996r2002b3046],
21	,	,	O	,	_	0	SENT_281	[p11l1598t2996r2002b3046],
22	et	FW	O	et	nn	23	SENT_281	[p11l2019t3002r2065b3039],
23	al.	FW	O	al.	dep	1	SENT_281	[p11l2080t2996r2145b3046],
24	,	,	O	,	_	0	SENT_281	[p11l2080t2996r2145b3046],
25	Cytochrome	NNP	O	Cytochrome	nn	27	SENT_281	[p11l143t3062r441b3116],
26	P450	NN	O	p450	nn	27	SENT_281	[p11l471t3064r591b3105],
27	2C9	NN	O	2c9	dep	1	SENT_281	[p11l621t3064r711b3105],
28	(	CD	NUMBER	(	num	30	SENT_281	[p11l745t3062r974b3116],
29	CYP2C9	NN	O	cyp2c9	nn	30	SENT_281	[p11l745t3062r974b3116],
30	)	NN	O	)	dep	27	SENT_281	[p11l745t3062r974b3116],
31	and	CC	O	and	_	0	SENT_281	[p11l1007t3062r1096b3105],
32	vitamin	NN	O	vitamin	nn	35	SENT_281	[p11l1124t3062r1314b3105],
33	K	NN	O	k	nn	35	SENT_281	[p11l1344t3064r1377b3105],
34	epoxide	NN	O	epoxide	nn	35	SENT_281	[p11l1405t3062r1599b3116],
35	reductase	NN	O	reductase	dep	1	SENT_281	[p11l1629t3062r1865b3105],
36	(	CD	NUMBER	(	num	39	SENT_281	[p11l1898t3062r2142b3116],
37	VKORC1	NN	O	vkorc1	nn	39	SENT_281	[p11l1898t3062r2142b3116],
38	)	NN	O	)	nn	39	SENT_281	[p11l1898t3062r2142b3116],
39	genotypes	NNS	O	genotype	dep	1	SENT_281	[p11l142t3135r408b3183],
40	as	IN	O	as	_	0	SENT_281	[p11l433t3141r482b3172],
41	determinants	NNS	O	determinant	prep_as	39	SENT_281	[p11l507t3128r856b3172],
42	of	IN	O	of	_	0	SENT_281	[p11l881t3128r933b3172],
43	acenocoumarol	NN	O	acenocoumarol	nn	44	SENT_281	[p11l951t3128r1348b3172],
44	sensitivity	NN	O	sensitivity	prep_of	41	SENT_281	[p11l1374t3129r1655b3183],
45	,	,	O	,	_	0	SENT_281	[p11l1374t3129r1655b3183],
46	Blood	NN	O	blood	appos	1	SENT_281	[p11l1680t3128r1825b3172],
47	106	CD	NUMBER	106	number	48	SENT_281	[p11l1853t3130r1943b3172],
48	(	CD	NUMBER	(	dep	46	SENT_281	[p11l1971t3128r2142b3182],
49	2005	CD	DATE	2005	dep	1	SENT_281	[p11l1971t3128r2142b3182],
50	)	CD	NUMBER	)	num	51	SENT_281	[p11l1971t3128r2142b3182],
51	135-140	CD	NUMBER	135-140	dep	49	SENT_281	[p11l146t3197r382b3238],
52	.	.	O	.	_	0	SENT_281	[p11l146t3197r382b3238],

1	[	NN	O	[	nn	3	SENT_282	[p12l42t18r103b72],
2	9	CD	NUMBER	9	num	3	SENT_282	[p12l42t18r103b72],
3	]	NN	O	]	nsubjpass	32	SENT_282	[p12l42t18r103b72],
4	G.	NNP	PERSON	G.	nn	5	SENT_282	[p12l143t20r190b62],
5	D'Andrea	NNP	PERSON	D'Andrea	rcmod	3	SENT_282	[p12l209t18r447b68],
6	,	,	O	,	_	0	SENT_282	[p12l209t18r447b68],
7	R.L.	NNP	PERSON	R.L.	nn	8	SENT_282	[p12l467t21r548b62],
8	D'Ambrosio	NNP	PERSON	D'Ambrosio	appos	5	SENT_282	[p12l568t18r866b68],
9	,	,	O	,	_	0	SENT_282	[p12l568t18r866b68],
10	P.	NNP	PERSON	P.	nn	12	SENT_282	[p12l886t21r924b62],
11	Di	NNP	PERSON	Di	nn	12	SENT_282	[p12l944t19r995b61],
12	Perna	NNP	PERSON	Perna	appos	5	SENT_282	[p12l1014t21r1164b68],
13	,	,	O	,	_	0	SENT_282	[p12l1014t21r1164b68],
14	M.	NNP	PERSON	M.	nn	15	SENT_282	[p12l1184t21r1242b62],
15	Chetta	NNP	PERSON	Chetta	appos	5	SENT_282	[p12l1261t18r1430b68],
16	,	,	O	,	_	0	SENT_282	[p12l1261t18r1430b68],
17	R.	NNP	PERSON	R.	nn	18	SENT_282	[p12l1451t21r1492b62],
18	Santacroce	NNP	PERSON	Santacroce	appos	5	SENT_282	[p12l1511t20r1788b68],
19	,	,	O	,	_	0	SENT_282	[p12l1511t20r1788b68],
20	V.	NNP	PERSON	V.	nn	21	SENT_282	[p12l1805t21r1851b62],
21	Brancaccio	NNP	PERSON	Brancaccio	appos	5	SENT_282	[p12l1871t19r2145b68],
22	,	,	O	,	_	0	SENT_282	[p12l1871t19r2145b68],
23	et	FW	O	et	nn	24	SENT_282	[p12l143t90r189b127],
24	al.	FW	O	al.	appos	5	SENT_282	[p12l216t84r281b134],
25	,	,	O	,	_	0	SENT_282	[p12l216t84r281b134],
26	A	DT	O	a	det	27	SENT_282	[p12l308t86r344b127],
27	polymorphism	NN	O	polymorphism	appos	5	SENT_282	[p12l370t84r732b138],
28	in	IN	O	in	dep	5	SENT_282	[p12l761t84r806b127],
29	VKORC1	NN	O	vkorc1	nn	30	SENT_282	[p12l832t86r1030b127],
30	gene	NN	O	gene	pobj	28	SENT_282	[p12l1064t96r1181b138],
31	is	VBZ	O	be	auxpass	32	SENT_282	[p12l1210t84r1245b127],
32	associated	VBN	O	associate	_	0	SENT_282	[p12l1274t84r1526b127],
33	with	IN	O	with	_	0	SENT_282	[p12l1553t84r1666b127],
34	an	DT	O	a	det	36	SENT_282	[p12l1694t96r1752b127],
35	interindividual	JJ	O	interindividual	amod	36	SENT_282	[p12l1780t84r2145b127],
36	variability	NN	O	variability	prep_with	32	SENT_282	[p12l142t150r410b204],
37	in	IN	O	in	_	0	SENT_282	[p12l439t150r485b193],
38	the	DT	O	the	det	42	SENT_282	[p12l515t150r596b193],
39	dose	NN	O	dose	nn	42	SENT_282	[p12l626t150r1128b204],
40	—	NN	O	—	nn	42	SENT_282	[p12l626t150r1128b204],
41	anticoagulant	JJ	O	anticoagulant	amod	42	SENT_282	[p12l626t150r1128b204],
42	effect	NN	O	effect	prep_in	36	SENT_282	[p12l1157t150r1300b193],
43	of	IN	O	of	_	0	SENT_282	[p12l1329t150r1381b193],
44	warfarin	NN	O	warfarin	prep_of	42	SENT_282	[p12l1404t150r1639b200],
45	,	,	O	,	_	0	SENT_282	[p12l1404t150r1639b200],
46	Blood	NN	O	blood	appos	44	SENT_282	[p12l1670t150r1814b193],
47	105	CD	NUMBER	105	num	46	SENT_282	[p12l1847t152r1936b193],
48	(	CD	NUMBER	(	num	49	SENT_282	[p12l1971t150r2142b204],
49	2005	CD	DATE	2005	dep	46	SENT_282	[p12l1971t150r2142b204],
50	)	CD	NUMBER	)	num	51	SENT_282	[p12l1971t150r2142b204],
51	645-649	CD	NUMBER	645-649	dep	46	SENT_282	[p12l144t219r382b260],
52	.	.	O	.	_	0	SENT_282	[p12l144t219r382b260],

1	[	NN	O	[	nn	5	SENT_283	[p12l11t282r103b337],
2	10	CD	NUMBER	10	num	5	SENT_283	[p12l11t282r103b337],
3	]	CD	NUMBER	]	num	5	SENT_283	[p12l11t282r103b337],
4	J.F.	NNP	PERSON	J.F.	nn	5	SENT_283	[p12l137t285r208b337],
5	Carlquist	NNP	PERSON	Carlquist	nsubj	44	SENT_283	[p12l235t283r465b337],
6	,	,	O	,	_	0	SENT_283	[p12l235t283r465b337],
7	B.D.	NNP	PERSON	B.D.	nn	8	SENT_283	[p12l493t285r584b327],
8	Horne	NNP	PERSON	Horne	appos	5	SENT_283	[p12l612t285r774b333],
9	,	,	O	,	_	0	SENT_283	[p12l612t285r774b333],
10	J.B.	NNP	PERSON	J.B.	nn	11	SENT_283	[p12l795t285r871b337],
11	Muhlestein	NNP	PERSON	Muhlestein	appos	5	SENT_283	[p12l899t283r1187b333],
12	,	,	O	,	_	0	SENT_283	[p12l899t283r1187b333],
13	D.L.	NNP	PERSON	D.L.	nn	14	SENT_283	[p12l1215t285r1301b327],
14	Lappé	NNP	PERSON	Lappé	appos	5	SENT_283	[p12l1329t282r1484b337],
15	,	,	O	,	_	0	SENT_283	[p12l1329t282r1484b337],
16	B.M.	NNP	LOCATION	B.M.	nn	17	SENT_283	[p12l1512t285r1615b327],
17	Whiting	NNP	LOCATION	Whiting	appos	5	SENT_283	[p12l1640t283r1854b337],
18	,	,	O	,	_	0	SENT_283	[p12l1640t283r1854b337],
19	M.J.	NNP	PERSON	M.J.	nn	20	SENT_283	[p12l1882t285r1969b337],
20	Kolek	NNP	PERSON	Kolek	appos	5	SENT_283	[p12l1997t283r2145b333],
21	,	,	O	,	_	0	SENT_283	[p12l1997t283r2145b333],
22	et	FW	O	et	nn	23	SENT_283	[p12l143t356r189b393],
23	al.	FW	O	al.	appos	5	SENT_283	[p12l214t349r278b400],
24	,	,	O	,	_	0	SENT_283	[p12l214t349r278b400],
25	Genotypes	NNS	O	genotype	appos	5	SENT_283	[p12l305t351r564b404],
26	of	IN	O	of	_	0	SENT_283	[p12l590t349r642b393],
27	the	DT	O	the	det	30	SENT_283	[p12l661t349r739b393],
28	cytochrome	NN	O	cytochrome	nn	30	SENT_283	[p12l765t349r1055b404],
29	p450	NN	O	p450	nn	30	SENT_283	[p12l1082t351r1204b404],
30	isoform	NN	O	isoform	prep_of	25	SENT_283	[p12l1231t349r1429b399],
31	,	,	O	,	_	0	SENT_283	[p12l1231t349r1429b399],
32	CYP2C9	NN	O	cyp2c9	appos	5	SENT_283	[p12l1456t351r1655b399],
33	,	,	O	,	_	0	SENT_283	[p12l1456t351r1655b399],
34	and	CC	O	and	_	0	SENT_283	[p12l1681t349r1770b393],
35	the	DT	O	the	det	41	SENT_283	[p12l1797t349r1874b393],
36	vitamin	NN	O	vitamin	nn	41	SENT_283	[p12l1898t350r2088b393],
37	K	NN	O	k	nn	41	SENT_283	[p12l2114t352r2147b392],
38	epoxide	NN	O	epoxide	nn	41	SENT_283	[p12l143t415r333b469],
39	reductase	NN	O	reductase	nn	41	SENT_283	[p12l352t415r582b458],
40	complex	NN	O	complex	nn	41	SENT_283	[p12l601t415r807b469],
41	subunit	NN	O	subunit	nsubj	44	SENT_283	[p12l825t415r1007b458],
42	1	CD	NUMBER	1	dep	41	SENT_283	[p12l1026t417r1045b458],
43	conjointly	RB	O	conjointly	advmod	44	SENT_283	[p12l1070t415r1311b469],
44	determine	VB	O	determine	_	0	SENT_283	[p12l1328t415r1576b458],
45	stable	JJ	O	stable	amod	47	SENT_283	[p12l1595t415r1735b458],
46	warfarin	NN	O	warfarin	nn	47	SENT_283	[p12l1752t415r1957b458],
47	dose	NN	O	dose	dobj	44	SENT_283	[p12l1976t415r2100b459],
48	:	:	O	:	_	0	SENT_283	[p12l1976t415r2100b459],
49	a	DT	O	a	det	51	SENT_283	[p12l2121t427r2146b458],
50	prospective	JJ	O	prospective	amod	51	SENT_283	[p12l143t482r420b535],
51	study	NN	O	study	dep	47	SENT_283	[p12l439t481r581b535],
52	,	,	O	,	_	0	SENT_283	[p12l439t481r581b535],
53	J.	NNP	PERSON	J.	nn	54	SENT_283	[p12l592t484r623b535],
54	Thromb	NNP	PERSON	Thromb	appos	51	SENT_283	[p12l638t481r841b525],
55	.	.	O	.	_	0	SENT_283	[p12l638t481r841b525],

1	Thrombolysis	NNP	O	Thrombolysis	_	0	SENT_284	[p12l857t481r1182b535],
2	22	CD	NUMBER	22	num	1	SENT_284	[p12l1200t483r1258b524],
3	(	CD	NUMBER	(	num	4	SENT_284	[p12l1279t481r1439b535],
4	2006	CD	DATE	2006	dep	1	SENT_284	[p12l1279t481r1439b535],
5	)	CD	NUMBER	)	num	6	SENT_284	[p12l1279t481r1439b535],
6	191-197	CD	NUMBER	191-197	dep	4	SENT_284	[p12l1461t483r1680b525],
7	.	.	O	.	_	0	SENT_284	[p12l1461t483r1680b525],

1	[	NN	O	[	nn	5	SENT_285	[p12l11t546r103b601],
2	11	CD	NUMBER	11	num	5	SENT_285	[p12l11t546r103b601],
3	]	CD	NUMBER	]	num	5	SENT_285	[p12l11t546r103b601],
4	G.	NNP	PERSON	G.	nn	5	SENT_285	[p12l143t549r190b590],
5	D'Andrea	NNP	PERSON	D'Andrea	_	0	SENT_285	[p12l205t546r436b597],
6	,	,	O	,	_	0	SENT_285	[p12l205t546r436b597],
7	R.	NNP	PERSON	R.	nn	8	SENT_285	[p12l452t549r492b590],
8	D'Ambrosio	NNP	PERSON	D'Ambrosio	appos	5	SENT_285	[p12l508t546r799b597],
9	,	,	O	,	_	0	SENT_285	[p12l508t546r799b597],
10	M.	NNP	PERSON	M.	nn	11	SENT_285	[p12l815t549r873b590],
11	Margaglione	NNP	PERSON	Margaglione	appos	5	SENT_285	[p12l888t547r1198b601],
12	,	,	O	,	_	0	SENT_285	[p12l888t547r1198b601],
13	Oral	JJ	O	oral	amod	14	SENT_285	[p12l1214t547r1313b590],
14	anticoagulants	NNS	O	anticoagulant	appos	5	SENT_285	[p12l1327t546r1689b601],
15	:	:	O	:	_	0	SENT_285	[p12l1327t546r1689b601],
16	pharmacogenetics	NNS	O	pharmacogenetic	nn	17	SENT_285	[p12l1708t546r2145b601],
17	relationship	NN	O	relationship	dep	14	SENT_285	[p12l144t613r446b667],
18	between	IN	O	between	_	0	SENT_285	[p12l473t613r691b656],
19	genetic	JJ	O	genetic	amod	22	SENT_285	[p12l717t613r901b667],
20	and	CC	O	and	_	0	SENT_285	[p12l927t613r1018b656],
21	non-genetic	JJ	O	non-genetic	conj_and	19	SENT_285	[p12l1046t613r1350b667],
22	factors	NNS	O	factor	prep_between	17	SENT_285	[p12l1377t612r1558b663],
23	,	,	O	,	_	0	SENT_285	[p12l1377t612r1558b663],
24	Blood	NN	O	blood	appos	5	SENT_285	[p12l1586t613r1727b656],
25	Rev.	NNP	O	Rev.	dep	24	SENT_285	[p12l1756t615r1857b657],
26	22	CD	NUMBER	22	num	25	SENT_285	[p12l1885t615r1943b656],
27	(	CD	NUMBER	(	num	28	SENT_285	[p12l1976t613r2143b667],
28	2008	CD	DATE	2008	dep	5	SENT_285	[p12l1976t613r2143b667],
29	)	CD	NUMBER	)	num	30	SENT_285	[p12l1976t613r2143b667],
30	127-140	CD	NUMBER	127-140	dep	28	SENT_285	[p12l146t682r375b724],
31	.	.	O	.	_	0	SENT_285	[p12l146t682r375b724],

1	[	NN	O	[	nn	5	SENT_286	[p12l11t745r103b800],
2	12	CD	NUMBER	12	num	5	SENT_286	[p12l11t745r103b800],
3	]	CD	NUMBER	]	num	5	SENT_286	[p12l11t745r103b800],
4	A.S.	NNP	O	A.S.	nn	5	SENT_286	[p12l141t747r228b789],
5	Aynacioglu	NNP	O	Aynacioglu	_	0	SENT_286	[p12l245t745r531b800],
6	,	,	O	,	_	0	SENT_286	[p12l245t745r531b800],
7	J.	NNP	PERSON	J.	nn	8	SENT_286	[p12l544t748r575b800],
8	Brockmoller	NNP	PERSON	Brockmoller	appos	5	SENT_286	[p12l595t745r906b796],
9	,	,	O	,	_	0	SENT_286	[p12l595t745r906b796],
10	S.	NNP	PERSON	S.	nn	11	SENT_286	[p12l926t748r962b789],
11	Bauer	NNP	PERSON	Bauer	appos	8	SENT_286	[p12l982t748r1133b796],
12	,	,	O	,	_	0	SENT_286	[p12l982t748r1133b796],
13	C.	NNP	PERSON	C.	nn	14	SENT_286	[p12l1152t748r1193b789],
14	Sachse	NNP	PERSON	Sachse	appos	8	SENT_286	[p12l1212t745r1387b796],
15	,	,	O	,	_	0	SENT_286	[p12l1212t745r1387b796],
16	P.	NNP	PERSON	P.	nn	17	SENT_286	[p12l1407t748r1446b789],
17	Giizelbey	NNP	PERSON	Giizelbey	appos	8	SENT_286	[p12l1465t745r1704b800],
18	,	,	O	,	_	0	SENT_286	[p12l1465t745r1704b800],
19	Z.	NNP	PERSON	Z.	nn	21	SENT_286	[p12l1722t748r1762b789],
20	Ongen	NNP	PERSON	Ongen	nn	21	SENT_286	[p12l1782t748r1940b800],
21	Z	NN	O	z	appos	8	SENT_286	[p12l1958t748r1998b796],
22	,	,	O	,	_	0	SENT_286	[p12l1958t748r1998b796],
23	et	FW	O	et	nn	24	SENT_286	[p12l2018t752r2063b789],
24	al.	FW	O	al.	appos	8	SENT_286	[p12l2080t745r2145b796],
25	,	,	O	,	_	0	SENT_286	[p12l2080t745r2145b796],
26	Frequency	NN	O	frequency	appos	8	SENT_286	[p12l144t815r399b866],
27	of	IN	O	of	_	0	SENT_286	[p12l428t812r479b856],
28	cytochrome	NN	O	cytochrome	nn	31	SENT_286	[p12l502t812r792b866],
29	P450	NN	O	p450	nn	31	SENT_286	[p12l823t814r943b856],
30	CYP2C9	NN	O	cyp2c9	nn	31	SENT_286	[p12l974t814r1160b856],
31	variants	NNS	O	variant	prep_of	26	SENT_286	[p12l1190t813r1386b856],
32	in	IN	O	in	_	0	SENT_286	[p12l1417t813r1462b855],
33	a	DT	O	a	det	35	SENT_286	[p12l1492t825r1517b856],
34	Turkish	JJ	MISC	turkish	amod	35	SENT_286	[p12l1544t812r1729b856],
35	population	NN	O	population	prep_in	31	SENT_286	[p12l1760t812r2026b866],
36	and	CC	O	and	_	0	SENT_286	[p12l2057t812r2145b856],
37	functional	JJ	O	functional	amod	38	SENT_286	[p12l144t877r390b921],
38	relevance	NN	O	relevance	conj_and	31	SENT_286	[p12l411t878r645b921],
39	for	IN	O	for	_	0	SENT_286	[p12l666t877r734b921],
40	phenytoin	NN	O	phenytoin	prep_for	38	SENT_286	[p12l752t878r1015b932],
41	,	,	O	,	_	0	SENT_286	[p12l752t878r1015b932],
42	Br	NN	O	br	appos	8	SENT_286	[p12l1036t880r1098b922],
43	.	.	O	.	_	0	SENT_286	[p12l1036t880r1098b922],

1	J.	NNP	PERSON	J.	nn	2	SENT_287	[p12l1113t880r1144b932],
2	Clin	NNP	PERSON	Clin	_	0	SENT_287	[p12l1164t878r1270b922],
3	.	.	O	.	_	0	SENT_287	[p12l1164t878r1270b922],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_288	[p12l1291t878r1561b922],
2	.	.	O	.	_	0	SENT_288	[p12l1291t878r1561b922],

1	48	CD	NUMBER	48	_	0	SENT_289	[p12l1580t880r1639b921],
2	(	CD	NUMBER	(	num	3	SENT_289	[p12l1664t878r1826b932],
3	1999	CD	DATE	1999	dep	1	SENT_289	[p12l1664t878r1826b932],
4	)	CD	NUMBER	)	num	5	SENT_289	[p12l1664t878r1826b932],
5	409-415	CD	NUMBER	409-415	dep	3	SENT_289	[p12l1848t880r2076b922],
6	.	.	O	.	_	0	SENT_289	[p12l1848t880r2076b922],

1	[	RB	O	[	dep	5	SENT_290	[p12l11t944r103b998],
2	13	CD	NUMBER	13	num	5	SENT_290	[p12l11t944r103b998],
3	]	CD	NUMBER	]	num	5	SENT_290	[p12l11t944r103b998],
4	M.S.	NNP	PERSON	M.S.	nn	5	SENT_290	[p12l144t946r243b988],
5	Wen	NNP	PERSON	Wen	_	0	SENT_290	[p12l258t947r386b994],
6	,	,	O	,	_	0	SENT_290	[p12l258t947r386b994],
7	M.	NNP	PERSON	M.	nn	8	SENT_290	[p12l403t947r462b988],
8	Lee	NNP	PERSON	Lee	appos	5	SENT_290	[p12l479t947r570b994],
9	,	,	O	,	_	0	SENT_290	[p12l479t947r570b994],
10	J.J.	NNP	PERSON	J.J.	nn	11	SENT_290	[p12l581t947r641b998],
11	Chen	NNP	PERSON	Chen	appos	5	SENT_290	[p12l658t944r792b994],
12	,	,	O	,	_	0	SENT_290	[p12l658t944r792b994],
13	H.P.	NNP	PERSON	H.P.	nn	14	SENT_290	[p12l810t947r901b988],
14	Chuang	NNP	PERSON	Chuang	appos	5	SENT_290	[p12l918t944r1113b998],
15	,	,	O	,	_	0	SENT_290	[p12l918t944r1113b998],
16	L.S.	NNP	PERSON	L.S.	nn	17	SENT_290	[p12l1131t946r1206b988],
17	Lu	NNP	PERSON	Lu	appos	5	SENT_290	[p12l1224t947r1290b994],
18	,	,	O	,	_	0	SENT_290	[p12l1224t947r1290b994],
19	C.H.	NNP	PERSON	C.H.	nn	20	SENT_290	[p12l1308t946r1401b988],
20	Chen	NNP	PERSON	Chen	appos	5	SENT_290	[p12l1418t944r1552b994],
21	,	,	O	,	_	0	SENT_290	[p12l1418t944r1552b994],
22	et	FW	O	et	nn	23	SENT_290	[p12l1570t950r1616b987],
23	al.	FW	O	al.	appos	5	SENT_290	[p12l1631t944r1695b994],
24	,	,	O	,	_	0	SENT_290	[p12l1631t944r1695b994],
25	Prospective	JJ	O	prospective	amod	26	SENT_290	[p12l1713t944r1995b998],
26	study	NN	O	study	appos	5	SENT_290	[p12l2012t944r2147b998],
27	of	IN	O	of	_	0	SENT_290	[p12l143t1009r194b1053],
28	warfarin	NN	O	warfarin	nn	30	SENT_290	[p12l206t1009r417b1053],
29	dosage	NN	O	dosage	nn	30	SENT_290	[p12l437t1010r605b1064],
30	requirements	NNS	O	requirement	prep_of	26	SENT_290	[p12l626t1010r956b1064],
31	based	VBN	O	base	partmod	5	SENT_290	[p12l977t1009r1117b1053],
32	on	IN	O	on	_	0	SENT_290	[p12l1137t1022r1197b1053],
33	CYP2C9	NN	O	cyp2c9	prep_on	31	SENT_290	[p12l1217t1012r1403b1053],
34	and	CC	O	and	_	0	SENT_290	[p12l1424t1010r1513b1053],
35	Vl	NN	O	vl	prep_on	31	SENT_290	[p12l1531t1012r1730b1053],
36	(	CD	NUMBER	(	num	38	SENT_290	[p12l1531t1012r1730b1053],
37	ORC1	NN	O	orc1	nn	38	SENT_290	[p12l1531t1012r1730b1053],
38	genotypes	NNS	O	genotype	tmod	31	SENT_290	[p12l1755t1016r2019b1064],
39	,	,	O	,	_	0	SENT_290	[p12l1755t1016r2019b1064],
40	Clin	NNP	PERSON	Clin	appos	38	SENT_290	[p12l2040t1010r2145b1053],
41	.	.	O	.	_	0	SENT_290	[p12l2040t1010r2145b1053],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_291	[p12l144t1076r414b1120],
2	.	.	O	.	_	0	SENT_291	[p12l144t1076r414b1120],

1	Ther	NNP	O	Ther	_	0	SENT_292	[p12l433t1076r557b1120],
2	.	.	O	.	_	0	SENT_292	[p12l433t1076r557b1120],

1	84	CD	NUMBER	84	_	0	SENT_293	[p12l577t1078r636b1119],
2	(	CD	NUMBER	(	num	3	SENT_293	[p12l659t1076r822b1130],
3	2008	CD	DATE	2008	dep	1	SENT_293	[p12l659t1076r822b1130],
4	)	CD	NUMBER	)	num	5	SENT_293	[p12l659t1076r822b1130],
5	83-89	CD	DATE	83-89	dep	3	SENT_293	[p12l845t1078r1009b1120],
6	.	.	O	.	_	0	SENT_293	[p12l845t1078r1009b1120],

1	[	RB	O	[	advmod	5	SENT_294	[p12l11t1142r103b1197],
2	14	CD	NUMBER	14	num	5	SENT_294	[p12l11t1142r103b1197],
3	]	CD	NUMBER	]	num	5	SENT_294	[p12l11t1142r103b1197],
4	V.	NNP	PERSON	V.	nn	5	SENT_294	[p12l141t1145r187b1186],
5	Tatarunas	NNP	PERSON	Tatarunas	_	0	SENT_294	[p12l204t1145r458b1193],
6	,	,	O	,	_	0	SENT_294	[p12l204t1145r458b1193],
7	V.	NNP	PERSON	V.	nn	8	SENT_294	[p12l475t1145r522b1186],
8	Lesauskaite	NNP	PERSON	Lesauskaite	appos	5	SENT_294	[p12l541t1142r832b1192],
9	,	,	O	,	_	0	SENT_294	[p12l541t1142r832b1192],
10	A.	NNP	PERSON	A.	nn	11	SENT_294	[p12l849t1144r895b1186],
11	Veikutiene	NNP	PERSON	Veikutiene	appos	5	SENT_294	[p12l912t1142r1190b1192],
12	,	,	O	,	_	0	SENT_294	[p12l912t1142r1190b1192],
13	P.	NNP	PERSON	P.	nn	14	SENT_294	[p12l1210t1145r1248b1186],
14	Jakuska	NNP	PERSON	Jakuska	appos	5	SENT_294	[p12l1260t1142r1463b1197],
15	,	,	O	,	_	0	SENT_294	[p12l1260t1142r1463b1197],
16	R.	NNP	PERSON	R.	nn	17	SENT_294	[p12l1482t1145r1524b1186],
17	Benetis	NNP	PERSON	Benetis	appos	5	SENT_294	[p12l1543t1143r1732b1192],
18	,	,	O	,	_	0	SENT_294	[p12l1543t1143r1732b1192],
19	The	DT	O	the	det	20	SENT_294	[p12l1749t1142r1838b1186],
20	inﬂuence	NN	O	inﬂuence	appos	5	SENT_294	[p12l1857t1142r2082b1186],
21	of	IN	O	of	_	0	SENT_294	[p12l2101t1142r2152b1186],
22	CYP2C9	NN	O	cyp2c9	nn	26	SENT_294	[p12l143t1210r330b1251],
23	and	CC	O	and	_	0	SENT_294	[p12l350t1208r439b1251],
24	VKORC1	NN	O	vkorc1	nn	26	SENT_294	[p12l456t1210r654b1251],
25	gene	NN	O	gene	nn	26	SENT_294	[p12l678t1220r795b1262],
26	polymorphisms	NNS	O	polymorphism	prep_of	20	SENT_294	[p12l814t1208r1198b1262],
27	on	IN	O	on	_	0	SENT_294	[p12l1219t1220r1279b1251],
28	optimal	JJ	O	optimal	amod	30	SENT_294	[p12l1298t1208r1486b1262],
29	warfarin	NN	O	warfarin	nn	30	SENT_294	[p12l1504t1208r1714b1251],
30	doses	NNS	O	dose	prep_on	5	SENT_294	[p12l1733t1208r1868b1251],
31	after	IN	O	after	_	0	SENT_294	[p12l1887t1208r2001b1251],
32	heart	NN	O	heart	nn	34	SENT_294	[p12l2019t1208r2147b1251],
33	valve	NN	O	valve	nn	34	SENT_294	[p12l142t1274r270b1317],
34	replacement	NN	O	replacement	prep_after	30	SENT_294	[p12l290t1274r609b1328],
35	,	,	O	,	_	0	SENT_294	[p12l290t1274r609b1328],
36	Medicina	NNP	PERSON	Medicina	nn	38	SENT_294	[p12l630t1274r857b1317],
37	(	NNP	O	(	nn	38	SENT_294	[p12l879t1274r1096b1328],
38	Kaunas	NNP	LOCATION	Kaunas	appos	5	SENT_294	[p12l879t1274r1096b1328],
39	)	NN	O	)	dep	38	SENT_294	[p12l879t1274r1096b1328],
40	47	CD	NUMBER	47	num	39	SENT_294	[p12l1118t1276r1178b1317],
41	(	CD	NUMBER	(	num	42	SENT_294	[p12l1202t1274r1364b1328],
42	2011	CD	DATE	2011	dep	5	SENT_294	[p12l1202t1274r1364b1328],
43	)	CD	NUMBER	)	num	44	SENT_294	[p12l1202t1274r1364b1328],
44	25-30	CD	NUMBER	25-30	dep	42	SENT_294	[p12l1388t1276r1552b1318],
45	.	.	O	.	_	0	SENT_294	[p12l1388t1276r1552b1318],

1	[	RB	O	[	dep	5	SENT_295	[p12l11t1339r103b1394],
2	15	CD	NUMBER	15	num	5	SENT_295	[p12l11t1339r103b1394],
3	]	CD	NUMBER	]	num	5	SENT_295	[p12l11t1339r103b1394],
4	R.	NNP	PERSON	R.	nn	5	SENT_295	[p12l144t1342r185b1383],
5	Montes	NNP	PERSON	Montes	_	0	SENT_295	[p12l207t1342r401b1390],
6	,	,	O	,	_	0	SENT_295	[p12l207t1342r401b1390],
7	E.	NNP	PERSON	E.	nn	10	SENT_295	[p12l422t1342r461b1383],
8	Ruiz	NNP	PERSON	Ruiz	nn	10	SENT_295	[p12l484t1340r588b1383],
9	de	IN	PERSON	de	amod	10	SENT_295	[p12l609t1339r666b1383],
10	Gaona	NNP	PERSON	Gaona	appos	5	SENT_295	[p12l687t1342r852b1390],
11	,	,	O	,	_	0	SENT_295	[p12l687t1342r852b1390],
12	M.A.	NNP	PERSON	M.A.	nn	13	SENT_295	[p12l874t1341r981b1383],
13	Martinez-Gonzales	NNP	PERSON	Martinez-Gonzales	appos	5	SENT_295	[p12l1003t1339r1481b1390],
14	,	,	O	,	_	0	SENT_295	[p12l1003t1339r1481b1390],
15	I.	NNP	PERSON	I.	nn	16	SENT_295	[p12l1503t1342r1527b1383],
16	Alberca	NNP	PERSON	Alberca	appos	5	SENT_295	[p12l1547t1339r1743b1390],
17	,	,	O	,	_	0	SENT_295	[p12l1547t1339r1743b1390],
18	J.	NNP	PERSON	J.	nn	19	SENT_295	[p12l1759t1342r1790b1394],
19	Hermida	NNP	PERSON	Hermida	appos	5	SENT_295	[p12l1812t1339r2036b1390],
20	,	,	O	,	_	0	SENT_295	[p12l1812t1339r2036b1390],
21	The	DT	O	the	det	22	SENT_295	[p12l2056t1339r2145b1383],
22	c.-1639G	NN	O	c.-1639g	appos	5	SENT_295	[p12l143t1408r443b1450],
23	>	JJR	O	>	amod	22	SENT_295	[p12l143t1408r443b1450],
24	A	DT	O	a	det	25	SENT_295	[p12l143t1408r443b1450],
25	polymorphism	NN	O	polymorphism	nsubj	33	SENT_295	[p12l466t1406r828b1460],
26	of	IN	O	of	_	0	SENT_295	[p12l852t1406r903b1449],
27	the	DT	O	the	det	29	SENT_295	[p12l921t1406r999b1449],
28	VKORC1	NN	O	vkorc1	nn	29	SENT_295	[p12l1021t1408r1220b1449],
29	gene	NN	O	gene	prep_of	25	SENT_295	[p12l1249t1418r1366b1460],
30	is	VBZ	O	be	cop	33	SENT_295	[p12l1391t1406r1426b1449],
31	a	DT	O	a	det	33	SENT_295	[p12l1452t1418r1477b1449],
32	major	JJ	O	major	amod	33	SENT_295	[p12l1500t1406r1645b1460],
33	determinant	NN	O	determinant	ccomp	23	SENT_295	[p12l1668t1406r1976b1449],
34	of	IN	O	of	_	0	SENT_295	[p12l1999t1405r2050b1449],
35	the	DT	O	the	det	36	SENT_295	[p12l2068t1406r2145b1449],
36	response	NN	O	response	prep_of	33	SENT_295	[p12l144t1485r357b1527],
37	to	TO	O	to	_	0	SENT_295	[p12l375t1479r422b1516],
38	acenocoumarol	NN	O	acenocoumarol	prep_to	23	SENT_295	[p12l441t1472r808b1516],
39	in	IN	O	in	_	0	SENT_295	[p12l828t1473r873b1515],
40	anticoagulated	JJ	O	anticoagulated	amod	41	SENT_295	[p12l891t1472r1244b1527],
41	patients	NNS	O	patient	prep_in	23	SENT_295	[p12l1263t1473r1466b1527],
42	,	,	O	,	_	0	SENT_295	[p12l1263t1473r1466b1527],
43	Br	NN	O	br	appos	41	SENT_295	[p12l1486t1475r1546b1516],
44	.	.	O	.	_	0	SENT_295	[p12l1486t1475r1546b1516],

1	J.	NNP	PERSON	J.	nn	2	SENT_296	[p12l1560t1475r1591b1527],
2	Haematol	NNP	PERSON	Haematol	_	0	SENT_296	[p12l1610t1472r1852b1516],
3	.	.	O	.	_	0	SENT_296	[p12l1610t1472r1852b1516],

1	133	CD	NUMBER	133	number	2	SENT_297	[p12l1875t1474r1959b1516],
2	(	CD	NUMBER	(	num	3	SENT_297	[p12l1983t1472r2142b1526],
3	2006	CD	DATE	2006	_	0	SENT_297	[p12l1983t1472r2142b1526],
4	)	CD	NUMBER	)	dep	3	SENT_297	[p12l1983t1472r2142b1526],
5	183-187	CD	NUMBER	183-187	dep	4	SENT_297	[p12l146t1541r365b1582],
6	.	.	O	.	_	0	SENT_297	[p12l146t1541r365b1582],

1	170	CD	DATE	170	_	0	SENT_298	[p12l314t1659r356b1680],
2	AD	NN	DATE	ad	dep	1	SENT_298	[p12l939t1659r985b1680],
3	.	.	O	.	_	0	SENT_298	[p12l939t1659r985b1680],

1	Buzoianu	NNP	MISC	Buzoianu	_	0	SENT_299	[p12l995t1658r1102b1680],
2	et	FW	O	et	nn	3	SENT_299	[p12l1112t1661r1134b1680],
3	al.	FW	O	al.	dep	1	SENT_299	[p12l1142t1658r1167b1680],
4	/	:	O	/	punct	1	SENT_299	[p12l1176t1659r1185b1683],
5	Blood	NN	O	blood	nn	6	SENT_299	[p12l1193t1658r1258b1680],
6	Cells	NNS	O	cell	dep	1	SENT_299	[p12l1267t1658r1323b1683],
7	,	,	O	,	_	0	SENT_299	[p12l1267t1658r1323b1683],
8	Molecules	NNS	O	molecule	dep	1	SENT_299	[p12l1333t1658r1448b1680],
9	and	CC	O	and	_	0	SENT_299	[p12l1458t1658r1500b1680],
10	Diseases	NNS	O	disease	dep	1	SENT_299	[p12l1509t1658r1606b1680],
11	50	CD	NUMBER	50	number	12	SENT_299	[p12l1615t1659r1644b1680],
12	(	CD	NUMBER	(	num	13	SENT_299	[p12l1654t1658r1732b1685],
13	2013	CD	DATE	2013	dep	6	SENT_299	[p12l1654t1658r1732b1685],
14	)	CD	NUMBER	)	number	15	SENT_299	[p12l1654t1658r1732b1685],
15	166-170	CD	NUMBER	166-170	num	13	SENT_299	[p12l1746t1659r1845b1680],

1	[	RB	O	[	advmod	3	SENT_300	[p12l6t1786r99b1841],
2	16	CD	NUMBER	16	number	3	SENT_300	[p12l6t1786r99b1841],
3	]	CD	NUMBER	]	_	0	SENT_300	[p12l6t1786r99b1841],
4	C.	NNP	PERSON	C.	nn	5	SENT_300	[p12l139t1789r180b1831],
5	Sipeky	NNP	PERSON	Sipeky	dep	3	SENT_300	[p12l201t1787r373b1841],
6	,	,	O	,	_	0	SENT_300	[p12l201t1787r373b1841],
7	V.	NNP	PERSON	V.	nn	8	SENT_300	[p12l392t1789r438b1831],
8	Csongei	NNP	PERSON	Csongei	appos	3	SENT_300	[p12l459t1787r660b1841],
9	,	,	O	,	_	0	SENT_300	[p12l459t1787r660b1841],
10	L.	NNP	PERSON	L.	nn	11	SENT_300	[p12l681t1789r716b1831],
11	Jaromi	NNP	PERSON	Jaromi	appos	8	SENT_300	[p12l730t1787r908b1841],
12	,	,	O	,	_	0	SENT_300	[p12l730t1787r908b1841],
13	E.	NNP	PERSON	E.	nn	14	SENT_300	[p12l929t1789r967b1831],
14	Safrany	NNP	PERSON	Safrany	appos	8	SENT_300	[p12l988t1787r1182b1841],
15	,	,	O	,	_	0	SENT_300	[p12l988t1787r1182b1841],
16	N.	NNP	PERSON	N.	nn	17	SENT_300	[p12l1203t1789r1251b1831],
17	Polgar	NNP	PERSON	Polgar	appos	8	SENT_300	[p12l1272t1787r1436b1841],
18	,	,	O	,	_	0	SENT_300	[p12l1272t1787r1436b1841],
19	L.	NNP	PERSON	L.	nn	21	SENT_300	[p12l1458t1789r1492b1831],
20	Lakner	NNP	PERSON	Lakner	nn	21	SENT_300	[p12l1513t1787r1679b1830],
21	L	NNP	PERSON	L	appos	8	SENT_300	[p12l1697t1789r1732b1837],
22	,	,	O	,	_	0	SENT_300	[p12l1697t1789r1732b1837],
23	et	FW	O	et	nn	24	SENT_300	[p12l1753t1793r1799b1830],
24	al.	FW	O	al.	appos	8	SENT_300	[p12l1817t1787r1882b1837],
25	,	,	O	,	_	0	SENT_300	[p12l1817t1787r1882b1837],
26	Vitamin	NN	O	vitamin	nn	30	SENT_300	[p12l1900t1787r2097b1830],
27	K	NN	O	k	nn	30	SENT_300	[p12l2117t1789r2150b1830],
28	epoxide	NN	O	epoxide	nn	30	SENT_300	[p12l139t1853r334b1908],
29	reductase	NN	O	reductase	nn	30	SENT_300	[p12l361t1853r598b1897],
30	complex	NN	O	complex	appos	8	SENT_300	[p12l625t1853r836b1908],
31	1	CD	NUMBER	1	number	32	SENT_300	[p12l864t1856r883b1896],
32	(	CD	NUMBER	(	num	33	SENT_300	[p12l919t1853r1163b1907],
33	VKORC1	NN	O	vkorc1	dep	30	SENT_300	[p12l919t1853r1163b1907],
34	)	CD	NUMBER	)	num	35	SENT_300	[p12l919t1853r1163b1907],
35	haplotypes	NNS	O	haplotype	dep	30	SENT_300	[p12l1194t1853r1463b1908],
36	in	IN	O	in	_	0	SENT_300	[p12l1491t1854r1536b1896],
37	healthy	JJ	O	healthy	amod	38	SENT_300	[p12l1563t1853r1749b1908],
38	Hungarian	JJ	MISC	hungarian	prep_in	35	SENT_300	[p12l1774t1854r2032b1908],
39	and	CC	O	and	_	0	SENT_300	[p12l2059t1853r2148b1897],
40	Roma	JJ	LOCATION	roma	amod	42	SENT_300	[p12l139t1921r278b1962],
41	population	NN	O	population	nn	42	SENT_300	[p12l298t1918r566b1973],
42	samples	NNS	O	sample	prep_in	35	SENT_300	[p12l586t1919r796b1973],
43	,	,	O	,	_	0	SENT_300	[p12l586t1919r796b1973],
44	Pharmacogenomics	NNP	O	Pharmacogenomics	appos	8	SENT_300	[p12l817t1918r1297b1973],
45	10	CD	NUMBER	10	num	44	SENT_300	[p12l1321t1921r1377b1962],
46	(	CD	NUMBER	(	num	47	SENT_300	[p12l1400t1919r1563b1973],
47	2009	CD	DATE	2009	dep	3	SENT_300	[p12l1400t1919r1563b1973],
48	)	CD	NUMBER	)	num	49	SENT_300	[p12l1400t1919r1563b1973],
49	1025-1032	CD	DATE	1025-1032	dep	47	SENT_300	[p12l1589t1921r1876b1962],
50	.	.	O	.	_	0	SENT_300	[p12l1589t1921r1876b1962],

1	[	NN	O	[	nn	5	SENT_301	[p12l6t1985r99b2039],
2	17	CD	NUMBER	17	num	5	SENT_301	[p12l6t1985r99b2039],
3	]	CD	NUMBER	]	num	5	SENT_301	[p12l6t1985r99b2039],
4	R.	NNP	PERSON	R.	nn	5	SENT_301	[p12l139t1988r181b2029],
5	Loebstein	NNP	PERSON	Loebstein	_	0	SENT_301	[p12l211t1985r457b2035],
6	,	,	O	,	_	0	SENT_301	[p12l211t1985r457b2035],
7	H.	NNP	PERSON	H.	nn	8	SENT_301	[p12l487t1988r535b2029],
8	Yonath	NNP	PERSON	Yonath	appos	5	SENT_301	[p12l562t1985r751b2035],
9	,	,	O	,	_	0	SENT_301	[p12l562t1985r751b2035],
10	D.	NNP	PERSON	D.	nn	11	SENT_301	[p12l780t1988r827b2029],
11	Peleg	NNP	PERSON	Peleg	appos	5	SENT_301	[p12l857t1985r998b2039],
12	,	,	O	,	_	0	SENT_301	[p12l857t1985r998b2039],
13	S.	NNP	PERSON	S.	nn	14	SENT_301	[p12l1028t1987r1064b2029],
14	Almog	NNP	PERSON	Almog	appos	5	SENT_301	[p12l1091t1985r1264b2039],
15	,	,	O	,	_	0	SENT_301	[p12l1091t1985r1264b2039],
16	M.	NNP	PERSON	M.	nn	17	SENT_301	[p12l1293t1988r1352b2029],
17	Rotenberg	NNP	PERSON	Rotenberg	appos	5	SENT_301	[p12l1382t1985r1646b2039],
18	,	,	O	,	_	0	SENT_301	[p12l1382t1985r1646b2039],
19	A.	NNP	PERSON	A.	nn	20	SENT_301	[p12l1674t1987r1720b2029],
20	Lubetsky	NNP	PERSON	Lubetsky	appos	5	SENT_301	[p12l1750t1985r1980b2039],
21	,	,	O	,	_	0	SENT_301	[p12l1750t1985r1980b2039],
22	et	FW	O	et	nn	23	SENT_301	[p12l2010t1991r2056b2029],
23	al.	FW	O	al.	appos	5	SENT_301	[p12l2083t1985r2147b2035],
24	,	,	O	,	_	0	SENT_301	[p12l2083t1985r2147b2035],
25	Interindividual	JJ	O	interindividual	amod	26	SENT_301	[p12l139t2051r506b2095],
26	variability	NN	O	variability	appos	5	SENT_301	[p12l535t2051r785b2106],
27	in	IN	O	in	_	0	SENT_301	[p12l814t2052r859b2094],
28	sensitivity	NN	O	sensitivity	prep_in	26	SENT_301	[p12l889t2052r1142b2106],
29	to	TO	O	to	dep	26	SENT_301	[p12l1169t2058r1216b2095],
30	warfarin	NN	O	warfarin	nn	32	SENT_301	[p12l1244t2051r1499b2095],
31	—	NN	O	—	nn	32	SENT_301	[p12l1244t2051r1499b2095],
32	nature	NN	O	nature	pobj	29	SENT_301	[p12l1530t2058r1689b2095],
33	or	CC	O	or	_	0	SENT_301	[p12l1719t2064r1770b2095],
34	nurture	VB	O	nurture	dep	26	SENT_301	[p12l1797t2053r2012b2095],
35	?	.	O	?	_	0	SENT_301	[p12l1797t2053r2012b2095],

1	Clin	NNP	O	Clin	_	0	SENT_302	[p12l2042t2051r2148b2095],
2	.	.	O	.	_	0	SENT_302	[p12l2042t2051r2148b2095],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_303	[p12l139t2117r411b2161],
2	.	.	O	.	_	0	SENT_303	[p12l139t2117r411b2161],

1	Ther	NNP	O	Ther	_	0	SENT_304	[p12l430t2117r554b2161],
2	.	.	O	.	_	0	SENT_304	[p12l430t2117r554b2161],

1	70	CD	NUMBER	70	_	0	SENT_305	[p12l575t2119r633b2160],
2	(	CD	NUMBER	(	num	3	SENT_305	[p12l657t2117r820b2171],
3	2001	CD	DATE	2001	dep	1	SENT_305	[p12l657t2117r820b2171],
4	)	CD	NUMBER	)	num	5	SENT_305	[p12l657t2117r820b2171],
5	159-164	CD	NUMBER	159-164	dep	3	SENT_305	[p12l846t2119r1070b2161],
6	.	.	O	.	_	0	SENT_305	[p12l846t2119r1070b2161],

1	[	NN	O	[	nn	5	SENT_306	[p12l6t2183r99b2237],
2	18	CD	NUMBER	18	num	5	SENT_306	[p12l6t2183r99b2237],
3	]	CD	NUMBER	]	num	5	SENT_306	[p12l6t2183r99b2237],
4	H.	NNP	PERSON	H.	nn	5	SENT_306	[p12l139t2186r188b2227],
5	Takahashi	NNP	PERSON	Takahashi	_	0	SENT_306	[p12l207t2183r468b2233],
6	,	,	O	,	_	0	SENT_306	[p12l207t2183r468b2233],
7	G.R.	NNP	PERSON	G.R.	nn	8	SENT_306	[p12l490t2185r582b2227],
8	Wilkinson	NNP	PERSON	Wilkinson	appos	5	SENT_306	[p12l601t2183r867b2233],
9	,	,	O	,	_	0	SENT_306	[p12l601t2183r867b2233],
10	Y.	NNP	PERSON	Y.	nn	11	SENT_306	[p12l887t2186r931b2227],
11	Caraco	NNP	PERSON	Caraco	appos	5	SENT_306	[p12l953t2185r1128b2233],
12	,	,	O	,	_	0	SENT_306	[p12l953t2185r1128b2233],
13	M.	NNP	PERSON	M.	nn	14	SENT_306	[p12l1151t2186r1209b2227],
14	Muszkat	NNP	PERSON	Muszkat	appos	5	SENT_306	[p12l1231t2183r1450b2233],
15	,	,	O	,	_	0	SENT_306	[p12l1231t2183r1450b2233],
16	R.B.	NNP	PERSON	R.B.	nn	17	SENT_306	[p12l1473t2186r1559b2227],
17	Kim	NNP	PERSON	Kim	appos	5	SENT_306	[p12l1581t2184r1690b2233],
18	,	,	O	,	_	0	SENT_306	[p12l1581t2184r1690b2233],
19	T.	NNP	PERSON	T.	nn	20	SENT_306	[p12l1710t2186r1751b2227],
20	Kashima	NNP	PERSON	Kashima	appos	5	SENT_306	[p12l1773t2183r1995b2233],
21	,	,	O	,	_	0	SENT_306	[p12l1773t2183r1995b2233],
22	et	FW	O	et	nn	23	SENT_306	[p12l2017t2189r2064b2227],
23	al.	FW	O	al.	appos	5	SENT_306	[p12l2083t2183r2147b2233],
24	,	,	O	,	_	0	SENT_306	[p12l2083t2183r2147b2233],
25	Population	NNP	O	Population	nn	26	SENT_306	[p12l139t2249r405b2303],
26	differences	NNS	O	difference	appos	5	SENT_306	[p12l438t2249r706b2292],
27	in	IN	O	in	_	0	SENT_306	[p12l740t2249r785b2292],
28	S-warfarin	NN	MISC	s-warfarin	nn	29	SENT_306	[p12l818t2248r1078b2292],
29	metabolism	NN	O	metabolism	prep_in	26	SENT_306	[p12l1110t2249r1401b2292],
30	between	IN	O	between	_	0	SENT_306	[p12l1432t2249r1645b2292],
31	CYP2C9	NN	O	cyp2c9	prep_between	5	SENT_306	[p12l1678t2251r1865b2292],
32	genotypematched	VBN	O	genotypematch	partmod	5	SENT_306	[p12l1897t2255r2148b2303, p12l139t2315r342b2359],
33	Caucasian	JJ	MISC	caucasian	amod	36	SENT_306	[p12l359t2316r589b2359],
34	and	CC	O	and	_	0	SENT_306	[p12l605t2315r691b2359],
35	Japanese	JJ	MISC	japanese	amod	36	SENT_306	[p12l702t2318r911b2370],
36	patients	NNS	O	patient	dobj	32	SENT_306	[p12l928t2316r1123b2370],
37	,	,	O	,	_	0	SENT_306	[p12l928t2316r1123b2370],
38	Clin	NNP	PERSON	Clin	appos	36	SENT_306	[p12l1141t2315r1240b2359],
39	.	.	O	.	_	0	SENT_306	[p12l1141t2315r1240b2359],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_307	[p12l1257t2315r1514b2359],
2	.	.	O	.	_	0	SENT_307	[p12l1257t2315r1514b2359],

1	Ther	NNP	O	Ther	_	0	SENT_308	[p12l1529t2315r1646b2359],
2	.	.	O	.	_	0	SENT_308	[p12l1529t2315r1646b2359],

1	73	CD	NUMBER	73	_	0	SENT_309	[p12l1665t2317r1719b2359],
2	(	CD	NUMBER	(	num	3	SENT_309	[p12l1741t2315r1895b2369],
3	2003	CD	DATE	2003	dep	1	SENT_309	[p12l1741t2315r1895b2369],
4	)	CD	NUMBER	)	num	5	SENT_309	[p12l1741t2315r1895b2369],
5	253-263	CD	NUMBER	253-263	dep	3	SENT_309	[p12l1916t2317r2130b2359],
6	.	.	O	.	_	0	SENT_309	[p12l1916t2317r2130b2359],

1	[	NN	O	[	nn	5	SENT_310	[p12l7t2381r99b2436],
2	19	CD	NUMBER	19	num	5	SENT_310	[p12l7t2381r99b2436],
3	]	CD	NUMBER	]	num	5	SENT_310	[p12l7t2381r99b2436],
4	D.	NNP	PERSON	D.	nn	5	SENT_310	[p12l139t2384r186b2425],
5	Williams	NNP	PERSON	Williams	_	0	SENT_310	[p12l204t2381r437b2431],
6	,	,	O	,	_	0	SENT_310	[p12l204t2381r437b2431],
7	J.	NNP	PERSON	J.	nn	8	SENT_310	[p12l451t2384r483b2436],
8	Feely	NNP	PERSON	Feely	appos	5	SENT_310	[p12l504t2381r641b2436],
9	,	,	O	,	_	0	SENT_310	[p12l504t2381r641b2436],
10	Pharmacol	NNP	O	Pharmacol	appos	5	SENT_310	[p12l663t2381r1571b2436],
11	<	JJR	O	<	amod	14	SENT_310	[p12l663t2381r1571b2436],
12	inetic-pharmacodynamic	JJ	O	inetic-pharmacodynamic	amod	14	SENT_310	[p12l663t2381r1571b2436],
13	drug	NN	O	drug	nn	14	SENT_310	[p12l1591t2381r1705b2436],
14	interactions	NNS	O	interaction	dep	5	SENT_310	[p12l1724t2382r2016b2425],
15	with	IN	O	with	prep	14	SENT_310	[p12l2035t2381r2149b2425],

1	HMG-CoA	JJ	O	hmg-coa	amod	3	SENT_311	[p12l139t2449r388b2491],
2	reductase	NN	O	reductase	nn	3	SENT_311	[p12l406t2447r643b2491],
3	inhibitors	NNS	O	inhibitor	_	0	SENT_311	[p12l663t2447r913b2497],
4	,	,	O	,	_	0	SENT_311	[p12l663t2447r913b2497],
5	Clin	NNP	PERSON	Clin	appos	3	SENT_311	[p12l934t2447r1039b2491],
6	.	.	O	.	_	0	SENT_311	[p12l934t2447r1039b2491],

1	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_312	[p12l1060t2447r1443b2491],
2	.	.	O	.	_	0	SENT_312	[p12l1060t2447r1443b2491],

1	41	CD	NUMBER	41	_	0	SENT_313	[p12l1463t2449r1517b2490],
2	(	CD	NUMBER	(	num	3	SENT_313	[p12l1546t2447r1709b2501],
3	2002	CD	DATE	2002	dep	1	SENT_313	[p12l1546t2447r1709b2501],
4	)	CD	NUMBER	)	num	5	SENT_313	[p12l1546t2447r1709b2501],
5	343-370	CD	NUMBER	343-370	dep	3	SENT_313	[p12l1732t2449r1960b2491],
6	.	.	O	.	_	0	SENT_313	[p12l1732t2449r1960b2491],

1	[	RB	O	[	advmod	3	SENT_314	[p12l6t2513r99b2567],
2	20	CD	NUMBER	20	number	3	SENT_314	[p12l6t2513r99b2567],
3	]	CD	NUMBER	]	_	0	SENT_314	[p12l6t2513r99b2567],
4	R.B.	NNP	PERSON	R.B.	nn	5	SENT_314	[p12l139t2516r225b2557],
5	Saraeva	NNP	PERSON	Saraeva	dep	3	SENT_314	[p12l244t2515r439b2563],
6	,	,	O	,	_	0	SENT_314	[p12l244t2515r439b2563],
7	I.D.	NNP	PERSON	I.D.	nn	8	SENT_314	[p12l459t2516r533b2557],
8	Paskaleva	NNP	PERSON	Paskaleva	appos	3	SENT_314	[p12l553t2513r797b2563],
9	,	,	O	,	_	0	SENT_314	[p12l553t2513r797b2563],
10	E.	NNP	PERSON	E.	nn	11	SENT_314	[p12l816t2516r855b2557],
11	Doncheva	NNP	PERSON	Doncheva	appos	8	SENT_314	[p12l874t2513r1123b2563],
12	,	,	O	,	_	0	SENT_314	[p12l874t2513r1123b2563],
13	C.B.	NNP	PERSON	C.B.	nn	14	SENT_314	[p12l1143t2515r1227b2557],
14	Eap	NNP	PERSON	Eap	appos	8	SENT_314	[p12l1246t2516r1344b2567],
15	,	,	O	,	_	0	SENT_314	[p12l1246t2516r1344b2567],
16	V.S.	NNP	PERSON	V.S.	nn	17	SENT_314	[p12l1361t2515r1447b2557],
17	Ganev	NNP	PERSON	Ganev	appos	8	SENT_314	[p12l1466t2515r1628b2563],
18	,	,	O	,	_	0	SENT_314	[p12l1466t2515r1628b2563],
19	Pharmacogenetics	NNP	O	Pharmacogenetics	appos	8	SENT_314	[p12l1648t2513r2085b2567],
20	of	IN	O	of	_	0	SENT_314	[p12l2105t2513r2154b2557],
21	acenocoumarol	NN	O	acenocoumarol	prep_of	19	SENT_314	[p12l139t2579r523b2623],
22	:	:	O	:	_	0	SENT_314	[p12l139t2579r523b2623],
23	CYP2C9	NN	O	cyp2c9	nn	34	SENT_314	[p12l557t2581r753b2629],
24	,	,	O	,	_	0	SENT_314	[p12l557t2581r753b2629],
25	CYP2C19	NN	O	cyp2c19	nn	34	SENT_314	[p12l785t2581r1011b2629],
26	,	,	O	,	_	0	SENT_314	[p12l785t2581r1011b2629],
27	CYP1A2	NN	O	cyp1a2	nn	34	SENT_314	[p12l1044t2581r1242b2629],
28	,	,	O	,	_	0	SENT_314	[p12l1044t2581r1242b2629],
29	CYP3A4	NN	O	cyp3a4	nn	34	SENT_314	[p12l1275t2581r1473b2629],
30	,	,	O	,	_	0	SENT_314	[p12l1275t2581r1473b2629],
31	CYP3A5	NN	O	cyp3a5	nn	34	SENT_314	[p12l1506t2581r1693b2622],
32	and	CC	O	and	_	0	SENT_314	[p12l1726t2579r1813b2622],
33	ABCB1	NN	O	abcb1	nn	34	SENT_314	[p12l1843t2581r1997b2622],
34	gene	NN	O	gene	dep	3	SENT_314	[p12l2034t2591r2149b2633],
35	polymorphisms	NNS	O	polymorphism	dep	34	SENT_314	[p12l139t2645r517b2700],
36	and	CC	O	and	_	0	SENT_314	[p12l535t2645r622b2689],
37	dose	NN	O	dose	nn	38	SENT_314	[p12l640t2645r750b2689],
38	requirements	NNS	O	requirement	dep	3	SENT_314	[p12l768t2646r1146b2700],
39	,	,	O	,	_	0	SENT_314	[p12l768t2646r1146b2700],
40	J.	NNP	PERSON	J.	nn	41	SENT_314	[p12l768t2646r1146b2700],
41	Clin	NNP	PERSON	Clin	appos	38	SENT_314	[p12l1163t2645r1266b2689],
42	.	.	O	.	_	0	SENT_314	[p12l1163t2645r1266b2689],

1	Pharm	NNP	O	Pharm	_	0	SENT_315	[p12l1284t2645r1453b2689],
2	.	.	O	.	_	0	SENT_315	[p12l1284t2645r1453b2689],

1	Ther	NNP	O	Ther	_	0	SENT_316	[p12l1468t2645r1590b2689],
2	.	.	O	.	_	0	SENT_316	[p12l1468t2645r1590b2689],

1	32	CD	NUMBER	32	_	0	SENT_317	[p12l1607t2647r1665b2689],
2	(	CD	NUMBER	(	num	3	SENT_317	[p12l1687t2645r1847b2699],
3	2007	CD	DATE	2007	dep	1	SENT_317	[p12l1687t2645r1847b2699],
4	)	CD	NUMBER	)	num	5	SENT_317	[p12l1687t2645r1847b2699],
5	641-649	CD	NUMBER	641-649	dep	3	SENT_317	[p12l1868t2647r2090b2689],
6	.	.	O	.	_	0	SENT_317	[p12l1868t2647r2090b2689],

1	[	NN	O	[	nn	5	SENT_318	[p12l7t2710r99b2765],
2	21	CD	NUMBER	21	num	5	SENT_318	[p12l7t2710r99b2765],
3	]	CD	NUMBER	]	num	5	SENT_318	[p12l7t2710r99b2765],
4	J.	NNP	PERSON	J.	nn	5	SENT_318	[p12l133t2713r164b2765],
5	Hermida	NNP	PERSON	Hermida	dep	48	SENT_318	[p12l180t2710r442b2765],
6	,	,	O	,	_	0	SENT_318	[p12l180t2710r442b2765],
7	J.	NNP	PERSON	J.	nn	8	SENT_318	[p12l180t2710r442b2765],
8	Zarza	NNP	PERSON	Zarza	appos	5	SENT_318	[p12l456t2713r598b2761],
9	,	,	O	,	_	0	SENT_318	[p12l456t2713r598b2761],
10	I.	NNP	PERSON	I.	nn	11	SENT_318	[p12l614t2713r639b2754],
11	Alberca	NNP	PERSON	Alberca	appos	5	SENT_318	[p12l652t2710r845b2761],
12	,	,	O	,	_	0	SENT_318	[p12l652t2710r845b2761],
13	R.	NNP	PERSON	R.	nn	14	SENT_318	[p12l861t2713r902b2754],
14	Montes	NNP	PERSON	Montes	appos	5	SENT_318	[p12l919t2713r1109b2761],
15	,	,	O	,	_	0	SENT_318	[p12l919t2713r1109b2761],
16	M.L.	NNP	PERSON	M.L.	nn	17	SENT_318	[p12l1125t2713r1221b2754],
17	Lopez	NNP	PERSON	Lopez	appos	5	SENT_318	[p12l1238t2709r1387b2765],
18	,	,	O	,	_	0	SENT_318	[p12l1238t2709r1387b2765],
19	E.	NNP	PERSON	E.	nn	20	SENT_318	[p12l1404t2713r1442b2754],
20	Molina	NNP	PERSON	Molina	appos	5	SENT_318	[p12l1459t2710r1636b2761],
21	,	,	O	,	_	0	SENT_318	[p12l1459t2710r1636b2761],
22	E.	NNP	PERSON	E.	nn	23	SENT_318	[p12l1653t2713r1691b2754],
23	Rocha	NNP	PERSON	Rocha	appos	5	SENT_318	[p12l1707t2710r1863b2761],
24	,	,	O	,	_	0	SENT_318	[p12l1707t2710r1863b2761],
25	Differential	JJ	O	differential	amod	26	SENT_318	[p12l1879t2710r2148b2754],
26	effects	NNS	O	effect	appos	5	SENT_318	[p12l139t2777r301b2821],
27	of	IN	O	of	_	0	SENT_318	[p12l321t2777r373b2821],
28	2C9	NN	O	2c9	prep_of	26	SENT_318	[p12l385t2777r531b2821],
29	*	CD	NUMBER	*	number	30	SENT_318	[p12l385t2777r531b2821],
30	3	CD	NUMBER	3	dep	28	SENT_318	[p12l385t2777r531b2821],
31	and	CC	O	and	_	0	SENT_318	[p12l552t2777r643b2821],
32	2C9	CD	NUMBER	2c9	num	35	SENT_318	[p12l663t2777r809b2821],
33	*	NN	O	*	nn	35	SENT_318	[p12l663t2777r809b2821],
34	2	CD	NUMBER	2	num	35	SENT_318	[p12l663t2777r809b2821],
35	variants	NNS	O	variant	conj_and	28	SENT_318	[p12l828t2778r1032b2821],
36	of	IN	O	of	_	0	SENT_318	[p12l1051t2777r1103b2821],
37	cytochrome	NN	O	cytochrome	nn	39	SENT_318	[p12l1115t2777r1414b2831],
38	P-450	NN	O	p-450	nn	39	SENT_318	[p12l1433t2779r1579b2821],
39	CYP2C9	NN	O	cyp2c9	prep_of	35	SENT_318	[p12l1598t2779r1789b2821],
40	on	IN	O	on	_	0	SENT_318	[p12l1808t2790r1870b2821],
41	sensitivity	NN	O	sensitivity	prep_on	39	SENT_318	[p12l1889t2778r2149b2831],
42	to	TO	O	to	_	0	SENT_318	[p12l139t2850r187b2887],
43	acenocoumarol	NN	O	acenocoumarol	prep_to	41	SENT_318	[p12l206t2843r606b2893],
44	,	,	O	,	_	0	SENT_318	[p12l206t2843r606b2893],
45	Blood	NN	O	blood	appos	5	SENT_318	[p12l625t2843r766b2887],
46	99	CD	NUMBER	99	num	45	SENT_318	[p12l786t2845r845b2887],
47	(	CD	NUMBER	(	num	48	SENT_318	[p12l868t2843r1035b2897],
48	2002	CD	DATE	2002	_	0	SENT_318	[p12l868t2843r1035b2897],
49	)	CD	NUMBER	)	num	50	SENT_318	[p12l868t2843r1035b2897],
50	4237-4239	CD	DURATION	4237-4239	dep	48	SENT_318	[p12l1056t2845r1354b2887],
51	.	.	O	.	_	0	SENT_318	[p12l1056t2845r1354b2887],

1	[	NN	O	[	nn	5	SENT_319	[p12l7t2908r99b2964],
2	22	CD	NUMBER	22	num	5	SENT_319	[p12l7t2908r99b2964],
3	]	CD	NUMBER	]	num	5	SENT_319	[p12l7t2908r99b2964],
4	D.	NNP	O	D.	nn	5	SENT_319	[p12l140t2911r187b2954],
5	Tassies	NNP	O	Tassies	dep	43	SENT_319	[p12l203t2909r388b2960],
6	,	,	O	,	_	0	SENT_319	[p12l203t2909r388b2960],
7	C.	NNP	PERSON	C.	nn	8	SENT_319	[p12l408t2911r448b2954],
8	Freire	NNP	PERSON	Freire	appos	5	SENT_319	[p12l468t2909r620b2960],
9	,	,	O	,	_	0	SENT_319	[p12l468t2909r620b2960],
10	J.	NNP	PERSON	J.	nn	11	SENT_319	[p12l633t2911r665b2964],
11	Pijoan	NNP	PERSON	Pijoan	appos	5	SENT_319	[p12l684t2909r847b2964],
12	,	,	O	,	_	0	SENT_319	[p12l684t2909r847b2964],
13	S.	NNP	PERSON	S.	nn	14	SENT_319	[p12l867t2911r903b2954],
14	Maragall	NNP	PERSON	Maragall	appos	5	SENT_319	[p12l923t2909r1148b2964],
15	,	,	O	,	_	0	SENT_319	[p12l923t2909r1148b2964],
16	J.	NNP	PERSON	J.	nn	17	SENT_319	[p12l1162t2911r1193b2964],
17	Monteagudo	NNP	PERSON	Monteagudo	appos	5	SENT_319	[p12l1212t2909r1536b2964],
18	,	,	O	,	_	0	SENT_319	[p12l1212t2909r1536b2964],
19	A.	NNP	PERSON	A.	nn	20	SENT_319	[p12l1554t2911r1600b2954],
20	Ordinas	NNP	PERSON	Ordinas	appos	5	SENT_319	[p12l1619t2909r1821b2960],
21	,	,	O	,	_	0	SENT_319	[p12l1619t2909r1821b2960],
22	J.C.	NNP	PERSON	J.C.	nn	23	SENT_319	[p12l1835t2911r1911b2964],
23	Reverter	NNP	PERSON	Reverter	appos	5	SENT_319	[p12l1930t2911r2151b2960],
24	,	,	O	,	_	0	SENT_319	[p12l1930t2911r2151b2960],
25	Pharmacogenetics	NNP	O	Pharmacogenetics	appos	5	SENT_319	[p12l140t2976r588b3032],
26	of	IN	O	of	_	0	SENT_319	[p12l614t2976r666b3021],
27	acenocoumarol	NN	O	acenocoumarol	nn	34	SENT_319	[p12l684t2976r1061b3021],
28	cytochrome	NN	O	cytochrome	nn	34	SENT_319	[p12l1087t2976r1379b3032],
29	P450	NN	O	p450	nn	34	SENT_319	[p12l1405t2978r1526b3021],
30	CYP2C9	NN	O	cyp2c9	nn	34	SENT_319	[p12l1551t2978r1739b3021],
31	polymorphisms	NNS	O	polymorphism	nn	34	SENT_319	[p12l1764t2976r2151b3032],
32	inﬂuence	NN	O	inﬂuence	nn	34	SENT_319	[p12l140t3042r372b3087],
33	dose	NN	O	dose	nn	34	SENT_319	[p12l401t3042r515b3087],
34	requirements	NNS	O	requirement	prep_of	25	SENT_319	[p12l544t3043r885b3098],
35	and	CC	O	and	_	0	SENT_319	[p12l913t3042r1005b3087],
36	stability	NN	O	stability	conj_and	25	SENT_319	[p12l1034t3042r1237b3098],
37	of	IN	O	of	_	0	SENT_319	[p12l1265t3042r1317b3087],
38	anticoagulation	NN	O	anticoagulation	prep_of	36	SENT_319	[p12l1339t3042r1745b3098],
39	,	,	O	,	_	0	SENT_319	[p12l1339t3042r1745b3098],
40	Haematologica	NNP	PERSON	Haematologica	appos	5	SENT_319	[p12l1775t3042r2152b3098],
41	87	CD	NUMBER	87	num	40	SENT_319	[p12l140t3112r198b3154],
42	(	CD	NUMBER	(	num	43	SENT_319	[p12l222t3110r389b3164],
43	2002	CD	DATE	2002	_	0	SENT_319	[p12l222t3110r389b3164],
44	)	CD	NUMBER	)	num	45	SENT_319	[p12l222t3110r389b3164],
45	1185-1191	CD	DATE	1185-1191	dep	43	SENT_319	[p12l414t3112r708b3154],
46	.	.	O	.	_	0	SENT_319	[p12l414t3112r708b3154],

1	[	NN	O	[	nn	5	SENT_320	[p12l7t3176r99b3232],
2	23	CD	NUMBER	23	num	5	SENT_320	[p12l7t3176r99b3232],
3	]	NNP	O	]	nn	5	SENT_320	[p12l7t3176r99b3232],
4	L.	NNP	PERSON	L.	nn	5	SENT_320	[p12l140t3179r174b3221],
5	Mark	NNP	PERSON	Mark	_	0	SENT_320	[p12l191t3176r327b3227],
6	,	,	O	,	_	0	SENT_320	[p12l191t3176r327b3227],
7	J.	NNP	O	J.	nn	8	SENT_320	[p12l336t3179r367b3232],
8	Marl	NNP	O	Marl	appos	5	SENT_320	[p12l383t3176r641b3232],
9	<	JJR	O	<	dep	8	SENT_320	[p12l383t3176r641b3232],
10	i	LS	O	i	dep	9	SENT_320	[p12l383t3176r641b3232],
11	.	.	O	.	_	0	SENT_320	[p12l383t3176r641b3232],

1	—	NN	O	—	_	0	SENT_321	[p12l383t3176r641b3232],
2	.	.	O	.	_	0	SENT_321	[p12l383t3176r641b3232],

1	Zay	NNP	O	Zay	_	0	SENT_322	[p12l383t3176r641b3232],
2	,	,	O	,	_	0	SENT_322	[p12l383t3176r641b3232],
3	G.	NNP	PERSON	G.	nn	4	SENT_322	[p12l657t3178r703b3221],
4	Paragh	NNP	PERSON	Paragh	appos	1	SENT_322	[p12l720t3176r895b3232],
5	,	,	O	,	_	0	SENT_322	[p12l720t3176r895b3232],
6	A.	NNP	PERSON	A.	nn	7	SENT_322	[p12l908t3178r954b3221],
7	Katona	NNP	PERSON	Katona	appos	1	SENT_322	[p12l970t3179r1148b3227],
8	,	,	O	,	_	0	SENT_322	[p12l970t3179r1148b3227],
9	Retrospective	JJ	O	retrospective	amod	10	SENT_322	[p12l1165t3177r1491b3232],
10	analyses	NNS	O	analysis	appos	1	SENT_322	[p12l1506t3176r1708b3232],
11	of	IN	O	of	_	0	SENT_322	[p12l1723t3176r1775b3221],
12	acenocoumarol	NN	O	acenocoumarol	nn	13	SENT_322	[p12l1783t3176r2152b3221],
13	doses	NNS	O	dose	prep_of	10	SENT_322	[p12l140t3243r272b3286],
14	and	CC	O	and	_	0	SENT_322	[p12l290t3243r377b3286],
15	bleeding	VBG	O	bleed	amod	16	SENT_322	[p12l394t3243r604b3297],
16	complications	NNS	O	complication	appos	1	SENT_322	[p12l619t3243r954b3297],
17	in	IN	O	in	_	0	SENT_322	[p12l971t3244r1017b3286],
18	patients	NNS	O	patient	prep_in	16	SENT_322	[p12l1033t3244r1225b3297],
19	with	IN	O	with	_	0	SENT_322	[p12l1242t3243r1353b3286],
20	wild	JJ	O	wild	amod	21	SENT_322	[p12l1369t3243r1475b3286],
21	type	NN	O	type	prep_with	18	SENT_322	[p12l1492t3249r1597b3297],
22	or	CC	O	or	_	0	SENT_322	[p12l1615t3255r1666b3286],
23	variant	JJ	O	variant	amod	27	SENT_322	[p12l1679t3244r1850b3286],
24	cytochrome	NN	O	cytochrome	nn	27	SENT_322	[p12l1866t3243r2151b3297],
25	P450	NN	O	p450	nn	27	SENT_322	[p12l140t3311r263b3353],
26	CYP2C9	NN	O	cyp2c9	nn	27	SENT_322	[p12l282t3311r474b3353],
27	alleles	NNS	O	allele	prep_in	16	SENT_322	[p12l493t3309r663b3359],
28	,	,	O	,	_	0	SENT_322	[p12l493t3309r663b3359],
29	Thromb	NNP	O	Thromb	appos	27	SENT_322	[p12l681t3309r894b3353],
30	.	.	O	.	_	0	SENT_322	[p12l681t3309r894b3353],

1	Haemost	NNP	O	Haemost	_	0	SENT_323	[p12l914t3312r1148b3353],
2	.	.	O	.	_	0	SENT_323	[p12l914t3312r1148b3353],

1	93	CD	NUMBER	93	_	0	SENT_324	[p12l1169t3311r1226b3353],
2	(	CD	NUMBER	(	num	3	SENT_324	[p12l1250t3309r1418b3363],
3	2005	CD	DATE	2005	dep	1	SENT_324	[p12l1250t3309r1418b3363],
4	)	CD	NUMBER	)	num	5	SENT_324	[p12l1250t3309r1418b3363],
5	396-397	CD	NUMBER	396-397	dep	3	SENT_324	[p12l1440t3311r1674b3353],
6	.	.	O	.	_	0	SENT_324	[p12l1440t3311r1674b3353],

1	[	NN	O	[	nn	5	SENT_325	[p12l7t3374r99b3430],
2	24	CD	NUMBER	24	num	5	SENT_325	[p12l7t3374r99b3430],
3	]	CD	NUMBER	]	num	5	SENT_325	[p12l7t3374r99b3430],
4	H.H.	NNP	PERSON	H.H.	nn	5	SENT_325	[p12l140t3377r241b3420],
5	Thijssen	NNP	PERSON	Thijssen	_	0	SENT_325	[p12l257t3375r472b3430],
6	,	,	O	,	_	0	SENT_325	[p12l257t3375r472b3430],
7	l.W.	NNP	PERSON	l.W.	nn	8	SENT_325	[p12l489t3377r583b3420],
8	Verkooijen	NNP	PERSON	Verkooijen	appos	5	SENT_325	[p12l598t3375r881b3430],
9	,	,	O	,	_	0	SENT_325	[p12l598t3375r881b3430],
10	H.L.	NNP	PERSON	H.L.	nn	11	SENT_325	[p12l899t3377r986b3420],
11	Frank	NNP	PERSON	Frank	appos	5	SENT_325	[p12l1004t3375r1152b3426],
12	,	,	O	,	_	0	SENT_325	[p12l1004t3375r1152b3426],
13	The	DT	O	the	det	14	SENT_325	[p12l1168t3375r1258b3419],
14	possession	NN	O	possession	nsubjpass	22	SENT_325	[p12l1275t3375r1538b3430],
15	of	IN	O	of	_	0	SENT_325	[p12l1555t3375r1606b3419],
16	the	DT	O	the	det	20	SENT_325	[p12l1615t3375r1694b3419],
17	CYP2C9	NN	O	cyp2c9	nn	20	SENT_325	[p12l1711t3374r1951b3419],
18	*	NN	O	*	nn	20	SENT_325	[p12l1711t3374r1951b3419],
19	3	CD	NUMBER	3	num	20	SENT_325	[p12l1711t3374r1951b3419],
20	allele	NN	O	allele	prep_of	14	SENT_325	[p12l1970t3375r2099b3419],
21	is	VBZ	O	be	auxpass	22	SENT_325	[p12l2116t3375r2151b3419],
22	associated	VBN	O	associate	dep	5	SENT_325	[p12l139t3442r392b3487],
23	with	IN	O	with	_	0	SENT_325	[p12l419t3442r533b3487],
24	low	JJ	O	low	amod	26	SENT_325	[p12l561t3442r652b3487],
25	dose	NN	O	dose	nn	26	SENT_325	[p12l678t3442r790b3487],
26	requirement	NN	O	requirement	prep_with	22	SENT_325	[p12l818t3443r1129b3498],
27	of	IN	O	of	_	0	SENT_325	[p12l1155t3442r1207b3487],
28	acenocoumarol	NN	O	acenocoumarol	prep_of	26	SENT_325	[p12l1228t3442r1618b3493],
29	,	,	O	,	_	0	SENT_325	[p12l1228t3442r1618b3493],
30	Pharmacogenetics	NNP	O	Pharmacogenetics	appos	5	SENT_325	[p12l1647t3442r2096b3498],
31	9	CD	NUMBER	9	num	30	SENT_325	[p12l2124t3445r2151b3487],
32	(	CD	NUMBER	(	num	33	SENT_325	[p12l143t3509r306b3563],
33	2000	CD	DATE	2000	dep	30	SENT_325	[p12l143t3509r306b3563],
34	)	CD	NUMBER	)	num	35	SENT_325	[p12l143t3509r306b3563],
35	71-80	CD	NUMBER	71-80	dep	30	SENT_325	[p12l331t3511r494b3553],
36	.	.	O	.	_	0	SENT_325	[p12l331t3511r494b3553],

1	[	NN	O	[	nn	5	SENT_326	[p12l7t3575r99b3629],
2	25	CD	NUMBER	25	num	5	SENT_326	[p12l7t3575r99b3629],
3	]	CD	NUMBER	]	num	5	SENT_326	[p12l7t3575r99b3629],
4	T.	NNP	PERSON	T.	nn	5	SENT_326	[p12l137t3578r177b3619],
5	Mushiroda	NNP	PERSON	Mushiroda	_	0	SENT_326	[p12l194t3575r465b3625],
6	,	,	O	,	_	0	SENT_326	[p12l194t3575r465b3625],
7	Y.	NNP	PERSON	Y.	nn	8	SENT_326	[p12l479t3578r523b3619],
8	Ohnishi	NNP	PERSON	Ohnishi	appos	5	SENT_326	[p12l539t3575r736b3625],
9	,	,	O	,	_	0	SENT_326	[p12l539t3575r736b3625],
10	S.	NNP	PERSON	S.	nn	11	SENT_326	[p12l752t3577r789b3619],
11	Saito	NNP	PERSON	Saito	appos	8	SENT_326	[p12l806t3576r933b3625],
12	,	,	O	,	_	0	SENT_326	[p12l806t3576r933b3625],
13	A.	NNP	PERSON	A.	nn	14	SENT_326	[p12l948t3577r993b3619],
14	Takahashi	NNP	PERSON	Takahashi	appos	8	SENT_326	[p12l1007t3575r1261b3625],
15	,	,	O	,	_	0	SENT_326	[p12l1007t3575r1261b3625],
16	Y.	NNP	PERSON	Y.	nn	17	SENT_326	[p12l1276t3578r1319b3619],
17	Kikuchi	NNP	PERSON	Kikuchi	appos	8	SENT_326	[p12l1335t3575r1527b3625],
18	,	,	O	,	_	0	SENT_326	[p12l1335t3575r1527b3625],
19	S.	NNP	PERSON	S.	nn	20	SENT_326	[p12l1543t3577r1580b3619],
20	Saito	NNP	PERSON	Saito	appos	8	SENT_326	[p12l1596t3576r1724b3625],
21	,	,	O	,	_	0	SENT_326	[p12l1596t3576r1724b3625],
22	et	FW	O	et	nn	23	SENT_326	[p12l1740t3581r1787b3618],
23	al.	FW	O	al.	appos	8	SENT_326	[p12l1800t3575r1863b3625],
24	,	,	O	,	_	0	SENT_326	[p12l1800t3575r1863b3625],
25	Association	NNP	O	Association	appos	8	SENT_326	[p12l1877t3576r2152b3618],
26	of	IN	O	of	_	0	SENT_326	[p12l140t3641r191b3685],
27	VKORC1	NN	O	vkorc1	nn	30	SENT_326	[p12l217t3643r414b3685],
28	and	CC	O	and	_	0	SENT_326	[p12l455t3641r543b3685],
29	CYP2C9	NN	O	cyp2c9	nn	30	SENT_326	[p12l580t3643r764b3685],
30	polymorphisms	NNS	O	polymorphism	prep_of	25	SENT_326	[p12l800t3641r1178b3695],
31	with	IN	O	with	_	0	SENT_326	[p12l1213t3641r1324b3685],
32	warfarin	NN	O	warfarin	nn	34	SENT_326	[p12l1359t3641r1565b3685],
33	dose	NN	O	dose	nn	34	SENT_326	[p12l1601t3641r1710b3685],
34	requirements	NNS	O	requirement	prep_with	30	SENT_326	[p12l1747t3642r2071b3695],
35	in	IN	O	in	_	0	SENT_326	[p12l2108t3642r2153b3684],
36	Japanese	JJ	MISC	japanese	amod	37	SENT_326	[p12l133t3709r349b3761],
37	patients	NNS	O	patient	prep_in	34	SENT_326	[p12l367t3707r571b3761],
38	,	,	O	,	_	0	SENT_326	[p12l367t3707r571b3761],
39	J.	NNP	O	J.	nn	40	SENT_326	[p12l583t3709r614b3761],
40	Hum	NNP	O	Hum	appos	8	SENT_326	[p12l632t3709r760b3751],
41	.	.	O	.	_	0	SENT_326	[p12l632t3709r760b3751],

1	Genet	NNP	PERSON	Genet	_	0	SENT_327	[p12l779t3709r931b3751],
2	.	.	O	.	_	0	SENT_327	[p12l779t3709r931b3751],

1	51	CD	NUMBER	51	_	0	SENT_328	[p12l950t3709r1002b3750],
2	(	CD	NUMBER	(	num	3	SENT_328	[p12l1028t3707r1189b3761],
3	2006	CD	DATE	2006	dep	1	SENT_328	[p12l1028t3707r1189b3761],
4	)	CD	NUMBER	)	num	5	SENT_328	[p12l1028t3707r1189b3761],
5	249-253	CD	NUMBER	249-253	dep	3	SENT_328	[p12l1209t3709r1432b3751],
6	.	.	O	.	_	0	SENT_328	[p12l1209t3709r1432b3751],

1	[	NN	O	[	nn	5	SENT_329	[p12l7t3773r99b3829],
2	26	CD	NUMBER	26	num	5	SENT_329	[p12l7t3773r99b3829],
3	]	CD	NUMBER	]	num	5	SENT_329	[p12l7t3773r99b3829],
4	J.	NNP	PERSON	J.	nn	5	SENT_329	[p12l133t3776r165b3829],
5	Skov	NNP	PERSON	Skov	_	0	SENT_329	[p12l192t3773r319b3824],
6	,	,	O	,	_	0	SENT_329	[p12l192t3773r319b3824],
7	E.M.	NNP	PERSON	E.M.	nn	8	SENT_329	[p12l346t3776r448b3818],
8	Bladbjerg	NNP	PERSON	Bladbjerg	dep	5	SENT_329	[p12l476t3773r720b3829],
9	,	,	O	,	_	0	SENT_329	[p12l476t3773r720b3829],
10	M.A.	NNP	PERSON	M.A.	nn	11	SENT_329	[p12l748t3775r855b3818],
11	Rasmussen	NNP	PERSON	Rasmussen	appos	8	SENT_329	[p12l883t3776r1168b3824],
12	,	,	O	,	_	0	SENT_329	[p12l883t3776r1168b3824],
13	J.J.	NNP	PERSON	J.J.	nn	14	SENT_329	[p12l1189t3776r1249b3829],
14	Sidelmann	NNP	PERSON	Sidelmann	appos	8	SENT_329	[p12l1277t3773r1550b3824],
15	,	,	O	,	_	0	SENT_329	[p12l1277t3773r1550b3824],
16	A.	NNP	PERSON	A.	nn	17	SENT_329	[p12l1575t3775r1622b3818],
17	Leppin	NNP	PERSON	Leppin	appos	8	SENT_329	[p12l1649t3774r1826b3829],
18	,	,	O	,	_	0	SENT_329	[p12l1649t3774r1826b3829],
19	J.	NNP	PERSON	J.	nn	20	SENT_329	[p12l1847t3776r1878b3829],
20	Jespersen	NNP	PERSON	Jespersen	appos	8	SENT_329	[p12l1899t3776r2151b3829],
21	,	,	O	,	_	0	SENT_329	[p12l1899t3776r2151b3829],

1	Genetic	JJ	O	genetic	nsubj	12	SENT_330	[p13l140t15r337b66],
2	,	,	O	,	_	0	SENT_330	[p13l140t15r337b66],
3	clinical	JJ	O	clinical	amod	6	SENT_330	[p13l363t14r535b59],
4	and	CC	O	and	_	0	SENT_330	[p13l560t14r650b59],
5	behavioural	JJ	O	behavioural	conj_and	3	SENT_330	[p13l675t14r967b59],
6	determinants	NNS	O	determinant	appos	1	SENT_330	[p13l992t14r1323b59],
7	of	IN	O	of	_	0	SENT_330	[p13l1349t14r1401b59],
8	vitamin	NN	O	vitamin	nn	11	SENT_330	[p13l1417t15r1608b59],
9	K-antagonist	JJ	MISC	k-antagonist	amod	11	SENT_330	[p13l1634t15r1950b70],
10	dose	NN	O	dose	nn	11	SENT_330	[p13l1974t14r2085b59],
11	—	NN	O	—	prep_of	6	SENT_330	[p13l2112t41r2151b45],
12	explored	VBN	O	explore	_	0	SENT_330	[p13l140t82r352b136],
13	through	IN	O	through	_	0	SENT_330	[p13l370t82r564b136],
14	multivariable	JJ	O	multivariable	amod	15	SENT_330	[p13l583t82r903b126],
15	modelling	NN	O	modelling	prep_through	12	SENT_330	[p13l923t82r1167b136],
16	and	CC	O	and	_	0	SENT_330	[p13l1183t82r1271b126],
17	visualization	NN	O	visualization	prep_through	12	SENT_330	[p13l1290t82r1606b132],
18	,	,	O	,	_	0	SENT_330	[p13l1290t82r1606b132],
19	Basic	JJ	PERSON	basic	amod	20	SENT_330	[p13l1625t83r1745b126],
20	Clin	NN	PERSON	clin	appos	15	SENT_330	[p13l1763t82r1866b126],
21	.	.	O	.	_	0	SENT_330	[p13l1763t82r1866b126],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_331	[p13l1885t82r2152b126],
2	.	.	O	.	_	0	SENT_331	[p13l1885t82r2152b126],

1	Toxicol	NNP	O	Toxicol	_	0	SENT_332	[p13l137t148r322b192],
2	.	.	O	.	_	0	SENT_332	[p13l137t148r322b192],

1	110	CD	NUMBER	110	number	2	SENT_333	[p13l343t150r429b192],
2	(	CD	NUMBER	(	num	3	SENT_333	[p13l450t148r610b202],
3	2012	CD	DATE	2012	_	0	SENT_333	[p13l450t148r610b202],
4	)	CD	NUMBER	)	dep	3	SENT_333	[p13l450t148r610b202],
5	193-198	CD	NUMBER	193-198	dep	4	SENT_333	[p13l633t150r852b192],
6	.	.	O	.	_	0	SENT_333	[p13l633t150r852b192],

